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Spinal cord injury leads to an increased response of innate immune cells (microglia, 
macrophages, neutrophils) in non-regenerating mammals and in successfully 
regenerating zebrafish. Here I characterize the axonal regrowth of the severed axons 
after complete spinal cord transection and define the role of the innate immune 
reaction in successful spinal cord regeneration in larval zebrafish.  
I found that axons start to regenerate at 18 hours post injury and by 48 hours 80% of 
the injured larvae show axonal growth across the injury site. The use of reporter lines 
to visualize the neuronal and glial elements of the spinal cord combined with 
immunostaining and live imaging allowed me to find that the axons and the glial 
processes are able to regenerate independently, following different kinetics. 
Inhibiting inflammation reduces and promoting it accelerates axon regrowth. Mutant 
analysis shows that peripheral macrophages, but not neutrophils or microglia, are 
crucial for axonal regeneration and functional recovery. Macrophage-deficient irf8 
mutants, characterized also by increased numbers of neutrophils, fail to down-
regulate pro-inflammatory cytokines TNF-α and Il-1β and to up-regulate anti-
inflammatory cytokines, indicating prolonged inflammation.  
Because sustained inflammation is considered to be detrimental to regeneration in 
mammals, I determined the role of increased expression of TNF-α and IIl-1β in axonal 
regeneration. Inhibition of TNF-α does not rescue the mutant but impairs axonal 
growth in wildtype larvae. Furthermore, CRISPR/Cas9-mediated disruption of TNF-α 
led to increased expression of the pro-inflammatory cytokine Il-1β. Taken together 
these findings indicate an unexpected pro-regenerative and anti-inflammatory role 
of TNF-α.  
In contrast, inhibition of Il-1β using pharmacological and genetic approaches rescues 
axonal regeneration and functional recovery in irf8 mutants, indicating that Il-1β is a 
major determinant during successful spinal cord regeneration. In order to determine 
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the relative importance of the neutrophils for the regenerative failure in irf8 mutants, 
we used morpholino injections to reduce their numbers. The treatment prevented 
the formation of the neutrophils and decreased the expression levels of Il-1β, 
indicating that neutrophils act as a source for Il-1β in the irf8 mutants.  In wildtype 
animals, early, but not late axon regrowth is attenuated by Il-1β inhibition, indicating 
dynamic changes in Il-1β function during regeneration. 
However, the regenerative potential of adult and larval zebrafish is not restricted only 
to their ability to re-grow severed axons, since they can make lost neurons as well 
after injury. In order to assess the role of the innate immune response during 
neuronal regeneration, I used dexamethasone to inhibit the inflammation that occurs 
after injury. I found that the treatment leads to a decreased number of new-born 
motor neurons in the injury site, indicating the importance of the inflammatory 
response for axonal, as well as, neuronal regeneration of the spinal cord after injury. 
Furthermore, I used the macrophage deficient irf8 mutants in order to assess how 
lost motor neurons are regenerated in an environment with no 
macrophages/microglia. I found that motor neurons fail to regenerate properly after 
injury in the mutants, indicating the importance of macrophages/microglia, during 
neuronal regeneration. 
Taken together, these results demonstrate the complex inflammatory response that 
occurs after spinal cord injury and provide insight into the role of macrophages that 
tightly control it, by expressing TNF-α and preventing prolonged expression of Il-1β, 






Mammals are unable to regenerate their injured nervous system after injury, leading 
to permanent behavioural deficits. In contrast to mammals, zebrafish larvae and 
adults exhibit regenerative capacity of their nervous system after injury. Their 
nervous system shares similarities with the mammalian. This feature  combined with 
their regenerative potential, make it an ideal model for studying the regenerative 
events that occur after injury and the contribution of the inflammatory response to 
this process. The immune system is a complex part of each organism. It consists of a 
variety of specialised cells that defend our body against pathogens and produce 
inflammatory signals (like Il-1β and TNF-α) to do so.  
Because of its complexity and the limited capacity for regeneration that characterizes 
the mammalian nervous system, it is very difficult to accurately assess the role of the 
immune reaction after an injury. For this reason, I used the larval zebrafish model.  
They exhibit a high regenerative capacity and their immune system shares common 
cellular and molecular processes with the one in mammals . Furthermore, the larval 
model allowed me to focus my analysis on each individual immune cell type and 
assess its role during regeneration independently of the other cell populations during 
the regeneration of the injured nervous system. This is because there are suitable 
tools, like different animal lines where the different cell populations are tagged with 
different colours or are manipulated using genetic techniques, and their response can 
be monitored live. Furthermore, their innate and adaptive immunity mature during 
different stages of development allowing their clear separation during the analysis. 
Here I characterized the immune response that occurs after spinal cord injury in 
zebrafish larvae, with a special focus on the role of three main immune cell types 
which are the macrophages, the neutrophils and the microglial cells. The hypothesis 
was that each cell type is important for functional spinal cord regeneration. In order 
to test this hypothesis, I used a variety of tools. The first thing to do was to perform 
spinal cord injuries and then characterize the cellular and molecular immune 
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response that occurs, which showed that neutrophils are the first cells that respond 
and accumulate in the injury site initiating the inflammatory response, whereas the 
other cell populations including macrophages and microglia respond much later. In 
addition, I assessed the levels of molecules produced by the immune cells during the 
same time points that were used for the analysis of the cellular response after injury.  
Next, after the injury, I manipulated the immune system with genetic and 
pharmacological approaches to highlight the importance of each cell type during 
regeneration of the injured spinal cord. In order to assess regeneration, I used the 
ability of the axons to cross the injury site within 24 and 48 hours post injury and 
quantified the number of animals that showed axonal continuity during these time 
points. 
I found that inhibiting inflammation reduces and promoting it accelerates 
regeneration after injury. Furthermore, I show that macrophages are the most 
important immune cell population that contribute to successful axonal regeneration 
and functional recovery after injury by reducing the levels of inflammation by 
regulating the levels of the inflammatory and anti-inflammatory proteins. My results 
highlighted two immune molecules that appear to have differential roles during 
regeneration, TNF-α and Il-1β. TNF-α has a pro-regenerative role whereas Il-1β 
appears to be detrimental for regeneration. 
Taken together, these results show the importance of the inflammatory response 
during the regenerative events after injury of the nervous system. Also, they 
demonstrate the different roles of each immune cell type suggesting that the 
knowledge obtained might contribute to the development of therapeutic strategies 
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 Chapter 1: General Introduction 
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1.1 Nervous system regeneration  
 
The nervous system is a complex organization of nerves and neurons that are 
responsible for the transmission of information between different parts of the body. 
Structurally, it is divided into two components: the central nervous system (CNS) and 
the peripheral nervous system (PNS). Their function is to relay signals from and to all 
other parts of the body. This is achieved through a complex network of neurons and 
supporting glial cells. An injury can cause axons to be partially or completely severed, 
crushed, compressed, or stretched. When an axon is severed, its distal part 
undergoes Wallerian degeneration. The injury also induces responses of glial cells, 
including oligodendrocytes, astrocytes, and microglia in the CNS, Schwann cells (SCs) 
in the PNS, and blood-derived macrophages and neutrophils. The responses of these 
cells cover a broad spectrum of events including cell death, proliferation, migration, 
and production of inflammatory mediators and growth factors, thus influencing 
processes of axonal degeneration and regeneration. Regeneration of the nervous 
system can be divided into two aspects: the neuronal regeneration which includes 
the replacement of lost neurons and glia, and the axonal regeneration which includes 
the regrowth of neuronal and/or glial processes. Neural regeneration differs between 
the PNS and the CNS due to the different environments that the regenerating axons 
and cells encounter. 
The PNS consists of motor neuron axons and sensory axons, which originate from the 
CNS and innervate tissues and send signals to sensory neurons, which reside in 
ganglia and transmit information to the CNS. After injury, when a peripheral axon is 
severed, the tip of the proximal segment develops a growth cone, which then 
navigates through its environment following growth signals derived from its target 
cells and extends toward them (Hu et al. 2010). 
On the other side of the spectrum, injured CNS neurons fail to regenerate their 
severed axons across the injury site. It has been shown that there are phylogenetic 
differences in the regeneration capacity of various species (Zhang et al. 2012).  
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Whereas axons in the CNS of mammals do not regenerate, those in many other 
vertebrates  such as, zebrafish (Becker et al. 1997, Becker and Becker 2014, Wehner 
et al. 2017), salamander (McHedlishvili et al. 2012) and newts (Oudkhir et al. 1992) 
can regenerate after injury. However, young mammals are also capable of substantial 
CNS neural regeneration (Terman et al. 2000) indicating that the lack of CNS 
regeneration in warm-blooded vertebrates may be due to evolutionary changes. In 
order to explain this difference across vertebrates, the neuron’s intrinsic growth state 
(Kumamaru et al. 2018), the glial (Cregg et al. 2014, Liddelow and Barres 2016) and 
fibrotic scar (Soderblom et al. 2013, Fernandez-Klett and Priller 2014),  myelin 
inhibitors (Filbin 2003, McKerracher and Rosen 2015), and invading cells from the 
periphery have been studied regarding their role in CNS regeneration. 
 The severity of CNS injuries has been described many centuries ago. Very 
characteristic is the following statement which was written on an ancient papyrus: “A 
medical condition that cannot be healed”. This is how the spinal injuries have been 
described in the Edwin Smith papyrus, the oldest known surviving trauma text in 
history, dating from the seventeenth century B.C. (Moore 2011). Although 
therapeutic and research techniques have advanced considerably over the years, 
spinal cord injury (SCI) remains a devastating condition that leads to permanent 
deficits and functional impairment affecting millions of people worldwide (Anand and 
Mondal 2018). 
The reason for these long-term impairments is the inability of the CNS to repair itself 
compared to other tissues of the human body where injuries are usually resolved 
within a few days. The main reason for this inability is the complex environment after 
the injury. SCI leads to cascade of events which include infiltration of immune cells to 
the injury site (Kasinathan et al. 2015), axonal transection, neuronal death (Ahuja et 
al. 2017) and the formation of a glial scar (Yuan and He 2013) and fibrotic scar 
(Kawano et al. 2012). Furthermore, there are inhibitory factors present like 
components of the extracellular matrix (ECM) that prevent the anatomical and 




















Figure 1.1. Pathophysiology of SCI showing the different events that occur after 
spinal cord injury (adapted from (Mothe and Tator 2013)). 
In many neurodegenerative disorders specific cell populations die, leading to specific 
deficits. For example, in Multiple Sclerosis (MS) there is loss of myelin (Love 2006), in 
Spinal Muscular Atrophy (SMA) where there is degeneration of motor neurons (Tu et 
al. 2017) and in Parkinson’s disease there is loss of dopaminergic neurons (Naoi and 
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Maruyama 1999). Similarly to the rest of the CNS, the mammalian spinal cord is 
characterized by the inability to replace the lost neurons (Hilton and Bradke 2017) 
and to re-establish functional connections of the severed axons (Hilton and Bradke 
2017). Like in all mammals, the regenerative capacity of the human CNS is low. 
However, previous studies have shown that although the mammalian CNS axons are 
not able to regenerate after an injury, they still possess an intrinsic capacity for axonal 
growth when given a permissive environment as shown by previous in vivo studies. 
More specifically, (Richardson et al. 1980) using adult rats, showed that CNS neurons 
can regenerate axons into peripheral nerve segments transplanted into the 
transected spinal cord when a 5-mm segment of the midthoracic spinal cord was 
removed and an autologous sciatic nerve graft was inserted sub-pially between 
rostral and caudal spinal cord stumps. Additionally, David and Aguayo demonstrated 
that after SCI the severed axons of adult rats exhibit regenerative capacity when the glial 
environment is replaced by peripheral nerve bridges (David and Aguayo 1981). These 
pioneering studies changed the thinking in the field, providing evidence that 
mammalian CNS exhibits regenerative potential after injury. Work from (Canty et al. 
2013) showed that depending on cell type some axons can exhibit spontaneous 
growth and at speed  comparable to peripheral nerve regeneration. Although never 
reconnecting to the original targets, axons consistently form new boutons at 
comparable prelesion synaptic densities, implying the existence of intrinsic 
homeostatic programmes, which regulate synaptic numbers on regenerating axons. 
CNS axons can be guided using the peripheral nerve graft towards their target, but 
they are not able to extend beyond the distal part of the graft due to of the inhibitory 
environment at the site of SCI (Côté et al. 2011). In order to overcome this, several 
studies have used PNS grafts combined with digestion of the chondroitin sulphate 
proteoglycans that are associated with a glial scar, which showed promising results 
in acute SCI models (Côté et al. 2011).  Based on this observation, that the mammalian 
neurons under specific conditions are able to extend axonal processes, it is important 
to study and understand the principles that control regeneration in other species that 
exhibit high regenerative potential in the CNS.  
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1.2 Overview of the immune system 
 
In all CNS insults across the literature, inflammation is always mentioned among 
others as one of the key regulators of the degenerative and/or regenerative events 
that occur. Inflammation is the orchestrated response of the immune system after an 
infection or injury. In other words, our body’s defence mechanism against diseases 
and pathogens. It is highly adaptable to defend our body against the wide spectrum 
of invaders that can be found in the environment that surrounds us. It can be divided 
into the innate and the adaptive immune system (Chaplin 2010).  These two systems 
work together to protect the body against foreign invaders.  
The innate immune response includes built-in molecular and cellular mechanisms 
that aim at preventing infection or quickly eliminating common invaders after injury. 
This includes physical (Gallo and Nizet 2008) and chemical (Gallo and Nizet 2008) 
barriers to infection, as well as receptors recognizing common chemical structures of 
many pathogens (Thompson et al. 2011) . Innate immunity also includes a plethora 
of proteins that bind common pathogen associated structures and initiate a cascade 
of events. This highly effective first line of defence eliminates infectious agents within 
hours.  
A second form of immunity, known as adaptive immunity, is much more specialised 
to subtle molecular differences. This part of the system, relies on B and T lymphocytes 
(Vitetta et al. 1991), takes longer to occur, but is much more antigen specific. 
Adaptive immunity is slower because fewer cells possess the perfect receptor that is 
antigen specific. Activation of the adaptive immune response is a multistep process. 
The number of epitopes which the T-cells and B-cells must recognize is extremely 
high. 
When an antigen enters the body, a B or T cell with specificity for this particular 
antigen has to encounter it while the cells circulate via blood and lymph. This process 
takes time, occurring in scale of hours (Valitutti et al. 2010). Furthermore, T cell cells 
require considerable amount of time after the antigen has been presented by the 
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antigen presenting cells (APCs). After antigen encounter, T and B lymphocytes 
undergo selection and proliferation (Pennock et al. 2013, Hoffman et al. 2016). Once 
these cells have been selected, they can typically resolve the infection. The adaptive 
immune response evolves in real time in response to injury or infection and adapts 
to better recognize, eliminate, and remember the invading pathogen.  
Although for simplicity the immune system is typically divided into these two kinds 
of the response, there is considerable communication of the cells and mechanisms 
involved in each of these two systems (Clark and Kupper 2005). This communication 
is achieved by both cell-cell contact and by soluble messengers. Most of these soluble 
proteins are molecules known as cytokines (Ito et al. 2013). Cytokines and cell surface 
ligands can bind to receptors found on responding cells and signal these cells to 
initiate functions, such as synthesis of other soluble factors or differentiation (Zhang 
and An 2007). A subset of these soluble signals is called chemokines because of their 
chemotactic activity.   
In contrast to the adaptive immune response, which takes days to occur, the cellular 
innate immune responses after an injury or infection are rapid, typically beginning 
within minutes. These responses are triggered by cell surface or intracellular 
receptors that recognize conserved molecular components of pathogens (Colaco and 
Moita 2016) and molecules produced by injured tissues cells like Adenosine 
triphosphate ATP and other danger signals (Rock and Kono 2008). During this 
macrophages and neutrophils are activated to rapidly engulf and destroy 
extracellular microbes through the process of phagocytosis (Schnyder and Baggiolini 
1978). Other receptors initiate the production of proteins and other substances that 
have a variety of beneficial effects, including the recruitment of cells, and 
accumulation of molecules to sites of infection. Such local innate responses usually 
are essential for eliminating pathogens and damaged or dead cells and promoting 
healing (MacLeod and Mansbridge 2016). For example, increased levels of 
antimicrobial substances and phagocytic cells help to eliminate the pathogens, and 
dendritic cells take up pathogens for presentation to lymphocytes, activating 
adaptive immune responses (den Haan et al. 2014). However, in some situations 
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these innate inflammatory responses can be harmful, leading to local or systemic 
consequences that can cause chronic inflammation and tissue damage (Xiao 2017, 
Chen et al. 2018).  
Macrophages, neutrophils, and dendritic cells in tissues and monocytes in the blood 
are the main cell types that carry out phagocytosis (Silva and Correia-Neves 2012). 
Élie Metchnikoff initially described the process of phagocytosis in the 1880s using 
cells from starfish similar to vertebrate white blood cells (Metchnikoff 1892). 
Phagocytes express on their surfaces a variety of receptors, some of which directly 
recognize specific conserved molecular components on the surfaces of microbes, 
such as cell wall components of bacteria and fungi. These conserved motifs are called 
pathogen-associated molecular patterns (PAMPs) (Emlet et al. 2019). The receptors 
that recognize PAMPs are called pattern recognition receptors (PRRs) (Emlet et al. 
2019). Most PAMPs that induce phagocytosis are cell wall components, including 
complex carbohydrates, lipopolysaccharides (LPS), other lipid-containing molecules, 
peptidoglycans, and surface proteins (Mogensen 2009).  
The binding of microbes to phagocytes via pattern recognition receptors activates 
signaling pathways. These signaling pathways trigger actin polymerization, resulting 
in membrane extensions around the microbe particles and their internalization, 
forming phagosomes (Pauwels et al. 2017). The phagosomes then fuse with 
lysosomes and, in neutrophils, with preformed primary and secondary granules. The 
resulting phagolysosomes contain an arsenal of antimicrobial agents that then kill 
and degrade the internalized microbes. These agents include antimicrobial proteins 
and peptides (including defensins and cathelicidins) (Jeschke and Haas 2016), low pH, 
acid-activated hydrolytic enzymes (including lysozyme and proteases) (Jeschke and 
Haas 2016), and specialized molecules that mediate oxidative attack (Libardo et al. 
2018). Oxidative attack on the phagocytosed microbes, performed by neutrophils, 
macrophages, and dendritic cells, employs reactive oxygen species (ROS) and reactive 
nitrogen species (RNS), which damage intracellular components.  Stimulated 
neutrophils activate their NADPH oxidase (NOX2) to generate large amounts of 
superoxide, which acts as a precursor of hydrogen peroxide and other reactive 
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oxygen species that are generated by their heme enzyme myeloperoxidase. When 
neutrophils engulf bacteria, they enclose them in small vesicles (phagosomes) into 
which superoxide is released by activated NOX2 on the internalized neutrophil 
membrane (Winterbourn et al. 2016). ROS and RNS can also be released from 
activated neutrophils and macrophages and kill extracellular pathogens (Fialkow et 
al. 2007). 
 
 1.2.1 Cells of the immune system 
 
All mature blood cells (red blood cells, granulocytes, macrophages, dendritic cells, 
and lymphocytes) arise from a single cell type, the hematopoietic stem cell (HSC) 
(Moore 2014). The process by which HSCs differentiate into mature blood cells is 
called hematopoiesis. An HSC after differentiation, loses its self-renewal capacity and 
makes one of two broad lineage commitment choices (Moore 2014). It can become 
a common myeloid-erythroid progenitor (CMP), which gives rise to all red blood cells 
(the erythroid lineage), granulocytes, monocytes, and macrophages (the myeloid 
lineage), or it can become a common lymphoid progenitor (CLP), which gives rise to 
B lymphocytes, T lymphocytes, and NK cells (Moore 2014). Myeloid cells and NK cells 
are members of the innate immune system and are the first cells to respond to 
infection or an injury (Porcelli 2017). Lymphocytes are members of the adaptive 
immune response and generate a refined antigen-specific immune response that also 
gives rise to immune memory (Bonilla and Oettgen 2010). Cells that arise from a CMP 
include red blood cells (erythroid cells) as well as various types of white blood cells 
(myeloid cells such as granulocytes, monocytes, macrophages, and some dendritic 
cells) (Figure 1.2). Myeloid cells are the first to respond to the invasion of a pathogen 
or injury and transmit the information regarding the presence of an insult to cells of 




Figure 1.2. Hematopoiesis. Hematopoietic stem cells give rise to lymphoid and 
myeloid progenitors which differentiate into innate and adaptive immune cell types. 





Granulocytes are white blood cells (leukocytes) that are classified as neutrophils, 
basophils, mast cells, or eosinophils based on differences in cellular morphology and 
the staining of their characteristic cytoplasmic granules (Bosch and Ramos-Casals 
2014). All granulocytes have multilobed nuclei that make them visually distinctive and 
easily distinguishable from lymphocytes, whose nuclei are round. Their cytoplasm is 
full of granules that are released in response to contact with pathogens (Bosch and 
Ramos-Casals 2014). These granules contain a variety of proteins with distinct 
functions: Some damage pathogens directly some regulate trafficking (Bosch and 
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Ramos-Casals 2014) and activity of other white blood cells, including lymphocytes; 
and some contribute to the remodelling of tissues at the site of infection. 
Neutrophils constitute the majority (50% to 70%) of circulating leukocytes (Bosch and 
Ramos-Casals 2014). After differentiation in the bone marrow, neutrophils are 
released into the peripheral blood and migrate into the tissues, where they have a 
life span of only a few days (Simon and Kim 2010). In response to many types of 
infections or insults, the number of circulating neutrophils increases, and more are 
recruited to tissues (Kolaczkowska and Kubes 2013). Neutrophils are recruited to the 
site of infection in response to inflammatory molecules (e.g., chemokines) generated 
by innate cells (including other neutrophils) that have engaged a pathogen. In tissues, 
neutrophils phagocytose bacteria very effectively, and also secrete a range of 
proteins that have antimicrobial effects and tissue remodelling potential. Although 
once considered a simple cell, the neutrophil has recently been connected with 
regulation of the adaptive immune response (Rosales et al. 2017).  
Basophils are nonphagocytic granulocytes that contain large granules filled with 
basophilic proteins. Basophils are relatively rare in the circulation but can be very 
potent. In response to an insult, basophils release the contents of their granules 
(Bosch and Ramos-Casals 2014).  
Eosinophils, like neutrophils, are motile phagocytic cells that can migrate from the 
blood into the tissues (Kolaczkowska and Kubes 2013). Their phagocytic role is 
significantly less important than that of neutrophils, and it is thought that they play 
their most important role in the defence against parasitic organisms (O'Connell and 
Nutman 2015). Like neutrophils and basophils, eosinophils may also secrete cytokines 
that regulate B and T lymphocytes, thereby influencing the adaptive immune 
response (Long et al. 2016). 
Mast cells are released from the bone marrow into the blood and can be found in a 
wide variety of tissues, including the skin, connective tissues of various organs, and 
mucosal epithelial tissue of the respiratory, genitourinary, and digestive tracts (St 
John and Abraham 2013). They possess cytoplasmic granules that contain histamine 
25  
and other active substances and play therefore an important role in the development 
of allergies and in the initiation and resolution of acute inflammation (St John and 




Myeloid progenitors give rise to monocytes, macrophages, and dendritic cells that 
act as antigen-presenting cells (APC) (Flaherty 2012). Each can ingest pathogens via 
phagocytosis, and then present these peptide antigens on their membrane surfaces. 
Macrophages and neutrophils are efficient in removing pathogens and damaged cells 
and provide a first line of defence. Activated, APCs are more effective than resting 
ones in eliminating potential pathogens. They exhibit greater phagocytic activity, an 
increased ability to kill ingested microbes, increased secretion of inflammatory and 
cytotoxic mediators, and the ability to activate T cells. Activated macrophages also 
function more effectively as antigen-presenting cells for helper T cells (TH cells), 




The components of dead/dying cells and damaged tissues that are recognized by 
PRRs leading to their clearance are sometimes referred to as damage-associated 
molecular patterns (DAMPs) (Emlet et al. 2019). Phagocytosis is the major way of 
clearance of cells that have undergone apoptosis as part of developmental 
remodelling of tissues, normal cell turnover, killing of infected cells by innate and 
adaptive immune responses or after injury. Apoptotic cells attract phagocytes by 
expressing on their surfaces an array of molecules such as phosphatidyl serine 
(Segawa and Nagata 2015), annexin I (Weyd et al. 2013), and specific carbohydrates 
(Eda et al. 2004). These are recognized directly by phagocytic receptors such as the 
phosphatidyl serine receptor and scavenger receptor SR-A1 (Labonte et al. 2017).  
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Healthy cells avoid being phagocytosed by not expressing signals, such as 
phosphatidyl serine, and also by expressing the protein CD47 (Schürch et al. 2018). 
CD47, expressed on many cell types throughout the body, is recognized by the SIRP-
receptor on macrophages, which transmits signals that inhibit phagocytosis (Métayer 
et al. 2017). 
 
 1.2.3 Cytokines and chemokines 
 
One key aspect of the immune system is the ability of its various components to 
communicate quickly and efficiently with one another, so that the right cells can 
move to the appropriate locations and take the necessary measures to destroy 
invading pathogens. Molecules that communicate among cells of the immune system 
are called cytokines (Chung 2009) (Figure 1.2). In general, cytokines are soluble 
molecules (Lewko and Oldham 2009), although some also exist in membrane-bound 
forms (Lewko and Oldham 2009). The interaction of a cytokine with its receptor on a 
target cell can cause changes in the expression of adhesion molecules and chemokine 
receptors on the target membrane, thus allowing it to move from one location to 
another (Spangler et al. 2015). Cytokines can also signal an immune cell to increase 
or decrease the activity of particular enzymes or to change its transcriptional 
program, thereby altering and enhancing its effector functions (Wojdasiewicz et al. 
2014). Finally, they can regulate the cell cycle of epithelial cells (Tanaka et al. 2009). 
Although the term cytokine refers to all molecules that communicate among immune 
cells, the name chemokine is used specifically to describe that subpopulation of 
cytokines that share the specific purpose of mobilizing immune cells from one organ, 
or indeed, from one part of an organ, to another. Chemokines belong to the class of 
molecules called chemo-attractants, molecules that attract cells by influencing the 
assembly, and disassembly of cytoskeleton proteins and the expression of cell-
surface adhesion molecules (Ambriz-Peña et al. 2014). Chemokines attract cells with 
the appropriate chemokine receptors to regions where the chemokine concentration 
is highest. For example, chemokines are important in attracting cells of the innate 
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immune system to the site of infection (Esche et al. 2005) and inducing T cells to move 
toward antigen-presenting cells in the secondary lymphoid tissues (Esche et al. 2005). 
 
 
Figure 1.2. Interaction between pro and anti-inflammatory cytokine signaling. 
(adapted from (Sultani et al. 2012)) 
 
 
1.3 Immune system and spinal cord regeneration 
 
Spinal cord injury results in often permanent motor and sensory impairment due to 
the inability of the adult Central Nervous System (CNS) to regenerate the severed 
axons, to establish new functional connections, and to replace the neurons lost. The 
lack of regeneration is caused by a variety of factors within the CNS environment and 
within the neurons themselves. However, the initial injury is followed by a cascade of 
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events that spreads the tissue damage throughout the spinal cord leading to 
additional neuronal loss, axonal damage, demyelination and cell death. These events 
are caused by injury induced factors released within the injury site such as adenosine 
triphosphate (ATP) (Davalos et al. 2005), damage-associated molecular patterns 
(DAMPs) (Piccinini and Midwood 2010), and cytokines (Pineau and Lacroix 2007). 
These factors trigger the inflammatory response that is one of the main events 
occurring after spinal cord injury and involves mainly infiltrating macrophages, 
neutrophils, and the resident microglia. This response occurs normally as the system 
tries to prevent infection because of the injury, clear the injury environment and 
eventually repair the wound. Several studies have shown the importance of the 
inflammatory response after injury highlighting that the balance during the different 
phases and the resolution of the immune reaction are crucial for successful 
regeneration. Absence or delay of the resolution lead to chronic inflammatory 
phenotypes which can exacerbate tissue damage after injury (Pruss et al. 2011).  
 
1.3.1 Cellular response to SCI 
 
Resident cells within the spinal cord, including microglia, neurons, oligodendrocytes, 
and astrocytes, respond rapidly to SCI by expressing cytokines and chemokines, which 
leads to a cascade of responses that culminate in the influx and activation of various 
immune cells from the periphery, as well as the activation of microglia and astrocytes. 
After injury neutrophils are the first cell type to enter the injury site followed by 




Neutrophils are the first cells that enter the spinal cord within minutes after the 
injury. In mammalian models their numbers peak at 24 hours post lesion (hpl) and 
return to basal levels within 3 days post injury (dpl) (Yang et al. 2005, Donnelly and 
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Popovich 2008). This early influx of neutrophils after injury is similar to what has been 
reported in CNS (Allan and Rothwell 2003) and non-CNS injury models (Yang and Hu 
2018). Neutrophils can remove pathogens by releasing factors such as lysozyme and 
collagenase (Odeberg and Olsson 1976), by phagocytosis (Lee et al. 2003), and by 
realising neutrophil extracellular traps (NETs) which trap and kill the pathogens (Shah 
et al. 2017). 
There is a debate regarding the role of the neutrophils after SCI. Several interventions 
that lead to a reduction in neutrophils and improved locomotor recovery and tissue 
protection after SCI have been interpreted as showing a detrimental effect of 
neutrophils (Taoka et al. 1997, Naruo et al. 2003, Bao et al. 2004, Gris et al. 2004, Bao 
et al. 2008, Geremia et al. 2012). A large number of neutrophils at 24 h after SCI 
express inducible nitric oxide synthase (iNOS), and there is evidence that blocking 
iNOS with antisense oligonucleotides improves outcome after SCI (Pearse et al. 2003, 
Maggio et al. 2012). Additionally, some of the products of NETs (antimicrobial peptide 
LL-37, DNA, and HMGB1) are DAMPs that trigger TLR signalling (Makuloluwa et al. 
2014). Depletion of neutrophils after SCI using the Ly6G/Gr-1 monoclonal antibody in 
mice led to impairment of functional recovery and tissue damage (Stirling et al. 2009). 
However, a study using the same antibody did not find any effect on neutrophil 
recruitment and locomotor recovery after SCI (Lee et al. 2011).  Depletion of both 
neutrophils and macrophages led to improvement in locomotor recovery and 
reduction in secondary damage (Lee et al. 2011). Conversely, neutrophils that enter 
the eye after optic nerve lesion produce oncomodulin, a neuroprotective and axon-
growth-promoting molecule (Kurimoto et al. 2013). The role of neutrophils in the CNS 




Microglia respond rapidly to injury and are the first cell type to respond within 
minutes in traumatic brain injury (TBI) models (Donat et al. 2017). They extend 
processes toward the injury site and obtain an activated phenotype by retracting 
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their processes and phagocytosing cellular debris. It has been shown that after injury, 
the nearby astrocytes and resident microglia are activated and migrate towards the 
injury site. Activated astrocytes and other glial cells form the glia scar. Microglial cells 
are mainly present in the marginal and uninjured areas, whereas  peripheral 
macrophages accumulate in the centre of injured spinal cord (Zhou et al. 2014). 
Whereas in TBI models, microglia are the key regulators of the inflammation and the 
regenerative outcome, in zebrafish, it has been shown that the activation and 
presence of peripheral macrophages in the injury site is essential for the regeneration 
of motor neurons and axons after SCI (Tsarouchas et al. 2018) by regulating the levels 
of pro-inflammatory cytokines and the number of neutrophils. 
 
1.3.2 Cytokines in SCI  
 
The other potent regulators of the lesion environment are pro- and anti-
inflammatory cytokines, which include interleukins, TNF-α, transforming growth 
factor-β, and others. Increase in proinflammatory cytokine expression after SCI 
occurs within minutes after injury and peaks in the first 24 h (Bartholdi and Schwab 
1997, Yang et al. 2004, Yang et al. 2005, Kigerl et al. 2006, Pineau and Lacroix 2007).  
 Interestingly, it has been reported that expression of cytokines is starting before the 
influx of peripheral immune cells (Kigerl et al. 2006), suggesting that CNS cells and 
other cell types respond to the insult by producing cytokines before the specialised 
immune cells I’ll focus here on two pro-inflammatory cytokines, Il-1β and TNF-α. 
These are the most common pro-inflammatory cytokines that respond rapidly after 
injury and I found that they are key mediators of axonal regeneration after spinal cord 








The interleukin-1 (Il-1) family consists of 11 proteins (Il-1F1 to Il1F11) encoded by 11 
distinct genes in mammals. These molecules are major mediators of innate immune 
reactions, and blockade of the founding members Il-1α or Il-1β by the interleukin-1 
receptor antagonist (Il-1RA) has demonstrated a central role of Il-1 in a number of 
human autoinflammatory diseases (Dinarello 1996, Farasat et al. 2008, Martinon et 
al. 2009). These cytokines rapidly increase mRNA expression of hundreds of genes in 
multiple different cell types. The potent proinflammatory activities of Il-1α and Il-1β 
are restricted at three major levels: (i) synthesis and release (Farasat et al. 2008), (ii) 
membrane receptors(Dinarello 2005), and (iii) intracellular signal 
transduction(Weber et al. 2010).  
In response to ligand binding of the receptor, a complex sequence of phosphorylation 
and ubiquitination events results in activation of nuclear factor κB signaling and the 
JNK and p38 mitogen-activated protein kinase pathways, which, induce the 
expression of canonical Il-1 target genes (such as Il-6, Il-8, MCP-1, COX-2, IκBα , Il-1α 
, Il-1β , MKP-1 ) by transcriptional and post-transcriptional mechanisms (Weber et al. 
2010) (Fig 1.3.1). Functional studies of the type I Il‐1R demonstrated that the 
cytoplasmic segments, possessing a sequence similarity with the Drosophila Toll gene 
product or Il‐6R β chain, gpl30, are important for transmitting activity that induces 
cytokine genes (Kuno and Matsushima 1994). Furthermore, several groups reported 
that Il‐1 and tumor necrosis factor (TNF) rapidly induce sphingomyelin turnover in 
various types of cells, producing ceramide, which may act as a second messenger 
molecule in an intracellular signaling cascade(Kuno and Matsushima 1994). 
For the rest of the thesis I focus on Il-1β because there is no zebrafish orthologue for 




Figure 1.3.1  Il-1 signaling pathway (modified from(Acuner Ozbabacan et al. 2014)) 
 
Expression studies have shown that Il-1β expression peaks 12 h after injury by 
microglia, astrocytes, and some infiltrating neutrophils (Pineau and Lacroix 2007). 
Signaling via Il-1R1 is required for the influx of neutrophils and monocytes after SCI 
(Pineau et al. 2010). Rodent studies have shown that administration of Il-1β into the 
mouse spinal cord white matter undergoing Wallerian degeneration led to a rapid 
macrophage/microglial activation and myelin clearance (Perrin et al. 2005). On the 
other hand the infusion of function-blocking antibody against Il-1β suppressed 
macrophage responses and myelin clearance, indicating that Il-1β can regulate the 
recruitment of macrophages from the circulation and their activation to remove 
cellular debris (Perrin et al. 2005). The endogenous antagonist of Il-1α (Il-1 receptor 
antagonist, Il-1ra) is also upregulated after SCI (Liu et al. 2008), that regulates the 
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effects of Il-1β. Administration of IL-1ra mediates a reduction in neuronal apoptosis 
and caspase-3 expression via p38 MAP kinase (Wang et al. 2005)  and improvement 
in functional recovery (Zong et al. 2012) after SCI. It also reduces neuronal death after 
brain ischemia (Loddick and Rothwell 1996, Relton et al. 1996), whereas treatment 
with exogenous Il-1β worsens brain injury in ischemic and excitotoxic models 
(Loddick and Rothwell 1996, Lawrence et al. 1998). Furthermore, administration of 
caspase-1 inhibitor leads to successful axonal regeneration and functional recovery 
in zebrafish (Tsarouchas et al. 2018). These and other studies indicate strongly that 
the expression of Il-1β increases after spinal cord and other CNS insults and that this 
proinflammatory cytokine mediates detrimental effects via multiple mechanisms. 
 
Tumour Necrosis Factor-α  
 
Tumor necrosis factor alpha (TNF-α) is a proinflammatory cytokine involved in various 
biological processes including regulation of cell proliferation, differentiation, 
apoptosis and immune response. TNF-α is mainly produced by macrophages, also by 
other tissues including lymphoid cells, mast cells, endothelial cells, fibroblasts and 
neuronal tissues. TNF was identified as a soluble cytokine produced upon the 
activation by the immune system and able to exert cytotoxicity on tumor cell lines 
and cause tumor necrosis in animal models. TNF is primarily produced as a type II 
transmembrane protein arranged as stable homotrimers.  
The members of TNF-α family exert their cellular effect through two distinct surface 
receptors of the TNF receptor family, TNFRSF1A (TNF-R1) and TNFRSF1B (TNF-R2). 
TNF-R1 is ubiquitously expressed, whereas TNF-R2 is found typically on cells of the 
immune system and is highly regulated. TNF-R1 and TNF-R2 binds membrane-
integrated TNF (memTNF) as well as soluble TNF (sTNF) TNF-R1 contains a protein-
protein interaction domain, called death domain (DD). This domain interacts with 
other DD-containing proteins and couples the death receptors to caspase activation 
and apoptosis. TNF-R2 induces gene expression by a TRAF-2 dependent signaling 
mechanism and also crosstalk's with TNF-R1. The pleiotropic biological effects of TNF 
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can be attributed to its ability to simultaneously activate multiple signaling pathways 
in cells. Binding of TNFα to TNF-R1 on the cell surface triggers trimerization of the 
receptor and exposes intracellular domain of TNF-R1 following the release of an 
inhibitory protein. This intracellular domain recruits a death-domain containing 
adaptor protein, TRADD by homophilic interactions. TRADD, which acts as a scaffold 
protein, recruits TRAF2 and RIPK1 to form a complex, referred to as complex 1. 
Complex 1 is believed to be important in NF-κB activation and JNK activation (Fig 
1.3.2). 
 
Figure 1.3.2  TNF-α signaling pathway (adapted from Thermo-Fisher Scientific) 
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Tumour necrosis factor acts as an acute-phase cytokine in regulating immune cell 
responses, inflammatory cascades, and cell death. TNF-α mediates its effects by 
binding to two receptors, TNFRI (Tseng et al. 2018) and TNFRII (Tseng et al. 2018). 
The expression of this cytokine is upregulated after SCI in mice (Pineau and Lacroix 
2007), zebrafish (Tsarouchas et al. 2018) and in human TBI and ischemia models 
(Tuttolomondo et al. 2014). In situ hybridization has shown that after injury, TNF-α is 
expressed firstly by all CNS cell types (Pineau and Lacroix 2007), whereas during later 
stages of inflammation, it is expressed mainly by activated microglia/macrophages 
(Pineau and Lacroix 2007), indicating that it mediates different effects during early 
and later periods after injury. In humans, TNF-α protein is expressed early after injury 
in neurons and in microglial cells (Yang et al. 2005), followed later by immune cells 
from the periphery that are recruited to the site of injury. In experimental models of 
SCI, pharmacological manipulations of TNF signaling (Genovese et al. 2006, Genovese 
et al. 2008) or TNFR1-knockout (Genovese et al. 2008) improved locomotor recovery 
in mice. However, another study showed that TNFR2-null mice exhibit poor 
locomotor recovery after SCI (Kim et al. 2001). There is also evidence that TNF-α 
increases cell death in the spinal cord by trafficking of GluR2 deficient AMPA 
receptors to the cell surface of neurons (Ferguson et al. 2008). Furthermore, in this 
thesis I show that pharmacological blocking of the release of TNF-α and CRISPR/Cas 
mediated genome editing in zebrafish led to impaired axonal regeneration after 
injury (Tsarouchas et al. 2018), showing that TNF-α has a pro-regenerative role after 
injury. 
These seemingly contradictory findings show that is very difficult to highlight the 
exact role of innate immune cells and cytokine signaling during spinal cord injury. It 
is even more difficult to address these questions in adult mammalian models, in 
which both adaptive and innate immune system are present due to interactions 
between the two. For these reasons it is important to study and understand the 
principles that regulate the role of the inflammatory response during regeneration of 
the CNS in other species that exhibit a high regenerative potential in the CNS and 
their immune response can be studied separately. This is the case in larval zebrafish 
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where innate and adaptive immune system mature during different stages of 
development. 
 
1.4 The zebrafish as an animal model 
 
Zebrafish (Danio rerio) is a teleost freshwater fish that belongs to the Cyprinidae 
family, first described by Francis Hamilton in 1822 (Hamilton 1822). George 
Streisinger used them in medical research as he was looking for a model that could 
easily be genetically manipulated (Streisinger et al. 1981). Over the years, zebrafish 
have become more popular and this is reflected in the information that is available 
and in the increasing number of studies that use zebrafish as an animal model. More 
specifically, according to Zebrafish Information Network (ZFIN) the number of 
publications with zebrafish as an animal model on 1998 was 1938, whereas 20 years 
later, on 2018, this number is 17 times higher reaching 32267 publications. There are 
many features that make zebrafish a good animal model. It develops rapidly, and the 
maintenance cost is low compared to other vertebrate models. 70% of human genes 
have zebrafish orthologues (Howe et al. 2013). They breed and can produce as many 
as 300 eggs at a time. Eggs are fertilized externally, which allows them to be 
manipulated easily by injecting DNA or RNA into the zygote in order to modify gene 
expression. Furthermore, zebrafish larvae are transparent which allows the 
visualization of fluorescent tissues under the microscope in vivo (Fetcho 2003). 
However, there are also some downsides like the long generation time. In order to 
have a breeding colony the fish need to be at least 3 months old. Furthermore, some 
conserved genes between mammals and zebrafish have multiple orthologues in 
zebrafish due to its genome duplication which makes them sometimes difficult to 
study. They are also greatly influenced by their environment, which means that 
parameters like water quality and temperature must be tightly controlled.  
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Figure 1.4 The zebrafish during different developmental stages (modified from (Saleem and 
Kannan 2018)) 
 
 1.5 Spinal cord regeneration in the zebrafish model 
 
Zebrafish, in contrast to mammals, are capable of functional CNS regeneration after 
injury during the larval but also during the adult stages. In the adult spinal cord, 
neurogenesis is rare across species, including primates, rodents, birds and fish (Alunni and 
Bally-Cuif 2016). A consequence of the spinal cord injury is the sudden loss of motor neurons 
and disconnection of axons. As part of the repair process, replenishing new motor neurons 
and a re-connection of axons may be necessary. This requires endogenous progenitors to exit 
from their quiescent stage to undergo active neurogenesis and cell proliferation. In the 
lesioned spinal cord of adult zebrafish, newly regenerated motor neurons are derived from 
the olig2-expressing ependymal radial glial cells (ERGs) that line in the central canal of the 
spinal cord (Reimer et al. 2008, Reimer et al. 2009). Transcription factors that define the 
progenitor zones in the neural tube of embryos, such as Olig2, Shh, Pax6 and Nkx6.1, were 
expressed in the ventrolateral ERGs around the central canal, indicating that these ERGs are 
equivalent to pMN progenitor cells in the neural tube that give rise to motor neurons during 
the development (Reimer et al. 2009). Ependymal cell activation was also observed in 
mammals following the spinal cord injury; however, the newly generated ependymal cells 
mainly give rise to astrocytes that migrate to the lesion site to form the glia scar and prevent 
axon regeneration (Panayiotou and Malas 2013). Similar to the adult zebrafish, neuronal 
replacement, axonal outgrowth and functional recovery also occurred in larval zebrafish. 
Many developmental signals, such as Notch, Hedgehog (Hh), Bone Morphogenetic Protein 
(BMP), Wnt, Fibroblast Growth Factor (FGF), Retinoic Acid (RA) and neurotransmitters are 
redeployed during regeneration in the larval model and activate resident spinal progenitor 
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cells in the fully patterned adult spinal cord. Furthermore, the neural and axonal repair is 
quicker in the larval model as it happened within 48 hours as opposed to 6 weeks in adults.  
 
 
Figure 1.3.3  Molecular basics of signalling pathways involved in zebrafish adult and larval 
spinal cord regeneration and development  (adapted from (Cardozo et al. 2017)) 
 
In mammals, including humans, damage to spinal cord after injury leads to 
permanent functional deficits. This is mainly due to the fact that adult axons cannot 
regenerate after transection in mammals. The main reason for this is an environment 
containing inhibitors of axon regeneration, such as the myelin-associated inhibitors 
nogo-A (Otero-Ortega et al. 2017), myelin-associated glycoprotein (MAG) 
(McKerracher and Rosen 2015), and oligodendrocyte myelin glycoprotein (Geoffroy 
and Zheng 2014). Another group of inhibitors are components of the ECM that are 
found in the glial scar formed at the injury site such as chondroitin sulfate 
proteoglycans. Other molecules, like ColXII (Wehner et al. 2017), Semaphorin 3D 
(Wolman et al. 2007), Tenascin-C (Schweitzer et al. 2005), have been shown to have 
pivotal roles in axonal growth. ColXII has been shown to be essential for axonal 
regeneration after injury (Wehner et al. 2017) whereas Semaphorin 3D is involved in 
39  
axon-axon interactions and promotes fasciculation (Wolman et al. 2007) and 
Tenascin-C is involved in motor axon out-growth  (Schweitzer et al. 2005).  
However, re-growth of injured axons in the mammalian CNS exhibits variability, 
depending on cell type. Whereas many cell types in the mammalian CNS show some 
axon re-growth when a permissive environment is provided, some neuronal cell 
types, such as Purkinje cells, are still unable to extend their axons (Rossi et al. 1995). 
The intrinsic capacity of neurons to extend their axons has been extensively studied 
over the years. (He and Jin 2016, Mahar and Cavalli 2018) and others have reviewed 
the intracellular communication mechanisms required to change the genetic and 
epigenetic programme of injured neurons in order to allow axon regeneration to 
occur and also the roles of the cellular environment, axon–soma signalling and 
growth cone formation and dynamics during regeneration. 
 The zebrafish has many features in common with non-regenerating mammals such 
as the brainstem organization (Moens and Prince 2002) and the genes activated 
during axon re-growth (Bernhardt 1999). They exhibit functional recovery after a 
different types of injuries, like spinal cord injuries (Becker et al. 1997, Wehner et al. 
2018), injury in the telecephalon (Kyritsis et al. 2012), and the retina (Rao et al. 2017) 
or optic nerve transection (Diekmann et al. 2015, Van houcke et al. 2017). Zebrafish 
have the capability of robust axonal regeneration following spinal cord and optic 
nerve injuries. Transected axons can regrow and functional restoration can take 
place. After injury, zebrafish are paralyzed caudal to the lesion site but regain their 
normal swimming behaviour within 6 weeks (Becker et al. 2004, Dias et al. 2012). 
They have the ability to replace lost neurons (Becker and Becker 2008, Reimer et al. 
2008, Ohnmacht et al. 2016) upon injury and also to establish new functional axonal 
connections (Becker et al. 1997, Becker and Becker 2014, Wehner et al. 2017).  
Over the years many different signalling molecules have been found to play a crucial 
role during regeneration after injury or ablation in the zebrafish CNS, like dopamine 
(Reimer et al. 2013), serotonin (Barreiro-Iglesias et al. 2015) and sonic hedgehog 
(Reimer et al. 2009) Fig. 1.3.4.  Additionally, it has been shown that upregulation of 
Nogo-A homologue, which has inhibitory role in axonal growth in mammals 
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(Grandpre and Strittmatter 2001), is required for the success of axon regeneration in 
the zebrafish visual system, and its downregulation caused severe defects in the 
retinotectal projection (Welte et al. 2015). The main source of inhibitors of 
regeneration is the glial scar formed at the injury site in mammals (Sofroniew 2009, 
Yuan and He 2013). There is no evidence of major astrocytic scar formation in fish. 
Studies in the spinal cord of goldfish (Nona and Stafford 1995), have shown the lesion 
site is devoid of glial fibrillary acidic protein-positive (GFAP) processes when axons 
cross the lesion site. This indicates the lack of an astroglial scar. Chondroitin sulfate 
proteoglycans are another hallmark of a glial scar, and mostly inhibit axonal 
regeneration (Bradbury et al. 2002). In contrast to mammals (Selles-Navarro et al. 
2001), there is also no increased immunoreactivity to chondroitin sulfates in the optic 
nerve of zebrafish at the lesion site (Becker and Becker 2002). This again indicates 






















Figure 1.3.5 Events occurring in the zebrafish spinal cord during regeneration after SCI and 
development. After an injury the neural progenitors upregulate the expression of genes present 
during spinal cord development, such as wnt, shh, notch1a/1b and bmp4 that are also upregulated in 
mammalian models after SCI. Furthermore, glial bridges are contributing to axonal regeneration after 
injury whereas the role of the innate immune system during this process remains unclear (modified 
from (Becker and Becker 2014, Cardozo et al. 2017) ). 
 
Another important characteristic of the zebrafish that makes them ideal CNS 
regeneration model is the fact that they are able to re-establish functional axonal 
connections. Recovery of swimming function critically depends on regeneration of 
axonal connections across the complex non-neural injury site (Becker et al. 1997, 
Wehner et al. 2018). In order to set the scene for functional regeneration five criteria 
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were proposed in 1980 which should be met in order to demonstrate functional 
recovery after SCI (Guth et al. 1980).  According to Guth et al., 1980 these criteria are 
the following: 
 1. The experimental lesion must cause disconnection of nerve processes. 
2. Processes of CNS neurons must bridge the level of injury. 
3. The regenerated fibers must make junctional contacts. 
4. The regenerated fibers must generate postjunctional responses. 
5. Changes in function must derive from regenerated connections   
Zebrafish manage to meet these criteria after SCI and can regenerate functionally. 
Understanding the mechanisms that allow this regenerative capacity will allow 
comparison with organisms in which regeneration is not as pronounced, such as 
humans. Given that there are many examples of gene conservation between the 
zebrafish and other vertebrate species, their study may eventually lead to the 
increased success of clinical regenerative methods. 
 
1.6 Zebrafish immune system 
 
The tools for identifying danger signals derived from either injury or infection are 
conserved within species. Several studies have identified that innate and adaptive 
immunity are present in fish and more specifically in zebrafish (Renshaw and Trede 
2012). Innate immunity includes autonomous mechanisms that are active not only in 
immune cells but also in cells with epithelial origin (Iversen et al. 2015, Ross and 
Herzberg 2016). Several hundreds of proteins are involved in autonomous immune 
protection which are present in zebrafish. They include receptors that recognize 
molecules specific for pathogens, called pattern recognition receptors (PRRs) and 
various effectors that restrict the spread of pathogen or induce cell death. In addition, 
infected cells produce cytokines such as interferons that activate autonomous 
immune mechanisms in neighbouring cells. Interferons regulate a large fraction of 
autonomous immune genes (Schneider et al. 2014). IFN type I and III are induced 
when PRRs bind products from pathogens activating IFN regulatory factors (IRF) 3, 5, 
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and 7, c-Jun, and NFkB. This leads to the formation of a signaling complex that 
contains STAT1 and 2 and interferon regulatory factor 9 (IRF9). This complex drives 
the expression of IFN-stimulated genes (ISGs). Another innate immune mechanism is 
the inflammation, which is associated with the recruitment of immune cells to the 
site of infection or injury. It translates autonomous response at the cellular level to 
the response on the level of organism. Many cells respond to infection, stress and 
other homeostasis-altering processes by assembly of inflammasomes (Liston and 
Masters 2017). Recently it has been characterized by (Li et al. 2018) that zebrafish 
exhibit a unique activation mechanism for the NLRP1 inflamamsome, which is one of 
the best-characterized inflammasomes in humans and in other mammalian models. 
Innate and adaptive immunity must coordinate for successful defence against 
pathogens, and for immunological memory to protect against future infections. 
Macrophages and Dendritic cells (DCs) are professional antigen presenting cells 
(APCs) that are endowed with both phagocytic functions and cell-surface receptors 
that allow them to orchestrate the activation of T and B cells. DCs were originally 
distinguished in mammals as cells with a distinct stellate morphology and later 
functionally defined as the most potent initiators of the adaptive immune response 
(Nussenzweig and Steinman 1980). Upon encounter with antigen, DCs migrate to the 
T cell areas of local lymph nodes and other lymphatic tissues. A hallmark feature of 
DCs that distinguishes them from other MPs is the interaction of DCs with T cells in 
these organized lymphatic areas, which results in highly efficient priming of T cells. 
Many different types of DCs have been identified in mammals based on divergent 
functional characteristics. DCs have been historically subdivided into two subsets: 
CD8− (CD11b+) DCs, which engage in conventional antigen presentation of external 
antigen upon MHC class II molecules and internal antigen upon MHC class I receptors, 
and CD8+ DCs, which are thought to specialize in cross-presentation, or the 
presentation of processed external antigen on MHC class I molecules rather than 
MHC class II molecules (Edelson et al. 2010). 
Cells that morphologically resemble classical DCs have been identified in several 
teleost species, including rainbow trout (Bassity and Clark 2012), medaka (Aghaallaei 
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et al. 2010), and Atlantic salmon (Haugland et al. 2012). In zebrafish, the work from 
(Lugo-Villarino et al. 2010) showed that cells with dendritic morphology have been 
isolated from kidney marrow, a hematopoietic site akin to the mammalian bone 
marrow. Similarly, the pivotal receptors CD40-CD40 ligand (Gong et al. 2009) and the 
adaptor molecule TRAF6, which is required for DC maturation (Kobayashi et al. 2003), 
have been identified in zebrafish and other jawed vertebrates. Additionally, the 
works from (Liu et al. 2017) and (Zhang and Wiest 2016) have provided evidence 
regarding the development and maturation of B and T cells in zebrafish. Hence, 
zebrafish resembles a good tool for the study of innate and adaptive 
immunity.Teleosts, like mammals, have a similar arsenal of defence mechanisms 
against infections. Like in other vertebrate models, these mechanisms include 
specialised immune cell types (macrophages, neutrophils, microglia, B-cells, T-cells) 
similar to mammals in terms of structure and cytochemistry, and phagocytic and 
secretory abilities (Traver et al. 2003) cytokine and interferon release. The cellular 
elements of the teleosts immune response have been described (Traver et al. 2003). 
Zebrafish leukocytes, even in embryos are fully functional and participate in host 
defence. Neutrophils are the first to respond to an injury; macrophages are 
subsequently recruited to inflamed tissues to phagocytose pathogens and tissue 
debris. In the first line of zebrafish defence,Toll-like receptors (TLRs) (Li et al. 2017) 
are expressed on the surface of dendritic cells and macrophages and recognize 
(PAMPs) derived from injury. Following PAMP binding, TLRs transduce signals to the 
nucleus, which leads to activation of MAP kinase family members, translocation of 
NFκB to the nucleus, that leads to gene expression (Akira and Hemmi 2003). In all of 
the aforementioned regeneration paradigms the common feature is the 
inflammatory response that occurs after injury. There are several studies that address 
the role of inflammation during regeneration of the zebrafish CNS after injury (Kyritsis 
et al. 2012, Carrillo et al. 2016, Bollaerts et al. 2017, Wang et al. 2017). The immune 
reaction to injury may be a determining factor for regenerative success (Kroner et al. 
2014, Chassot et al. 2016). In mammals, a prolonged and non-resolving immune 
response, consisting of pro-inflammatory macrophages (Kigerl et al. 2009), microglia 
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cells (Norden et al. 2015) and neutrophils (Taoka et al. 1997) together with cytokines 
released from other cell types, such as endothelial cells, oligodendrocytes or 
fibroblasts (Tran et al. 2018) contribute to an inflammatory environment that is 
hostile to axonal regeneration. However, activated macrophages can also promote 
axonal regeneration (Gensel et al. 2009), suggesting complex roles of the immune 
response after spinal injury. 
In zebrafish, the roles of all of these cell types can be distinguished in a system that 
shows a high capacity for axonal regeneration and functional spinal cord repair 
(Becker and Becker 2014). Similar to mammals (Renshaw and Trede 2012), zebrafish 
possess an innate immune system from early larval stages and develop an adaptive 
immune system at juvenile stages (Meijer and Spaink 2011). CNS injury models in 
zebrafish have shown that there is an activation of the microglia as response to injury 
(Kyritsis et al. 2012). Stimulation of acute inflammatory response after optic nerve 
injury in zebrafish activates microglia and leads to recruitment of neutrophils and 
peripheral macrophages, similar to what is observed in mammalian models (Bollaerts 
et al. 2017). Although several factors and pathways like LIF (Ogai et al. 2014) and the 
JAK/STAT3 (Elsaeidi et al. 2014) and mTOR (Huang et al. 2017) signaling pathways are 
implicated in CNS regeneration in zebrafish, the exact mechanism of how the positive 
effects of acute inflammation is mediated remains unclear. Retina studies show that 
immunomodulation can enhance or impair regeneration of photoreceptors after 
ablation (White et al. 2017). After a SCI in zebrafish, microglia are activated (Becker 
and Becker 2001, Ghosh and Hui 2018) and neutrophils and blood-borne 
macrophages infiltrate the lesion site, although their precise contribution to axonal 
regeneration is still unknown. Despite the similarities between zebrafish and 
mammals the contribution of inflammation to the regenerative process after SCI is 
still unclear.  
 Zebrafish larvae exhibit temporal separation of innate immunity from adaptive 
responses. This makes zebrafish larvae particularly useful for dissecting the innate 
host factors involved in pathology without any implications derived from the 
interaction between innate and adaptive immune response. For this reason, I decided 
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to use the larval model in order to assess the role of the innate immune system 
(macrophages, neutrophils, microglial cells) during the regeneration of the zebrafish 
spinal cord. I find that innate immune response is essential for regeneration after 
spinal cord injury. Peripheral macrophages are necessary in order to tightly control 
the levels of inflammation by regulating the expression of Il-1β and preventing other 
cells like neutrophils and keratinocyte form increasing its levels. Furthermore, 
macrophages are the main source of TNF-α which has a pro-regenerative role after 
injury and an anti-inflammatory role during inflammation as CRISPR mediated 
disruption of TNF-α led to increased numbers of neutrophils and increased 
expression of Il-1β after injury. However, the potential beneficial role of the adaptive 
immunity cannot be excluded and in order to assess it, experiments in adult zebrafish 
should be carried out. 
1.7 Conclusions and statement of aims 
In this thesis I investigated the contribution of the innate immune system to the 
regeneration of the motor neurons and axons in zebrafish larvae. In order to achieve 
this, I addressed the following aims:  
• To characterize the cellular and molecular immune response that occurs after 
injury 
• To investigate the neuronal regeneration after genetic and pharmacological 
inhibition of the immune response 
• To investigate and characterize the axonal regeneration that occurs after 
injury 
• To characterize the axonal regeneration after genetic and pharmacological 
manipulation of the immune response 
• To determine which innate immune cell types are the most important during 






















Chapter 2: Materials and methods  
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2.1 Zebrafish techniques 
 
2.1.1 Fish husbandry 
 
All zebrafish lines that were used for the purpose of this study were kept and raised 
under standard conditions (Westerfield 2000), at the temperature of 26.5°C and a 
14 hour-light and 10 hour-dark cycle. Larvae were kept at 28.5°C in conditioned 
aquarium water containing methylene blue (2ml of 0.1% methylene blue, to 1 liter 
of fish water). The following lines were used: wild type (wik), Tg(Xla.Tubb:DsRed), 
abbreviated as nbt:DsRed where neuronal elements of the spinal cord fluoresce 
red (Peri and Nusslein-Volhard 2008); Tg(mpeg1:EGFP), abbreviated as mpeg:GFP 
where macrophages/microglial cells fluoresce green (Ellett et al. 2011), and 
Tg(mpx:GFP), abbreviated as mpx:GFP where neutrophils fluoresce green 
(Renshaw et al. 2006), Tg(fli1:EGFP), abbreviated as fli:GFP where blood vessels 
fluoresce green (Lawson and Weinstein 2002), irf8st95/st95 (Shiau et al. 2015), these 
animals do not have macrophages/microglial cells during the larval stage of 
development, Tg(gfap:GFP)mi2001, abbreviated as GFAP:GFP where glial elements 
fluoresce green, (Bernardos and Raymond 2006), 
TgBAC(pdgfrb:Gal4FF);Tg(UAS:GFP), abbreviated as pdgfrb:GFP where pericytes 
and epithelial cells fluoresce green (Ando et al. 2016), Tg(her4.3:GFP) where the 
glial elements of the spinal cord fluoresce green (Yeo et al. 2007), 
Tg(gfap:Gal4ffs995;UAS:NTR-mCherry) where the glial cells express the enzyme 
nitroreductase under the gfap promoter which allows to selectively ablate the glial 
population after addition of metronidazole which is the substrate for 
nitroreductase (Matsuoka et al. 2016), Tg(her4.3:irtTAM2(3F)-p2a-AmCyanulm6), 
abbreviated as her4.3:TetA AmCyan where the glial elements of the spinal cord 
fluoresce cyan (Geurtzen et al. 2014), Tg(her4.1:Tet-GBD-p2A-mCherrytud6) 
abbreviated as her4.3:mCherry where the glial elements of the spinal cord 
fluoresce red (Knopf et al. 2010), Tg(claudin k:Gal4)ue101; Tg(14xUAS:GFP) 
abbreviated as cldnK:GFP where the myelin associated protein claudin K fluoresces 
49  
green  (Munzel et al. 2012), Tg(TNFTNFa:eGFPF)sa43296, abbreviated as TNFTNFTNF-
α:GFP where the TNF-α expressing cells fluoresce green(Nguyen-Chi et al. 2015) , 
Tg(Il-1β:eGFP)sh445, abbreviated as Il-1β:GFP where the il-1β expressing cells 
fluoresce green (Ogryzko et al. 2018), csf1ra−/−; csf1rb−/− abbreviated as csf1ra/b. 
These animals carry double mutation on the csf1ra and csf1rb genes which regulate 
the density and the distribution of microglial cells leading to microglia loss  
(Oosterhof et al. 2018).  
 
2.1.2 Drug treatment 
 
Dexamethasone (Sigma) was dissolved in DMSO to a stock concentration of 5mM. 
The working concentration was 100μM prepared by dilution from stock solution. 
Ac-YVAD-cmk (Sigma) was dissolved in DMSO to a stock concentration of 10mM. 
The working concentration was 50μM prepared by dilution from the stock solution. 
Q-VD-OPh (Sigma) was dissolved in DMSO to a stock concentration of 10mM. The 
working concentration was 50μM prepared by dilution from stock solution. 
IWR-1 (Sigma) was dissolved in DMSO to a stock concentration of 6mM. The working 
concentration was 15µM prepared by dilution from the stock solution. 
O-Phospho-L-serine (Sigma) was dissolved in PBS to a stock concentration of 10mM. 
The working concentration was 10μM prepared by dilution from stock solution. 
Lipopolysaccharides from Escherichia coli O55:B5 (LPS, Sigma) was dissolved in PBS to 
a stock concentration of 1mg/ml. The working dilution was 50μg/ml prepared by 
dilution from stock solution. 
Pomalidomide (Cayman Chemicals) was diluted in DMSO at a stock concentration of 
10mg/ml. The working concentration for the experiments was 170 μΜ. 
Larvae were collected from the breeding tanks and divided into Petri dishes at a 
density of maximum 30 larvae per dish. For the Dexamethasone experiment the 
larvae were treated from 6 hours post fertilization until 5 days post fertilization 
(dpf). For the pomalidomide treatment, larvae were pre-treated for 2 hours before 
the injury and were incubated for 24 and 48 hpl. For the rest of the drug 
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treatments, larvae were incubated with the drug from 3 days post fertilization until 
5 days post fertilization. The larvae were divided into groups of 20 into 6 well-plates 
for every drug treatment. For all the experiments the drugs were tested using 
treatment after injury and pre-treatment and the effects were compared. For all 
the experiments in this thesis I used the pre-treatment in order to maximise the 
effect which could be less profound, due to pharmacokinetics, when the animals 
were treated after injury. 
 
2.1.3 EdU administration 
 
Zebrafish larvae at 3 dpf were anesthetized in PBS containing 0.02% aminobenzoic 
acid-ethyl-methyl-ester (MS222, Sigma) and were placed in a lateral position on an 
agar plate and injected into the yolk with ∼5 nl 5 mM EdU in 0.1 M sterile KCl and 
7.5% DMSO. After washing, larvae were allowed to develop under standard 
conditions. 
 
2.1.4 Spinal cord lesions and behavioral recovery 
 
Zebrafish larvae at 3 dpf were anesthetized in PBS containing 0.02% aminobenzoic-
acid-ethyl methyl-ester (MS222, Sigma). Larvae were transferred to a plastic Petri 
dish coated with agarose. Following removal of excess water, the larvae were 
placed in lateral position, and the tip of a sharp 30G 1/2 syringe needle was used to 
inflict a lesion in the dorsal part of the trunk at the level of the end of the yolk 
extension.  
Figure 2.1.4. Picture 
showing the injury site 
in a 3 dpf zebrafish 
larva (adapted from 
(Ohnmacht et al. 2016) 
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In order to assess behavioral recovery, lesioned and unlesioned control larvae were 
touched with a glass capillary on the median fin fold caudal to the lesion site. The 
swim path of their escape response was recorded and analysed using a Noldus 
behavior analysis set-up and EthoVision software (v. 7). Data are shown as distance 
travelled during the first 15 s after touch, averaged from triplicate measures per 
larva.  
 
2.2 Molecular biology 
 
2.2.1 Primer design 
 
Primers were designed using Primer3web and Primer Blast tool available at 
(https://www.ncbi.nlm.nih.gov/tools/primer-blast). The primers were selected 
based on their length, melting temp and %GC content to achieve high specificity of 
amplification and checked for self-complementarity using the Oligo-Calc: Oligo-
Calc: Oligonucleotide Properties Calculator 
(http://biotools.nubic.northwestern.edu/OligoCalc.html). Primer oligonucleotides 
were ordered from Integrated DNA Technologies, BVBA; Leuven, Belgium.  
The list of designed primers is given below: 
 
Primer name Orientation Sequence 
irf8 Forward 5’-ACATAAGGCGTAGAGATTGGACG-3’ 
Reverse 5’-GAAACATAGTGCGGTCCTCATCC-3’ 
col1a1a Forward 5’-AACACGTCTGGTTCGGAGAG-3’ 
Reverse 5’-AAATCCTGACCTGGTGTTGG-3’ 
col1a1b Forward 5’-TACACAGACCGGACCCTACG-3’ 
Reverse 5’-TCACTGCCATAAGCCATCTG-3’ 







col5a2b Forward 5’-TGATTATTGGATAGACCCGAATG-3’ 
Reverse 5’-TGCTGTACGAAGTGCAAGTTAAA-3’ 
col5a3b Forward 5’-AAATGGCTTCATGGAGCAAAGAG-3’ 
Reverse 5’-CTATACACCCTTACTGACGCCTC-3’ 
col12a1a Forward 5’-TCCAGCTCCAGATGTTTGATATT-3’ 
Reverse 5’-AGGTCCAGGTAATCCTCTCTGTC-3’ 
col12a1b Forward 5’-CATTGATCCCACATTCACAACCC-3’ 
Reverse 5’-CCGTATTTGGTTGCAGGTTTCTT-3’ 
fn1b Forward 5’-CAACCTCCAATTCACCTCCCTAA-3’ 
Reverse 5’-ATAAGAGTGGCAGTTGTGGATGT-3’ 
beta actin qPCR Forward 5’-CACTGAGGCTCCCCTGAATCCC-3’ 
Reverse 5’-CGTACAGAGAGAGCACAGCCTGG-3’ 
tgfb-1a qPCR Forward 5’-GCTGTATGCGCAAGCTTTACA-3’ 
Reverse 5’-GGACAATTGCTCCACCTTGTG-3’ 
Il-1β qPCR Forward 5’-ATGGCGAACGTCATCCAAGA-3’ 
Reverse 5’-GAGACCCGCTGATCTCCTTG-3’ 
tgfb3 qPCR Forward 5’-AAAACGCCAGCAACCTGTTC-3’ 
Reverse 5’-CCTCAACGTCCATCCCTCTG-3’ 
TNF-α qPCR Forward 5’-TCACGCTCCATAAGACCCAG-3’ 
Reverse 5’-GATGTGCAAAGACACCTGGC-3’ 
mpeg1 ISH(Ellett 
et al. 2011) 
Forward 5′-GGATCCATCATGAAGTCAAG-3’′ 
Reverse 5′-CTCGAGTACTTGAACCCGTG-3’′ 
tgfb1a probe Forward 5’-AAAGAGCCTGAATCCGGAGC-3’ 
Reverse 5’-ACTTGCAGTTCCTCACCACC-3’ 
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Il-1β gRNA Forward 5’-GAGATCAGCGGGTCTCTGG-3’ 
Reverse 5’-GATGCGCACTTTATCCTGCAG-3’ 







mmp2 Forward 5’-TGGCCGAAATGAACATGGTG-3’ 
Reverse 5’-GGAACCCATCATCTCGACCC-3’ 
mmp9 Forward 5’-TACGGTAATGCTGAGGGTGC-3’ 
Reverse 5’-GCCGTATCTCTGTTAGGGCA-3’ 
mmp11a Forward 5’-CGCGAGATGCTTGCCTTTAC-3’ 
Reverse 5’-AGCGCTGGATTTTGTAGGTGA-3’ 
mmp11b Forward 5’-GCAGAGAGACGACCCACATT-3’ 
Reverse 5’-ACCCAGTAATTCTGGCCTTGG-3’ 
mmp13a Forward 5’-GCCAACAACCAGGTTTACAGTTAT-3’ 
Reverse 5-TCTTCAGGCGGTAAGTATTAAAGAA-3’ 
mmp13b Forward 5’-GCTCACGAGTTTGGTCATGC-3’ 
Reverse 5’-CAGCCTCCAGTAAAACCTGTCT-3’ 
mmp14a Forward 5’-TGAGTGAGGATGGAGCCAATG-3’ 
Reverse 5’-GCGGTGACAGTAGAGTAGGC-3’ 
mmp14b Forward 5’-AACGTCTGTATTCTCCCGCT-3’ 
Reverse 5’-AGCCATGCCTCAGGTTTCAT-3’ 
mmp15a Forward 5’-TTCAATGCGGAGTCTTGGCT-3’ 
Reverse 5’-CTTTGGGCGAGTGGTTTTGG-3’ 
mmp15b Forward 5’-AAAATCAGACTGGAGGTGGCA-3’ 
Reverse 5’-TTGTTAGCAGATGACGGCGA-3’ 
     mmp16a Forward 5’-TGGACAACGAAACCAGCACT-3’ 
Reverse 5’-AGAGCATAAACGCACCCCTC-3’ 
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mmp16b Forward 5’-GTGAGAGAACGGCAGGTAATG-3’ 
Reverse 5’-GAATCCTCCGTCGCAGATGT-3’ 
mmp17a Forward 5’-ATCTTTCCTGGAGGGTGAGGA-3’ 
Reverse 5’-TGCAAACAGGTCCATCCCAT-3’ 
mmp17b Forward 5’-CGGTCTGTAATGCGTCCGTA-3’ 
Reverse 5’-ACATGCTCTGGCCTTTGAAGA-3’ 
mmp19 Forward 5’-TGTCGCACAACTAGGGTTTCA-3’ 
Reverse 5’-AGCAGTGCCGAAGTGAATCT-3’ 
mmp20a Forward 5’-CGCAACGAGTGGCATATGTT-3’ 
Reverse 5’-TGAACGCGTCCATTGAGTTC-3’ 
mmp20b Forward 5’-’ATTCCCATCAGGCGGACATC-3’ 
Reverse 5’-GTCTCTTGGCCCGTAGAGC-3’ 
mmp23bb Forward 5’-GCTCATGAAATCGGTCACGC-3’ 
Reverse 5’-CTGCATCCAGAGGCTCGTAG-3’ 
mmp24 Forward 5’-CATGACGGCAATGACCTGTTC-3’ 
Reverse 5’-GAGACTGACGCTCGTGTTTG-3’ 
mmp28 Forward 5’-TGCTATCAGAGAGTTTCAGTGGTT-3’ 
Reverse 5’-CCTGACTGGTAGAAAGGCTCC-3’ 
mmp30 Forward 5’-GGTGTTCTGGCTCATGCAAA-3’ 
Reverse 5’-TCGAACACCGTACAAAGCCT-3’ 
 
2.2.2 RNA preparation 
 
RNA from the desired tissue (lesion site of larvae), was extracted using the RNeasy 
Mini Kit (Qiagen), according to manufacturer’s protocol.  
Procedure 
1. Disrupt the tissue and homogenize the lysate in 350 μl of Buffer RLT. Centrifuge the 
lysate for 3 min at maximum speed.  
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      Carefully remove the supernatant by pipetting and use it in step 2. 
2. Add 1 volume of 70% ethanol to the lysate and mix well by pipetting. Do not 
centrifuge. Proceed immediately to step 3. 
3. Transfer up to 700 µl of the sample, including any precipitate, to an RNeasy Mini spin 
     column placed in a 2 ml collection tube. Close the lid, and centrifuge for 15 sec at     
    ≥8000 x g. Discard the flow-through. 
4. Add 700 µl Buffer RW1 to the RNeasy spin column. Close the lid, and centrifuge for    
    15 sec at ≥8000 x g. Discard the flow-through. 
5. Add 500 µl Buffer RPE to the RNeasy spin column. Close the lid, and centrifuge for   
    15 sec at ≥8000 x g. Discard the flow-through. 
6. Add 500 µl Buffer RPE to the RNeasy spin column. Close the lid, and centrifuge for 2   
    min at ≥8000 x g. 
7. Place the RNeasy spin column in a new 1.5 ml collection tube (supplied). Add 30 µl   
    RNase-free water directly to the spin column membrane. Close the lid, and  
    centrifuge for 1 min at ≥8000 x g to elute the RNA. 
8. Check the quality by running a small amount on a gel. Intact total RNA run on a   
    denaturing gel will have sharp, clear 28S and 18S rRNA bands. 
9. The RNA was stored at -80°C. 
 
2.2.3 cDNA preparation 
 
cDNA was prepared using the iScriptTM cDNA synthesis kit (BIO-RAD). 500 ng of RNA 
was mixed with 4 µl 5xiScript Reaction Mix and 1µl of iScript Reverse Transcriptase. 
Total volume up to 20μl was filled with Nuclease-free water. The samples were 
placed in thermal cycler and incubated using the following protocol: Priming – 5min 
at 25oC, Reverse transcription – 20 min at 46oC, RT inactivation -1 min at 95oC. The 





2.2.4 Polymerase Chain Reaction (PCR) 
 
TAG DNA Polymerase (NEB) was used for PCR. Master mix was made according to 
the manufacturer’s instructions. The annealing temperature was calculated based 
on the melting temperature (Tm) of the primer. The cycler was set to the following 
values: 
• Initial denaturation: 3 min  
• Denaturation: 30 sec, 95 oC 
• Annealing: 30 sec, 58 oC 
• 35 cycles 
• Extension: 15 - 40 sec, 72 oC 
• Final extension: 10 min, 72 oC 
• Hold: forever, 4 oC 
 
2.2.5 Reverse transcriptase PCR and quantitative RT-PCR 
 
Standard RT-PCR was performed using 10mM of each dNTP and each primer. 
qRT-PCR was performed at 58 °C using Roche Light Cycler 96 and relative mRNA 
levels determined using the Roche Light Cycler 96 SW1 software. Samples were 
run in duplicates and expression levels were normalized to β-actin control. 
 
2.2.6 Gel electrophoresis and purification 
 
The PCR products were run on 2% agarose gel in TAE buffer with 0.005% GelRed. 
For the in situ probe generation, the bands of appropriate size were cut out of the 
gel under UV light and subsequently extracted using the QIAquick® Gel Extraction 
Kit (Qiagen) according to manufacturer’s instructions. 
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2.2.7 Ligation into vector and transformation into bacteria 
 
The ligation into pGEM-T Easy vectors (Promega) was performed according to the 
manufacturer’s protocol (Promega). The vectors were transformed into NEB5’-
’alpha competent cells (NEB). The cells were initially pre-incubated with the vectors 
for 20 min on ice, heat-shocked at 42oC for 50s, and incubated on ice for further 5 
min. After adding 950µl SOC medium, the cells were incubated for 1 hour on orbital 
shaker at 37oC and 250rpm. 100µl bacterial colonies were plated on restrictive LB 
Agar plates containing 100µg/ml ampicillin and grown overnight at 37oC. Before 
plating the bacteria, the plates were freshly coated with 20ul 50mg/ml (X-Gal, 
Sigma) allowing the selection of colonies based on the blue/white selection 
cassette within the pGEM-T Easy vectors. Bacteria transfected with empty vectors 
contained a functional lacZ gene, which mediated the conversion of X-Gal into a 
blue product. The successfully ligated PCR product disrupted the lacZ sequence 
present within the blue/white selection cassette making the colonies appear white. 
Single, circular, white colonies were picked using a sterile pipette tip. The selected 
cultures were grown overnight at 37oC on orbital shaker in 15ml blue cap tubes 
containing 2ml of the restrictive 2-YT medium containing 100µg/ml ampicillin. 
 
2.2.8 Plasmid isolation and sequencing 
 
The 2ml cultures were used for plasmid purification using QIAGEN Mini-
preparation kit (QIAprep Spin Miniprep Kit) according to manufacturer’s 
instructions. All sequencing was performed by Source Bioscience UK. The plasmids 







1. Resuspend pelleted bacterial cells in 250 μl Buffer P1 and transfer to a 
microcentrifuge tube. 
2. Add 250 μl Buffer P2 and mix thoroughly by inverting the tube 4–6 times. 
Mix gently by inverting the tube.  
3. Add 350 μl Buffer N3. Mix immediately and thoroughly by inverting the tube 4–
6 times. 
4. Centrifuge for 10 min at 13,000 rpm (~17,900 x g) in a table-top microcentrifuge. 
5. Apply 800 μl of the supernatant from step 4 to the QIAprep 2.0 spin column 
by pipetting. 
6. Centrifuge for 30–60 s. Discard the flow-through. 
7. Wash QIAprep 2.0 spin column by adding 0.75 ml Buffer PE and centrifuging for 
30–60 s. 
8. Discard the flow-through, and centrifuge at full speed for an additional 1 min to 
remove residual wash buffer. 
9. Place the QIAprep 2.0 column in a clean 1.5 ml microcentrifuge tube. To elute 
DNA, add 50 μl Buffer EB (10 mM Tris·Cl, pH 8.5) or water to the center of each 
QIAprep 2.0 spin column, let stand for 1 min and centrifuge for 1 min. 
 
 
2.2.9 Restriction and probe synthesis 
 
The plasmid was cut upstream of the insert using appropriate NEB enzymes and 
buffers and a polymerase downstream was used for the transcription reaction to 
prepare the anti-sense probe. The success of the digestion was assessed using 
agarose gel. The linearized DNA was precipitated overnight at -20°C with 0.3M 
Sodium Acetate, and two volumes of 100% ethanol. The in vitro transcription of 
the RNA probe was done using MAXIScript® Kit (Ambion), according to 
manufacturer’s instructions. 1µg of linearized plasmid DNA was used for the 
reaction setup. For the generation of labelled in situ probes, the DIG RNA Labeling 
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Mix (Roche) was used. The probes were purified by precipitation with 2.5 volumes 
of 100% ethanol and 0.1 volumes of 8M Lithium Chloride for at least 1 hour. The 
reactions were centrifuged at 13000 rpm at 4°C for 45 min, washed with 70% 
ethanol, centrifuged again for 15 min (13000 rpm, 4°C), air dried and resuspended 
in 20µl RNase-free water. In order to verify the probe synthesis and test the 
integrity, 1µl of the transcription reaction was loaded on an agarose gel. 
 
2.2.10 CRISPR-mediated genome editing 
 
CRISPR gRNA for il-1beta was designed using CRISPR Design (http://crispr.mit.edu) 
and ZiFit (http://zifit.partners.org/ZiFiT) webtools. Vectors were made by ligating 
the annealed oligonucleotides into pT7-gRNA expression vector as previously 
described (Wehner et al. 2018)_ENREF_36. The gRNA was transcribed using the 
mMESSAGE mMACHINE T7 kit (Ambion) and assessed for size and quality on an 
electrophoresis gel.  
The injection mix consisted of 75 pg il-1beta gRNA (target sequence: 5’-
TGTGGAGCGGAGCCTTCGGCGGG-3’) and 150pg Cas9 RNA and was injected into 
single cell stage larvae.  The gRNA for the TNF-αlpha (target sequence: 5’-
CCCGATGATGGCATTTATTTTGT-3’) and the generic crRNAs/tracrRNA were ordered 
from (Merck KGaA, Darmstadt). The injection mix included 1μl Tracer 250 ng /μl, 1 
μl gRNA, 1μl Cas9 protein, 1μl RNAse free H20, 1μl fluorescent dextran. Larvae 
injected with GFP gRNA (target sequence: 5′GGCGAGGGCGATGCCACCTA-3’) and 
uninjected larvae were used as controls. The efficiency of the mutagenesis was 
assessed by Restriction Fragment Length Polymorphism (RFLP) analysis. The basic 
technique for the detection of RFLPs involves fragmenting a sample of DNA with 
the application of a restriction enzyme, which can selectively cleave a DNA 
molecule wherever a short, specific sequence is recognized in a process known as 
a restriction digest. The DNA fragments produced by the digest are then separated 
by length through a process known as agarose gel electrophoresis and transferred 
to a membrane via the Southern blot procedure. Hybridization of the membrane 
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to a labeled DNA probe then determines the length of the fragments which are 
complementary to the probe. A restriction fragment length polymorphism is said 
to occur when the length of a detected fragment varies between individuals, 
indicating non-identical sequence homologies. Each fragment length is considered 
an allele, whether it actually contains a coding region or not, and can be used in 
subsequent genetic analysis. 
  
2.2.11 Morpholino injection 
 
All morpholinos were injected into single cell stage larvae in total volume of 2 nl. 
Knockdown of Il-1β was carried out using the antisense morpholino Il-1β (5′-
CCCACAAACTGCAAAATATCAGCTT-3′) targeting the splice site between intron 2 
and exon 3 according to (Nguyen-Chi et al. 2014). In order to block neutrophil 
development, we used the previously described MO combination (Feng et al. 2012) 
of pu.1 (5’-GATATACTGATACTCCATTGGTGGT-3’)(Rhodes et al. 2005) which targets 
the translational start (ATG) of the pu.1 and the splice blocking MO against gcsfr  
(5′- TTTGTCTTTACAGATCCGCCAGTTC-3’) (Halloum et al. 2016) . All morpholinos 
and standard control (5’-CCTCTTACCTCAGTTACAATTTATA-3’) were obtained from 
Gene Tools, LLC. 
 
2.2.12 Fluorescence-activated cell sorting 
 
Macrophages and microglia were isolated from 4 dpf transgenic mpeg1:eGFP 
embryos by FACS. For this purpose, about 500 fish were lesioned by transecting 
the spinal cord. Trunk-containing lesion site were dissected and collected at 24 hpl 








2.3.1 In situ hybridisation (ISH) on whole mount larvae 
 
The larvae were fixed overnight at 4 °C in 4% PFA-PBS. On the following day, larvae 
were washed twice in PBT (0.1% Tween-20 in PBS) and incubated for 30 min in PBT 
containing 40 μg/ml Proteinase K (Invitrogen). Thereafter, larvae were washed 
briefly in PBT and were refixed for 20 min in 4% PFA-PBS followed by five washes 
in PBT for 5 min each. After washes, larvae were incubated at 67 °C for 2h in pre-
warmed hybridization buffer (5x SSC, 500 μg/ml type VI Torula yeast RNA, 50 μg/ml 
Heparin, 0.1% Tween 20, 9mM citric acid, 50% formamide, pH 6.0). Hybridization 
buffer was replaced with digoxigenin (DIG) labelled ISH probes diluted in 
hybridization buffer and incubated at 67 °C overnight. The next day, larvae were 
washed at 67 °C twice in hybridization buffer, three times in 50% 2×SSCT/50% 
deionized formamide, and three times in 2xSSCT for 20 min each, followed by four 
washes at 67 °C in 0.2x SSCT (20x SSC: 300mM NaCl, 200mM Na-Citrate, pH 7; SSCT: 
0.1 % Tween 20 in 1xSSC) for 30 min each. Larvae were then washed in PBT and 
incubated for 1 h in blocking buffer (5% heat-inactivated sheep serum, 10 mg/ml 
BSA in PBT) under slow agitation. Thereafter, larvae were incubated overnight at 4 
°C in blocking buffer containing pre-absorbed anti-DIG antibody coupled to alkaline 
phosphatase (1:3000–4000). The next day, larvae were washed five times in PBT 
for 20 min each, followed by three washes in staining buffer (50mMMgCl2, 
100mMNaCl, 100mM Tris-HCl, 0.1% Tween 20, pH 9.5) for 5 min each. Color 
reaction was performed by incubating larvae in staining buffer supplemented with 
NBT/BCIP (Sigma-Aldrich) substrate. The staining reaction was terminated by 
washing larvae in PBT. For chromogenic ISH, background staining was cleared by 
incubating larvae two times in 100% EtOH for 15 min each, followed by five washes 




2.3.2 Immunohistochemistry (IHC) on whole mount larvae 
 
All incubations were performed at room temperature unless stated otherwise. For 
most immunolabelling experiments, the larvae were fixed in 4% PFA-PBS containing 
1% DMSO at 4°C overnight. After washes in PBS, larvae were washed in PBTx. After 
permeabilization by incubation in PBS containing 2 mg/ml Collagenase (Sigma) for 
25 min larvae were washed in PBTx. They were then incubated in blocking buffer for 
2 h and incubated with primary antibody (1:50–1:500) diluted in blocking buffer at 
4°C overnight. On the following day, larvae were washed times in PBTx, followed by 
incubation with secondary antibody diluted in blocking buffer (1:300) at 4°C 
overnight. The next day, larvae were washed three times in PBTx and once in PBS 
for 15 min each, before mounting in glycerol.  
For whole mount immunostaining using primary antibodies from the same host 
species (rabbit anti-Il-1b, rabbit anti-Mpx, rabbit anti-Tp63) after fixation the 
samples were initially incubated with the first primary antibody at 4oC overnight. 
After washes with PBTx the samples were incubated with the conjugated first 
secondary antibody overnight at 4oC. Subsequently samples were incubated with 
blocking buffer for 1 h at RT in order to saturate open binding sites of the first 
primary antibody. Next, the samples were incubated with unconjugated Fab 
antibody against the host species of the primary antibody in order to cover the IgG 
sites of the first primary antibody, so that the second secondary antibody will not 
bind to it. After this, samples were incubated with the second primary antibody 
overnight at 4oC and subsequently with the second conjugated secondary antibody 
overnight at 4oC before mounting in glycerol. No signal was detected when the 
second primary antibody was omitted, indicating specificity of the consecutive 
immunolabeling protocol.  
For whole mount immunostaining of acetylated tubulin, the protocol was 
performed as previously described 1. Briefly, larvae were fixed in 4% PFA for 1 h and 
then were dehydrated and transferred to 100% MeOH and then stored at 20°C 
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overnight. The next day head and tail were removed, and the samples were 
incubated in pre-chilled Acetone. Thereafter larvae were washed and digested with 
Proteinase K and re-fixed in 4% PFA. After washes the larvae were incubated with 
BSA in PBTx for 1 h. Subsequently the larvae were incubated for 2 overnights with 
primary antibody (acetylated tubulin). After washes and incubation with the 
secondary antibody the samples were washed in PBS for 15 min each, before 
mounting in glycerol. 
 
2.3.3 Evaluation of cell death using Acridine orange 
 
In order to assess the levels of cell death after injury I used the acridine orange 
live staining. At 1day and two days post lesion the larvae were incubated in 
2.5μg/ml solution of dye diluted into conditioned water for 20 minutes. After 




2.3.4 Identification of dying cells after injury 
 
In order to assess the levels of cell death after injury and identify the type of cells 
that are dying after the injury whole mount larvae and cross sections of larvae were 
used. Larvae were fixed in 4% PFA overnight at 4oC. After washes with PBSTx 0,5%, 
the larvae were transferred to 100% Methanol and incubated for 10 min at room 
temperature. After rehydration, the larvae were washed with PBSTx 0,5%. The 
larvae were then permeabilized using 14μg/ml diluted in 0,5%PBSTx. After brief 
wash with PBSTx the larvae were postfixed for 20min in 4%PFA. Excess of PFA was 
washed out and the larvae were incubated with the TUNEL reaction mix according 
to In Situ Cell Death Detection Kit TMR red protocol. Following this the larvae were 
processed for Immunofluorescence. After washes, larvae were then incubated in 
blocking buffer (0.7% PBTx, 1% DMSO, 1% normal donkey serum, 1% BSA) for 2 h, 
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and incubated with primary antibody (1:50–1:300) diluted in blocking buffer at 4 
°C overnight. On the following day, larvae were washed 5 times in PBTx, followed 
by incubation with secondary antibody diluted in blocking buffer (1:300) at 4 °C 
overnight. The next day, larvae were washed three times in PBTx and once in PBS 
for 15 min each, before mounting in 70% Glycerol-PBS. 
 
2.3.5 EdU detection 
 
For the detection of EdU in larvae, the IHC protocol was modified as follows: After 
washing the tissue with PBSTx and PBS washes, the larvae were permeabilized by 
incubation in PBS containing 2 mg/ml Collagenase (Sigma) for 25 min after washes 
with PBSTx larvae were incubated for 2.5 hours in the Click-iT™ reaction cocktail 
(Invitrogen) at room temperature with gentle agitation, protected from light. The 
reaction cocktail was removed with several PBS washes, and the larvae cleared with 
70% glycerol in PBS. The components of the reaction cocktail, previously optimized 
for the use in either larvae or the adult tissue, are listed in the table below: 
 
Reaction components Whole-mount embryo 
10 x Click-iT
TM reaction buffer 10.75 µl 
H2O          233 µl 
CuSO4              5 µl 
Alexa Fluor azide 647    0.25 µl 
Reaction buffer additive    1.25 µl 







2.3.6 EdU detection/HB9 IHC 
 
For the detection of newborn motor neurons the larvae were washed with PBSTx 
and PBS washes followed by permeabilization by incubation in PBS containing 2 
mg/ml Collagenase (Sigma) for 25 min. After washes with PBSTx larvae were 
incubated for 2.5 hours in the Click-iT™ reaction cocktail (Invitrogen) at room 
temperature with gentle agitation, protected from light. The reaction cocktail was 
removed with several PBS washes, and the larvae were washed with PBStx 0.5%, 3x 
10 min each.  
After this, the larvae were incubated into 10mM citric acid, pH=6 at 110 oC 10min 
using a pressure cooker for antigen retrieval. Samples were then washed once with 
PBStx and transferred to blocking buffer (1% NDS, 1% DMSO, 1% BSA, 0.7% Triton 
X-100) for 1 hour at room temperature under slow agitation. After this the larvae 
were incubated with mouse anti-HB9 1:200 at 4 oC for 2 nights. The primary 
antibody was removed by washing the samples with PBStx and then they were 
incubated with secondary antibody overnight at 4oC. Following this the larvae were 
washed with PBStx once in PBS for 15 min each, before mounting in 70% Glycerol-
PBS. 
 
2.4 Quantification and data analysis 
 
2.4.1 Live imaging of zebrafish larvae and time-lapse imaging 
 
For the acquisition of all fluorescent images, LSM 710 and LSM 880 confocal microscopes 
were used. For live confocal imaging, zebrafish larvae were anesthetized in PBS 
containing 0.02% MS222 and mounted in 1.5% low melting point agarose (Ultra- 
PureTM, Invitrogen). During imaging, the larvae were covered with 0.01% MS222-
containing fish water to keep preparations from drying out. For time-lapse imaging, 
agarose covering the lesion site was gently removed after gelation. Time-lapse imaging 
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was performed for 19 h starting at 6 hpl. Acquired time-lapse images were denoised 
using the ImageJ plugin CANDLE-J algorithm, which allows to remove the noise 
compartment while preserving the structural information with high fidelity (Coupe et al. 
2012). Comparison of raw movies with CANDLE-J-processed movies, showed that edges 
of features remained conserved after denoising. 
 
2.4.2 Assessment of spinal cord bridging 
 
Re-established axonal or glial connections (bridges) were scored in static preparations 
(fixed immunolabelled samples, live transgenic animals) or in still images of time-lapse 
movies at time points of interest. Larvae were directly visually evaluated using confocal 
imaging (Zeiss LSM 710, 880). A larva was scored as having a bridged lesion site when 
continuity of the neuronal or glial labeling between the rostral and caudal part of the 
spinal cord was observed. Continuity of labeling was defined as at least one fascicle 
being continuous between rostral and caudal spinal cord ends irrespective of the fascicle 
thickness. Larvae in which the lesion site was obscured by melanocytes were excluded 
from analysis. Quantification of axonal and glial fascicle composition in static 
preparations at 1 dpl it was performed after confocal imaging (Zeiss LSM 880) of 
immunolabeled or live animals. Fascicles were identified as fluorescent protrusions from 
the severed spinal cord that projected into the injury site for at least 20 µm or had 
crossed it completely. This was done by inspecting single optical sections and 3D 
renderings of the lesion site. If more than half of the length of a fascicle contained 
fluorescence for both glial and neuronal markers it was scored as “mixed”, otherwise it 
was scored as purely “axonal” or “glial” depending on the markers used. The threshold 
of half the length was used to exclude situations in which one type of process followed 
the other long after that one was established. For quantification of axonal and glial 
fascicle composition in time-lapse movies we included only fascicles that grew during 
the observation period. Fascicles were classified as purely “axonal” or “glial” when the 
distal part of a given fascicle was labelled by the respective marker throughout the entire 
observation period. In “mixed” fascicles, both markers were present in the distal portion 
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of the fascicle. In some cases, the thickness of the axonal bridge was measured in 
collapsed confocal image stacks, by determining the length of (a) vertical line(s) that 
covers the width of crossing fascicles at the center of the injury site. For all 
quantifications, I was blinded to the experimental treatments. Before starting the 
experiment, a member of the lab was blinding the groups for me by remaining them 
using numbers and after I was done with the quantifications the groups were unblinded. 
 
2.4.3 3D cell counting 
 
A volume of interest was defined centered on the lesion site from confocal images. 
The dimensions were: width = 200 μm, height = 75 μm (above the notochord), 
depth = 50 μm. Images were analysed using the Imaris (Bitplane, Belfast, UK) or the 
ImageJ software. The number of cells was quantified manually in 3D view, blinded 
to the experimental condition on at least three independent clutches of larvae. 
 
2.4.4 Quantification of diffused signal in whole mount larvae 
 
For most quantifications of diffuse signal, image stacks, centered in the lesion site 
(height: 50 µm) were collapsed and an area of interest defined: width = 100 μm, 
height = 50 μm (above the notochord). The image was thresholded and the ‘’Analyze 
Particles’’ tool in Fiji (Schindelin et al. 2012) with default settings was used to 
calculate the percentage of area taken up by signal. To quantify Col I in the injury 
site we used a previously published protocol (Wehner et al. 2017). All analyses were 
performed blinded to the experimental condition on at least three independent 






2.4.5 Image acquisition and analysis 
 
For the acquisition of all fluorescent images, Zeiss LSM 710 and Zeiss LSM 880 
confocal microscopes operated by Zeiss Zen 2011 software were used. Image 
analysis was performed using ImageJ (http://imagej.nih.gov/ij). Power analysis 
using G*Power (Faul et al. 2009), was used to calculate power (aim > 0.8) for the 
experiments and determine the group sizes accordingly. Statistical power was > 
0.8 for all experiments. All quantitative data were tested for normality and 
analyzed with parametric and non-parametric tests as appropriate. The 
statistical analysis was performed using IBM SPSS Statistics 23.0. Shapiro-Wilk’s 
W-test was used in order to assess the normality of the data. Quantitative RT-
PCR data were analyzed as previously described (Livak and Schmittgen 2001, 
Ganger et al. 2017). Kruskal-Wallis test followed by Dunn’s multiple 
comparisons, One-way ANOVA followed by Bonferroni multiple comparisons 
test, two-way ANOVA, followed by Bonferroni multiple comparisons, t-test, 
Mann–Whitney U test or Fischer’s exact test were used, as indicated in the 
Figure legends. *P< 0.05, **P< 0.01, ***P< 0.001, n.s. indicates no significance. 
Error bars indicate the standard error of the mean (SEM). The Figures were 
prepared with Adobe Photoshop CC and Adobe Illustrator CC. Graphs were 
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Contribution: Assessing the role of the immune system during regeneration of the 






In this chapter I assessed the role of the innate immune response to the regeneration 
of the motor neurons after injury. This part of my thesis has already been published 
with me as a contributing author (Ohnmacht et al., 2016). The purpose of this study 
was to establish a larval regeneration paradigm and assess the plasticity of the spinal 
progenitors after injury and whether these cells react to signals from the 
environment similar to those during regeneration in the adult model. It has been 
shown from (Kyritsis et al. 2012) that the microglial response is essential for neuronal 
regeneration after stab injury of the adult zebrafish telencephalon. Furthermore, the 
inflammatory response is one of the key events that occur after injury in different 
models and it’s diverse role in each case has been mentioned by different studies. 
Therefore, I wanted to assess the role of the immune response in the larval SCI injury 
context and used pharmacological and genetic approaches. What I found is that 
motor neuron regeneration is inhibited after manipulation of the immune response, 
suggesting that direct or indirect signalling from the innate immune cells to the 
progenitor cells occurs and is important for regeneration after injury. 
 
3.1.1 Zebrafish as a model to study neuroregeneration. 
 
In contrast to mammals, fish and amphibians are characterized by high regenerative 
potential of their CNS after injury. In the lesioned spinal cord of salamander, 
ependymal cells migrate to the lesion site and contribute to the production of new 
neurons. These animals can also regenerate their severed axons and establish new 
functional connections which contributes to successful spinal cord repair (Tazaki et 
al. 2017). Amphibians such as frogs are also capable of regenerating their injured 
spinal cord, however, this regenerative capacity lasts only until the metamorphosis 
stage (Beattie et al. 1990). Regeneration of spinal cord has also been described in 
birds but their regenerative ability declines during development (Shimizu et al. 1990). 
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Until recently there has been a dogma that adult neurogenesis occurs in distinct 
proliferative zone in the mammalian brain. It has been demonstrated that there are 
some populations of neural stem cells that have the ability to self-renew and 
differentiate in the adult mammalian brain (Reynolds and Weiss 1992). For example, 
in rodents it has been observed that new neurons are generated throughout 
adulthood (Lois and Alvarez-Buylla 1994). However, the regenerative capacity of 
mammals is limited (Gage and Temple 2013) and a recent study suggests that 
hippocampal neurogenesis drops to undetectable levels in humans after childhood 
(Sorrells et al. 2018).  
In order to explain the difference in neurogenic capability between organisms such 
as mammals and teleosts, such as the zebrafish, it has been suggested that this 
difference is due to the number of proliferative zones present in the CNS (Grandel et 
al. 2006). The number of proliferative zones in mammals has been proposed to be 
reduced across evolution (Tanaka and Ferretti 2009). Another theory suggests that 
the reduction in neurogenic capacity in the mammalian CNS might also be because 
their brains stop growing in size during adult stages. In other animals, like zebrafish, 
which have a higher neurogenic capacity, growth of the brain is life-long and may 
therefore exhibit higher levels of proliferation (Grandel et al. 2006).  Several studies 
have shown that zebrafish as well as other members of the teleost family have an 
extensive network of proliferative zones in the adult brain including in the olfactory 
bulb, telencephalon, diencephalon and mesencephalon (Grandel et al. 2006). It has 
also been shown that apart from adult neurogenesis there is also differentiation into 
different types of neurons as dopaminergic neurons and serotonergic neurons which 
are incorporated into areas such as the olfactory bulb and diencephalon in adult 
stages (Grandel et al. 2006). This evidence of constitutive neurogenesis makes the 
zebrafish an attractive model to study the mechanisms underlying adult neurogenesis 
which is very restricted in the mammalian models. The neurogenic regions of the 
mammalian CNS have been localised to the dentate gyrus of the hippocampus in the 
subgranular zone and the lateral ventricles of the forebrain in the subventicular zone 
(Gross 2000, Alvarez-Buylla and Garcıá-Verdugo 2002).  
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In  zebrafish, after CNS injury, cells contained in proliferative zones are triggered and 
carry out neurogenesis (Ghosh and Hui 2016). However, there are different factors 
that affect the survival of the newly formed neurons, for example the lack of 
functional integration into the system. Other factors may also influence the survival 
of newly generated neurons such as the formation of glial scars and a non-favourable 
extracellular environment for growth of axons (Ming and Song 2005). In the 
mammalian brain, parenchymal astrocytes after activation following injury, are 
recruited to the injury site. These activated astrocytes then form a glial scar which is 
known to be impermeable to axon growth (Rolls et al. 2009).  
Unlike mammals, zebrafish do not form glial scars following CNS injury. Instead they 
demonstrate recovery of tissue integrity without scarring, such as in the spinal cord 
and brain (Becker and Becker 2007, Reimer et al. 2008, Kizil et al. 2011). This suggests 
that the zebrafish brain maintains a more permissive environment following injury 
for the recovery of neurons and their axons to re-establish brain architecture. This 
regenerative quality is independent on the type of injury, as recovery is observed 
following a plethora of lesions such as spinal cord injuries (Becker et al. 1997, Wehner 
et al. 2018), injury in the telecephalon (Kyritsis et al. 2012), and the retina(Rao et al. 
2017) or optic nerve transection (Diekmann et al. 2015, Van houcke et al. 2017). 
Assessment of regeneration and its functional results can be achieved in that model 
through genetic techniques including the use of reporter lines as well as established 
behavioural and electrophysiological testing (Becker et al. 2004, Ohnmacht et al. 
2016, Moreno et al. 2017, Wehner et al. 2017). Although proliferative zones are more 
numerous in the zebrafish compared to mammals, the underlying processes of 
neurogenesis are believed to be similar. Neurogenesis within the zebrafish brain 
occurs in subventricular proliferative zones arising from radial glia-type progenitors 
and then the newly generated neurons migrate to their intended destinations 
(Kroehne et al. 2011). In the zebrafish these cells are referred to as ependymoradial 
glia cells (ERGs) due to their soma being located on the ependymal lining of the 
ventricle and their characteristic radial processes that contact the pial surface and 
believed to be the stem cells within the zebrafish CNS responsible for the 
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regenerative capacity of zebrafish (Becker and Becker 2015). Following an injury to 
the brain proliferation of ERGs could be activated in two ways; either directly due to 
the injury causing disruption to the radial processes of the ERGs, or indirectly via 
chemical signals such as glutamate and ATP leading to calcium release by surrounding 
tissues (Sieger et al. 2012, Franze et al. 2013).  
CNS injuries also lead to the activation of the immune system which leads to the 
recruitment of CNS immune cells such as microglia. This immune response is believed 
to be a crucial component of regeneration as illustrated by studies in which this 
immune response is inhibited, leading to less neuronal regeneration (Kizil et al. 2012). 
(Kyritsis et al. 2012) showed that a microglia reaction following injury increases the 
amount of proliferation and tissue repair in the zebrafish. Therefore, factors released 
by microglia have been suggested as promotors of neurogenesis. Evidence for this 
hypothesis comes from experiments in which a signalling molecule, believed to be 
released by microglia - leukotriene C4, was shown to promote neurogenesis in a non-
injured context (Kyritsis et al. 2012). However, the role of inflammation during CNS 
injury is still unclear. 
One main reason for this relative lack of knowledge of the role of inflammation in 
CNS is the complexity of the system. The majority of injury models are characterised 
by an interaction between innate and adaptive immunity. Therefore, it is very difficult 
to characterise the contribution of either the innate or the adaptive immune 
response alone during injury. Several studies mention the role of innate immunity 
(Kyritsis et al. 2012, McMurran et al. 2016) and adaptive immunity (Kipnis 2016)  
during CNS regeneration. Zebrafish larvae offer the advantage that we can selectively 
study the contribution of the two arms of immunity due to the time difference 
between their development and maturation (Meijer and Spaink 2011). Additionally, 
it has been shown that motor neuron regeneration can be studied in larvae after CNS 
injury (Ohnmacht et al. 2016). Injury in the larval spinal cord leads to increased 
proliferation of larval progenitor cells in the neuron progenitor domain (pMN). This 
feature makes zebrafish larvae an excellent model to study the regenerative events 
that occur CNS after injury combined with the inflammatory response.  
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 3.1.2 The Inflammatory response in zebrafish larvae 
 
Teleosts, like mammals, are equipped with defence mechanisms against pathogens. 
These include production of molecules like cytokines and chemokines and specialised 
cells like neutrophils and macrophages that are responsible for maintaining 
homeostasis. The cellular machinery of the teleosts has been described by Traver et 
al.,2003 (Traver et al. 2003). Signaling pathways that are well studied in mammals 
and include activation of NF-κB, TLRs and TIR are conserved in fish (Oshiumi et al. 
2003, Oshiumi et al. 2003) in general and more specifically in zebrafish (Jault et al. 
2004). Adaptive immunity is also conserved in zebrafish. However, although the 
development of the thymus initiates early in zebrafish, with the thymic rudiment to 
be formed by 60 hours post fertilization (hpf), there is no clear distinction between 
cortex and medulla derived from the interaction between T cell precursors and 
thymic epithelial cells until 3-4 weeks of age (Lam et al. 2002). Conversely, in mice 
this process is completed shortly after birth (Ritter 1978). This allows a temporal 
separation of innate and adaptive immunity in zebrafish studies which is not possible 
in mammals. 
Zebrafish transparency and the ease of manipulation of its genome has allowed the 
development of transgenic lines that can be used for in vivo monitoring of leukocyte 
recruitment towards the injury or infection site over time. The first cells responding 
to the insult are the neutrophils which migrate into the wound, initiating the 
inflammatory response. They phagocytose debris and produce molecules like 
cytokines, chemokines and ROS that attract other cells like macrophages to the injury 
site. Over time the number of neutrophils decreases, and macrophages become the 
main cell type at the insult site. They phagocytose larger debris, resolve the 
inflammatory response and regulate tissue repair. The inflammatory response in 
zebrafish recapitulates what is known in mammals regarding the progression of 
inflammatory response after injury.  
In order to assess the role of the inflammatory response for the regeneration of 
motor neurons after injury I used the larval injury model that has been established in 
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the Becker group (Ohnmacht et al. 2016) and quantified the inflammatory response 
and the regeneration of motor neurons two days post injury with or without 
manipulation of the immune response. The tools that were used to manipulate the 
immune response were pharmacological inhibition using dexamethasone and the irf8 
mutant line that lacks macrophages and microglia during the early stages of 
development (Shiau et al. 2015) These animals have a TALEN-mediated mutation that 
leads to embryos null for the Interferon regulatory factor 8 (Irf8) which is critical for 
mammalian macrophage development and innate immunity. Irf8 is required for 
formation of all macrophages during primitive and transient definitive 
hematopoiesis, but not during adult-phase definitive hematopoiesis. These 
experiments showed that after injury the number of newborn motor neurons is 
significantly decreased compared to lesioned age-matched control groups, indicating 
that inflammatory response is essential for neuronal regeneration similar to what has 
been previously described in adult zebrafish (Kyritsis et al. 2012). 
Therefore, it is essential to understand the immune mediators involved and the 
mechanisms behind successful regeneration in fish to apply these findings to future 
therapeutic interventions and treatments in mammals.    
 
3.2 RESULTS  
 
3.2.1 Dexamethasone impairs the migration of immune cells after injury 
 
Reactive immune cells promote neuronal regeneration (Kyritsis et al. 2012) and the 
larval spinal cord offers the opportunity to study the innate immune system in 
isolation from the adaptive immune response, which develops only later (Danilova 
and Steiner 2002, Lam et al. 2004). To determine whether the innate immune system 
promoted motor neuron generation after a larval lesion, we labelled microglial cells 
with a 4C4 antibody (Becker and Becker 2001), and all macrophages/microglia and 
neutrophils with an L-plastin  antibody (Feng et al. 2010). At 48 h after the lesion, 
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labelling of both 4C4 and L-plastin was concentrated in the lesion site (Fig. 3.1.A,B,D). 
This response was suppressed by incubating the larvae in the immunosuppressant 
dexamethasone (Kyritsis et al. 2012). In order to find the optimum concentration I 
performed a dose response using 1 μM, 5 μΜ, 10 μΜ, 20 μΜ 100 μΜ and 200 μΜ 
and found that 100 μΜ is the optimum concentration that shows an effect in the 
number of immune cell in the lesion site without impacting the survival of larvae. I 
also searched the literature and found that the same concentration has also been 
used by other groups (Meijer et al. 2015, Wilson et al. 2016). This strongly dampened 
the microglia/macrophage response (Fig. 3.1.C,E,F). This treatment also led to a 
reduction in the number of newly generated Hb9:GFP+/EdU+ motor neurons by 60% 
within 48 h of the lesion (3-5 dpf; Fig. 3G-I), suggesting that macrophages/microglial 
cells exert a positive influence on motor neuron regeneration. 
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Figure 3.1. Suppression of the immune response inhibits motor neuron 
regeneration. (A) Time line for the experiments. (B-F) Incubation with dexamethasone does 
not lead to visible changes in unlesioned larvae (B,C), but strongly reduces the immune 
reaction at the lesion site (D,E) as indicated by reduced 4C4 (arrowheads indicate 4C4+ cells) 
and L-plastin immunoreactivity. Quantification of immunoreactivity is shown in F (Student’s 
t-test, ***P<0.001; untreated, n=21; dexamethasone, n=25). (G-I) Dexamethasone 
treatment reduces the number EdU-labelled Hb9:GFP+ motor neurons (arrowheads). Higher 
magnifications of double-labelled neurons indicated by asterisks in G,H are shown in single 
optical sections in G′-H‴. (I) Quantification of the reduction in newly generated motor 
neurons (t-test; **P=0.0085; unlesioned, n=16; dexamethasone, n=13). Each point on figure 
relate to each larva used. Lateral views are shown; rostral is left, dorsal is up. The lesion site 
is indicated by a dashed line. Values are means±s.e.m. Scale bars: 100 µm in E for B-E; 100 
µm in H for G,H; 50 µm in H‴ for G′-H‴. 
 
3.2.2 Absence of macrophages and microglia leads to decreased number of 
new-born motor neurons  
 
The use of the irf8 mutant model (Shiau et al. 2015) allowed to use an extra tool to 
study the regeneration of the motor neurons in the zebrafish larvae after injury. 
These animals are characterized by absence of macrophages and microglial cells and 
increased numbers of neutrophils (see Chapter 5) during the early stages of 
development. This allowed me to assess the role of the macrophages/microglia 
during regeneration of the spinal cord after injury. Hb9 immunostaining combined 
with EdU injections showed that the number of motor neurons after injury was 
significantly decreased compared to wildtype larvae. This showed that the absence 
of macrophages and microglia or increased presence of neutrophils in this model has 























Figure 3.1. Absence of macrophages and microglia leads to decreased neuronal 
regeneration after spinal cord injury. (A) Wild type spinal cord after injury. (B) Spinal cord of 
the irf8-/- larvae. (A’-B’’’) Higher magnifications and single channels showing the the co-
localization of the Hb9/EdU in wt and irf8-/- larvae. Each point on graph relates to each 
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zebrafish larva used. Quantification of immunoreactivity is shown in C (Student’s t-test, 




3.3.1 Microglia/macrophage signaling might contribute to regeneration 
 
Activation of the immune system is one of the key features that is similar to what is 
happening to adult models after injury. It has been described in previous work of the 
Becker group that after injury in the adult CNS of the zebrafish there is an increase in 
the number of microglial cells in the injury site (Becker and Becker 2001). 
Furthermore, the importance of the microglial response during regeneration has 
been analysed by Kyritsis et al. (Kyritsis et al. 2012). Here is demonstrated that 
manipulation of the immune response either using pharmacology or mutant larvae 
lacking macrophages and microglia leads to impaired motor neuron regeneration 
after spinal cord injury.  
Dexamethasone decreased the recruitment of immune cells to the injury site which 
subsequently led to decreased motor neuron regeneration. This is in agreement with 
previous studies, where inhibition of the inflammatory response led to decreased 4C4 
and L-plastin immunoreactivity around the injury site, leading eventually to 
decreased neuronal regeneration (Kyritsis et al. 2012). This may be because immune 
cells produce molecules that have been shown to support neurogenesis from neural 
progenitor cells (Ziv and Schwartz 2008). Recruitment and induction of neural stem 
cells is crucial for the neuronal regeneration. Evidence regarding the involvement of 
the inflammatory response to neuronal regeneration mention that innate immune 
cell can act directly on neural progenitor cells or induce the production of growth 
factors from adjacent endothelial cells through cytokine production. Some of these 
factors, including TGF-β and SDF-1, induce neuronal progenitor cell proliferation and 
migration towards the injury site (Merino and Oset-Gasque 2013, Cheng et al. 2017). 
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Furthermore, neuronal and glial differentiation can be promoted by Notch and BDNF 
ligands that are produced by macrophages or microglia (Ziv and Schwartz 2008). 
Another interesting aspect of the irf8 mutants that exhibit decreased neuronal 
regeneration, is the fact that these animals exhibit also increased numbers of 
neutrophils under naïve conditions (Shiau et al. 2015)but also after injury.  
Neutrophils have been shown to be detrimental for regeneration in different tissues. 
One example is a study from Li et al.,2012 where they highlight the different roles of 
macrophages and neutrophils during zebrafish tail fin regeneration. More specifically 
they have found that ablation of macrophages leads to delayed and impaired 
regeneration whereas ablation of neutrophils results in acceleration of the growth 
rate after injury (Li et al. 2012). Furthermore, neutrophils contribute to tissue injury 
by amplifying the inflammatory response by producing ROS and proteolytic enzymes 
and antimicrobial proteins (Wilgus et al. 2013). A possible explanation in our model 
for decreased neuronal regeneration could be that the increased number of 
neutrophils in the injury site creates a hostile environment by amplifying the immune 
response that occurs. It has been shown that there are multiple feedback 
amplification mechanisms, like tyrosine kinase signaling after injury which are 
involved in various neutrophil functions including cellular polarization, neutrophil 
recruitment, effector responses, and interactions with other immune and non-
immune cells (Cheng et al. 2017). Furthermore, recent study on rats showed that 
inhibition of neutrophils elastase promoted upregulation of angiopoietin-1 which 
led to decreased glial scar and increased number of neurons after SCI (Kumar et al. 
2018). 
Questions to be answered in future research on this system: In order to get a better 
insight of how neuronal regeneration is mediated through inflammatory response 
the signal to the progenitors from the neutrophils and the macrophages needs to be 
found. For this, RNA sequencing could be a necessary experiment which will show 
what signals produced by neutrophils over time after injury. Taken together these 
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data combined with the results from Ohnmacht et al., 2016 can help to answer the 
question regarding which immune cell type is needed after injury. 
Taken together these data show that after manipulation of the immune response 
using pharmacology or genetic manipulation, regeneration of the spinal cord is 
impaired indicating that inflammatory response is essential for regeneration after 
spinal cord injury, showing that there is a possible direct or indirect signaling from 
the immune system to the progenitors.  Furthermore, this shows that the larval 
zebrafish SCI model resembles what is known in the adult system where activation of 



























Chapter 4: Axonal regeneration in zebrafish 
larvae after spinal cord injury 
 
 
Wehner, D., Tsarouchas, T. M., Michael, A., Haase, C., Weidinger, G., Reimer, M. M., 
Becker,T., Becker, C. G. Wnt signaling controls pro-regenerative Collagen XII in 
functional spinal cord regeneration in zebrafish (2017). Nat Commun. 2017 Jul 
25;8(1):126. doi: 10.1038/s41467-017-00143-0. 
 
Contribution: Characterization of the axonal regeneration after spinal cord injury and 
deciphering the role of the glial processes (Figure 1) using live imaging and 
immunohistochemical tools and the NTR/MTZ system to ablate the glia, behavioural 
testing to assess the role of Wnt/β-catenin during functional recovery after spinal 




In this chapter I assessed how axons regenerate after injury in zebrafish larvae and 
checked the hypothesis that the formation of glial scar is an essential substrate for 
the axons to grow on. This part of my thesis has already been published with me as a 
contributing author (Wehner et al. 2017). The purpose of this study was to 
characterise the substrate that the axons are growing on after injury and assess the 
role of the extracellular matrix (ECM) during axonal regeneration since very little is 
known about the regulation and composition of the growth promoting ECM in 
zebrafish. This study shows that the ECM is controlled by the Wnt signalling pathway 
and that the axons are able to navigate the lesion site without glial support. I used 
different reporter lines in order to visualize the glial and the neuronal elements of 
the spinal cord in combination with high resolution microscopy and 
immunohistochemical methods. I managed to show for the first time in zebrafish that 
axons are able to cross the injury site and establish new functional connections 
without the glial support. Furthermore, I used the MTZ/NTR system in order to 
selectively ablate the glial population. The treatment did not affect the ability of the 
axons to cross the injury site indicating that axons are able to navigate the ECM-rich 
lesion site and glial bridges do not appear to be an obligatory substrate during this 
process. 
 
4.1.1 Axonal regeneration after injury 
 
 
Following spinal cord transection, fish and amphibians have the ability to re-grow 
their severed axons across the injury site and establish functional connections, which 
leads to behavioural recovery. Severed axons can regrow following injury and 
therefore functional restoration can occur. However, not all the axons exhibit the 
same growth capacity. Regeneration of some axons after SCI is robust (Becker et al. 
1997), but axonal regrowth to a large extent is variable, like in zebrafish where dorsal 
root axons and ascending axons of intraspinal neurons do not exhibit any significant 
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regrowth into the distal spinal cord stump (Becker et al. 1998, Becker et al. 2004), 
whereas aminergic axons regrow only a few micrometers.  
Previous studies suggest that one of the reasons for failure of axonal regeneration 
after mammalian CNS injury is inefficient myelin clearance, whereas in the PNS 
myelin debris are efficiently cleared during Wallarian degeneration by Schwann cells 
and macrophages promotes regeneration (David and Lacroix 2003, Vargas and Barres 
2007, Neumann et al. 2009) . In agreement with this concept, it has been observed 
that zebrafish macrophages are also involved in debris clearance, removal of 
apoptotic neurons, and engulfment of axonal fragments after SCI (Hui et al. 2010). 
After peripheral nerve injury in zebrafish, macrophages recruitment to the injured 
site occurs before axonal fragmentation, and is independent of Schwann cell derived 
signals as shown by (Rosenberg et al. 2012) where the use of sox10-/- mutants that 
lack Schwann cells, showed that after lesion, macrophages arrived at the lesion site 
with timing and morphology similar to those observed in wild-type larvae. 
Additionally, macrophages in these mutants were able to phagocytose axonal debris 
similarly to wild-type larvae.  
A major determinant for successful axon regeneration of adult mammalian CNS is the 
poor intrinsic property of injured neurons.  In order to promote regeneration a great 
deal of effort has been made to induce the intrinsic growth capacity of adult CNS 
neurons, and some studies involving peripheral conditioning lesions showed that 
several regeneration associated transcription factors such as c‐Jun, CCAAT/enhancer 
binding protein, cAMP responsive element binding, STAT‐3, ATF‐3, SRY‐box 1 and 
Smad 1 can enhance growth of the central process beyond the lesion (Filous and 
Schwab 2018). 
Additionally, it has been reported that either suppression of inhibitory factors such 
as phosphatase and tensin homolog (PTEN), suppressor of cytokine signaling (Socs3) 
or overexpression of genes involved in PNS regeneration such as Klf7, CREB, and c‐
Jun could have a positive effect on axonal regrowth in adult CNS (Gao et al. 2004, 
Smith et al. 2009, Sun and He 2010, Smith et al. 2011, Blackmore et al. 2012, Lerch et 
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al. 2014). There are also several negative regulators axonal growth such as cAMP, 
PTEN and Socs3 in mammals. These are conserved and it has been shown that they 
exhibit similar roles in zebrafish (Smith et al. 2009, Liu et al. 2011, Elsaeidi et al. 2014, 
Diekmann et al. 2015). Similarly, mammalian target of rapamycin (mTOR) activation 
promotes axon regeneration. Activation of PI3K or inhibition of PTEN in DRG neurons 
increases neurite outgrowth. Blocking mTOR by rapamycin fails to inhibit neurite 
growth, suggesting that an mTOR independent mechanism may mediate the 
regeneration of peripheral sensory axons.  
In order to understand whether active mTOR plays a role in zebrafish optic nerve 
regeneration, (Diekmann et al. 2015) studied mTOR signaling after injury and found 
that regulation of mTOR activity after optic nerve injury is different from that of 
mammals showing that inhibition with rapamycin only delays rather than abolishes 
axonal regeneration and functional recovery after optic nerve crush, whereas in 
mammals similar treatment led to impairment of optic nerve regeneration (Abe et al. 
2010).  
The most important aspect of axonal regeneration is that the regenerated axons 
reach the appropriate targets over long distances and re-establish functional 
connections, a phenomenon that does not happen in mammals. It has been 
hypothesized that regenerating axons could trace their original pathways along the 
degenerating tracts as happens in PNS (Graciarena et al. 2014). CSPG and other 
inhibitory molecules are known to play an important role during development by 
repelling axons from certain areas that are not meant to be innervated. The 
composition of the ECM in the CNS is different from that in the PNS. The dense glial 
scar that forms after injury and the ECM network act as a physical and molecular 
barrier to axon regeneration in the injured CNS. The major ECM molecules in the CNS 
include glycosaminoglycan hyaluronan and the glycoproteins tenascin‐C and 
thrombospondin whereas the PNS ECM includes laminins, collagen, and heparin 
sulfate proteoglycan. (Wehner et al. 2017) have shown the importance of the ECM 
during axonal regeneration. Following injury, activation of Wnt/β-catenin signaling 
controls the composition of the spinal lesion ECM, which is crucial for functional 
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axonal regeneration in zebrafish. Upregulation of Wnt/β-catenin signaling in non-
neural fibroblast-like cells leads to collagen deposition in the spinal lesion ECM which 
promotes axon growth and functional recovery in zebrafish.  
In order to understand these findings, the relationship between axons and glia 
needed to be analysed. A major impediment to axonal growth in mammalian models 
is the formation of a glial scar. Astrocytes and oligodendrocyte progenitors are at the 
centre of reactive gliosis. In contrast to mammals, the adult zebrafish CNS is 
characterized by decreased expression of some glial and intermediate filament 
markers such as GFAP and vimentin following injury (Ghosh and Hui 2018). Unlike 
mammalian models, in which glial scar formation creates an obstacle to axon 
regrowth, in zebrafish there is an obvious lack of a permanent glial scar. Instead 
several studies mention the formation of a growth permissive glial bridge that may 
lead to axonal regeneration in adult zebrafish (Hui et al. 2010, Baumgart et al. 2012, 
Goldshmit et al. 2012, Mokalled et al. 2016). This glial bridging response is similar to 
Schwann cell behaviour in mammalian PNS. Upregulation of laminin triggers 
cytoskeletal rearrangements, which are essential for PNS regeneration (Chen et al. 
2007).  
Glial bridge formation appears to be conserved between mammals and fish. One 
example of this is the work from (Goldshmit et al. 2014) which suggests that fibroblast 
growth factor 2 (FGF2), given to a hemisection SCI model in mice, decreases 
infiltration of immune cells and gliosis, increases radial glia markers like Pax6 and 
promotes axonogenesis, and ultimately leads to improved functional recovery, 
through the formation of glial bridges, similar to what has been shown in zebrafish 
from the same group where Fgf-dependent glial cell bridges are essential for spinal 
cord regeneration after injury (Goldshmit et al. 2012). Another study from Mokalled 
et al.,2016 (Mokalled et al. 2016) identified connective tissue growth factor (ctgfa) as 
a major determinant for glial bridge formation and axonal regeneration. However, 
the role of the glial bridge for axonal regeneration after SCI is not clear as the data 
from these and other studies show that the manipulations influence both glia and 
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axons in the same way and but there is not a direct correlation between axonal re-
growth and glial manipulation. 
In order to address the question whether axons need a glial bridge as substrate to 
cross the injury site or whether glial and axonal processes cross the injury site 
independently, the following reporter lines were used: Tg(Xla.Tubb:DsRed), 
abbreviated as nbt:DsRed where neuronal elements of the spinal cord fluoresce 
red (Peri and Nusslein-Volhard 2008); Tg(gfap:GFP)mi2001, abbreviated as 
GFAP:GFP where glial elements fluoresce green, (Bernardos and Raymond 2006), 
Tg(her4.3:GFP) where the glial elements of the spinal cord fluoresce green (Yeo 
et al. 2007), Tg(gfap:Gal4ffs995;UAS:NTR-mCherry) where the glial cells express 
the enzyme nitroreductase under the gfap promoter which allows to selectively 
ablate the glial population after addition of metronidazole which is the substrate 
for nitroreductase (Matsuoka et al. 2016), Tg(her4.3:irtTAM2(3F)-p2a-
AmCyanulm6), abbreviated as her4.3:TetA AmCyan where the glial elements of the 
spinal cord fluoresce cyan (Geurtzen et al. 2014), Tg(her4.1:Tet-GBD-p2A-
mCherrytud6) abbreviated as her4.3:mCherry where the glial elements of the 
spinal cord fluoresce red (Knopf et al. 2010). This allowed me to visualise the 
neuronal and glial elements of the zebrafish spinal cord and also to selectively ablate 
the glial population. These lines combined with live imaging allowed me to 
characterise the relationship between axons and glial processes. This showed that 
axons are able to re-grow across the injury site without the glia support. Fascicles 
crossing the injury site are mostly neuronal at 1 day post injury whereas at 2 dpl the 
majority of the fascicles contain both neuronal and glial processes. Furthermore, 








4.2.1 There is no direct interaction between the regenerating axons and the 
glial processes  
 
To determine how axons cross the lesion site, we analysed their relationship with 
astrocyte-like glial processes, as these have been shown to be supportive for axon 
regeneration in zebrafish (Goldshmit et al. 2012, Mokalled et al. 2016). We imaged 
axonal and glial processes in time-lapse video microscopy using double transgenic 
fish for Xla.Tubb:DsRED, to visualize neuronal processes, and either gfap:GFP 
(Bernardos and Raymond 2006) (n = 6 fish, 33 fasicles) or her4.3:EGFP (Yeo et al. 
2007) (n=3 fish, 30 fasicles) to label astroglia-like processes. This revealed that the 
majority of fascicles that entered the lesion site were composed of axons without 
detectable glial processes (49–53%). Some fascicles contained both glial and axonal 
processes (20–21%) and some pure glial fascicles were observed (27–30%; Fig.4.1 see 
Methods section for scoring criteria). To confirm these findings, we used a range of 
combinations of immunohistochemical and transgenic markers for neuronal and glial 
processes in static images of live animals and histological preparations at 1 dpl. This 
showed that 63–77% of axon-containing fascicles (≙46–62% of all fascicles analysed) 
were devoid of detectable glial processes (Fig. 4.1b). Nineteen to 26% contained both 
axonal and glial processes and 19–28% of all analysed fascicles were only composed 
of glial processes. Moreover, double-immunohistochemistry for anti-acetylated 
Tubulin and anti-GFAP showed that at 1 dpl, only 36% of animals had glial processes 
bridging the lesion site, in contrast to 57% of the fish with an axonal bridge. At 2 dpl, 
glial processes had caught up (Fig. 4.1c). This suggests that axons cross the lesion site 
more rapidly than glial processes. In summary, these observations support that many 




Figure 4.1. Regenerating axons navigate a non-neural lesion environment that is rich 
in ECM independently of astroglia-like processes. a Time-lapse video microscopy reveals 
that axonal growth cones (arrow, Xla.Tubb:DsRED) extend into the lesion site independently 
of astroglia-like processes (her4.3:EGFP, empty arrow points out lack of glial labelling). 
Arrowhead indicates glial process extending into the lesion site. Single frames are shown. 
Abbreviations: fin, dorsal fin fold; sc, spinal cord; nc, notochord. b Quantification of fascicle 
composition at 1 dpl using different combinations of immunohistochemical and transgenic 
markers for astroglia-like processes and axons indicates that the majority of fascicles are 
neuronal with no detectable glial component (46–62% of all fascicles analyzed). In the 
example scans on the left, yellow arrows indicate mixed fascicles, containing neurites and 
glial processes; green arrows indicate pure glial fascicles and red arrows indicate pure axonal 
fascicles. c Time course of re-growth of axons (anti-acetylated Tubulin+) and astroglia-like 
processes (anti-GFAP+) after spinal cord transection. Quantification of labelling continuity 
between rostral and caudal spinal cord stumps at 1 dpl and 2 dpl suggests faster bridging of 
the lesion site by neuronal rather than glial processes. Arrow points to axonal bridge with 
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very few glial processes in the lesion site at 1 dpl at higher magnification (Fischer’s exact test: 
**P < 0.01; n.s. indicates not significant) N numbers on figure relate to number of larvae 
used. 
 
4.2.2 Glial bridges are not an obligatory substrate for the axons to grow 
 
To experimentally test a role of astroglia-like processes in supporting axonal 
regeneration, we ablated the majority of glial cells using gfap:Gal4ff;UAS:NTR-
mCherry transgenic fish that express the enzyme nitroreductase under regulatory 
sequences of the gfap gene (Matsuoka et al. 2016) that uses the NTR/Mtz system 
(Curado et al. 2008). More specifically, bacterial Nitroreductase (NTR) is used to 
catalyze the reduction of the innocuous prodrug metrodinazole (Mtz), thereby 
producing a cytotoxic product that induces cell death. Based on this principle, NTR is 
expressed in transgenic zebrafish using the gfap promoter. Subsequent exposure to 
Mtz by adding it to the media induces cell death exclusively within NTR(+) glial cells. 
The treatment did not alter the viability of the larvae which did not exhibit any 
obvious deformities or functional impairment. The treatment almost completely 
eliminated transgene-expressing glial cells by 3 dpf (Fig. 4.2A). A dramatic depletion 
of astroglia-like processes in the lesion site was confirmed by anti-GFAP 
immunohistochemistry (Fig. 4.2 B). However, this treatment did not reduce the 
proportion of animals with axonal bridge (anti-acetylated Tubulin+; Fig. 4.2 B). This 
further supports that glial processes do not have a major role in facilitating axonal 
regrowth across a spinal lesion site. However, we cannot rule out that glial processes 
that were not detected with our markers and were spared by the ablation still 








Figure 4.2. A. Treatment of gfap:Gal4ff;UAS:NTR-mCherry transgenic fish with the 
pro-drug Metronidozole (MTZ) almost completely ablates transgene-expressing glial cells 
by 3 dpf. B.  Treatment of gfap:Gal4ff;UAS:NTRmCherry transgenic fish with MTZ dramatically 
reduces anti-GFAP+astroglia-like processes (t-test: ***P < 0.001) but does not reduce the 
proportion of larvae with axonal bridges at 2 dpl (Fischer’s exact test: n.s indicates not 






4.3.1 Astro-glial bridges are not an obligatory substrate for axonal 
regeneration after SCI 
 
The data presented in this chapter suggest that re-grown axons can navigate through 
the lesion environment and are not following the glial processes. In histological 
preparations this is difficult to assess, as axons and glial processes tend to fasciculate. 
Fasciculation is the ability of neuronal and glial processes to form bundles in order to 
ensure that they will reach their targets (Davis et al. 2017). In zebrafish larvae at 2 dpl 
almost all tissue bridges observed were composed of neuronal and glial processes. 
This makes it difficult to assess the dynamics of the neuronal and glial processes and 
how they interact while they navigate through the non-neural lesion site during the 
regeneration process. For this reason, time-lapse video imaging on double transgenic 
animals where both, their neuronal and glial elements are fluorescent, was 
performed. This showed that both axons and glia can grow independently across the 
injury site. Furthermore, live imaging during the first 24hours after injury showed that 
re-establishment of axonal continuity across the injury site precedes that of   
continuity and this was also verified with histological preparations in which 55% of 
the injured larvae exhibited axonal bridge at 1 dpl whereas, only 37% had glial 
processes that crossed the injury site. This is in agreement with previous studies in 
adult eel (Dervan and Roberts 2003) where after injury cells expressing GFAP do not 
appear in the injury site until 16 days post injury. Additionally, previous works 
studying the regeneration of the visual system of goldfish from Nona 2005 and also 
the spinal cord (Nona and Stafford 1995), have shown that the outgrowth of axons 
after injury does not appear to depend on direct association with glial cells. They 
found that glial processes are not observed among the axons that manage to cross 
the injury site indicating that glial processes follow rather than acting as a substrate 
for the axons to grow on.  
In order to test the role of the glial processes during axonal regeneration of the 
zebrafish spinal cord I used the NTR/MTZ system which allowed me to selectively 
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ablate the glial population, by driving the expression of Nitroreductase under the 
GFAP promoter and assess the regenerative response of the axons in an environment 
devoid of GFAP+ glia. This treatment showed again that the axons are able to grow 
through the injury site without the glial support in contrast to what has previously 
been concluded from other studies which suggest that glial bridges are essential for 
functional axonal regeneration (Goldshmit et al. 2012, Goldshmit et al. 2014, 
Mokalled et al. 2016). While these observations support the hypothesis that glial 
substrates are not essential for axonal regeneration, we cannot exclude that fine glial 
processes that escaped detection and ablation still served as a substrate for axon 
regrowth. Every available reporter line to visualise the glial population, including 
gfap:Gal4ffs995;UAS:NTR-mCherry31);gfap:GFPmi200129, her4.3:EGFPy83; 
her4.3:irtTAM2(3F)-p2a-AmCyanulm6; her4.3:mCherry41  was used and found that 
after injury neuronal axons where growing independently of the glial processes. Most 
of the glial fascicles quantified were purely neuronal. There were also cases where 
the glial processes were bridging the lesion site similarly to the axons, exhibiting the 
same time course but they were not in close proximity with the neuronal fascicles. 
However, we cannot exclude that maybe not all the glial populations have been 
expressing the fluorescent protein that allowed their detection. Additionally, I tried 
to perform immunostaining against nestin in order to visualise the young glial 
population that accumulate in the injury site very short after injury according to 
(Goldshmit et al. 2012) but never got it to work and therefore we cannot exclude the 
possibility that this cell population may act as a substrate for neuronal axons to grow 
across the lesion site. 
Moreover, glial process are likely to support regeneration by physically aligning with 
regenerating fascicles (Goldshmit et al. 2012) and producing essential growth-factors 
(Mokalled et al. 2016). During this study I scored the number of animals that showed 
axonal continuity across the injury site after GFAP glia ablation. In both cases, with or 
without ablation, the fish exhibited similar bridging score after the injury. However, 
no formal assessment of the functionality of the axonal connections after the glial 
ablation was performed. Electrophysiological experiments or behavioural 
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experiments can be utilized in order to see if the treatment leads to any swimming 
defects already before the injury and if this ability of the axons to cross the injury site 
in the absence of glial support can lead to functional recovery. Furthermore, since 
ECM regulation by Wnt has been shown to be essential for axonal regeneration it 
would be good to see if the ECM composition was altered after the treatment. This 
would show if there are any other adverse effects and the crossing of the axons is not 
due to alteration of the ECM, for example due to possible increase in Collagen XII. 
 
4.3.3 But what is the substrate for the axons to grow on and bridge the lesion 
site if not the glial processes?  
 
It is still unknown the substrate that allows zebrafish axons to regenerate after spinal 
cord injury. What is that key element that makes their axons to grow through the 
lesion site? In order to answer this question more experiments need to be performed 
following up the data of this study.  Axons can sense and follow signals from their 
environment through their growth cones. An EM study on the growth cones during 
different stages of axonal growth could provide more information regarding their 
composition and organization which may be different compared to mammals where 
the axons fail to regenerate after transection.  
In addition, there also other cell populations that have been shown to be essential 
for axonal regeneration like fibroblasts (Wehner et al. 2017) or cells that respond 
rapidly and migrate into the injury site like immune cells (Ohnmacht et al. 2016, 
Tsarouchas et al. 2018) and pericytes (Wehner et al. 2017). Time lapse video 
microscopy could provide further information regarding the direct interaction of 
these cells with the axons during regeneration after spinal cord injury. Zebrafish 
larvae can be easily manipulated using pharmacological or genetic tools. In order to 
identify possible substrates for the axons the aforementioned cell populations can be 
easily manipulated generally or in a time dependent manner. It has been shown in 
this chapter that axons start to regenerate in the first 17 hours after injury. One 
possible experiment can be the use of vivo morpholino or the NTR/MTZ method in 
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order to ablate these cells during this early time window and assess the behaviour of 
the axons. 
Very useful information for all the above will provide an unbiased approach to 
determine the composition of the injury site during different time points after injury. 
The use of zebrafish larvae allows the collection of hundreds of larvae relatively easy. 
The larvae can easily be injured, and their injury site can be collected and sent for 
RNA sequencing in bulk or specific populations can be isolated and sent for single cell 
RNA sequencing. The data obtained can be compared over different conditions and 
after different manipulations that have a positive or negative effect on axonal re-


















Chapter 5: The role of the macrophages 
during axonal regeneration 
 
 
Tsarouchas, T. M., D. Wehner, L. Cavone, T. Munir, M. Keatinge, M. Lambertus, A. 
Underhill, T. Barrett, E. Kassapis, N. Ogryzko, Y. Feng, T. J. van Ham, T. Becker and C. 
G. Becker (2018). "Dynamic control of proinflammatory cytokines Il-1beta and Tnf-
alpha by macrophages in zebrafish spinal cord regeneration." Nat Commun 9(1): 
4670. 
According to the guidelines regarding inclusion of publications in Postgraduate 
research theses, for this chapter I wrote a new introduction and discussion. The 
results and figures have been taken from the paper which has been accepted in 
Nature Communications on the 12th of October 2018. 
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Trauma to the central nervous system (CNS) triggers inflammation and 
systemic immunity which regulates the mechanisms of tissue repair.  
The inflammatory response that occurs after injury shows conserved features 
among vertebrates (Riera Romo et al. 2016). Neutrophils are the first cells that 
migrate to the injury site whereas microglia and peripheral macrophages 
migrate into the injury site later. It has been suggested that of these three cell 
types macrophages and neutrophils are crucial regulators of axonal 
regeneration after SCI by producing pro-and anti-inflammatory signals 
(Neirinckx et al. 2014, Wang et al. 2015) which regulate positively or negatively 
axonal regeneration after spinal cord injury. Both microglia and peripheral 
macrophages produce neuroprotective cytokines and growth factors like TGF-
β which has beneficial effects on neurons (Kiefer et al. 1993). Other  factors 
including CNTF, IGF, HGF, PDGF, NGF, BDNF, GDNF and NT-3 also are released 
by activated macrophages (Elkabes et al. 1996, Kerschensteiner et al. 1999, 
Nakajima et al. 2001, Nakajima and Kohsaka 2004, Hashimoto et al. 2005, Kim 
and de Vellis 2005) and have a neuroprotective role. However, the exact role 
of the immune system during CNS injuries is still unclear.    
Zebrafish, in contrast to mammals, are capable of functional CNS regeneration 
after injury. Recovery of swimming behavior critically depends on regeneration 
of axons and the re-establishment of functional connections across the 
complex non-neural injury site (Becker et al. 1997, Wehner et al. 2017). 
Furthermore, several events and signaling cascades that follow injury in the 
CNS are conserved between mammals and zebrafish, although zebrafish regain 
motor function, whereas functional deficits in mammals are often permanent. 
It is therefore important to determine the factors that allow axons to cross the 
lesion site in zebrafish. 
In mammals, a prolonged immune response, consisting of pro-inflammatory 
macrophages (Kigerl et al. 2009), microglia cells (Norden et al. 2015) and 
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neutrophils (Taoka et al. 1997) together with cytokines released from other cell 
types, such as endothelial cells, oligodendrocytes or fibroblasts (Tran et al. 
2018) contribute to an inhibitory environment for axonal regeneration. 
Inflammatory responses and their role during injuries have been studied for 
many years. Interestingly there are several studies that mention that 
inflammation can be essential for regeneration but at the same time it can be 
detrimental, leading to chronic inflammatory phenotypes that result in 
exacerbation of the tissue damage. However, activated macrophages can also 
promote axonal regeneration (David et al. 1990, Yin et al. 2006, Gensel et al. 
2009), suggesting complex roles of the immune response after spinal injury. The 
main difficulty in deciphering the exact role of the inflammatory cascades after 
injury is due to the complexity of the system and the plethora of cellular and 
molecular players. Compared to mammals, in zebrafish, we can dissect the roles 
of these cell types in successful functional spinal cord repair. Their main advantage 
from the inflammatory perspective is in zebrafish the innate immune system is fully 
functional during the early stages of development, whereas their adaptive immune 
system is fully functional after 4 weeks post fertilization (Renshaw and Trede 2012). 
This allows for the separate study of the innate or adaptive immune response 
contribution during axonal regeneration Furthermore, the cellular components of 
immunity in zebrafish are similar to mammals and show similar responses after 
injury. Indeed, microglia are activated after spinal cord injury in adult (Becker and 
Becker 2001, Hui et al. 2010) and larval zebrafish  (Ohnmacht et al. 2016), suggesting 
functions of innate immune cells in repair. Adaptive immunity is also important for 
spinal cord regeneration (Hui et al. 2017). As with macrophages and neutrophils, 
the beneficial or detrimental nature of adaptive immune cells in CNS injury is 
becoming clearer. Studies from Pasare and Medzhitov on mice (Pasare and 
Medzhitov 2003, Pasare and Medzhitov 2004, Iwasaki and Medzhitov 2010) have 
identified the beneficial role of TLR signaling during T-cell-mediated 
neuroprotection, indicating the importance of adaptive immunity on top of the 
innate immunity for CNS regeneration. However, in case of neurodegenerative 
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disorders some studies have shown that TLR signaling exacerbates the pathology by 
amplifying  the immune response (Hanke and Kielian 2011), whereas (Gesuete et al. 
2014) mention that whether TLR activation is detrimental or neuroprotective 
depends on the timing and intensity of receptor stimulation. 
In this chapter I focused only on the contribution of the innate immune response 
during regeneration of the zebrafish spinal cord. Zebrafish larvae regenerate more 
rapidly than adults. Their easiness in manipulating their genome combined with 
their transparency makes them an excellent tool to visualize in vivo the 
regenerative events that take place after injury at the same time with the 
inflammatory response. Previous work in the lab has shown that axons 
encounter Pdgfrb+ fibroblast-like cells that deposit regeneration-promoting Col 
XII in the lesion site in a Wnt-signalling dependent manner (Wehner et al. 2017). 
These cells and molecules are present also in the injury sites of adult zebrafish and 
mammals (Wehner et al. 2017, Tran et al. 2018). How immune cells contribute 
to this growth-conducive lesion site environment in zebrafish is unclear. 
In this chapter I show that after spinal cord injury, peripheral macrophages are 
a major determinant of axonal regeneration. Macrophages promote axonal 
regeneration by producing pro-regenerative tumour necrosis factor alpha (TNF-
α) and by reducing levels of interleukin-1 β (Il-1β). Early expression of Il-1β 
promotes axonal regeneration, whereas prolonged high levels of Il-1β in the 
macrophage-less irf8 mutant has a negative effect on regeneration. 
Additionally, preventing formation of Il-1β producing neutrophils or inhibiting 










5.2.1The immune response coincides with axonal regeneration 
 
I analysed axonal regrowth in larval zebrafish that underwent complete spinal 
cord transection at 3 days post-fertilisation (dpf) in relation to invasion of the 
injury site by different cell types. Axons were present in the injury site by 1 day 
post- lesion (dpl). The thickness of the axonal bundle that connects the injured 
spinal cord increased up to 2 dpl and thereafter plateaued for up to at least 4 dpl 












Fig. 1: Presence of fibroblast-like cells, but not myelinated cells or endothelial cells 
correlates with axonal regeneration. A: The thickness of the axonal bridge observed in 
XIa.tubb:DsRed transgenic animals increases after injury, starting at 1 dpl and plateauing at 
2 dpl (One-way ANOVA followed by Bonferroni multiple comparisons: F 3, 107 = 17.77 ***P < 
0.0001, ns indicates no significance). B: Presence of fibroblast-like cells (pdfrb:GFP+) in the 
lesion site is substantial from 1 dpl, it peaks at 2 dpl, and declines thereafter (One-way 
ANOVA followed by Bonferroni multiple comparisons: F 3, 36 = 53.92, **P<0.01,***P<0.0001, 
ns indicates no significance). C: Myelinating cells (cldnK:GFP+) appear in the injury site only 
at 2 dpl (One-way ANOVA followed by Bonferroni multiple comparisons: F 3, 39 = 14.52, *P0.05, 
***P<0.0001, ns indicates no significance). D: Endothelial cells (fli1:GFP+) do not invade the 
lesion site (One-way ANOVA followed by Bonferroni multiple comparisons: F 3, 22 = 7.939, 
*P0.05, **P<0.01). Identical animals are imaged on consecutive days. Lateral views of the 
injury site are shown; rostral is left. Scale bar: 25 μm. Error bars indicate SEM. Numbers on 
figure relate to number of larvae used. 
 
The thickness of the connecting axon bundles positively correlated with the 
recovery of touch-evoked swimming distance for individual animals at 2 dpl 
(Fig. 2A-C). This is consistent with previous results showing continuous axon 
labelling over the lesion site (axon bridging) in 80 % of animals by 2 dpl, which 
then plateaued. Presence of an axon bridge correlates with functional 
recovery, as animals without axon bridge showed worse recovery of touch-
evoked swimming distance (Wehner et al. 2017) and re-lesioning abolished 
functional recovery (Ohnmacht et al. 2016). Hence, a percent score of larvae 
with bridged injury sites is a quick and reliable measure for anatomical repair 




Fig. 2: Dexamethasone treatment impairs axonal and glial crossing of the injury site 
and recovery of touch-evoked swim distance. A: The thickness of the axonal bridge 
correlates with the distance swum after injury, following treatment with vehicle or 
dexamethasone. B: Distance swum is significantly impaired after treatment with 
dexamethasone (t-test:**P<0.01). C: Correlation table. There is a positive correlation 
between thickness of the axonal bridge and the distance swum, whereas there is a negative 
correlation between bridge thickness and dexamethasone treatment and between distance 
swum and dexamethasone treatment. D: Dexamethasone treatment impairs formation of 
glial bridges (arrow) over the injury site (Fisher’s exact test: **P<0.01). Lateral views of the 
injury site are shown; rostral is left; Dex = dexamethasone. Scale bar in D: 100 μm. Error bars 
indicate SEM. Numbers on figure relate to number of larvae used. 
 
After injury, we observed a rapid and massive influx of immune cells, with 
neutrophils (Mpx+) peaking at 2 hours post-lesion (hpl) and macrophages 
(mpeg1:GFP+; 4C4-) and microglia (mpeg1:GFP+; 4C4+) accumulating in the 
lesion site a few hours later and peaking at 2 dpl (Fig. 3A, ). 
Myelinating cells (cldnK:GFP+) and endothelial cells (fli1:GFP+) were not 
abundant in the lesion site during axonal regrowth (Fig. 1C,D), in contrast to 
functionally important pdgfrb:GFP+ fibroblasts1 that were present in the lesion 
site at 1 dpl, peaking at 2 dpl (Fig. 1B). This suggests that myelinating cells and 
endothelial cells are not essential for axon bridging. However, at later time points 
after injury, axons were clearly associated with processes of myelinating cells 
(Fig. 1C), which may impact functional repair. In contrast, the spatio- temporal 
pattern of immune cell invasion of the injury site suggests an early role for the 
immune system in orchestrating axon growth over the lesion site. 
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Fig. 3: Spinal injury leads to an inflammatory response that promotes axonal 
regeneration. A: Neutrophils, macrophages and microglial cells show different dynamics 
after injury. Neutrophils (Mpx+) accumulate in the injury site very early, peaking at 2 hpl. 
Macrophages (mpeg1:GFP+/4C4-) and microglial cell (mpeg1:GFP+/4C4+) numbers peak at 
48 hpl. Fluorescence images were projected onto transmitted light images. B-E: Incubation 
with dexamethasone (timeline in B) reduces neutrophil and macrophage numbers (C,D; 
Mann-Whitney U test: **P<0.01, ***, P<0.001), as well as the proportion of animals with 
axonal bridging (E; Fisher’s exact test: ***P<0.001). F-I: Incubation of animals with LPS during 
early regeneration (timeline in F) increased numbers of neutrophils and macrophages (G, H; 
t-test: **P<0.01, ***, P<0.001), as well as the proportion of animals with axonal bridging at 
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24 hpl (I; Fisher’s exact test: *P<0.05). Lateral views of the injury site are shown; rostral is 
left. Rectangles indicate region of quantification; arrows indicate axonal bridging. Scale bars: 
50 μm; Error bars indicate SEM. Numbers on figure relate to number of larvae used. 
 
 
5.2.2 Immune system activation promotes axonal regeneration 
 
To determine the importance of the immune reaction, we inhibited it using the 
anti-inflammatory synthetic corticosteroid dexamethasone (Ohnmacht et al. 
2016). This reduced the number of microglia, macrophages and neutrophils in 
the injury site (Fig. 3B-D) and the proportion of larvae exhibiting axon bridging 
(control: 78 % of examined animals, dexamethasone: 30 %; Fig. 3E).  
The average thickness of axon bridges was also reduced by dexamethasone 
treatment and correlated with impaired recovery of touch- evoked swimming 
distance (Fig. 2A-C). gfap:GFP+ astroglia-like processes that cross the injury site 
slightly later than axons1 also showed reduced bridging, from 77.6 % of 
examined animals to 48.3 % (Fig. 2D) under dexamethasone treatment. In 
addition, depleting the number of immune cells with a well-established 
morpholino combination against pu.1 and gcsfr (Feng et al. 2012) reduced the 
proportion of larvae with axonal bridges from 81 % of examined animals to 57 
% (Fig. 4A,B). 
For a gain-of-function approach, we used incubation with bacterial 
lipopolysaccharides (LPS) (Novoa et al. 2009). This increased the number of 
neutrophils and macrophages in the lesion site (Fig. 3F-H). To detect a potential 
accelerating effect on axonal regrowth, we analysed larvae at 18 hpl, when axonal 
regeneration was incomplete in untreated animals. This showed an increase in the 
proportion of larvae with axonal bridges from 41 % of examined animals in 
wildtype to 60 % in LPS-treated animals (Fig. 3I). Hence, immune system activity is 
necessary for and promotes axonal regeneration across a spinal lesion site.  
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Fig. 4: Inhibiting immune cell development impairs axonal regeneration. A: 
Neutrophils are strongly reduced in number in pu.1 and gcsfr double morpholino-injected 
animals (Mann-Whitney test: ***P<0.001). B: Quantification of axonal bridging (arrow; anti-
acetylated Tubulin) shows that morpholino injection decreases the proportion of animals 
with axonal bridges (Fisher’s exact test: **P<0.01). Lateral views of the injury site are shown; 
rostral is left. Scale bar: 100 μm. Error bars indicate SEM. Numbers on figure relate to number 
of larvae used. 
 
5.2.3 Macrophages determine regenerative success 
 
To analyse the role of different immune cell types in repair, we used mutants. In 
mutants for the macrophage-lineage determining transcription factor irf8, 
macrophages and microglial cells, but not neutrophils are missing during early 
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development (Shiau et al. 2015). Homozygous mutants are adult viable and 
show no overt developmental aberrations, except for an increased number of 
neutrophils (Shiau et al. 2015).  
In situ hybridisation for the macrophage and microglia marker mpeg1 
confirmed expression in the ventral trunk of unlesioned larvae and in a spinal 
lesion site at 2 dpl in wildtype larvae, but complete absence of signal in 
unlesioned and lesioned irf8 larvae (Fig. 5A). 
Next, I determined axonal regrowth and recovery of parameters of swimming 
capacity in irf8 mutants compared to wildtype animals. Wildtype and mutants 
showed comparable proportions of animals with axon bridges at 1 dpl 
(wildtype: 44% of examined animals; irf8 mutant: 43%). At 2 dpl, however, 
axonal continuity was observed in 80 % of wildtype animals but only in 41 % of 
irf8 mutants (Fig. 5B). At 5 dpl – 2.5 times as long as wildtype animals need for 
maximal axon bridging – the proportion of mutant larvae with bridged lesion 
sites was increased compared to 2 dpl (55 % of examined animals vs 41 %), but 
regenerative success was still strongly reduced compared to wildtype controls 
(55 % of examined animals vs. 87 %; Fig. 5C). 
Analysing touch-evoked swimming, we found that wildtype animals swam 
comparable distances to unlesioned controls at 2 dpl, as previously described 
(Wehner et al. 2017). In contrast, recovery of touch-evoked swimming distance 
in irf8 larvae plateaued at 2 dpl and did not reach levels of unlesioned animals to 
at least 5 dpl (Fig. 5C). This indicates that in the absence of macrophages and 
microglia in irf8 mutants, initial axonal regeneration is unaffected, but axonal 
regrowth and functional recovery after spinal cord injury are impaired long-
term. To determine the importance of microglia for regeneration, we analysed 
csf1ra/b double-mutants (see Methods) in which the function of colony-
stimulating factor 1 receptor (Csf1r) is compromised. Csf1r is selectively needed 
for microglia differentiation (Oosterhof et al. 2018). After injury in csf1ra/b 
mutants, we observed a strong reduction in the number of microglial cells (to 17 
% of wildtype), but an increase in macrophage numbers (by 55 % compared to 
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wildtype) in the injury site (Fig. 6A,C). Interestingly, neutrophil numbers were 
also strongly reduced (to 64.1 % of wildtype at 2 hpl and 16 % at 1 dpl) (Fig. 6B), 
perhaps due to feedback regulation from increased macrophage numbers. 
Whereas microglia cells were reduced in number in the entire fish, neutrophils 
were still present in the ventral trunk area. In these mutants, axon bridging was 
unimpaired (Fig. 6D). Hence, microglia are not necessary for axonal regeneration 
and reduced numbers of neutrophils do not negatively affect axonal regrowth. 
Combined with results from the irf8 mutant, this indicates that recruitment of 





Fig. 5: In the irf8 mutant, axonal regeneration and functional recovery after injury 
show long-term impairment. A: In situ hybridization for mpeg1 confirms the absence of 
macrophages and microglial cells before and after injury in the irf8 mutant compared to 
controls. Arrows indicate labeling around the injury site and brackets indicate the ventral 
area of the larvae where the macrophages can be found in the circulation. Note that blackish 
colour is due to melanocytes. B: Quantification of the proportion of larvae with axonal 
bridging (anti-acetylated Tubulin) shows that at 1 dpl, axonal bridging is unimpaired in irf8 
mutants, whereas at 2 dpl, irf8 mutants fail to show full regrowth and even by 5 dpl, the 
proportion of irf8 larvae with a bridged lesion site is still lower than in wildtype controls 
(Fisher’s exact test: ***P<0.001, n.s. indicated no significance). C: Irf8 mutants never fully 
recover touch-evoked swimming distance in the observation period, whereas wildtype 
control animals do. Representative swim tracks are displayed. Note that unlesioned irf8 
larvae show swimming distances that are comparable to those in wildtype controls (Two-way 
ANOVA: F 15, 1372 = 11.42, P<0.001; unles. = unlesioned, les. = lesioned). All lesions are done at 
3 dpf. The experiment was performed using 3 different biological replicates and the samples 
were blinded during the whole experiment. Lateral views of the injury site are shown; rostral 
is left. Arrows indicate axonal bridging. Scale bars: 200 μm in A and 50 μm in C. Error bars 
indicate SEM. Numbers on figure relate to number of larvae used. 
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Fig. 6: Absence of microglial cells and reduced neutrophil numbers do not affect 
axon bridging. A: Numbers of microglial cells (4C4+; arrows) in the injury site of the csfr1a/b 
mutants are much lower than in wildtype animals (One-way Anova F 3, 59 = 87.7 followed by 
Bonferroni multiple comparisons: ***P<0.001). B: Fewer neutrophils (Mpx+) are found in 
the injury site (arrows) of csfr1a/b mutants than in wildtype animals (One-way Anova F 5, 
146 = 19.91 followed by Bonferroni multiple comparisons: *P<0.05, ***P<0.001). Note 
neutrophils ventral to the injury site (brackets). C: The number of macrophages (Mfap4+) 
is increased in the injury site in the mutants at 1dpl, but not at 2dpl (One-way Anova F 3, 89 
= 7.224 followed by Bonferroni multiple comparisons: ***P<0.001, ns indicated no 
significance). D: Immunostaining against acetylated tubulin shows that axon bridging 
(arrows) is not affected in the mutants compared to wildtype animals at 2 dpl (Fisher’s exact 
test: ns indicates no significance). Lateral views of the injury site are shown; rostral is left. 
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Wt = wildtype; Scale bars: 50 µm in A, B, D; 25 µm in B. Error bars indicate SEM. Numbers 
on figure relate to number of larvae used. 
 
5.2.4 Macrophages are not necessary for Col XII deposition 
 
Next, I asked whether macrophages act via a previously reported regeneration-
promoting mechanism, comprising Wnt-dependent deposition of Col XII in the 
lesion site by pdgfrb:GFP+ fibroblast-like cells (Wehner et al. 2017). Inhibition of 
the immune response with dexamethasone did not inhibit appearance of 
pdgfrb:GFP+ fibroblast- like cells in the lesion site (Fig. 7A). 
 By crossing a reporter line for Wnt pathway activity (6xTCF:dGFP)1 into the irf8 
mutant, we found that activation of the pathway was unaltered in the mutant 
(Fig. 7E). Similarly, expression of col12a1a and col12a1b mRNA in irf8 mutants 
was indistinguishable from that in wildtype animals (Supplementary Fig. 4B). 
Deposition of Col I protein and mRNA expression of 11 other ECM components 
were also not altered in the irf8 mutant at 1 and 2 dpl (Fig. 7B,C). Moreover, 
immunolabelling against Tp63 showed that by 2 dpl, the injury site in the irf8 
mutants was completely covered by basal keratinocytes, an additional source 
of Col XII (Wehner et al. 2017), as in wildtype animals (Fig. 7D).  
In contrast, a PCR screen of 21 potentially macrophage- derived ECM-modifying 
matrix metalloproteinases (Newby 2008) (mmps) indicated lower mRNA levels 
for mmp11a, mmp16a/b, mmp24, and mmp28 in the injury site of irf8 mutants 
compared to wildtype animals (Fig. 8A,B). This suggests a potential for 
macrophages to alter the lesion site ECM with mmps. Overall, macrophages do 
not overtly regulate Wnt-signalling, deposition of some crucial ECM components 






Fig. 7: Wnt-dependent ECM deposition and wound healing are not affected by 
compromising the immune reaction. A: The density of fibroblast-like cells (pdgfrb:GFP+) in 
the lesion site is not affected by inhibition of the immune response with dexamethasone 
(Dex) (t-test, ns = not significant). B: Expression of mRNAs for major ECM components, 
including col12a1a and col12a1b (red box) is not impaired in the absence of macrophages in 
irf8 mutants. C: Immunoreactivity for Collagen I (Col I) is not altered in irf8 mutants, 
compared to wildtype controls at 1 dpl and 2 dpl (One-way Anova F (3, 56) = 16.52 followed 
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by Bonferroni multiple comparisons: ns indicated no significance). D: Basal keratinocytes 
(anti-Tp63+) cover the injury site (indicated by rectangle) in irf8 mutants by 2 dpl, similar to 
wildtype animals. E: Activation of the Wnt pathway is unaltered in irf8 mutants after injury. 
The 6xTCF:dGFP reporter line crossed into the irf8 mutants shows activation of Wnt signalling 
that is comparable to that in wildtype animals at 2 dpl. Lateral views of the injury site are 
shown.; rostral is left. Scale bars: 50 μm. Error bars indicate SEM. Numbers on figure relate 
to number of larvae used. 
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Fig. 8: Some matrix metalloproteases showed reduced expression in irf8 mutants. 
A: RT-PCR showed lower expression of 5 mmp genes in the injury site of irf8 mutants 
compared to wildtype. B: mmp genes for which no robust change in irf8 mutants could be 
detected are listed. 
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5.2.5 Cellular debris is not a major impediment to regeneration 
 
Macrophages could serve as a substrate for axon growth or promote 
regeneration by removing debris by phagocytosis - a major function of 
macrophages in peripheral nerve regeneration in zebrafish (Rosenberg et al. 
2012, Villegas et al. 2012). In time-lapse movies of double transgenic animals in 
which neurons (Xla.Tubb:DsRed) and macrophages (mpeg1:GFP) were labelled 
(Fig. 9B) we observed axons crossing the spinal lesion site at the same time 
macrophages migrated in and out of the injury site.  
However, no obvious physical interactions between these cell types were 
observed, making it unlikely that macrophages acted as an axon growth 
substrate. We frequently observed macrophages ingesting neuronal material 
and transporting that away from the injury site in time-lapse movies (Fig. 9B). 
 In agreement with this observation, TUNEL labelling indicated strongly increased 
levels of dead or dying cells in the late (48 hpl), but not the early (24 hpl) phase 
of axonal regeneration in the injury site of irf8 mutants (Fig. 9A). To determine 
the impact of debris on regeneration, we prevented cell death and consequently 
debris accumulation in irf8 larvae using the pan-caspase inhibitor QVD (Keoni 
and Brown 2015), that is functional in zebrafish (Ogryzko et al. 2014).  
This treatment led to lower debris levels that were comparable to those seen 
in wildtype larvae at 2 dpl (Fig. 9C) but failed to increase regenerative success in 
irf8 mutants (control, 38 % of examined larvae with axon bridges; QVD, 40 %. 
Thickness of axon bridge: control 19.03 µm +/- 2.14 µm; QVD: 18.32 µm +/- 2.53 
µm; t-test: P > 0.05. Supplementary Fig. 6E).  Conversely, inhibiting debris 
phagocytosis with the pharmacological inhibitor O- phospho-L-serine (L-SOP) 
(Witting et al. 2000) in wildtype animals increased levels of debris in the injury 





 This suggests no obvious connection between debris levels and/or 
phagocytosis and regenerative success. 
 
Fig. 9: Debris removal by macrophages is not a major factor for axonal 
regeneration. A: TUNEL labelling on cross sections of larvae (dorsal is up) shows an increased 
number of TUNEL+ cells in the injury site (indicated by rectangle) of the irf8 mutant fish at 2 
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dpl, but not at 1 dpl ( Two-way Anova F 3, 121 = 112.5 followed by Bonferroni multiple 
comparisons: ***P<0.001, ns = not significant). B: Time-lapse video-microscopy shows that 
macrophages (cyan, mpeg1:EGFP) are in the injury site and remove neuronal debris 
(XIa.tubb:DsRed). Arrowheads point out a macrophage with phagocytosed neuronal 
material. C: Acridine orange labelling at 2 dpl indicates increased levels of debris in the irf8 
mutant, which is reduced to wildtype levels with the pan-caspase inhibitor QVD (Kruskal-
Wallis with Dunn’s multiple comparisons post-test: *** P<0.001, ns indicates no significance). 
D,E: Inhibition of cell death with QVD does not alter regenerative success in wildtype animals 
(D) or irf8 mutants (E) at 2 dpl (Fisher’s exact test: ns indicates no significance). Rectangles 
indicate regions of quantification and arrows indicate axonal bridges. Lateral views of the 
injury site are shown (except A); rostral is left. Scale bars: 25μm A, 100 μm B, C, D, E, 50 μm. 
Error bars indicate SEM. Numbers on figure relate to number of larvae used. 
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Fig. 10: Treatment with the phagocytosis inhibitor O-Phospho-L-serine (L-SOP) does 
not affect regenerative success. A: The experimental timeline is shown. B: Treatment with L-
SOP increases the amount of debris, detected with acridine orange (t-test: ***P<0.001), but 
has no effect on axon bridging (XIa.tubb:DsRed; Fisher’s exact test: ns indicates no 
significance) at 2 dpl. Lateral views of the injury site are shown; rostral is left. Scale bar: 100 




5.2.6 Pro-and anti-inflammatory phases are altered in irf8 mutants 
 
To determine a possible role of cytokines in the regenerative failure of irf8 
mutants, we analysed relative levels of pro-and anti-inflammatory cytokines 
in the lesion site during regeneration in wildtype animals and irf8 mutants by 
qRT-PCR. In wildtype animals, expression levels of pro-inflammatory cytokines 
Il-1β and TNF-α were high during initial regeneration (> 25-fold for Il-1β; >12-
fold for TNF-α for approximately to 12 hpl) and reduced again during late 
regeneration (12- 48 hpl), although still elevated compared to unlesioned 
controls (Fig. 11A,B). Anti-inflammatory cytokines, such as tgf-β1a and tgf-β3 
were expressed at low levels during initial regeneration, and upregulated 
during late regeneration (approximately 3-fold for tgf-β1a and 2-fold for tgf-
β3), indicating a bi-phasic immune response within the 48-hour time frame of 
analysis (Fig. 11C,D). 
In irf8 mutants, levels of pro-inflammatory cytokines remained high during the 
late phase of regeneration (Fig. 11A,B) and anti-inflammatory cytokines were 
not upregulated (Fig. 11C,D), resulting in a sustained pro-inflammatory 






















Fig. 11: Inflammation is bi-phasic and dysregulated in irf8 mutants. A,B: Absence of 
macrophages in the irf8 mutant fish leads to increased Il-1β and TNF-α mRNA levels during 
the late stage of inflammation (>12hpl). An early peak in TNF-α expression is missing in irf8 
mutants. C,D: Expression of anti- inflammatory cytokines, tgf-β1a and tgf-β3, which peak 
during late regenerative phases in wildtype animals, is strongly reduced in irf8 mutants (t- 
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tests: *P<0.05, **P<0.01, ***P<0.001; wt = wildtype animals). # indicates statistical 
significance when compared to unlesioned animals. Error bars indicate SEM. 
The lack of anti-inflammatory cytokines correlated with the lack of macrophages 
and microglia in irf8 mutants. We performed qRT-PCR in fluorescence activated 
flow sorted mpeg1:GFP cells in wildtype animals to determine whether 
macrophages and microglial cells expressed tgf-β1a and tgf-β3. mpeg1:GFP+ cells, 
but also mpeg1:GFP negative cells expressed these cytokines (Fig. 12A). In situ 
hybridisation showed wide-spread labelling with some more strongly labelled 
cells around the injury site in wildtype, but not irf8 mutants (Fig. 12B). This is 
consistent with expression of tgf-β1a and tgf-β3 in microglia/macrophages and 
other cell types (Finnson et al. 2013). Hence, the immune response is bi-phasic 
with an initial pro-inflammatory phase, followed by an anti-inflammatory phase in 
wildtype animals. In the absence of macrophages in irf8 mutants, animals fail to 





Fig. 12: Tgf-β is expressed by macrophages and other cell types. A: In situ 
hybridization for tgf-β1a shows widespread expression in the lesioned trunk of wildtype and 
irf8 mutant larvae at 2 dpl. Arrows show possible macrophages around the injury site of 
wildtype larvae that are not present around the injury site of irf8 mutant larvae. B: 
Quantitative RT-PCR using the GFP+ and the GFP- cell populations of the injury site tissue of 
lesioned mpeg1:GFP larvae shows expression of tgf-β1a and tgf-β3 in purified macrophages 
(GFP+) and other cell types (GFP-). Lateral views of the injury site are shown; rostral is left. 






5.2.7 TNF-α promotes axonal regeneration 
 
To determine whether increased levels of pro-inflammatory cytokines 
contributed to impaired axon growth in irf8 mutants, we first inhibited TNF-α 
signaling. The animals were originally treated with pomalidomide, a selective 
pharmacological inhibitor of TNF-α release (Muller et al. 1999). The animals were 
pre-treated with the inhibitor, injured and then transferred back to the inhibitor 
until the analysis. Previous work in the lab has shown that pre-treatment is more 
efficient than treatment after injury. The working concentration that was used 
(170 μΜ) was selected based on the work from (Mahony et al. 2013) which 
showed that this concentration has anti-inflammatory effects in zebrafish, it’s 
able to reduce the levels of TNF-α protein and is not teratogenic for zebrafish 
larvae. The treatment had no effect on axonal regrowth in irf8 mutants. In 
contrast, in wildtype animals Pomalidomide strongly inhibited axon bridging at 1 
dpl (control: 62 % of examined animals showed an axonal bridge; Pomalidomide: 
36 %) and 2 dpl (control: 75 % of examined animals; Pomalidomide: 45 %) (Fig. 
13A). To confirm pharmacological results, we targeted TNF-α by using CRISPR 
manipulation with a gene–specific guideRNA (gRNA). Injection of the gRNA into the 
zygote efficiently mutated the gene as shown by restriction fragment length 
polymorphism (RFLP) analysis (Fig. 13B) and produced function-disrupting 
insertion- deletion mutations in a highly conserved domain (Savan et al. 2005) 
(Table 1). Western blots of 4-day old larvae and immunohistochemistry in the 
injury site showed robustly reduced TNF-α protein levels (Fig. 14A,B). 
Axon bridging was inhibited in wildtype animals by TNF-α gRNA injection in a way 
that was comparable to drug treatment (1 dpl: control: 51 % of examined animals 
showed bridging; gRNA: 27 %; 2 dpl: control: 88 % of examined animals showed 
bridging; gRNA: 40 %). At 5 dpl, axon bridging was still strongly impaired (control: 
84.1 % of examined animals showed bridging; gRNA: 38.3 %; Fig. 13C), indicating 
long-term impairment of regeneration. Hence, TNF-α dysregulation is not a major 
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cause of regenerative failure in irf8 mutants, but TNF-α is necessary for axonal 
regeneration in wildtype animals.  
 
Fig. 13: TNF-α is essential for axonal regeneration. A: TNF-α inhibition by 
Pomalidomide reduces the proportion of wildtype animals with axon bridging at 1 and 2 dpl. 
No effect is observed in irf8 mutants (Two-way ANOVA followed by Bonferroni post-test: F 3, 
16 = 12.16, **P<0.01, n.s indicates no significance). B: CRISPR/Cas9-mediated disruption of 
TNF-α is effective as shown by RFLP analysis. This reveals efficient somatic mutation in the 
gRNA target site, indicated by resistance to restriction endonuclease digestion (arrow). C: 
Axonal bridging (arrow; Xla.Tubb:DsRed+) is strongly impaired after disruption of the TNF-α 
gene. (Fisher’s exact test: **P<0.01) and the impairment persists at 5 dpl. Lateral views of 
the injury site are shown; rostral is left. Scale bar: 50 μm. Error bars indicate SEM. Numbers 
on figure relate to number of larvae used. 
 
To determine which cells expressed TNF-α in wildtype animals, we used 
immunohistochemistry for L-Plastin, labelling all immune cells, in TNF-α:GFP 
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transgenic fish (Fig. 14D). Nearly all TNF-α:GFP+ cells co-labelled with L-Plastin (96 
%) at 12 hpl. Thus, expression of TNF-α occurred mainly in immune cells (Fig. 14A). 
Double-labelling TNF-α:GFP reporter fish with neutrophil (Mpx), microglia (4C4) 
and macrophage (Mfap4) markers at 24 hpl, when axons were actively growing, 
indicated that >95 % of TNF-α:GFP+ cells in the injury were peripheral 
macrophages. However other cell types, such as neurons (Kisiswa et al. 2013), may 
also express TNF-α. More than 72 % of macrophages were TNF- α:GFP+, whereas 
for microglia (< 6.5 %) and neutrophils (< 0.7 %) the proportion was much smaller. 
Over time, the proportion of TNF-α:GFP+ macrophages was reduced (from 72.5 % 
at 1dpl to 59 % at 2 dpl) (Fig. 6B). Our observations suggest that macrophages 
promote regeneration by expressing TNF-α. To elucidate effects of TNF-α 
inhibition, we determined numbers of neutrophils and macrophages/microglia at 
24 and 48 hpl in TNF-α gRNA injected animals. This showed no changes in 
macrophages, but a 49.7 % increase in the number of neutrophils at 1 dpl (Fig. 
14C). qRT-PCR indicated that Il-1β mRNA levels were increased by 108 %, whereas 
TNF-α, tgf-β1a and tgf-β3 mRNA levels remained unchanged at 2 dpl (Fig. 14D). 
This suggests a moderate enhancement of the pro- inflammatory response when 







Fig. 14: TNF-α is mostly expressed by macrophages in the lesion site of wildtype 
animals. A: Top row: TNF-α:GFP labelling occurs almost exclusively in L-plastin+ immune cells 
(L-plastin in green; TNF-α:GFP in magenta; yellow arrow indicates a rare TNF- α:GFP+ 
microglial cell; 12 hpl) B: In the injury site, the number and proportion of macrophages 
(Mfap4+) that are TNF-α:GFP+  are much higher than numbers and proportions of microglia 
(4C4+) and neutrophils (Mpx+), indicating that the main source of TNF-α is the macrophages. 
Arrows indicate double-labelled cells and arrowheads indicate immune cells that are TNF-
α:GFP-. Single optical sections are shown; the proportion of macrophages that are TNF-
α:GFP+ decreases over time, whereas the proportion of TNF-α:GFP+ microglial cells slightly 
increases (One-way ANOVA followed by Bonferroni post-test: F 4, 195 = 376.3, **P<0.01, 
*P<0.05). C: Quantification of the immune cells after TNF-α gRNA injection shows that TNF-
α disruption leads to increased numbers of neutrophils (Mpx+) at 1 dpl but not at 2 dpl, 
whereas the numbers of macrophages/microglia (mpeg1:GFP+) remains unchanged (Kruskal-
Wallis test followed by Dunn’s multiple comparisons: *P<0.05, ns indicates no significance). 
D: qRT-PCR indicates that TNFTNF-α disruption leads to increased levels of Il-1β mRNA at 2 
dpl (t- tests: *P<0.05). Lateral views of the injury site are shown; rostral is left. Scale bars: 50 















5.2.8 Il-1β inhibits regeneration in irf8 mutants 
 
To test whether sustained high levels of Il-1β were responsible for regenerative 
failure in irf8 mutants, we interfered with Il-1β function in three different ways. 
Firstly, we inhibited caspase-1, which is necessary for activation of Il-1β, using 
the pharmacological inhibitor YVAD that is functional in zebrafish (Vojtech et al. 
2012)  (Fig.15A-E). Secondly, we disrupted Il-1β RNA splicing with an established 
morpholino (Supplementary Fig. 10A-D) (Nguyen-Chi et al. 2014). Finally, we 
targeted Il-1β in a CRISPR approach (Fig. 16E- H).  
To determine whether interfering with Il-1β function mitigated inflammation 
in irf8 mutants, we quantified immune cells, expression of Il-1β, TNF-α and 
dead cells. Indeed, after YVAD treatment we observed a reduction of 
neutrophil peak numbers (by 38 % at 2 hpl; Fig. 15B), as well as strongly reduced 
levels of Il-1β and TNF-α mRNA expression (at 2 dpl; Fig. 15A) in irf8 mutants. 
Moreover, the number of TUNEL+ cells was reduced at 2 dpl in the irf8 mutant, 
but not to wildtype levels (Fig. 15C). In lesioned wildtype animals, YVAD reduced 
peak numbers of neutrophils (by 40 % at 2 hpl) and macrophages (by 28 % at 48 
hpl), but no influence on low numbers of TUNEL+ cells at 2 dpl was observed. 
Hence, interfering with Il-1β function reduces inflammation in irf8 mutants and 
wildtype animals. Axon bridging in wildtype animals was not affected by YVAD 
treatment at 2 dpl (control: 79 % of examined animals showed bridging; YVAD: 
78 %) (Fig. 15D), indicating that high levels of Il-1β were not necessary for 
axonal regeneration. In contrast, in YVAD-treated irf8 mutants, we observed a 
remarkable rescue of axon bridging at 2 dpl (control: 38 % of examined animals 





Fig. 15: Inhibition of Il-1β function rescues axonal regeneration in irf8 mutants. 
Lateral views of the injury site are shown; rostral is left. A: YVAD reduces expression levels of 
Il-1β and TNF-α in irf8 mutants (two-sample t-test: *P<0.05) at 2 dpl. B: YVAD impairs 
migration of peripheral macrophages (Mfap4+) and neutrophils (Mpx+) in wildtype animals 
and irf8 mutants (only neutrophils quantified, due to absence of macrophages) (t-tests: 
***P<0.001). C: YVAD moderately reduces the number of TUNEL+ cells in the irf8 mutants at 
2 dpl. (Two-Way ANOVA followed by Bonferroni multiple comparisons: F 3, 121 = 112.5, 
***P<0.001). D: YVAD does not influence axonal regeneration in wildtype animals but 
rescues axonal bridging (arrows) in irf8 mutants (Fisher’s exact test: **P<0.01, ns indicates 
no significance) at 2 dpl. E: Impaired touch-evoked swimming distance in irf8 mutants is 
rescued by YVAD treatment, to levels that are no longer different from lesioned and 
unlesioned wildtype animals at 2 dpl. YVAD has no influence on swimming distance in 
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lesioned or unlesioned wildtype animals (Two-way ANOVA followed by Bonferroni multiple 
comparisons: F 1, 309 = 35.229, ***P<0.0001, ns indicates no significance). Rectangle in B 
denotes quantification area. Scale bar: 50 μm for B, D. Error bars indicate SEM. Numbers on 
figure relate to number of larvae used. 
Injecting a well-established (Nguyen-Chi et al. 2014) morpholino targeting Il-1β 
into irf8 mutants at the one-cell-stage inhibited Il-1β splicing (Fig. 16A,D). 
Morpholino-injected animals showed a rescue of axon bridging at 2 dpl (control: 
40 % of examined animals showed bridging; YVAD: 60 %) (Fig. 16B,C). Finally, 
injecting a gRNA targeting Il-1β at the one-cell stage led to somatic mutation 
in the target site of Il-1β, indicated by RFLP analysis (Fig. 16E,H). This strongly 
rescued axonal bridging in lesioned irf8 mutants (control: 40 % of examined 
animals showed bridging; acute Il-1β gRNA: 70 %) (Fig. 16F,G). Hence, three 
independent manipulations show that excessive Il-1β levels in irf8 mutants are 
a key reason for impaired axonal regeneration. 
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Fig. 16: Inhibition of Il-1β expression or disruption of the gene rescue axon bridging 
and parameters of touch-evoked swimming in irf8 mutants. A: The timeline for the 
morpholino manipulations is given. B-D: Morpholino gene knockdown of Il-1β by injecting 
into the zygote shows characteristic mis-splicing of Il-1β mRNA, compared to wildtype 
animals (D) and partially rescues the bridging phenotype of the irf8 mutant fish (B,C; Fisher’s 
exact test: *P<0.05). D: Morpholino gene knockdown of Il-1β shows characteristic mis-
splicing of Il-1β mRNA, compared to wildtype animals. E: The timeline for gRNA manipulation 
is given. F-G: CRISPR/Cas9-mediated disruption of Il-1β by injecting specific gRNA into the 
zygote leads to somatic mutations, as shown by RFLP analysis (arrow in H) and rescues the 
bridging phenotype in irf8 mutants (F,G; Fisher’s exact test: **P<0.01). I,J: YVAD incubation 
rescues speed (mean velocity) and path shape (meander) that the irf8 larvae achieve after 
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injury (Kruskal-Wallis with Dunn’s multiple comparisons post-test: *** P<0.001, ** P<0.01, 
ns indicates no significance). Lateral views of the injury site are shown; rostral is left. Scale 
bars: 50 μm. Error bars represent SEM. Numbers on figure relate to number of larvae used. 
 
5.2.9 Reduction of Il-1β levels rescues swimming in irf8 mutants. 
 
To determine whether ll-1β inhibition also rescued recovery of swimming 
function in irf8 mutants, we analysed touch-evoked swimming distances. YVAD 
had no effect in unlesioned mutant or wildtype animals and did not affect recovery 
in lesioned wildtype animals (Fig. 15E). In contrast, YVAD-treatment rescued the 
touch-evoked swimming distance in irf8 mutants to levels that were 
indistinguishable from wildtype lesioned or unlesioned animals (Fig. 15E). Mean 
velocity and path shape (meandering) were also rescued (Fig. 16I,J). These 
observations indicate that inhibition of Il-1β alone restores most axonal 
regeneration and recovery of touch- evoked swimming parameters in the absence 
of  macrophages. 
 
5.2.10 Neutrophils are a major source of Il-1β. 
 
To understand Il-1β regulation, we determined the source of Il-1β in wildtype 
and irf8 mutants. Using Il-1β immunohistochemistry and a transgenic reporter 
line (il- 1β:GFP), we found expression in microglia, macrophages, neutrophils 
and basal keratinocytes in the injury site (Figs 17C,D; 18A). Neuronal labelling 
(HuC/D+) did not overlap with Il-1β:GFP labeling (Fig. 18B). While numbers of 
Il-1β:GFP+ immune cells did not change significantly between 1 and 2 dpl, the 
percentage of macrophages (from 50.6 % to 34.3 %) and neutrophils that were 
labelled for the Il-1β:GFP transgene were reduced (from 53.3% to 23.7%), likely 
reflecting resolution of inflammation (Fig. 18A). 
In irf8 mutants, detection of Il-1β mRNA by qRT-PCR and in situ hybridisation 
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confirmed increased levels at 2 dpl, but not 1 dpl (Fig. 17A,B), despite lack of Il-
1β expressing microglia and macrophages. Instead, we observed increased 
numbers of Il-1β+ neutrophils (by 97 %) and basal keratinocytes (by 58 %) 
compared to wildtype animals at 1 dpl (Fig. 17C,D). Importantly, the proportion 
of neutrophils that were Il-1β+ was also increased from 33.6 % in wildtype 
animals to 49 % in the irf8 mutant at 1 dpl. This demonstrates that neutrophils 
are more likely to express Il-1β in the absence of macrophages. 
 
 
Fig. 17: Levels of Il-1β expression are increased in the injury site of irf8 mutants. A: 
At 1 dpl, expression levels of Il-1β are comparable between irf8 mutants and wildtype (Wt) 
animals but are higher in the mutant at 2 dpl in qRT-PCR (t-test: **P<0.01, ns indicates no 
significance). B: In situ hybridization confirms increased expression of Il-1β mRNA at 2 dpl. C: 
In the injury site, the number and proportion of neutrophils (Mpx+) that are Il-1β immuno-
positive (arrows) are increased in irf8 mutants at 1 dpl compared to wildtype animals. D: The 
number of basal keratinocytes (Tp63+) that are Il-1β immuno-positive is increased in irf8 
mutants. Single optical sections are shown; boxed areas are shown in higher magnifications 
(t-test: *P<0.05, **P<0.01). Lateral views of the injury site are shown; rostral is left. Scale 
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bars: 100 μm in B,C,D and 50 µm for higher magnification areas. Error bars indicate SEM. 
Numbers on figure relate to number of larvae used. 
 
Fig. 18: Il-1β is expressed in immune cells, but not neurons in wildtype animals. A: In 
the Il-1β reporter line, Il-1β:GFP+ cells are co- labelled (arrows) with the macrophage marker 
Mfap4, microglial marker 4C4 and the neutrophil marker Mpx. Arrowheads indicate immune 
cells that are negative for Il-1β:GFP. The proportion of macrophages (Mfap4+) and 
neutrophils (Mpx+) that are Il-1β:GFP+ changes over time, whereas the proportion of 
microglial cells that are Il-1β:GFP+ remains the same (One-way ANOVA followed by 
Bonferroni post-test: F 5, 282 = 22.55, ***P<0.001, **P<0.01, ns = no significance). B: Il-1β:GFP+ 
cells were rarely co-labelled with the neuronal marker HuC/D at 1 dpl. Lateral views of the 
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injury site are shown; rostral is left. Single optical sections are shown. Scale bars: 50 μm. Error 
bars represent SEM. Numbers on figure relate to number of larvae used. 
 
5.2.11 Neutrophils inhibit regeneration in irf8 mutants. 
 
Increased numbers of Il-1β+ neutrophils in irf8 mutants could, at least in part, be 
due to higher overall numbers of neutrophils in the injury site. We found a peak 
of neutrophil numbers in the lesion site of irf8 mutants at 2 hpl, as in wildtype 
animals (Fig. 19A). However, the number of neutrophils was 27 % higher than in 
wildtype, potentially due to the higher abundance of this cell type in the irf8 
mutant (Shiau et al. 2015). While neutrophil numbers declined over time in 
wildtype and irf8 mutants, they did so more slowly in irf8 mutants. At 24 hpl, 
twice, and at 48 hpl, three times the number of neutrophils as in wildtype animals 
remained in the mutant. Hence, macrophages control number of and cytokine 
expression by neutrophils (Tauzin et al. 2014), leading to prolonged presence of 
Il-1β+ neutrophils in the injury site of irf8 mutants. 
To determine the relative importance of the neutrophils for regenerative failure 
in irf8 mutants, we reduced their numbers using pu.1/gcsfr morpholino 
treatment. This strongly reduced numbers of neutrophils by 84.6 % in the injury 
site at 2 hpl, when the neutrophil reaction peaked in untreated irf8 mutants (Fig. 
19B). pu.1/gcsfr morpholino treatment also reduced Il-1β mRNA levels by 54 % 
and TNF-α mRNA levels by 70 % at 2 dpl (Fig. 19C). 
Remarkably, axon bridging (control: 43 % of examined animals showed 
bridging; pu.1/gcsfr morpholino: 60 %; Fig. 19D) and recovery of touch-evoked 
swimming distance were partially rescued in these neutrophil-depleted 
mutants at 2 dpl (Fig. 19E). This shows that in the absence of macrophages, the 




Fig.19: Preventing neutrophil formation partially rescues functional spinal cord 
regeneration in the irf8 mutant. A: In irf8 mutants, higher peak numbers of neutrophils 
(Mpx+) at 2 hpl and slower clearance over the course of regeneration are observed (Two-
Way ANOVA followed by Bonferroni multiple comparisons: F 8, 427 =13.19 *P<0.05, **P<0.01, 
***P<0.001). Note that wildtype data are the same as shown in Fig. 1A, as counts in irf8 
mutants and wildtype animals were done in the same experiments. B: Combination 
treatment with pu.1 and gcsfr morpholinos efficiently prevents neutrophil accumulation in 
the lesion site (Mann-Whitney U-test: ***P<0.001). C: In pu.1/gcsfr morpholino injected irf8 
mutant fish, levels of Il-1β and TNF-α mRNA expression are reduced at 2 dpl, as shown by 
qRT-PCR (t-test: ***P<0.001). D,E: In pu.1/gcsfr morpholino injected irf8 mutant fish, axonal 
bridging (arrows, D; Fisher’s exact test: **P<0.01) and behavioural recovery (E; One-Way 
ANOVA followed by Bonferroni multiple comparisons: F 5, 142 = 23.21, **P<0.01, ns indicates 
no significance) are partially rescued. Lateral views of the injury site are shown; rostral is left. 
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Scale bars: 100 μm. Error bars indicate SEM. Numbers on figure relate to number of larvae 
used. 
5.2.12 Il-1β promotes axonal regeneration during the early regeneration. 
 
To determine whether roles of Il-1β and general inflammation differed for 
different phases of the inflammation, we separately analysed early (0-1 dpl; 
Fig. 20A) and late (1-2 dpl; Fig. 20B) regeneration by drug incubation. During the 
early phase, YVAD treatment led to a weak inhibition of axonal regeneration in 
both wildtype (control: 58 % of examined animals showed bridging; YVAD: 41 
%) and irf8 mutants (control: 41 % of examined animals showed bridging; 
YVAD: 36 %).  
Similarly, dexamethasone treatment inhibited axonal regeneration in both 
wildtype (control: 57.5 % of examined animals showed bridging; 
dexamethasone: 36.6 %) and irf8 (control: 44.6 % of examined animals 
showed bridging; dexamethasone: 34 %). Interestingly, while LPS promoted 
regeneration in the early phase in wildtype animals (control: 53.2 % of 
examined animals showed bridging; LPS: 68.7 %), it was detrimental in irf8 
mutants (control: 39 % of examined animals showed bridging; LPS: 25.5 %), 
perhaps because baseline inflammation was already high in the mutant. 
During late regeneration, only dexamethasone had an inhibitory effect in 
wildtype animals (from 82.1 % of examined animals that showed bridging to 
64.4 %). YVAD had no effect in wildtype animals during late regeneration, 
when Il-1β was already down-regulated (control: 81 % crossing; YVAD: 78 % 
crossing), but a strong rescue effect of YVAD was observed in the irf8 mutant 
(control: 37 % of examined animals showed bridging; YVAD: 68 %). This rescue 
effect was comparable to that observed when Il-1β was suppressed for the 
entire 48 hours (cf. Fig. 15D). LPS had no effect in wildtype or mutants during 
late regeneration. Hence, early inflammation and Il-1β upregulation promote 




Fig. 20: Temporally restricted manipulations of the immune response reveal time-
dependent effects on axon bridging. A: During early regeneration, dexamethasone and YVAD 
143  
treatments impair regeneration in both wildtype animals and irf8 mutants. Stimulation of the 
immune response with LPS promotes regeneration in wildtype animals but inhibits it in irf8 
mutants (Two-way ANOVA followed by Bonferroni multiple comparisons: F 5, 12 = 25.32. 
*P<0.05, **P<0.01). B: Manipulations during late regeneration show persistent negative 
effects of dexamethasone in wildtype animals and a strong rescuing effect of YVAD in irf8 
mutants (Two-way ANOVA followed by Bonferroni multiple comparisons: F 5, 12 = 16.05. 
*P<0.05, ***P<0.001, ns = no significance; Dex = dexamethasone). Error bars represent SEM. 


























 5.3 DISCUSSION 
 
In this chapter I identified a biphasic role of the innate immune response during 
axonal regeneration in zebrafish larvae.  Initiation of the inflammatory response 
is beneficial for regeneration and the presence of Il-1β promotes axon bridging, 
whereas later, Il-1β expression is regulated by peripheral macrophages (Fig.22). 
Pharmacological and genetic Inhibition of Il-1β largely was able to improve 
axonal regeneration in macrophage-deficient larvae, highlighting the essential 
role of Il-1β as a central regulator for axonal re-growth.  
On the other hand, TNF-α derived from the macrophages, although being a pro-
inflammatory cytokine like Il-1β, has a pro-regenerative role, by reducing 
neutrophil number and Il-1β expression. These observations indicate that the 
inflammatory response is highly dynamic, and its tight regulation is essential for 





Fig. 21: Working model of the influence of the innate immune system on axonal 
regrowth. During the early stage, within hours of inflammation, spinal cord injury triggers 
neutrophil invasion of the injury site and initiation of the inflammatory response, including 
Il-1β production. This initially promotes regeneration but is later strongly inhibitory. At 
later stages, Il-1β positively regulates presence of neutrophil and macrophages in a 
feedback mechanism. Macrophages invade the lesion site and down-regulate levels of Il-
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1β in neutrophils and basal keratinocytes, while promoting regeneration by releasing TNF-
α. This leads to successful axonal regeneration and recovery of parameters of touch-
evoked swimming. 
 
5.3.1 The role of Il-1β 
 
After injury the reaction of the immune system changes rapidly over time. Very 
soon after injury, neutrophils are the first cells that accumulate to the injury site 
and the levels of pro-inflammatory Il-1β and TNF-α increase in the injury site. 
This is essential for axonal growth initially, indicated by the increased axonal 
bridging after LPS stimulation during the early stages of inflammation and by 
the decreased bridging after Il-1β inhibition during the same time point. In 
agreement to this, other studies have shown that Il-1β can promote neurite 
growth (Temporin et al. 2008, Boato et al. 2013).  
The next crucial event that occurs after injury is the migration of macrophages 
to the lesion site, where by producing anti-inflammatory cytokines like tgf-β 
resolve the inflammation and promote tissue regeneration during the late 
stages of inflammation. This doesn’t occur to the macrophage-less irf8 mutants 
where the absence of macrophages together with increased levels of Il-1β and 
decreased levels of anti-inflammatory cytokines inhibit regeneration. 
Furthermore, irf8 mutants are characterized by increased numbers of 
neutrophils, levels of Il-1β and TNF-α expression, as well as cell death in the 
lesion environment. Inhibition of Il-1β led to significant decrease of the 
numbers of neutrophils accumulating to the injury site, decreased the levels of 
pro-inflammatory cytokines and decreased also the cell death levels. Indicating 
that increased levels of Il-1β may condition the lesion environment to be hostile 
for axonal regeneration. Additionally, some matrix metalloproteinases showed 
decreased expression in the irf8 mutant suggesting that the lesion site ECM 
may be altered. However, the expression of several ECM components, 
including functionally important Col XII (Wehner et al. 2017), was not altered in 
the irf8 mutant. Similar to these observations, (Boato et al. 2013) showed that 
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Il-1β deficient mice exhibit slightly increased axonal regrowth after SCI. 
 
5.3.2 The role of TNF-α 
 
Inhibition of TNF-α showed a pro-regenerative role of this pro-inflammatory 
cytokine during axonal regeneration. Axonal regeneration is promoted by TNF-
α. Even though both Il-1β and TNF-α were upregulated in the irf8 mutant, only 
reducing Il-1β levels was able to rescue the mutant. This is similar to what has 
previously been shown by the work of (Turrin and Rivest 2006) which showed 
that the two-proinflammatory cytokines exhibit different roles. Another key 
difference in their cellular source in the injury site. Whereas Il-1β is expressed 
by a substantial proportion of neutrophils, microglia and macrophages, TNF-α 
is mainly expressed by macrophages. In mammals, TNF-α is produced by both 
microglia and macrophages (Kroner et al. 2014). TNF-α may exert its pro-
regenerative role partially by controlling neutrophil numbers and Il-1β levels. 
Both of these parameters are increased when TNF-α is inhibited. The anti-
inflammatory role of TNF-α has been described in the context of auto-immunity 
(Liu et al. 1998), but whether this interaction between TNF-α and Il-1β is direct 
or indirect, is still unclear. During fin regeneration, TNF-α has an important 
promoting function for blastema formation (Nguyen-Chi et al. 2017) suggesting 
that TNF-α may be involved in tissue remodeling in the lesion site after spinal 
injury, which then creates an axon growth-promoting environment. However, 
the role of TNF-α during axonal regeneration in mammals is not clear. There are 
some studies indicating the promoting properties of TNF-α during axonal growth 
(Schwartz et al. 1991, Saleh et al. 2011), whereas others show inhibition of axon 
growth (Kato et al. 2010). However, TNF-α deficient mice had no reported effect 





5.3.3 The role of macrophages 
 
Preventing neutrophil formation in irf8 mutants, led to partial rescue of axon 
regrowth and swimming function. This could be explained by the absence of 
the early pro-regenerative role of the inflammation after injury.  In mammals,  
it has  been reported  that neutrophils cause secondary cell death (Saiwai et 
al. 2010, Kubota et al. 2012) whereas neutrophil depletion leads to favorable 
injury outcomes (Taoka et al. 1997), similar to my data. Macrophages control 
inflammatory response, as their absence in irf8 mutants leads to abnormally 
high expression levels of pro-inflammatory cytokines Il-1β and TNF-α and 
increased numbers of neutrophils, similarly to observations during fin 
regeneration (Hasegawa et al. 2017). Moreover, higher proportion of 
neutrophils were Il-1β+ in irf8 mutants, indicates that macrophages prevent 
neutrophils from obtaining a more pro- inflammatory phenotype.  
Using FACS and ISH I show that macrophages/microglia, together with other 
tissues, express tgf-β1a and tgf-β3 and could thus be partially responsible for 
reducing pro-inflammatory phenotypes in wildtype animals. 
Macrophages do not promote regeneration primarily by preventing cell death or 
removing debris. Debris levels were clearly increased in the absence of 
macrophages in irf8 mutants. However, during Il-1β inhibition and rescue of 
decreased axonal bridging, debris levels were still higher than in controls. 
Furthermore, prevention of cell death did not rescue axon growth and 
inhibition of phagocytosis in wildtype animals did not impair regeneration. 
Hence, debris abundance is not a major determinant for regenerative success. 
Interestingly, in fin regeneration paradigm, lack of macrophages leads to death 
of tissue progenitor cells, and subsequently, fin regeneration is impaired 
(Hasegawa et al. 2017). On the other hand, studies in mammalian models have 
shown that debris and especially myelin debris have an inhibitory role during 
regeneration (Church et al. 2017). Microglial cells may not be essential for 
axonal re-growth as the unimpaired axonal bridging was observed in the 
csfr1a/b mutant. However, the increase in peripheral macrophages in this 
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mutant within the lesion site could have compensated for a possible 
regeneration-promoting role of microglia.  
 
5.3.4 What about the other cell types present in the injury site? 
 
The use of different reporter lines to visualize the neuronal elements of the 
spinal cord alongside with other cell populations that respond to the injury site 
showed that the endothelial cells from the injured blood vessels were slow to 
reform blood vessels. In contrast, in mammals, endothelial cells accumulate in 
the injury site, where they may have anti-inflammatory functions (Kadl and 
Leitinger 2005, Al-Soudi et al. 2017, Cohen et al. 2017).  
The use of cldnK reporter line showed that after injury there is myelinating cells 
bridged the lesion site, when axons had already crossed the lesion site, which 
may contribute to recovery of swimming behavior after injury. In mammals SCI 
models, transplanted myelinating cells, have been shown to improve recovery 
after spinal injury (Bunge 2016, Nakhjavan-Shahraki et al. 2018). 
In order to assess how glial processes, respond after injury I treated zebrafish 
larvae with dexamethasone. I found that glial processes cross the injury site, 
and this depends on the immune response similarly to the axons. Although 
these processes cross the injury site independently of axons and axons still cross 
when these cells are ablated (Wehner et al. 2017), astroglia-like processes have 
been shown to support axonal growth by producing growth factors like Fgf and 
ctgfa  (Goldshmit et al. 2012, Mokalled et al. 2016).  
In summary I’ve shown that tight control of the inflammatory response after 
SCI is crucial for regenerative success in zebrafish larvae. Inflammation is rapidly 
down-regulated in zebrafish concurrent with the upregulation of anti-
inflammatory cytokines, which does not readily occur in mammals (Kigerl et al. 
2009).  
Furthermore, the use of the zebrafish larval model provides an in vivo system to 
study the complexity of the inflammatory response alone or with combination of 
the regenerative events that occur after SCI and allow zebrafish to regain their 
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swimming capacity. In addition to this, the larval model can be used an easily 
accessible high-throughput model which can give insights to help understand 
mammalian SCI and test specific molecules leading eventually to the 
































       Chapter 6: General Discussion 
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6.1 Zebrafish larva as a model to study regeneration 
 
Unlike mammals, adult zebrafish are able to regenerate their CNS and spinal cord 
after injury.  Several studies have elegantly demonstrated that adult zebrafish can 
replace a plethora of lost neurons by regenerating new neurons such as motor 
neurons (Reimer et al. 2008), interneurons (Kuscha et al. 2012, Barreiro-Iglesias et al. 
2015) and radial glia progenitor cells (Briona and Dorsky 2014, Ghosh and Hui 2016). 
The adult zebrafish is a very well-established model to study regenerative 
neurogenesis (Reimer et al. 2009, Kuscha et al. 2012, Reimer et al. 2013, Barreiro-
Iglesias et al. 2015, Becker and Becker 2015). However, it takes up to 3-4 months for 
them to reach adulthood and the study of regenerative events includes further tissue 
handling in order for the CNS to be accessible, such as surgery, perfusion, dissection 
and section for antibody staining. Furthermore, another limiting factor is the number 
of animals that can be processed in each round of experiments and the time that the 
regeneration is complete, as it takes up to 6 weeks for an adult zebrafish to 
functionally repair its spinal cord (Becker et al. 2004). 
 In contrast to the adult animals, zebrafish larvae are transparent and small in size. 
Spinal cord injury can be easily performed with an injection needle and we can easily 
proceed with further analysis. We have established larval zebrafish as a model for 
lesion induced motor neurogenesis (Ohnmacht et al. 2016) and have shown that 
zebrafish larvae have the ability to reclose the wound, regenerate motor neurons and 
restore swimming ability within 2 days postinjury (dpi), with a survival rate of 85%-
90% after a lesion (Ohnmacht et al. 2016). Other studies from our group (Becker et 
al. 1997, Becker and Becker 2001, Schweitzer et al. 2005) have shown that adult fish 
are able to repair severed axons and regain swimming behaviour and this is also 
observed in the larval injury model (Wehner et al. 2017). Zebrafish larvae exhibit 
functional regeneration within 48 hours post injury, much quicker than the 4-6 weeks 
in adults.  Furthermore, they are very easy to handle, and a high number of animals 
can be handled during each experiment, such that high statistical power is easier to 
achieve than in adults. It is also very important to mention that zebrafish larvae up to 
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5 days post fertilization are not protected under the A(SP)A 1986 which regulates the 
use of animals in research. This allowed us to replace the adult zebrafish with larval 
zebrafish and therefore to reduce at the same time the number of adult experiments, 
in agreement with the 3R guidelines that regulate the use of animals in research.  
One of the key features of the larval model is the transparency of the larvae which 
makes them ideal for live imaging. This feature combined with the high number of 
reporter lines allows the live observation of the cell types of interest. These offer a 
lot of possibilities. Live imaging combined with different manipulations allows us to 
perform regenerative or drug screening using a vertebrate in vivo model which is 
highly plastic. For these reasons I used the larval injury model for my experiments in 
this thesis. 
 
6.2 Zebrafish larva as a model to study inflammation after injury in the CNS 
 
The immune response is one of the key events that occur after an infection or an 
injury. There are many different injury models that show the orchestrated events that 
occur during the different stages of inflammation after injury. The presence of 
immune cells in the CNS was considered to be detrimental and was characterized as 
a hallmark for pathology. However, over the last few years several groups were able 
to go into more detail regarding the interaction between CNS and immunity. Several 
studies challenged the dogma that immune system can have a negative effect on 
neurons by providing data that show that multiple signals and reactions from the 
immune response can have neuroprotective effects on the injured CNS (Baumert 
1995, Kyritsis et al. 2012, Ohnmacht et al. 2016).  
Injury to the CNS leads to an inflammatory cascade that begins with cell death and 
continues through complex cellular and molecular interactions. Briefly, after injury 
DAMPS and ATP are released by the injured cells. This activates the inflammasome 
which produces mature cytokines like Il-1β which is the principal cytokine that 
responds immediately after injury. Studies have shown that Il-1β can be produced 
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directly and very rapidly by cells within the injured CNS, like neurons (Watt and Hobbs 
2000), microglia (Giulian et al. 1986) and oligodendrocytes (Blasi et al. 1999).  
Subsequently neutrophils arrive to the injury site and amplify the immune response 
by producing cytokines, ROS and proteases while during the first day monocytes start 
to accumulate in the lesion environment and remain there until the resolution of 
inflammation (Gadani et al. 2015). These cells produce specific molecules during the 
different stages of inflammation. However, the consequences of the immune 
response for the CNS remain controversial. Some groups report aspects of it that can 
be beneficial like oncomodulin that is produced by the neutrophils and has been 
shown to promote optic nerve regeneration (Kurimoto et al. 2013) and il4 that 
activates CD4+ T cells which have a neuroprotective role after injury (Walsh et al. 
2015) whereas other studies suggest that immunity can be destructive for the CNS. 
Work from Kroner et al., show that TNF signalling can alter macrophage polarization 
towards the so-called M1 phenotype leading to extensive tissue damage after SCI 
(Kroner et al. 2014). Similarly, Yawata et al., showed that macrophages can exhibit a 
neurotoxic role through glutamate which can be attenuated by glutaminase 
inhibition (Yawata et al. 2008). These studies and others elegantly highlight the 
complexity of the events that occur in the CNS after injury. Another aspect that adds 
extra difficulty is in all vertebrate injury models there is an interaction between innate 
and adaptive immunity. As a result, we cannot assess accurately the role of each of 
the cellular and molecular players during inflammation. 
In order to tackle this caveat, I used the larval zebrafish injury model for the purposes 
of this thesis to study the role of the innate immune response during the regeneration 
of the spinal cord after transection. While the adult zebrafish model exhibits 
regeneration of the spinal cord and can be considered closer to mammalian models 
since it’s a fully developed system, the larval model was used due to certain 
advantages. After complete transection we can study how axons grow and establish 
new functional axonal connections that allow zebrafish to swim again within 48 hours 
(larval model) (Wehner et al. 2017) instead of 6 weeks (adult model) (Becker et al. 
2004).  
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Furthermore, one advantage over the other models and also the adult zebrafish 
model is the lag between the development of the innate and adaptive immune 
system (Meijer and Spaink 2011). This is very important because it allows the study 
of the contribution of the innate immune response to the regeneration of the spinal 
cord after injury without having to considering the influence of the adaptive 
immunity. This way the exact role of the macrophages, neutrophils or microglial cells, 
can be assessed without implications derived from the interaction between innate 
and adaptive immunity as occur in mammalian injury models or in the adult zebrafish 
injury model.  
After SCI in zebrafish larvae the innate immune response is initiated within minutes. 
The injury site is characterized by an influx of immune cells. Live imaging using 
reporter lines showed that the cellular response is similar to the mammalian in terms 
of timing, with the neutrophils being the first cell population that responds. After the 
initial response of the neutrophils the inflammatory response continues with the 
recruitment of the macrophages from the periphery that migrate into the injury site 
and phagocytose debris and release cytokines. Il-1β and TNF-α are the key cytokines 
that can be found in the lesion environment which, as in mammals, regulate the 
inflammatory response and the regenerative events. However, the whole process, 
from the initiation to the resolution of inflammation, occurs much faster compared 
to mammals, where the immune response after injury is prolonged. Zebrafish larvae 
are able to resolve the inflammation and regenerate their injured spinal cord in 48 
hours which makes them ideal model for studying the inflammatory response after 
injury. 
 
 6.3 The role of the innate immune response to the axonal 
regeneration  
 
Using the larval zebrafish model, I was able to characterize how axons are re-growing 
and establishing new functional connections after injury. Time lapse imaging and 
immunohistochemical observations showed that axons are starting to grow within 15 
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hours after injury. During this time window, only axons were found to cross the injury 
site. The majority of the fascicles that were observed consisted only of axonal 
processes whereas only 20% of the fascicles quantified were positive for glial markers 
indicating that axons can grow independently of the glial scaffold which is in contrast 
with previous studies where the importance of the glial bridge for axonal 
regeneration was mentioned (Goldshmit et al. 2012, Mokalled et al. 2016). By 48 
hours post injury the glial fascicles have been caught up with the axons and the 
majority of the fascicles contain axonal and glial processes (Fig. 4.1.C). In order to give 
a more definitive answer, to the question regarding the glial contribution I selectively 
ablated the glial population, performed spinal cord injuries and assess the axonal 
regrowth after ablation. Interestingly what I found was that the axons were able to 
navigate through the lesion site even after the glial ablation. This showed that indeed 
the axons do not necessarily need the glial population to re-grow and establish 
functional connections with the distal stump.  In agreement with this observation a 
study from Dervan and Roberts showed that adult eel exhibits axonal regeneration 
after spinal cord injury without glial support as GFAP+ processes were found in the 
injury site 16 days after lesion (Dervan and Roberts 2003). Similar results were 
obtained after optic nerve (Nona 2005) and spinal cord transection in goldfish (Nona 
and Stafford 1995). Optic nerve axons are able to regenerate after transection 
without glial bridges. 
Regeneration of axons after injury is something that many groups have worked on 
and continue working. Several studies in zebrafish and other injury models have 
mentioned the role of inflammation during this regenerative process (Becker and 
Becker 2001, Gadani et al. 2015, Ohtake et al. 2015, Jin and Yamashita 2016, 
D'Rozario et al. 2017, Hill 2017, Filous and Schwab 2018). However, it is very difficult 
to exactly determine the actual contribution of the immune response during axonal 
regeneration. 
In order to address this question I used the larval zebrafish model which allowed me 
to focus my analysis only on the innate immune system due to the fact that the 
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adaptive immune system needs a few weeks to be functionally developed and mature 
(Meijer and Spaink 2011) (Fig.6.3.1).  
 
Fig. 6.3.1. Schematic overview of the development of the zebrafish immune system 
(adapted from (Meijer and Spaink 2011)) 
Firstly, I manipulated the immune system using pharmacology to see how the system 
will respond. After inhibition using dexamethasone the bridging score was decreased 
compared to the control group. On the other hand, stimulation with LPS led to 
increased inflammatory response which subsequently resulted in increased axonal 
regeneration (Fig. 3). Taken together, these data indicate that inflammatory response 
is essential for axonal growth after injury, similar to what has been found in adult 
zebrafish for which acute inflammation is beneficial for neuronal and axonal 
regeneration (Becker and Becker 2001, Kyritsis et al. 2012). 
In order to go one step further I used genetic tools to manipulate the immune 
response because the use of drugs very often has adverse effects. Using the csf1ra/b 
double knock-out line I assessed the role of the microglia during regeneration of the 
injured axons. These animals retain their neutrophils and macrophages, but do not 
have microglia. After injury the bridging score was similar between wt and csf1ra/b 
mutants indicating that the microglia cells are not the major cell type necessary for 
axonal regeneration (Fig. 6).  
Next, I used the macrophage-less irf8 mutant line and I found that after injury there 
is increased number of neutrophils in the injury site (Fig. 17),  the levels of the pro-
inflammatory cytokines Il-1β and TNF-α were increased compared to the wt control 
group where they were initially increased and then by 2 days post injury returned to 
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basal levels (Fig. 11), indicating prolong inflammation which resulted in decreased 
bridging score in the mutant fish.  
Cytokine mediated inflammation plays an important role after CNS injury. Il-1β and 
TNF-α have been shown to induce neurotoxicity through glutamate release (Ye et al. 
2013). In order to assess the role of these cytokines during my injury paradigm I 
manipulated them separately using pharmacology and CRISPR/Cas mediated genome 
editing. Pharmacological inhibition of Il-1β rescued the decreased bridging 
phenotype in the irf8 mutants (Fig. 15). Furthermore, it rescued the swimming 
behaviour, indicating that axonal re-growth leads to functional connections and that 
increased levels of Il-1β can be detrimental for regeneration. This is similar to what 
was found by Hasegawa et al.,2017 who showed that after ablation of macrophages 
using irf8 morpholino the levels of Il-1β were increased and this led to impaired 
regeneration of the zebrafish fin fold (Hasegawa et al. 2017). Also modulation of the 
immune system and more specifically pro-inflammatory modulators promotes 
successful tissue regeneration (Julier et al. 2017).  
In contrast to what I found after inhibition of Il-1β, manipulation of TNF-α either by 
blocking its release using pharmacology or by CRISPR had a negative effect on 
regeneration (Fig. 13). The bridging score was significantly decreased and this 
impairment persisted even up to 5 days post injury, indicating a pro-regenerative role 
of TNF-α similar to what was found in the past during fin (Nguyen-Chi et al. 2017) and 
vascular (Bowers et al. 2018) regeneration respectively. 
Interestingly, manipulation of TNF-α led to a phenotype similar to what has been 
observed in the irf8 mutants. The number of neutrophils was increased after injury 
and also the expression of Il-1β was doubled two days post-injury, coinciding with the 
decreased bridging (Fig. 14). This indicated a paradoxical anti-inflammatory role of 
TNF-α that was not expected. However, there are studies in the past that mention 
that treatment of neutrophils with TNF-α in vitro decreases their chemotactic ability 
(Vollmer et al. 1992). Furthermore, Il-1β can be indirectly controlled by TNF-α as it 
has been shown that TNF-α regulates the transcription of NLRP3 inflammasome 
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components (McGeough et al. 2017). Il-1β production occurs via NLRP3 
inflammasome.  TNF-α knockout mice show decreased mRNA expression of Nlrp3, 
Pycard and pro-Casp-1 and subsequently decreased pro-Il-1β and pro-il-18 
(McGeough et al. 2017). 
In summary, I propose that inflammation has a very dynamic role during axonal 
regeneration which is finely tuned by the macrophages. More specifically, after injury 
there are two phases of the inflammatory response. During the early phase, within 
hours of inflammation, spinal cord injury triggers neutrophil invasion of the injury site 
and initiation of the inflammatory response, including Il-1β production which 
amplifies the immune response and through specific signals they attract 
macrophages to the injury site. This initially promotes regeneration, but if it persists 
becomes inhibitory. During the late phase, Il-1β positively regulates the presence of 
neutrophil and macrophages in a feedback mechanism. Macrophages invade the 
lesion site and down-regulate levels of Il-1β in other cells like neutrophils and basal 
keratinocytes, while promoting regeneration by releasing TNF-α. This leads to 
successful axonal regeneration and recovery of parameters of touch-evoked 
swimming. 
 
Concluding remarks and future directions 
 
In this thesis I presented how axons are able to regenerate after mechanical injury of 
the spinal cord and found that axons are able to navigate through the non-neural 
lesion site without the glial support and manage to establish functional axonal 
connections. However, one cannot exclude that we may have missed some glial 
processes that have already bridged the lesion site and acted as a substrate for the 
axons.  
Further experiments need to be carried out in order to identify what is the substrate 
for the axons to grow if not the glial processes. As mentioned in Chapter 4, mRNA 
sequencing of the injury site will provide useful information regarding the molecular 
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components of the lesion site that are essential for axonal re-growth during different 
time points post injury. Furthermore, the lesion site after the spinal cord injury is 
characterized by a complex composition consisted of many different cell types and 
molecules that condition the environment. Several cell types have been previously 
identified in the spinal cord lesion site, like endothelial cells that regulate myeloid cell 
activity (Cohen et al. 2017), immune cells (Kasinathan et al. 2015), oligodendrocytes 
(Almad et al. 2011), matrix metalloproteinases (Zhang et al. 2011), fibroblasts 
(Wehner et al. 2017) and ECM molecules like chondroitin sulphate proteoglycans (Iaci 
et al. 2007). These can all be possible substrates for the axons that cross the injury 
site after injury. Their role during axonal regeneration can be easily assessed because 
there are zebrafish reporter lines available so their response and interaction with 
axons can be observed in vivo performing high-resolution time-lapse imaging on the 
larvae. Furthermore, ablation studies targeting these cells and molecules can be 
performed quote easily on zebrafish due to the easiness in manipulating their 
genome using the CRISPR/Cas system or other genetic tools.  
 In addition to this, another experiment that can be done is an expression profile of 
mammalian embryonic and adult tissue that show robust and limited regenerative 
potential respectively. These data will be compared with data from embryonic and 
larval zebrafish in order to identify differential regulated genes like Epac that it has 
been shown to regulate the c-AMP dependent guidance in rats and shows differential 
expression during (Murray and Shewan 2008, Murray et al. 2009).Furthermore, there 
are genes like Nogo that in mammals has been shown to negatively regulate neuronal 
plasticity (Vanek et al. 1998) whereas in zebrafish the Nogo-A homologue Rtn4b has 
been discovered in differentiating CNS regions and downregulation caused severed 
effects in retinal axonal projections (Welte et al. 2015). The RNA-seq data possibly 
will show other differentially expressed genes between mammals and zebrafish. 
Their role could be further assessed in vivo using the CRISPR/Cas system or 
pharmacological approaches combined with the zebrafish larval injury model. 
I found that the inflammatory response is important for axonal and neuronal 
regeneration in the zebrafish larval model which recapitulates the findings in adult 
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zebrafish, indicating that adult zebrafish can be replaced to some extend with 
zebrafish larvae which allows more rapid conduction of experiments.  
I also found that peripheral macrophages appear to be the most important innate 
immune cell type during spinal cord regeneration. However, one cannot exclude that 
in terms of neuronal regeneration this may be different. (Kyritsis et al. 2012) have 
shown that activation of microglia is important for neuronal proliferation after injury 
in the adult zebrafish CNS. In the csf1ra/b double KO microglia did not appear to be 
necessary for axonal regeneration, possibly because of the infiltration of peripheral 
macrophages, but it would be interesting to assess the neuronal regeneration in a 
system that lacks microglial cells both during the larval and the adult stages.  
The findings derived from the CRISPR manipulations indicate the different roles of 
two mainly proinflammatory cytokines. In order to go one step further these findings 
can be verified using stable mutant lines instead of just using acutely gRNA injected 
embryos. However, there is still the risk of genetic compensation which is the ability 
that the cells have to fix mutations that have been introduced to the genome and 
affect their functionality and survival. The loss of one gene may be compensated by 
another that exhibits similar functions and expression pattern. This is something that 
has been reported in different models (El-Brolosy and Stainier 2017).  
During this thesis the role of anti-inflammatory cytokines like tgf-β was not assessed. 
Anti-inflammaotry cytokines have been found to be beneficial for axonal 
regeneration (Vidal et al. 2013). It would be useful for better understanding of the 
system to assess the role of anti-inflammatory molecules during axonal and neuronal 
regeneration of the spinal cord. One example can be the overexpression of the tgf-
β1a and tgf-β3 in the irf8 embryos which exhibited decreased expression of these 
two anti-inflammatory cytokines after injury.  
It is very important to see how the neurons respond to the different manipulations 
of the innate immune response. What are the cues that are detected by the 
progenitors and can lead to proliferation or differentiation after injury ? Neurons and 
axons may exhibit differential requirements regarding the immune response.  
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Possibly during neuronal regeneration microglial cells may be the most important cell 
type.  In order to address this, expression profiling experiments of the injury site of 
zebrafish larvae after different manipulations or from different mutant lines will 
provide a better insight of the lesion environment and help to identify possible 
targets that are key mediators of neuronal and axonal regeneration.  
Current interventions for the treatment of the spinal cord injury are focusing on 
protecting the surviving cells from secondary damage, replacing injured or dead cells, 
and promoting axon regeneration from the glial scar formed by reactive astrocytes 
that plays a crucial part in the regeneration failure in mammals. To achieve these 
goals requires to develop economical and powerful model organisms that could be 
used for real-time imaging of pathogenesis and to provide gene or drug target 
information. Similar to the adult zebrafish, neuronal replacement, axonal outgrowth 
and functional recovery also occurred in larval zebrafish. However, the axonal repair 
is quicker as it happened within 48 hours as opposed to 6 weeks in adults. In this 
regard, larval zebrafish are amenable to study the intrinsic and extrinsic signals that 
control regeneration in vivo and to identify how the regenerated axons integrate into 
the CNS circuit to restore neural function.  
In this context the findings of this thesis can be validated in adult zebrafish and then 
in mammals. There are mutant lines in house available for Il-1β and TNF-α and tools 
that can be used and assess the effect on axonal and neuronal regeneration.  
The temporal separation that zebrafish larvae exhibit during the development and 
the maturation of their innate and adpative immune system although is very useful, 
because it allows the separate study of the contribution of the innate immune 
response during regeneration, can potentially be also a caveat of the model. One 
main reason is that previous studies have shown that adaptive immunity plays 
significant roles in shaping post-traumatic inflammation and downstream cascades 
of neurodegeneration and repair (Ankeny and Popovich 2009, Gadani et al. 2015). 
Furthermore, important factors and interactions that are more typical in injury 
models may be overlooked. In order to assess the role of the adaptive immune 
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response experiments in adult zebrafish should be carried out. However, the larval 
model is still powerful because the innate inflammatory response occurs very early 
after injury and is essential in order to condition the lesion environment in such a way 
so that the tissue can start to regenerate whereas the adaptive response occurs much 
later (days or weeks post injury) (Gadani et al. 2015).Another aspect that should be 
taken into account is the type of injury. For the purpose of this thesis I performed a 
complete transection of the spinal cord and assessed the regenerative events that 
occur. However, around 70% of the spinal cord injuries are incomplete which partially 
impedes the spinal cord and can be caused by a spinal cord contusion (bruising), a 
partial severance of the spinal cord, stretching, having something pressing against the 
spinal cord, or even having bone fragments or foreign bodies embedded or otherwise 
affecting it. Although complete transections are clinically rare, they provide 
specificity and allow us to assess the regenerative potential that mammals and other 
animal models exhibit. On the other hand, it would be useful if more clinically 
relevant injury models were used. However, the problem with this would be the 
reproducibility because it can be more variable in terms of tissue and axonal sparing 
compared to the complete transection. Previous studies have shown that crush injury 
can be performed in zebrafish optic nerve in a reproducible way (Liu and Londraville 
2003, Diekmann et al. 2015). Based on this, contusion injuries on the zebrafish spinal 
cord should be feasible in order to establish a model which could exhibit more clinical 
relevance.  
Taken together the data presented in this thesis could ultimately help to consolidate 
our understanding on how axons regenerate and manage to establish new functional 
connections after injury and what is the role of the immune response. The clinical 
relevance of the larval regeneration model is that it can be used for screening drugs 
in living animals and genetic manipulations that are not feasible in models such as 
mouse. Early drug screens for clinical use involves the identification of a protein or 
pathways that may result in a therapeutic effect, validation of the discovered 
development candidate in experimental models, and the screening of compounds 
that are likely to have activity at the target protein. The transparency of zebrafish 
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larvae enables small molecule screens that assay compound libraries against disease 
targets to identify drug-like compounds in vivo. The VAST (Vertebrate Automated 
Screening Technology) Biolmager system, which is designed for high-resolution 
imaging of 2-7 dpf zebrafish larvae automatically, can be used for chemical or genetic 
screening in a more efficient manner to identify “hit” molecules and genes that are 
immune related and may have an effect on successful motor neuron and axonal 
regeneration. These hits can be further validated in adult zebrafish and then in 
mammalian models leading eventually to the development of efficient therapeutic 
strategies of SCI. 
Furthermore, following up on this, future studies on zebrafish could  try to investigate 
if the new-born neurons are able to extend new processes across the injury site and 
reinnervate their original or new targets or if the axons that regenerate are derived 
from neurons that were spared during injury and its’ downstream events. This could 
be relatively easily answered using the zebrafish larval model and more specifically 
the Zebrabow reporter line which allows multispectral cell labelling that can be used 
for cell tracing and lineage analysis (Pan et al. 2013). This will provide very useful 
information because it could possibly show which is more important; axonal 
regeneration or neurogenesis. There is evidence that axons in the mammalian CNS 
have an intrinsic regenerative potential, whereas the evidence that new neurons can 
be born are very limited, so the knowledge obtained from this experiment could 







Chemicals and reagents 
 
Name Cat. No. Source 
Agarose BPE1356 Sigma-Aldrich 
Aminobenzoic acid ethylmethylester 
(MS222) 
A5040 Sigma-Aldrich 
Ampicillin A9518 Sigma-Aldrich 
BCIP/NBT tablet B5655 Sigma-Aldrich 
β-‐‐Mercaptoethanol M6250 Sigma-Aldrich 
Bovine serum albumin (BSA) A3912 Sigma-Aldrich 
Calcium Chloride, CaCl2 C/1500/53 Fisher Scientific 
α-Digoxygenin-AP conjugate 11093274910 Roche 
Digoxygenin-11-UTP 3359247910 Roche 
Dimethyl sulfoxide (DMSO) D2650 Sigma-Aldrich 
Ethanol E7023 Sigma-Aldrich 
Ethylenediaminetetraacetic acid (EDTA) E6635 Sigma-Aldrich 
Formamide 47670 Sigma-Aldrich 
Glycerol G5516 Sigma-Aldrich 
Glycine 50046 Fisher Scientific 
Heparin sodium salt H3393 Sigma-Aldrich 
Hydrochloric acid, HCl 
320331 
Sigma-Aldrich 
Magnesium Chloride, MgCl2 31413 Sigma-Aldrich 
Methanol M/4000/17 Fisher 
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Normal donkey serum S30 Millipore 
Normal goat serum ab7481 Abcam 
Normal sheep serum SMI-6050C Covance 
Paraformaldehyde (PFA) P6148 Sigma-Aldrich 
2-‐‐Propanol; Isopropanol I9516 Sigma-Aldrich 
Potassium chloride, KCl P4504 Sigma-Aldrich 
Potassium dihydrogen orthophosphate, 
KH2PO4 
60218 Sigma-Aldrich 
RNaseZAP R2020 Sigma-Aldrich 
Sodium acetate, CH3COONa 241245 Sigma-Aldrich 
Sodium chloride, NaCl S7653 
Sigma-Aldrich 
Sodium citrate S1804 Sigma-Aldrich 
Sodium hydroxide 30620 Sigma-Aldrich 
Sodium phosphate dibasic S0876 Sigma-Aldrich 
Sodium dihydrogen phosphate,  S5011 Sigma-Aldrich 
Superfrost coated glass slides 48311-703 VWR International 
Torula yeast tRNA 10109517001 Roche 
Triton X-100 93426 Sigma-Aldrich 
Trizma Base 93362 Sigma-Aldrich 
Tween 20 P1379 Sigma-Aldrich 
X-‐‐Gal B8503 Sigma-Aldrich 
EdU Click-iT C10340 Invitrogen 
MAXIScript® Kit AM1322 Ambion 
Qiaprep Spin Miniprep kit 27106 Qiagen 
pGEM-T Easy Vector kit A1360 Promega 
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MinElute Gel Extraction kit 28604 Qiagen 
iScript cDNA synthesis kit 170-8891 Bio-rad 
Rneasy Mini kit 74104 Qiagen 
SsoAdvancedTM Universal SBR Green 
Supermix 
172-5271 Bio-rad 
Collagenase C9891 Sigma-Aldrich 
Proteinase K 03115887001 Roche 
Trypsin-EDTA 25200-056 Gibco 
Dexamethasone D1756 Sigma 
LPS L2880 Sigma 
Ac-YVAD-cmk SML0429 Sigma 
Q-VD-OPh SML0063 Sigma 
IWR-1 I0161 Sigma 
O-Phospho-L-serine P0878 Sigma 
TAG DNA polymerase M023X NEB 
In Situ Cell Death Detection Kit TMR red     
12156792910 
Roche 





Name Host Source Cat.no Dilution 
Anti-GFP 
(Wehner et al. 
2018) 
chicken Abcam AB13970 1:300 
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     Anti-HB9 
(Barreiro-Iglesias et 
al. 2015) 
     mouse      DSHB      81.5c10      1:500 
Anti-4c4 













(Wehner et al. 
2018) 
mouse Sigma T6793 1:300 
Anti-tp63 
(Wehner et al. 
2018) 
rabbit Sigma SAB2701838 1:300 
Anti-collagen I 
(Wehner et al. 
2018) 
rabbit Abcam ab23730 1:300 
Anti-GFAP 
(Wehner et al. 
2018) 
rabbit Dako Z0334 1:300 
Anti-HuC/HuD 
(Ulrich et al. 
2016) 
mouse Invitrogen A-21271 1:100 
Anti-mpx (Kenyon 
et al. 2018) 
rabbit GeneTex GTX128379 1:300 
Anti-mfap4 rabbit GeneTex GTX132692 1:300 
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Anti-Il-1β (Zheng 
et al. 2015) 
rabbit Proteintech 16806-1-AP 1:200 
Anti-TNF-α 
(Nelson et al. 
2013) 




et al. 2016) 





et al. 2016, Prost 
et al. 2016) 
donkey Jackson 
ImmunoResearch 
711-007-003 40 μg/ml 




























Alkaline Tris buffer 
100 mM Tris HCl (1 M stock, pH 9.5) 
50 mM MgCl2 
100 mM NaCl 
0.1% Tween® 20 







5 x SSC 
0.1% Tween® 20  
50 µg / ml heparin 
5 mg / ml tRNA from Torula yeast 
complete with RNase free H2O, adjust 
pH to 6.0 
Hybridisation mix for washes (HMW) 
50% Formamide5 x SSC 
complete with RNase free water 
 
ISH blocking buffer 
1x PBS 
0.1% Tween® 20 
5% normal sheep serum 
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10mg / ml Bovine Serum Albumin (BSA) 




1% normal donkey 




40 ml 10 x PBS 
complete with d H2O up to 400 ml 
 
10 x Phosphate buffered saline (PBS), pH 7.5 
80 g NaCl 
14.16 g Na2HPO4 
2.4 g KH2PO4 
2 g KCl 
adjust pH to 7.5 
complete with d H2O up to 1L 
 
1 x Phosphate buffered saline (PBS), pH 7.5 
100 ml of 10x Phosphate buffered saline (PB) 






0.2% Phosphate buffered saline (PBS), TritonX-100 
100 ml of 10x Phosphate buffered saline (PBS) 
2ml TritonX-100 
complete with d H2O up to 1L 
 
0.5% Phosphate buffered saline (PBS), TritonX-100 
100 ml of 10x Phosphate buffered saline (PBS) 
5ml TritonX-100 
complete with d H2O up to 1L 
 
1% Phosphate buffered saline (PBS), TritonX-100 
25 ml of 10x Phosphate buffered saline (PBS) 
2,5ml TritonX-100 
complete with d H2O up to 250mL 
 
0,1% Phosphate buffered saline (PBS), Tween-20 
100 ml of 10x Phosphate buffered saline (PBS) 
1 ml Tween-20 
complete with d H2O up to 1L 
 
Sodium citrate (10 mM) 
2.94 g sodium citrate 
complete with d H2O up to 1L 
adjust pH to 6.5 
 
20 x SSC stock solution, pH 7 
175.3 g NaCl 
88.2 g Citric acid trisodium salt 
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100 mM Tris-HCL pH 9,5 
50mM MgCl2 
100mM NaCl 
0.1% Tween 20 
 
Staining Solution 
1 tablet NBT/BCIP 
10ml Staining Buffer 
 
Stop solution 
1 x PBS, pH 5.5 
1 mM EDTA 
0.1% Tween® 20 
 
50 x TAE buffer 
484 g Tris Base 
114.2 ml Acetic Acid 
1000 ml 0.1 EDTA, pH 8 
adjust pH to 6.5 with HCl 




Tris HCl (1 M), pH 9.5 
121.1 g Trizma base dissolved in 900 ml RNase free H2O 
adjust pH to 9.5 with HCl 
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Spinal motor neurons are regenerated after mechanical lesion and
genetic ablation in larval zebrafish
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Themistoklis M. Tsarouchas, Daniel Wehner, Dirk Sieger, Catherina G. Becker§ and Thomas Becker§
ABSTRACT
In adult zebrafish, relatively quiescent progenitor cells show lesion-
induced generation of motor neurons. Developmental motor neuron
generation from the spinal motor neuron progenitor domain (pMN)
sharply declines at 48 hours post-fertilisation (hpf). After that, mostly
oligodendrocytes are generated from the same domain. We
demonstrate here that within 48 h of a spinal lesion or specific genetic
ablation of motor neurons at 72 hpf, the pMN domain reverts to motor
neuron generation at the expense of oligodendrogenesis. By contrast,
generation of dorsal Pax2-positive interneurons was not altered. Larval
motor neuron regeneration can be boosted by dopaminergic drugs,
similar to adult regeneration. We use larval lesions to show that
pharmacological suppression of the cellular response of the innate
immune system inhibits motor neuron regeneration. Hence, we have
established a rapid larval regeneration paradigm. Either mechanical
lesions or motor neuron ablation is sufficient to reveal a high degree of
developmental flexibility of pMN progenitor cells. In addition, we show
an important influence of the immune system on motor neuron
regeneration from these progenitor cells.
KEY WORDS: Dopamine, Macrophage, Microglia, Nitroreductase,
Hb9, Olig2, Sox10
INTRODUCTION
In contrast to mammals, adult zebrafish are capable of regenerating
neurons in the central nervous system (CNS), including the spinal
cord (Grandel and Brand, 2013; Goldman, 2014; Becker and
Becker, 2015; Than-Trong and Bally-Cuif, 2015). To understand
these differences, it is important to elucidate the signals and
mechanisms leading to successful CNS regeneration in fish. In adult
zebrafish, a lesion to the spinal cord induces ependymo-radial glial
cells (ERGs) to proliferate and, subsequently, distinct ERG domains
give rise to different types of neurons (Reimer et al., 2008;
Goldshmit et al., 2012; Kuscha et al., 2012a,b). For example, olig2-
expressing ERGs in the ventromedial aspect of the spinal cord
generate new motor neurons after a lesion (Reimer et al., 2008).
Motor neuron-generating adult ERGs are likely to be derived from
embryonic motor neuron progenitor (pMN) cells. The spinal pMN
domain thus transitions from a motor neuron generating program
during early development [up to 48 hours post-fertilisation (hpf)]
(Reimer et al., 2013) to generation of oligodendrocytes (Kirby et al.,
2006; Kim et al., 2008; Czopka et al., 2013) and eventually, to
relative quiescence at the adult stage (Reimer et al., 2008).
A mechanical lesion in adults reinitiates the program for motor
neuron generation (Reimer et al., 2008). This is positively regulated
by Hedgehog (Reimer et al., 2009), dopamine signalling acting on
the Hedgehog pathway (Reimer et al., 2013) and serotonin
(Barreiro-Iglesias et al., 2015). To explore the plasticity of spinal
progenitors, we asked whether motor neuron regeneration can be
triggered when their developmental generation has been completed
but cells in the pMN domain are still proliferating and generate
oligodendrocytes, and if so, whether progenitors react to signals
similar to those during adult regeneration.
The immune system probably plays an important role in
regeneration. For example, there is a strong microglia/macrophage
reaction to a spinal lesion (Becker and Becker, 2001) and activation
of microglia/macrophages alone is sufficient to trigger neuronal
regeneration in the adult zebrafish telencephalon (Kyritsis et al.,
2012). This suggests that signalling of microglia/macrophages to
progenitor cells occurs.
However, with mechanical lesions, it is difficult to dissociate the
effects of extrinsic signals from those of injuring the intricate radial
processes of the progenitors themselves. For example, it has been
shown that the stem cell potential of astrocytes in mammals differs
following mechanical lesion versus cell ablation or a chronic disease
state (Sirko et al., 2013). Therefore, we use a genetic strategy
(Curado et al., 2008) to selectively ablate motor neurons in order to
determine whether this loss is sufficient to trigger motor neuron
regeneration in the larval spinal cord.
We find that a mechanical lesion of the larval spinal cord leads to
regeneration of motor neurons close to the spinal lesion site and
that this can be enhanced with a dopamine agonist, similar to adult
regeneration. A macrophage/microglial reaction promotes motor
neuron regeneration. Cell type-specific ablation is sufficient to induce
motor neuron regeneration. Hence, motor neuron regeneration can be
studied in larvae, as it replicates some features of adult regeneration.
Motor neuron regeneration can be dissociated frommechanical lesion
of progenitors and is promoted by the innate immune system.
RESULTS
Larval lesion induces local regeneration of motor neurons
Embryonic motor neuron generation from the pMN domain
largely ceases by 48-51 hpf (Reimer et al., 2013), whereas
oligodendrogenesis from these progenitors continues for weeks
(Park et al., 2007). To determine whether pMN progenitors can
switch to generating motor neurons during oligodendrogenesis, we
inflicted a mechanical lesion to the spinal cord at 3 days post-
fertilisation (dpf), leaving the notochord and major blood vesselsReceived 28 July 2015; Accepted 25 February 2016
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intact (Fig. 1A-C). Such a wound closes quickly (within 48 h;
Fig. 1D) and larvae recover swimming capability within 2 days
post-lesion, as measured by distance moved after tail touch
(Fig. S1). This indicates that functional regeneration is extremely
quick at the larval stage.
To label newly generated motor neurons, we applied the DNA
base analogue and proliferation marker EdU to Hb9:GFP (also
known as mnx1:GFP) transgenic animals directly after the lesion at
3 dpf and counted double labelled neurons at 4, 5 and 6 dpf. No
increase in the number of Hb9:GFP+ neurons that incorporated
EdU, which would have been newly generated after the lesion, was
observed at 4 dpf. However, at both 5 and 6 dpf, the number ofHb9:
GFP+/EdU+ cells was strongly increased by up to 400% close to
(within 50 µm), but not far from (within 50-100 µm) the lesion site,
compared with unlesioned controls (Fig. 1E-H). To test whether
regenerative neurogenesis would also occur at later stages, we
shifted the injury paradigm to 5 dpf, when larvae had become fully
behaving predators (Semmelhack et al., 2014; Bianco and Engert,
2015). Analysis of Hb9:GFP+/EdU+ neurons at 7 dpf indicated a
257% increase in the number of new motor neurons, comparable to
the 3 to 5 dpf standard protocol (Fig. S2). This supports the presence
of local lesion-induced signals that lead to motor neuron
regeneration within 48 h of the lesion.
To determine whether larval pMN progenitor cells react to a
lesion with increased proliferation, we injected EdU into olig2:
DsRed transgenic larvae, in which pMN progenitors and motor
neurons contain DsRed protein. To label acutely proliferating cells
in the pMN domain, we chose a paradigm in which larvae were
lesioned at 3 dpf and EdU was injected at 4 dpf with a subsequent
survival time of 4 h. This indicated a 165% increase in the number
of olig2:DsRed+/EdU+ cells (Fig. 2A-D). Hence, proliferation in the
pMN domain was increased after a lesion.
To assess whether newly generated motor neurons in larvae were
derived from the olig2-expressing cells, we used EdU labelling in
Hb9:GFP; olig2:DsRed double transgenic larvae. If newly generated
motor neurons are derived from these progenitors, they retain the
DsRed protein, which is expressed in progenitors under the
regulatory sequences for olig2. Thus DsRed protein acts as short-
term lineage tracer. Indeed, all newly generatedmotor neurons (Hb9:
GFP+/EdU+; 23 neurons in 4 animals) were also positive for DsRed
(Fig. 2E). This suggests that after a lesion, newly generated motor
neurons originate from olig2-expressing pMN progenitor cells.
To determine whether generation of oligodendrocytes, which are
derived from the same progenitor domain (Kucenas et al., 2008;
Czopka et al., 2013), was altered by the lesion, we assessed numbers
of olig2:GFP/sox10:mRFP/EdU triple-labelled cells, representing
newly generated oligodendrocytes and their precursors (Kirby et al.,
2006), at 5 dpf, after a lesion at 3 dpf. These cells were present in
unlesioned larvae, confirming previous evidence for continuous
generation of oligodendrocytes in unlesioned larvae (Kucenas et al.,
2008; Czopka et al., 2013), and reduced in number by 88% after a
lesion (Fig. 3A-D). We assessed the number of newly generated
differentiated oligodendrocytes in the mbp:GFP (Almeida et al.,
2011) transgenic line, in which oligodendrocytes are labelled under
the regulatory sequences of the myelin basic protein a (mbpa) gene.
The number of EdU double-labelled mbp:GFP+ cells was also
strongly reduced by 94% (Fig. 3E-G).
Importantly, we did not observe any olig2:GFP/sox10:mRFP
double-labelled cells that were labelled by the TUNEL reaction,
indicating that lower numbers of oligodendrocyte-lineage cells were
not due to increased cell death (Fig. S3). To determine whether a
sub-class of pMN progenitors show selective cell death, we also
assessed the number of olig2:GFP/TUNEL double-labelled cells
within the pMN domain, but did not detect increased cell death after
a lesion. Occasionally, we observed double-labelled cells in the
pMN domain outside the area of interest in both conditions,
demonstrating that we were able to detect such cells (not shown).
Taken together, these observations suggest that after a lesion,
progenitor cells in the pMN domain switch from oligodendrocyte
generation to motor neuron generation.
To elucidate whether other progenitor cells are induced to
generate new neurons after a lesion, we analysed the number of
Fig. 1. A mechanical lesion to the spinal cord heals within 48 h and leads
to motor neuron regeneration close to the lesion site. (A) Time line for
experiments. (B) A zebrafish larvawith a lesion in the dorsal trunk area, leaving
the notochord intact at 3 dpf. (C,D) The same larva imaged at 0 and 48 h post
lesion shows closure of the wound. (E,F) The lesion area is outlined with
double-labelled Hb9:GFP+/EdU+ neurons indicated by arrowheads. A lesion
leads to increased numbers of Hb9:GFP+/EdU+ double-labelled motor
neurons (compare E and F). E′ to F‴ show higher magnifications of areas
boxed in E and F, respectively, in single optical sections indicating double
labelling. (G) Motor neurons are regenerated close to (<50 µm rostral and
caudal), but not far from (100 µm>×>50 µm rostral and caudal) the lesion site
(one-way ANOVA with Bonferroni’s multiple comparisons test, ***P<0.001,
****P<0.0001; unlesioned, n=10; far, n=11; close, n=11). (H) Time line of the
increase in the number of EdU-labelled motor neurons (t-test, ****P<0.0001).
Values are means±s.e.m. Lateral views of larvae are shown (rostral is left;
dorsal is up). Scale bars: 100 µm in B; 500 µm in D for C,D; 50 µm in F for E,F;
15 µm in F‴ for E′-F‴.
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newly generated dorsal pax2a:GFP+ interneurons, which are
regenerated after an adult spinal cord lesion (Kuscha et al.,
2012b). pax2a:GFP+ post-mitotic neurons have been suggested to
be derived from more dorsal progenitor domains and not the pMN
domain (England et al., 2011). The analysis in larvae showed
equally low numbers of pax2a:GFP/EdU double-labelled cells in
unlesioned controls and lesioned larvae (Fig. S4). This suggests that
for some dorsal progenitor domains, a lesion might not be sufficient
to trigger increased generation of neurons.
To determine whether larval regeneration shares mechanisms
with adult regeneration, we decided to analyse dopamine
signalling, which is shown to promote spinal motor neuron
regeneration in adults (Reimer et al., 2013). To detect an
endogenous source for dopamine, we labelled descending,
mostly dopaminergic axons, by immunohistochemistry for
tyrosine hydroxylase 1 (TH1; the rate-limiting enzyme in
dopamine synthesis). Thus, we could detect descending TH1+
axons in the spinal cord of unlesioned larval zebrafish at 78 hpf
(Fig. S5). In lesioned larvae, TH1+ axons were not detected caudal
to the lesion site, 6 h after the lesion. These distal axon segments
had most likely degenerated. Incubation in the dopamine agonist
pergolide after a lesion (3-5 dpf ), increased the number of newly
generated Hb9:GFP+ motor neurons by 63% (Fig. 4), with no
difference between the rostral and caudal spinal cord. These data
suggest that larval pMN progenitors react to similar signals as adult
pMN-like progenitors after a lesion.
The immune response is important for motor neuron
regeneration
Reactive immune cells promote neuronal regeneration (Kyritsis
et al., 2012) and the larval spinal cord offers the opportunity to
study the innate immune system in isolation from the adaptive
immune response, which develops only later (Danilova and
Steiner, 2002; Lam et al., 2004). To determine whether the innate
immune system promoted motor neuron generation after a larval
lesion, we labelled microglial cells with a 4C4 antibody (Becker
and Becker, 2001), and all macrophages and neutrophils with an
L-plastin (Lcp1) antibody (Feng et al., 2010). Labelling with the
4C4 antibody was significantly increased in the lesion site by
369% (data not shown). At 48 h after the lesion, labelling of
both 4C4 and L-plastin was concentrated at the lesion site
(Fig. 5A,B,D). Suppressing this response by incubation of
larvae in the immunosuppressant dexamethasone (Kyritsis et al.,
2012), strongly dampened the microglia/macrophage response
(Fig. 5C,E,F). This treatment also led to a reduction in the number
of newly generated Hb9:GFP+/EdU+ motor neurons by 60%
within 48 h of the lesion (3-5 dpf; Fig. 5G-I), suggesting that
macrophages/microglial cells exert a positive influence on motor
neuron regeneration.
Genetic ablation of motor neurons triggers specific motor
neuron apoptosis and macrophage/microglial activation
To determine whether a mechanical lesion is necessary to trigger
motor neuron regeneration or whether loss of motor neurons
alone is sufficient to trigger a regenerative response, we expressed
a nitroreductase transgene in motor neurons for selective ablation
in Tg(mnx1:Gal4, UAS:nfsB-mCherry) double-transgenic fish.
Lateral views of larvae showed obvious labelling in motor
neurons in the ventral half of the spinal cord with axons growing
into the muscle periphery, as well as in the heart and pancreas at
3 dpf (Fig. 6A). Expression levels varied, but could be
substantially increased through selective breeding. There was a
Fig. 2. After a lesion, the pMN domain shows
increased proliferation and gives rise to motor
neurons. (A) Time line of the experiment. (B,C) olig2:
DsRed+ cells (arrowheads) in the pMN domain that
incorporated EdU within the last 4 h. (B′-C‴) Higher
magnifications of single optical sections of the cells
indicated by asterisks in B and C, respectively, showing
double labelling. (D) The number of proliferating cells in
the pMN domain is significantly increased in the vicinity
of the lesion site (Mann–Whitney test; **P=0.0049).
(E) In Hb9:GFP and olig2:DsRed double-transgenic
larvae (lesion: 3 dpf; analysis: 5 dpf), newly generated
motor neurons (Hb9:GFP+/EdU+) that retain DsRed
protein are indicated by arrowheads. Lateral views are
shown; rostral is left, dorsal is up. Values are
means±s.e.m. Scale bars: 50 µm in C for B,C; 20 µm in
C‴ for B″-C‴ and 10 µm for B′,C′; 15 µm in E.
1466











general decline in the number of labelled cells with progressing
development. mCherry+ cells were still detectable at 10 dpf, but
had completely disappeared in adults (data not shown).
At 3 dpf, triple labelling of Hb9, ChAT and mCherry revealed
that 86% of the mCherry-labelled spinal cells were also positive for
Hb9, ChAT or both, indicating that the vast majority of mCherry+
cells were indeed motor neurons (Fig. 6B,C). Conversely, 42% of
Hb9+ and 54% of ChAT+ motor neurons expressed the nfsB-
mCherry transgene at 3 dpf (Table S1). At 5 dpf, the proportion of
Hb9+ motor neurons that were also labelled by mCherry was
reduced to 25% (data not shown), in line with the developmental
reduction in transgene and endogenous hb9 expression.
Incubation with metronidazole (MTZ) led to a visible loss of
mCherry signal starting 4-5 h into the treatment and by 24 h,
almost no intact cell bodies were observable in the spinal cord of
whole-mounted larvae or sections (Fig. 7A-D; Fig. S6). TUNEL
and FLICA labelling of motor neurons confirmed loss of these
cells (Fig. S7). In Tg(mnx1:Gal4, UAS:nfsB-mCherry); slc6a5:
GFP triple-transgenic fish, in which glycinergic neurons in the
ventral spinal cord are additionally labelled for GFP (McLean
et al., 2007), mCherry+ motor neurons, but not slc6a5:GFP+
interneurons were ablated, indicating specificity of ablation
(Fig. S8). Counts of Hb9 and ChAT immunoreactive neurons
showed a reduction by 12% and 17%, respectively (Fig. 8I).
Treatment of Hb9:GFP larvae with 5 and 10 mM MTZ did not
result in any cell loss, indicating that MTZ alone was not toxic to
motor neurons (data not shown).
mCherry fluorescence was also reduced in the heart (Fig. S6),
suggesting ablation of heart tissue and blood flow in ventral and
intersegmental vessels had stopped in at 24 h into the treatment
(n=5), but not in MTZ-treated control animals (n=5). These larvae
still survived the treatment for several days. This is probably
because small zebrafish larvae do not depend on circulation for
oxygen diffusion until about 14 dpf (Jacob et al., 2002). For
example, mutants without a heartbeat show no obvious aberrations
in the first week of development (Rottbauer et al., 2001). The latest
time point we analysed was at 9 dpf.
Fig. 3. Oligodendrocyte generation is reduced after a spinal lesion.
(A) Time line of the experiment. (B,C) Newly generated oligodendrocytes and
their precursors, triple labelled by olig2:GFP, sox10:mRFP and EdU
(arrowheads), are reduced in number after lesion. (B′-B″″) A triple-labelled cell
(indicated with asterisk in B) in a single optical section at higher magnification.
(D) The number of triple-labelled cells is reduced (Student’s t-test,
****P<0.0001). (E)mbp:GFP+ oligodendrocytes incorporate EdU (indicated by
arrowheads) in unlesioned larvae. (E′-E‴) Two double-labelled neurons
indicated in E at higher magnification in a single optical section. (F) Fewer
double-labelled cells are observed after a lesion. (G) The number of new
oligodendrocytes is significantly reduced after a lesion (Mann–Whitney U-test;
***P=0.0005). Lateral views are shown; rostral is left, dorsal is up. The lesion
site is indicated by a dashed line. Values are means±s.e.m. Scale bars:
100 µm in B for B,C; 20 µm in B″″ for B′-B″″; 50 µm in F for E,F; 20 µm in E‴.
Fig. 4. Motor neuron regeneration is enhanced by application of a
dopamine agonist. (A) Experimental time line. (B,C) Double-labelled Hb9:
GFP+/EdU+ neurons are indicated by arrowheads. (B′-C‴) Double-labelled
cells fromB,C (asterisks) are indicated by arrowheads in single optical sections
at higher magnification. (D) Pergolide treatment during the regeneration phase
significantly increases the number of Hb9:GFP+/EdU+ double-labelled motor
neurons (t-test, **P=0.0092; DMSO, n=12; Pergolide, n=9). Lateral views are
shown; rostral is left, dorsal is up. The lesion site is indicated by a dashed line.
Values aremeans±s.e.m.Scale bars: 50 µm inB for B,C; 10 µm inB‴ for B′-C‴.
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Using the 4C4 antibody, we detected that MTZ treatment resulted
in an increased number of 4C4+ cell profiles in the spinal cord,
which were often found to contain red fluorescing debris from
mCherry+ cells after 24 h of MTZ incubation (Fig. 7E-G). The
increase in numbers of macrophages/microglial cells was specific to
the spinal cord, because we did not observe an increase in cell
numbers in the eyes or brain (Fig. S9). Moreover, in wild-type
larvae, no increase in macrophage/microglial cell counts was
observed after MTZ treatment (data not shown). Hence, ablation of
motor neurons leads to a specific reaction of macrophages/
microglial cells in the spinal cord.
Motor neurons regenerate after targeted ablation
As ablation of mCherry+ cells in Tg(mnx1:Gal4, UAS:nfsB-
mCherry) double transgenic fish was almost complete,
reappearance of these cells would indicate regeneration of motor
neurons. However, we did not observe any new mCherry+ cells for
at least 7 days post-ablation (n=7). To test whether this was due to a
lack of regeneration or an inability to re-express the transgene, we
treated larvae with MTZ from 3 to 4 dpf and additionally inflicted a
mechanical lesion at 4 dpf, because mechanical lesions trigger
motor neuron regeneration (see above). However, no mCherry+
cells were observed for up to 8 dpf (n=7, data not shown). In
addition, at 2 weeks after a spinal lesion in adult Tg(mnx1:Gal4,
UAS:nfsB-mCherry) fish (n=3), we observed small strongly Hb9
immunoreactive cells, previously shown to be lesion-induced newly
generated motor neurons (Reimer et al., 2008), but none of these
were mCherry+ (data not shown). This indicates that the transgene is
not expressed by newly generated motor neurons at later stages of
development or in adult fish.
To determine whether motor neuron regeneration took place after
ablation of motor neurons, we used Hb9 immunohistochemistry
after EdU injections at different injection and detection time points.
After two injections of EdU at 16 and 22 h into the MTZ treatment,
we observed a significant increase in the number of Hb9+/EdU+
motor neurons at 9 dpf (Fig. 8A-C,F,G) but not at 5 dpf (48 h after
treatment onset; n=4, data not shown). By contrast, the number of
Pax2 immunoreactive interneurons that were double labelled with
Fig. 5. Suppression of the immune response inhibits motor neuron regeneration. (A) Time line for the experiments. (B-F) Incubation with dexamethasone
does not lead to visible changes in unlesioned larvae (B,C), but strongly reduces the immune reaction at the lesion site (D,E) as indicated by reduced 4C4
(arrowheads indicate 4C4+ cells) and L-plastin immunoreactivity. Quantification of immunoreactivity is shown in F (Student’s t-test, ***P<0.001).
(G-I) Dexamethasone treatment reduces the number EdU-labelled Hb9:GFP+ motor neurons (arrowheads). Higher magnifications of double-labelled neurons
indicated by asterisks in G,H are shown in single optical sections inG′-H‴. (I) Quantification of the reduction in newly generatedmotor neurons (t-test; **P=0.0085;
unlesioned, n=16; dexamethasone, n=13). Lateral views are shown; rostral is left, dorsal is up. The lesion site is indicated by a dashed line. Values are
means±s.e.m. Scale bars: 100 µm in E for B-E; 100 µm in H for G,H; 50 µm in H‴ for G′-H‴.
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EdU was not increased at 9 dpf after motor neuron ablation at 3 dpf
(Fig. 8D,E,H). Application of EdU at 48 and 72 h post treatment did
not result in Hb9/EdU co-labelled profiles in either controls (n=4) or
MTZ-treated larvae (n=4 at 48 h post-treatment; n=4 at 72 h post
treatment), indicating that newmotor neurons were generated within
48 h of treatment.
The overall number of Hb9+ profiles was significantly reduced
24 h after ablation at 3 dpf and was back to control levels at 7 dpf.
Fig. 6. The Tg(mnx1:Gal4, UAS:nfsB-mCherry) transgene is
expressed in motor neurons. (A) Lateral view of a whole larva
(rostral left, dorsal up, 3 dpf) indicates labelling in spinal motor
neurons, the pancreas and heart. (B,C) Spinal cross sections
(3 dpf) indicate that most mCherry+ cells are also Hb9+ or ChAT+,
or both. Arrowheads indicate triple-labelled cells. (C) Venn
diagram showing the overlap of mCherry expression with motor
neuron markers. Scale bars: 500 µm in A; 25 µm in B‴ for B-B‴.
Fig. 7. MTZ treatment leads to ablation of all transgene-
expressing cells and to microglia/macrophage activation.
(A) Treatment time line. (B-D) mCherry+ motor neurons and
their axons are visible in untreated control larvae at 3 and 4 dpf
(B,B′), but mCherry labelling is completely lost after 24 h
treatment with MTZ (C,C′), quantified in D (Mann–Whitney
U-test, ****P<0.0001). (E-G) Cross sections show that
mCherry-labelled cells fragment during MTZ treatment and
that microglia/macrophages appear and phagocytose the cell
debris (arrow in F,F′). Microglia/macrophages are quantified in
G (Mann–Whitney U-test, ***P<0.0001). Values are
means±s.e.m. Scale bars: 100 µm in C′ for B-C′; 25 µm in
F′ for E-F′.
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Similarly, numbers of ChAT profiles were significantly reduced up
to 7 dpf and were not significantly different from controls by 10 dpf
(Fig. 8I). This suggests that at least some newly generated motor
neurons mature into ChAT-positive cells by 10 dpf. Taken together,
the data suggest that motor neuron ablation leads to a rapid lesion-
induced regeneration of motor neurons, which is completed within
48 h of ablation, followed by slow differentiation of motor neurons,
whereas generation of Pax2+ interneurons was unaffected by motor
neuron ablation.
DISCUSSION
Here, we demonstrate that spinal progenitors can be induced to
regenerate motor neurons in larval zebrafish at the expense of
oligodendrocyte generation and identify the immune response as a
regeneration-promoting signal. This supports the view that spinal
progenitors in zebrafish are highly plastic in terms of the
developmental programs they execute. Moreover, we show that
genetic ablation of a proportion of motor neurons is sufficient to
induce their specific regeneration.
Larval motor neuron regeneration is similar to adult
regeneration
Our previous birth dating study of motor neurons indicated that
motor neuron generation sharply declines at 48 hpf (Reimer et al.,
2013). Our present results confirm that few motor neurons are
generated after that time. This allows us to distinguish regenerative
from developmental neurogenesis at early larval stages. However,
the larval zebrafish spinal cord is still a developing system. This is
demonstrated by the observation that Pax2+ interneurons (this
report) and other interneurons (Briona and Dorsky, 2014) are still
being generated. Nevertheless, some key features of motor neuron
regeneration are similar between larval and adult regeneration. For
example, the highest numbers of regenerating motor neurons are
observed close to the lesion site, motor neurons are derived from
olig2-expressing progenitors and regeneration is promoted by
dopamine (this study and Reimer et al., 2008; Reimer et al.,
2013). We show here that motor neuron regeneration and functional
recovery in larvae are very rapid, occurring within 48 h, whereas in
adults, motor neuron regeneration and recovery of swimming take
weeks. However, the possible contribution of regenerated motor
neurons to functional recovery still needs to be determined. Our
observations show that motor neuron regeneration can be studied in
larvae.
Microglia/macrophage signalling might contribute to
regeneration
Another aspect that is similar for larval and adult lesions (Becker
and Becker, 2001) is activation of the immune system, which might
carry pro-regenerative signals. Here, we demonstrate accumulation
of immune cells at a spinal lesion site and after motor neuron
ablation in larvae and we find that suppression of the immune
response using dexamethasone reduces motor neuron regeneration.
Manipulation of the adult immune response with dexamethasone in
the stab-lesioned telencephalon similarly suppressed neurogenesis
from progenitor cells (Kyritsis et al., 2012). Analysis of the immune
response at early larval stages has the advantage that the innate
immune system can be studied in isolation of the adaptive immune
system, because the latter is not functional at early larval stages
(Danilova and Steiner, 2002; Lam et al., 2004). Hence, microglia/
macrophages are positive regulators of lesion-induced neurogenesis
in the lesioned adult and larval CNS.
pMN progenitors are highly plastic
It is likely that regenerated motor neurons are derived from the pMN
domain, because they are found close to it in the ventral spinal cord,
the pMN domain exhibits increased proliferation after a lesion and
Fig. 8. Motor neuron ablation leads to regeneration of
motor neurons. (A) Experimental timeline. (B-H) In spinal
cross sections, Hb9+/EdU+ motor neurons are only
observed in MTZ-treated larvae (B,C, shown in a whole
cross section of the spinal cord including orthogonal views
in F), whereas Pax2+ interneurons are labelled by EdU in
untreated and MTZ-treated larvae, quantified in G (Mann–
Whitney U-test, **P=0.0063) and H (Mann–Whitney
U-test, P>0.99), respectively. (I) Overall numbers of Hb9+
and ChAT+ profiles are reduced after a lesion, but return to
control values at 7 dpf (Hb9 only) or 10 dpf (ChAT) (t-test,
*P=0.0188; **P=0.0012; ***P=0.0004). Values are
means±s.e.m. Scale bars: 25 µm in B for B-E; 5 µm in
inset in C for all insets; 25 µm in F.
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new motor neurons retain DsRed protein expressed from the olig2
promoter. The pMN progenitor domain generates motor neurons
during embryonic development (Shin et al., 2007) and can be
reactivated to generate motor neurons from relative quiescence in
adults (Reimer et al., 2008). Here, we demonstrate that motor
neuron generation can be reactivated by either transection or
ablation lesion, even when pMN progenitors are actively generating
oligodendrocytes at larval stages (Park et al., 2005; Czopka et al.,
2013).
During development, evidence suggests that distinct pMN
progenitors generate either motor neurons or oligodendrocytes in a
time-dependent fashion (Wu et al., 2006; Ravanelli andAppel, 2015).
In the context of larval regeneration, this means that either the
oligodendrocyte-restricted progenitors change their developmental
program to generate motor neurons, or that new motor neuron
progenitors are recruited after lesion/ablation. Our observation that
oligodendrogenesis sharply declines during motor neuron
regeneration supports a view in which pMN progenitors change fate
from oligodendrogenesis to motor neuron generation after a lesion.
Ablated motor neurons are slowly regenerated
Ablation of a specific cell type allows us to ask whether the loss of
this cell type is sufficient to elicit its regeneration. We found that
after ablation of motor neurons, these are replenished over the
course of a few days. Cell numbers for the immature motor neuron
marker Hb9 were back to control levels earlier than those for the
mature motor neuron marker ChAT. This reflects the differentiation
sequence in developing motor neurons and in adult regeneration
(Reimer et al., 2008). Interestingly, we observed new motor
neurons (Hb9+/EdU+) by 48 h after the transection lesion, whereas
after ablation, these were only observed at later time points.
However, new motor neurons could no longer be labelled by EdU
application at 48 h or later after the onset of ablation. This suggests
rapid generation of new neuroblasts after ablation, followed by a
prolonged differentiation phase. Interestingly, in mice, astrocytes in
the telencephalon express a neurosphere-forming potential in vitro
after a mechanical stab injury, but not after cell ablation, indicating
that in mammals too, a mechanical lesion might lead to a stronger
regenerative response in glial cells (Sirko et al., 2013).
In general, motor neuron regeneration in larvae is substantially
quicker than lesion-induced regeneration in adults, in which newly
generated, mature ChAT+ motor neurons were observed at 42 days,
but not 14 days post injury (Reimer et al., 2008). Rapid motor
neuron regeneration is an advantage of larval regeneration studies.
Progenitor domains differ in their regenerative potential
Generation of pax2a:GFP+ or Pax2+ neurons was not enhanced in
either of the experimental paradigms. These cells are most likely
derived from amore dorsal progenitor domain than the pMNdomain
(England et al., 2011), indicating that progenitors for dorsal Pax2+
cells do not react to either a mechanical spinal lesion or ablation of
motor neurons with enhanced generation of Pax2+ neurons. This
underscores the highly plastic nature of the pMN progenitor domain.
Technical considerations of genetic motor neuron ablation
The Tg(mnx1:Gal4, UAS:nfsB-mCherry) transgene is reliably and
specifically expressed in a proportion of motor neurons at 3 dpf.
Ablation is complete, with undetectable bystander effects on slc6a5:
GFP+ interneurons. This all-or-nothing situation could be harnessed
for regeneration screens in the future. However, even though
Hb9+ motor neurons regenerate, the transgene, driven by hb9
regulatory sequences, is not re-expressed. Possible explanations are
developmentally reduced expression of the endogenous gene
(Reimer et al., 2008) and silencing of the highly repetitive UAS
sequences used in the generation of this transgenic model (Akitake
et al., 2011).
Motor neuron ablation in this system leads to an impaired
swimming behaviour (Reimer et al., 2013). This could become
interesting for future studies of behavioural recovery during motor
neuron regeneration. Currently, oedema formation due to ablation of
heart cells precludes behaviour studies. Finally, we cannot exclude
the possibility that the cessation of blood flow affects regeneration
dynamics, even though larvae do not depend on oxygen (Jacob
et al., 2002) and mutants without circulation develop normally for at
least a week (Rottbauer et al., 2001). Next-generation models might
employ less-repetitive versions of UAS (Akitake et al., 2011),
which could be driven by regulatory sequences of more mature
motor neuron markers (e.g. ChAT). Hence, ablation of motor
neurons holds promise for future screening and functional studies of
regeneration.
Conclusion
Motor neuron progenitor cells can be induced to regenerate motor
neurons at larval stages by mechanical lesion or motor neuron
ablation and they react to similar signals (e.g. dopamine) as
progenitor cells do during adult regeneration. This indicates
considerable plasticity of larval progenitor/stem cells. We use this
paradigm to demonstrate a pro-regenerative role of the immune
system. Of note, some experiments can be performed at very early
unprotected larval stages, thus replacing the need for work with
older animals in the sense of reduction, refinement and replacement
(the 3Rs; Tannenbaum and Bennett, 2015). We expect that the
combination of rapid regeneration with the classical advantages of
the zebrafish larva, i.e. small size, transparency and genetic
accessibility will lead to a wide range of larval regeneration studies.
MATERIALS AND METHODS
Animals
All fish were kept and bred in our laboratory fish facility according to
standard methods (Westerfield, 2000) and all experiments were approved by
the British Home Office. We used wild-type (wik); Tg(mnx1:GFPml2),
abbreviated as Hb9:GFP (Flanagan-Steet et al., 2005); Tg(slc6a5:GFP),
abbreviated as slc6a5:GFP (McLean et al., 2007); Tg(mnx1:Gal4s300t)
(Wyart et al., 2009); Tg(UAS:nfsB-mCherry) (Davison et al., 2007); Tg
(olig2:EGFP), abbreviated as olig2:GFP (Shin et al., 2003); Tg(olig2:
DsRed2), abbreviated as olig2:DsRed (Kucenas et al., 2008); Tg(pax2a:
GFP), abbreviated as pax2a:GFP (Picker et al., 2002); Tg(sox10(7.2):
mRFP), abbreviated as sox10:mRFP (Kirby et al., 2006); and Tg(mbp:
EGFP), abbreviated as mbp:GFP (Almeida et al., 2011). Male and female
fish were used for the experiments.
Larval lesion
Larvae were anaesthetized in 0.02% MS222 (Sigma-Aldrich), embedded in
1.5% low melting point agarose and placed in a lateral position on a
microscope slide. Lesions were performed using a sharp 30-gauge injection
needle, leaving the notochord and major blood vessels intact. After the
lesions, larvae were either immediately injected with 5-ethynyl-2′-
deoxyuridine (EdU; Sigma-Aldrich) into the yolk (as described below) or
immediately released by gently removing the agarose.
Quantification of behavioural recovery
Lesioned and unlesioned control larvae were touched with a glass capillary
on the median fin fold caudal to the lesion site. The swim path of their escape
responsewas recorded and analysed using aNoldus behaviour analysis set-up
and EthoVision software (v. 7). Data are shown as distance travelled during
the first 15 s after touch, averaged from triplicate measures per larva.
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Completeness of injury was verified by the absence of an escape response in
freshly lesioned larvae. Dependence of recovery on continuity of the spinal
cord was tested by re-lesioning at the end of the regeneration period.
Dexamethasone treatment
To suppress the immune system, we used the glucocorticoid receptor agonist
dexamethasone (Sigma), which was previously shown to suppress the
immune response in adults (Kyritsis et al., 2012) and larvae (Zhang et al.,
2008; Hall et al., 2014). Embryos were incubated with 200 μg/ml
dexamethasone in fish water containing 1% DMSO (Sigma-Aldrich) from
6 hpf. Embryos were kept in 5 ml Petri dishes in groups of 10 and fish water
was changed every day. At 3 dpf, larvaewere lesioned as described above and
returned into clean Petri dishes with dexamethasone until analysis at day 5.
Genetic ablation
For motor neuron ablation, larvae were treated from 72 hpf onwards for 24 h
with 5 mM metronidazole (Sigma-Aldrich) in fish water containing 0.2%
DMSO in darkness at 28°C.
TUNEL labelling
Cryosections were dehydrated in methanol for 10 min at −20°C, washed for
10 min in PBS at room temperature. Terminal deoxynucleotidyl transferase
dUTP nick end labelling (TUNEL) was performed using the Fluorescein In
Situ Cell Death Detection Kit (Roche) according to the manufacturer’s
protocol. Sections were covered with Parafilm to prevent evaporation and
incubated in a humid chamber at 37°C for 1 h. After the labelling procedure,
the sections were extensively washed in PBS.
Whole mounted zebrafish larvae at 5 days post lesion were anaesthetized,
fixed in 4% paraformaldehyde (PFA)/1% DMSO in PBS at room
temperature for 3 h, washed in PBS and PBST (PBS with 0.2% Tween
20). Then larvae were digested with collagenase (Sigma; 0.2 mg/ml in
PBST) for 50 min. The TDT reaction cocktail was prepared according to the
manufacturer’s instructions (Click-iT TUNEL imaging assay; Roche) and
larvaewere incubated at room temperature overnight. Larvaewerewashed in
PBS and Click-iT reaction cocktail was prepared and larvae were incubated
at room temperature in the dark for 3 h. After extensive washing in PBS,
larvae were either processed for immunohistochemistry or transferred to
70% glycerol in PBS.
Detection of activated caspases using fluorochrome-labelled
inhibitors of caspases
Fluorochrome-labelled inhibitors of caspases (FLICAs) were used for the
detection of activated caspases in motor neurons during metronidazole
treatment. We adapted this method for in vivo zebrafish larvae from that
recently reported for the ex vivo brain and spinal cord of larval sea lampreys
(Barreiro-Iglesias and Shifman, 2012). The Image-iT LIVE Green Poly
Caspases Detection Kit (Invitrogen) was used for the detection of activated
caspases in motor neurons. This kit contains one vial (component A of the
kit) of the lyophilized FLICA reagent (FAM-VAD-FMK). The reagent
contains a fluoromethyl ketone (FMK) moiety, associated with a caspase-
specific amino acid sequence (VAD). A carboxyfluorescein group (FAM) is
attached as a fluorescent reporter. The FLICA reagent interacts with the
enzyme active centre of any activated caspase via the recognition sequence,
and then attaches covalently through the FMKmoiety (Barreiro-Iglesias and
Shifman, 2012). The 150× stock FLICA reagent solution was prepared by
adding 50 µl of DMSO to the vial.
Six hours after treatment, DMSO control andmetronidazole-treated 78 hpf
Tg(mnx1:Gal4, UAS:nfsB-mCherry) zebrafish were incubated at 28.5°C in
1× FLICA labelling solution (made from 150× FLICA reagent stock diluted
in PBS) for 1 h. After incubation, the animals were washed in PBS on a
shaker 9×15 min in PBS to remove unbound FLICA (Barreiro-Iglesias and
Shifman, 2012). After washes, the animals were anaesthetized and fixed in
4% PFA in PBS for 1 h and then mounted in 70% glycerol in PBS.
Antibodies
We used mouse anti-Hb9 (MNR2, Developmental Studies Hybridoma
Bank, 1:400) (Reimer et al., 2013); rabbit anti-Pax2 (PRB-276P, Covance,
1:1000) (Kuscha et al., 2012b), goat anti-choline acetyltransferase (ChAT)
(AB144P, Millipore, 1:500) (Reimer et al., 2008), rabbit anti-L-plastin (a
gift from Yi Feng, University of Edinburgh; 1:500) recognizing
macrophages, microglia and neutrophils (Feng et al., 2010) and the mouse
monoclonal antibody 4C4 (hybridoma line 7.4.C4; 92092321, Public
Health England; supernatant, 1:50), recognizing microglia/macrophages
(Becker and Becker, 2001), as previously described.
Whole-mount immunohistochemistry
Whole larvae were fixed in 4% PFA/1% DMSO in PBS for 2 h. After
washing in PBS, larvaewere permeabilized in collagenase (2 mg/ml in PBS)
for 25 min. After washing with PBStx (0.2% Triton X-100 in PBS) larvae
were incubated in 50 mM glycine for 10 min and washed. After blocking in
blocking buffer (1% DMSO, 1% goat serum, 1% BSA and 0.7% Triton X-
100) for 2 h, larvae were incubated with primary antibodies at 4°C
overnight. Secondary antibodies were added after extensive washes at 4°C
overnight. After washing, larvae were mounted in 70% glycerol for
subsequent imaging.
Section immunohistochemistry
Larvae were fixed in 4% paraformaldehyde for 2 h, cryoprotected in 30%
sucrose overnight, flash-frozen and cryosectioned at a thickness of 14 µm.
Sections were fixed in ice cold methanol at −20°C for 10 min and then
rehydrated in PBS at room temperature for 10 min. After incubation in
blocking buffer (2% goat serum in 0.2% Triton X-100 in PBS) at room
temperature for 1.5 h they were incubated with primary antibody overnight
at 4°C. Sections were washed in PBStx (0.2% Triton X-100 in PBS) before
secondary antibody incubation for 1 h at room temperature. After three
5 min washes in PBStx and two 5 min washes in PBS, sections were
mounted in Fluoromount (Sigma).
EdU labelling and detection
Zebrafish larvae from 3 days post-lesion onwards were anaesthetized,
placed on a silicone elastomere mount (Sylgard 527 A&B; Dow Corning,
1675167) and injected into the yolk with ∼5 nl 5 mM EdU in 0.1 M sterile
KCl and 7.5% DMSO. After washing, larvae were allowed to develop under
standard conditions. For analysis, larvaewere fixed in 4% paraformaldehyde
for 2 h, cryoprotected in 30% sucrose overnight, flash-frozen and
cryosectioned at 14 µm. Sections were fixed in methanol for 10 min at
−20°C and washed for 10 min in PBS at room temperature. The EdU Click-
iT reaction solution (Roche) was prepared fresh according to the
manufacturer’s protocol. Sections on slides were covered with solution
and incubated in a humid chamber at room temperature in the dark for 3 h.
After three 10 min washes in PBS, sections were used for imaging or
subsequent processing for immunohistochemistry.
Whole-mounted larvae were fixed in 4% PFA/1%DMSO in PBS at room
temperature for 3 h, washed in PBS, transferred to methanol and incubated
at −20°C for at least 2 h. After rehydrating in a dilution row from methanol
to PBST (0.2% Tween 20) larvae were washed in PBST and digested with
collagenase (Sigma; 0.2 mg/ml in PBST) for 30 min. The EdU Click-iT
reaction solution was prepared and larvae were incubated in 2 ml tubes at
room temperature in the dark for 3 h. After extensivewashing in PBS, larvae
were either processed for immunohistochemistry or transferred to 70%
glycerol in PBS.
Quantification and statistical analyses
Cell quantifications in whole-mounted larvae were performed manually by
analysing all consecutive images in stacks taken with a confocal microscope.
Multiply labelled cells were scored when labels occurred on the same optical
section (<2 µm). As a standard, counts were performed within the 50 µm
rostral and caudal closest to the lesion site and expressed as cells/100 µm,
unless stated differently. For quantification in cryosections (14 µm
thickness) we counted all cell profiles and expressed this as number of
profiles/section. All variability indicated represents s.e.m. All images were
captured with a 20× objective on an Zeiss LSM710 confocal microscope. At
least two independent experiments were performed per treatment and cell
counts were carried out blinded to the treatment. We used t-tests (for
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normally distributed data) and Mann–Whitney U-tests (for non-normal
distributions) for comparisons of two conditions. For multiple comparisons,
we used one-way analysis of variance followed by Bonferroni’s test for
comparisons of individual groups (for normally distributed data) or the
Kruskal–Wallis test followed by Dunn’s test for comparing individual
groups (for non-normal distributions), using GraphPad Prism software.
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Wnt signaling controls pro-regenerative Collagen
XII in functional spinal cord regeneration in
zebrafish
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Michell M. Reimer4, Thomas Becker1 & Catherina G. Becker1
The inhibitory extracellular matrix in a spinal lesion site is a major impediment to axonal
regeneration in mammals. In contrast, the extracellular matrix in zebrafish allows substantial
axon re-growth, leading to recovery of movement. However, little is known about regulation
and composition of the growth-promoting extracellular matrix. Here we demonstrate that
activity of the Wnt/β-catenin pathway in fibroblast-like cells in the lesion site is pivotal for
axon re-growth and functional recovery. Wnt/β-catenin signaling induces expression of
col12a1a/b and deposition of Collagen XII, which is necessary for axons to actively navigate
the non-neural lesion site environment. Overexpression of col12a1a rescues the effects
of Wnt/β-catenin pathway inhibition and is sufficient to accelerate regeneration. We
demonstrate that in a vertebrate of high regenerative capacity, Wnt/β-catenin signaling
controls the composition of the lesion site extracellular matrix and we identify Collagen XII as
a promoter of axonal regeneration. These findings imply that the Wnt/β-catenin pathway and
Collagen XII may be targets for extracellular matrix manipulations in non-regenerating
species.
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After a spinal injury, non-neural cells invade the lesion siteand set up a complex extracellular matrix (ECM)1, 2. Thelesion site ECM consists of a plethora of molecules that
may be inhibitory, permissive, or promoting for axon re-growth.
In mammals, the balance of ECM molecules is shifted towards an
inhibitory matrix that does not allow axons to cross the lesion
site, in turn preventing recovery of function1, 2. In vertebrates
capable of functional spinal cord regeneration, such as fishes
and salamanders, the lesion site ECM naturally allows crossing
of regenerating axons, offering potential insight into how this
ECM is controlled and which ECM molecules may promote
regeneration3–6.
A candidate to control the composition of the lesion site ECM
in zebrafish is the Wnt/β-catenin pathway, because Wnt/β-cate-
nin signaling has been shown to control fibroblast biology
and ECM deposition7–10. Moreover, axonal reconnection,
which is necessary for functional recovery in adult11 and larval
zebrafish12, 13, also depends on Wnt/β-catenin pathway activity in
both systems14, 15. Wnt/β-catenin signaling involves extracellular
Wnt ligand-induced stabilization and translocation of β-catenin
into the nucleus where it modifies target gene transcription
together with Tcf/Lef family proteins16. To understand how Wnt/
β-catenin signaling promotes spinal cord regeneration, cell
types of action and downstream mechanisms of pathway activa-
tion, such as deposition of ECM factors, need to be identified.
Different ECM molecules have specific functions for axon
growth and regeneration. For example, among the collagens,
col19a1, col18a1, and col15a1b promote growth of developing
motor axons, whereas only col4a5 is necessary for the correct
growth of regenerating motor axons in zebrafish17–20. Hence, it is
important to identify specific axon re-growth-promoting ECM
components in the lesion site.
Adult and larval zebrafish show robust axonal and functional
regeneration after complete spinal cord transection11–13, 21.
Importantly, axon regeneration in larvae is rapid and can be
observed in real-time. Lesion-induced paralysis at 3 days-post
fertilization (dpf) is followed by recovery of touch-evoked
swimming within 2 days post-lesion (dpl)13. Swimming capa-
city is lost upon re-transection15, 16. This makes zebrafish larvae a
powerful tool to identify mechanisms responsible for establishing
a lesion environment that is conducive to axon growth. Moreover,
sensitive reporter lines and inducible cell-type specific pathway
inhibition using the TetON system can be used to interrogate the
Wnt/β-catenin signaling pathway in zebrafish22–25.
Here, we find that Wnt/β-catenin signaling in fibroblast-like
cells accumulating in the lesion site is pivotal for axon re-growth
and functional regeneration. A gene expression screen
identifies col12a1a/b expression and deposition of Collagen XII
downstream of Wnt/β-catenin signaling to be required for
regeneration. Hence, Wnt/β-catenin signaling in non-neural cells
controls the composition of an axon-growth promoting ECM
environment in the spinal lesion site in zebrafish.
Results
Axonal bridging correlates with functional recovery. To
identify molecular mechanisms regulating the spinal lesion ECM,
we first analysed dynamics of axon regeneration in zebrafish
larvae. Using anti-acetylated Tubulin immunohistochemistry we
observed little to no axonal re-growth within the first 12 h after a
spinal lesion. At 12 h post-lesion (hpl) mainly axonal debris,
indicated by fragmented anti-acetylated Tubulin immunor-
eactivity, and only very few and thin re-growing axon fascicles
were found in the lesion site (5/20 animals; Supplementary
Fig. 1a). We found no animals with a completely bridged lesion
site (0/20 animals). Analysis of stills from time-lapse video
microscopy imaging at this time point confirmed little axonal re-
growth (2/9 animals with axons in the lesion site, 0/9 animals
with axonal bridge; Supplementary Movies 1 and 2). After this
initial lag phase axons rapidly re-grew (Supplementary Fig. 1a).
At 1 dpl, 57% of all larvae showed axonal bridging of the lesion
site, as indicated by continuous axonal labelling between rostral
and caudal spinal cord (n= 112). Bridging further increased to
>80% of the animals at 2 dpl (n= 111; Fig. 1c). Remarkably, we
found that in the 18% of lesioned larvae in which no axonal
bridge was established by 2 dpl, functional recovery, as measured
by touch-evoked swim distance, was also impaired (analysed in
Xla.Tubb:DsRED26 transgenic fish; Supplementary Fig. 1b,c).
This underscores the importance of axonal re-growth for
functional recovery in larvae.
Axons navigate a non-neural lesion site that is rich in ECM. To
determine how axons cross the lesion site, we analysed their
relationship with astroglia-like processes, as these have been
shown to be supportive for axon regeneration in zebrafish27, 28.
We imaged axonal and glial processes in time-lapse video
microscopy using double transgenic fish for Xla.Tubb:DsRED, to
visualize neuronal processes, and either gfap:GFP29 (n= 6 fish, 33
fasicles) or her4.3:EGFP30 (n= 3 fish, 30 fasicles) to label
astroglia-like processes. This revealed that the majority of
fascicles that entered the lesion site were composed of
axons without detectable glial processes (49–53%). Some fascicles
contained both glial and axonal processes (20–21%) and
some pure glial fascicles were observed (27–30%; Fig. 1a and
Supplementary Movies 1 and 2; see Methods section for scor-
ing criteria). To confirm these findings we used a range of
combinations of immunohistochemical and transgenic markers
for neuronal and glial processes in static images of live animals
and histological preparations at 1 dpl. This showed that 63–77%
of axon-containing fascicles (≙46–62% of all fascicles analysed)
were devoid of detectable glial processes (Fig. 1b). Nineteen to
26% contained both axonal and glial processes and 19–28% of
all analysed fascicles were only composed of glial processes.
Moreover, double-immunohistochemistry for anti-acetylated
Tubulin and anti-GFAP showed that at 1 dpl, only 36% of
animals had glial processes bridging the lesion site, in contrast to
57% of the fish with an axonal bridge. At 2 dpl, glial processes
had caught up (Fig. 1c). This suggests that axons cross the
lesion site more rapidly than glial processes. In summary,
these observations support that many axons rapidly extend into
the lesion site and cross it independently of detectable glial
processes.
To experimentally test a role of astroglia-like processes in
supporting axonal regeneration, we ablated the majority of glial
cells using gfap:Gal4ff;UAS:NTR-mCherry transgenic fish that
express the enzyme nitroreductase under regulatory sequences of
the gfap gene31. Adding the prodrug Metronidazole (MTZ) at 1
dpf, which is converted by nitroreductase into a cytotoxic
compound, almost completely eliminated transgene-expressing
glial cells by 3 dpf (Fig. 1d)31. A dramatic depletion of astroglia-
like processes in the lesion site was confirmed by anti-GFAP
immunohistochemistry (Fig. 1e). Remarkably, this treatment
did not reduce the proportion of animals with axonal bridge
(anti-acetylated Tubulin+; Fig. 1e). This further supports that
glial processes do not have a major role in facilitating axonal
re-growth across a spinal lesion site. However, we cannot rule out
that glial processes that were not detected with our markers and
were spared by the ablation still supported axonal regeneration.
To explore possible substrates for the highly dynamic growth
cones other than glia, we determined regulation and protein
deposition for two major ECM components, collagen1a2 (col1a2)
and fibronectin1a (fn1a). Both genes showed robust upregulation
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of expression in the lesion site (Fig. 1f). Using specific antibodies
we indeed observed an accumulation of Collagen I (Col I) and
Fibronectin proteins in the lesion matrix (Fig. 1g). The Col I and
Fibronectin immunoreactivity appeared diffuse, but also
formed fibrous structures, often with a longitudinal orientation.
Double immunohistochemistry at 1 dpl revealed close apposition
of regenerating axonal fascicles (anti-acetylated Tubulin+)
with anti-Col I (11 of 13 fascicles associated with Col I
immunoreactivity; n= 7 fish) or anti-Fibronectin (15 of 22
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fish) immunoreactive fibres in the lesion site (arrows in Fig. 1g,
Supplementary Movies 3 and 4). Hence, regenerating axons
navigate the non-neural lesion environment in close association
with ECM, suggesting that axon-ECM interactions might be
important for axonal re-growth.
Wnt signaling is activated after spinal cord lesion. To
determine a potential role of the Wnt/β-catenin pathway in
controlling the composition of the spinal lesion ECM, we first
characterized the cells in which the pathway was active after
lesion. We used in situ hybridisation to detect transcripts of three
different transgenic reporter lines of Wnt/β-catenin-dependent
transcription, 6xTCF:dGFP, Top:dGFP, 7xTCF:mCherry22–24.
We also determined expression levels of direct Wnt/β-catenin
target genes axin2 and lef132, 33, which are commonly used as
read-outs of pathway activation and act as feedback inhibitor
(axin2) and transcriptional activator (lef1) in the pathway,
respectively (see Fig. 2a). All probes showed increased labelling in
the lesion site at 2 dpl (Fig. 2b; Supplementary Fig. 2a,b). Time
course analysis in the highly sensitive 6xTCF:dGFP Wnt
reporter line indicated incipient pathway activity in the lesion
site at 0.5 dpl (12 hpl; arrows in Supplementary Fig. 2c),
increased activity at 1 dpl, maximal activation at 2 dpl and
return to undetectable control levels by 5 dpl after dorsal
incision lesion or lateral stab lesion (Fig. 2b, Supplementary
Fig. 2d,e). This correlates well with the time course of axonal
regeneration. The 6xTCF:dGFP reporter also labelled a
few additional cells within the spinal cord at 1 and 2 dpl
(empty arrows in Fig. 2c). These cells have previously been
described as glial cells14.
6xTCF:dGFP reporter labelling was specific for Wnt/β-catenin
pathway activity in our experimental paradigm, as pharmacolo-
gical inhibition (IWR-1) or heat shock-induced ubiquitous
overexpression of the negative regulator axin1 in hs:Axin134
transgenic larvae strongly reduced the signal in the lesion
site (Supplementary Fig. 2f,g). Importantly, using anti-GFP
immunohistochemistry on whole mounts and sections confirmed
the strong signal in the lesion site and only sparse labelling in the
adjacent spinal cord in 6xTCF:dGFP transgenic animals (Supple-
mentary Fig. 2h,i). Moreover, our in situ hybridization protocol
allowed us to detect gfp-expressing glial cells throughout the
spinal cord in whole mount preparations of 5 dpf her4.3:EGFP
transgenic fish (Supplementary Fig. 2j). This shows that lack of
labelling in neural tissue was not due to potential probe
penetration issues in whole mount preparations. Hence, after
spinal cord lesion, Wnt/β-catenin signaling is mainly increased in
the non-neural lesion site, which is a major, previously
undescribed, domain of Wnt/β-catenin pathway activity.
Wnt signaling is active mainly in fibroblast-like cells. To
characterize the Wnt-responding cell types in the non-neural
lesion site environment, we utilized 6xTCF:dGFP transgenic
fish. GFP protein and mRNA was mainly detectable at the
lesion edge at 1 and 2 dpl (Fig. 2c; Supplementary Fig. 2h). Wnt-
responding cells did not co-label with markers of muscle
fibres (MyHC/F5935, n> 10; Supplementary Fig. 3a,b) or immune
cells (L-Plastin36, n> 10; Supplementary Fig. 3c). In contrast,
31% of GFP-labeled cells (cell counts in immunolabeled sections
of individual animals, n= 10) were co-labeled with the basal
keratinocyte marker p6337 (arrowheads in Fig. 2d; Supplementary
Fig. 3d). The remaining two thirds of the Wnt-responsive cells
(6xTCF:dGFP+/p63−) were located subepidermally in the lesion
site and could thus be fibroblasts. There is no definitive
fibroblast marker. However, fibroblasts are known to express the
ECM core components col1a2 and fn1a during dermal
stroma formation in developing zebrafish38, 39. Indeed we found
that at 1 dpl and 2 dpl, Wnt-responding subepidermal cells
were positive for col1a2 and fn1a transcripts (arrows in Fig. 2e;
Supplementary Fig. 3e–g), which were both upregulated in the
lesion site (Fig. 1f). Interestingly, in the peripheral lesion area,
where the myotome was still intact, a population of 6xTCF:dGFP
+/p63− cells, continuous with the subepidermal cells in the lesion
site, were found sandwiched between basal keratinocytes (p63+)
and slow twitch muscle fibres (MyHC/F59+) (insets in Supple-
mentary Fig. 3a,b). Additional 6xTCF:dGFP+/p63− cells were
found covering the spinal cord (arrows in Supplementary
Fig. 3h). These positions correspond to previously described
dermal and meningeal fibroblast locations in the developing
zebrafish and adult eel39, 40. Based on these observations, we
tentatively identify the vast majority of Wnt-responding cells as
fibroblast-like. Importantly, we found fibroblast-like Wnt-
responding cells (6xTCF:dGFP+/p63−) in close proximity to
regenerating axons (anti-acetylated Tubulin+) in the spinal lesion
site at 1 dpl (arrows in Fig. 2f). Hence, the majority of Wnt-
responding cells after a lesion are non-neural fibroblast-like cells
that are part of the lesion environment through which axons
navigate.
Regeneration requires Wnt signaling in non-neural cells. To
functionally inhibit Wnt/β-catenin pathway activity selectively in
lesion site cells, we took advantage of the TetON system that
allows for Doxycycline (DOX)-inducible (Supplementary Fig. 4a),
cell type-specific pathway manipulation41. To interfere with Wnt/
β-catenin signaling, we used TetRE:Axin1-YFP transgenic fish, a
TetResponder line that has been shown to efficiently inhibit the
pathway when activated during zebrafish development or adult
tail fin regeneration25, 41. To specifically target cells that activate
Fig. 1 Regenerating axons navigate a non-neural lesion environment that is rich in ECM independently of astroglia-like processes. a Time-lapse video-
microscopy reveals that axonal growth cones (arrow, Xla.Tubb:DsRED) extend into the lesion site independently of astroglia-like processes (her4.3:EGFP,
empty arrow points out lack of glial labelling). Arrowhead indicates glial process extending into the lesion site. Single frames are shown. Abbreviations: fin,
dorsal fin fold; sc, spinal cord; nc, notochord. b Quantification of fascicle composition at 1 dpl using different combinations of immunohistochemical and
transgenic markers for astroglia-like processes and axons indicates that the majority of fascicles are neuronal with no detectable glial component (46–62%
of all fascicles analyzed). In the example scans on the left, yellow arrows indicate mixed fascicles, containing neurites and glial processes; green arrows
indicate pure glial fascicles and red arrows indicate pure axonal fascicles. c Time course of re-growth of axons (anti-acetylated Tubulin+) and astroglia-like
processes (anti-GFAP+) after spinal cord transection. Quantification of labelling continuity between rostral and caudal spinal cord stumps at 1 dpl and 2 dpl
suggests faster bridging of the lesion site by neuronal rather than glial processes. Arrow points to axonal bridge with very few glial processes in the lesion
site at 1 dpl at higher magnification (Fischer’s exact test: **P< 0.01; n.s. indicates not significant). d Treatment of gfap:Gal4ff;UAS:NTR-mCherry transgenic
fish with the pro-drug Metronidozole (MTZ) almost completely ablates transgene-expressing glial cells by 3 dpf. e Treatment of gfap:Gal4ff;UAS:NTR-
mCherry transgenic fish with MTZ dramatically reduces anti-GFAP+astroglia-like processes (t-test: ***P< 0.001) but does not reduce the proportion of
larvae with axonal bridges at 2 dpl (Fischer’s exact test: n.s indicates not significant). f fn1a and col1a2 expression is upregulated after lesion, shown
by in situ hybridization. g Regenerating axons (anti-acetylated Tubulin+; arrows) are closely associated with Collagen I and Fibronectin immunoreactivity
in a lesion site (confocal depth was limited to spinal cord). Also see Supplementary Movies 3 and 4. a–g Views are dorsal (a; rostral is left) or lateral
(b-g; dorsal is up, rostral is left). BF: brightfield. Scale bars: 100 µm a,c–f and 50 µm b,g. Error bars indicate s.e.m
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the Wnt/β-catenin pathway in the lesion site, we generated
a TetActivator line using regulatory elements of the direct Wnt/β-
catenin target lef1 (lef1:TetA AmCyan; Supplementary Fig. 4b).
Indeed, this strategy showed injury-induced TetActivator
expression (amcyan mRNA) in Wnt-responding cells in the
lesion site in lef1:TetA AmCyan;6xTCF:dGFP double-transgenic
fish (Supplementary Fig. 4c). YFP fluorescence was likewise
concentrated in the lesion site in lef1:TetA AmCyan;TetRE:Axin1-
YFP double-transgenic fish after DOX treatment (Fig. 3a,b). This
indicates successful selective targeting of Wnt-responding cells in
the lesion site. The inhibition was effective, as lesion site
expression of axin2, an established read-out for Wnt/β-catenin
pathway activity33 (Fig. 2a), was strongly reduced (Supplementary
Fig. 4d).
To determine whether functional spinal cord regeneration
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double-transgenic fish after DOX treatment, we scored fish
showing continuity of axonal labeling over the lesion site (anti-
acetylated Tubulin+) and quantified swim distance after touch at
2 dpl. The proportion of larvae with bridged lesion sites was
reduced by 48% (Fig. 3c). Moreover, larvae recovered to
swim only less than half the distance (42%) of unlesioned Wnt-
inhibited animals, whereas lesioned control larvae recovered
to swim the same distance as their unlesioned age-matched
controls (Fig. 3d).
Importantly, neuronal (Xla.Tubb:TetA AmCyan) and glial
(her4.3:TetA AmCyan25)-specific Axin1 induction did not
induce a phenotype, whereas ubiquitous expression (ubi:TetA
AmCyan25) recapitulated the axonal and behaviour phenotypes
of lesion site-specific manipulations (Fig. 3e–m; Supplementary
Fig. 4e). Of note, Axin1 was correctly targeted in all of these lines,
as indicated by YFP fluorescence of the Axin1-YFP fusion
protein in neurons (Xla.Tubb:TetA AmCyan), glia (her4.3:TetA
AmCyan) or throughout the larvae (ubi:TetA AmCyan).
Moreover, axin1 induction in neural cells reached functional
levels. This is indicated in the neuronal-driven TetActivator
line (Xla.Tubb:TetA AmCyan), in which axin2 expression in
the lesion site remained unaffected but was strongly reduced in
a constitutively Wnt-responsive domain in the brain (Supple-
mentary Fig. 4f,g). Hence, Wnt/β-catenin pathway activity
in neurons or glia is not detectably involved in axonal
regeneration. To exclude non-specific effects of the TetON
system or Axin1-YFP induction, we also interfered systemically
with Wnt/β-catenin signaling using a pharmacological approach
(IWR-1) or via heat shock-induced ubiquitous overexpression of
the pathway antagonists axin1 or dkk1 in hs:Axin1 or hs:dkk142
transgenic fish, respectively. Using dkk1 overexpression as an
additional control was important, as it specifically antagonizes the
pathway at the receptor level, whereas axin1 overexpression
and IWR-1 promote degradation of the transcriptional co-
activator β-catenin (Fig. 2a; Supplementary Note 1). All of these
manipulations robustly reduced the proportion of larvae with
an axonal bridge (reduction by 51–72%) and functional recovery
(≤ 48% of the swim distance covered by unlesioned Wnt-
inhibited animals; Supplementary Fig. 5a–c). Inhibition of Wnt/
β-catenin signaling (IWR-1 treatment) starting at different time
points post-lesion showed that axon re-growth was still
maximally inhibited when the treatment was started at 0.5 dpl
(12 hpl), but the effect of IWR-1 was greatly diminished when the
treatment was started at 1 dpl and had no effect when it was
started at 1.5 dpl (Supplementary Fig. 5d). Hence, Wnt/β-catenin
pathway activity is required mainly between 0.5 dpl and 1 dpl
for axon regeneration, when axons actively grow across the
lesion site.
Two lines of evidence support that effects of Wnt/β-catenin
pathway inhibition on axon regeneration were not merely a
secondary consequence of potential defects in wound healing.
Firstly, a lateral stab lesion, which generates minimal tissue
disruption (Supplementary Fig. 2e), showed a similar reduction in
axonal regeneration and functional recovery after pharmacologi-
cal Wnt/β-catenin pathway inhibition, as was observed
after dorsal incision lesion (Supplementary Fig. 5e). Second,
wound re-epithelialization by basal keratinocytes, providing a
protective layer over the lesion site43, robustly occurred in
controls (30/30) and in larvae in which Wnt/β-catenin signaling
had been systemically inhibited using IWR-1 (30/30) (visualized
in krtt1c19e:EGFP transgenic fish44; arrow in Supplementary
Fig. 6; also see Fig. 4h). We conclude that Wnt/β-catenin
signaling in fibroblast-like cells in the lesion site, but not in neural
cells, is necessary for functional axon regeneration.
Interestingly, systemic but not glial cell-specific Wnt-inhibition
also reduced the number of animals with glial bridges.
This suggests that glial crossing of the lesion site also depends
on Wnt/β-catenin signaling in a non-cell autonomous way
(Supplementary Fig. 7a,b).
Wnt signaling promotes Col XII deposition. We hypothesized
that Wnt/β-catenin signaling in lesion site fibroblast-like cells
controls ECM deposition, as fibroblasts are a major source
of ECM under physiological and pathological conditions. To
identify relevant Wnt/β-catenin-controlled ECM components, we
compared labelling intensities between control and IWR-1-
treated stab-lesioned larvae in an in situ hybridisation
screen for two fibronectins and 44 collagen chain-encoding genes
at 1 dpl (Fig. 4a; Supplementary Fig. 8a). These genes were
chosen, because of roles of these ECM protein classes in axon
growth and regeneration17–20, 45. In DMSO-treated controls we
found expression of both fibronectins and 10 collagens to
be locally upregulated in the lesion site compared to adjacent
unlesioned trunk tissue. Of these upregulated genes, only
expression of col6a2 and of the paralogs col12a1a and col12a1b
were noticeably reduced when Wnt/β-catenin signaling was
inhibited (IWR-1 treatment). We did not find any increased
expression of ECM molecules after IWR-1 treatment. We focused
our further analysis on col12a1a and col12a1b, because both
paralogs code for the essential α-chain of Collagen XII (Col XII)
and are regulated by Wnt/β-catenin signaling. Since functional
Col XII molecules assemble as α-chain trimers, Col XII protein
expression likely also depends on Wnt/β-catenin signaling, as no
other paralogs were found in the genome that could substitute for
col12a1a and col12a1b46.
First we determined the time course of col12a1a/b expression
after a lesion. Parallel to the time course of Wnt/β-catenin
pathway activation, col12a1a/b transcripts were detectable in the
lesion site at 0.5 dpl (12 hpl). Further increased expression was
detected at 1 dpl, when axons started to regenerate. Expression
peaked at 2 dpl and had returned to baseline levels by 5 dpl
(Fig. 4b; Supplementary Fig. 8b).
To verify control of col12a1a/b expression by Wnt/β-catenin
signaling, we quantified fluorescence in situ hybridisation signals
for col12a1a/b transcripts at 1 dpl after 24 h of IWR-1 treatment.
This confirmed transcriptional downregulation of col12a1a and
Fig. 2 Wnt/β-catenin signaling is mainly active in fibroblast-like cells after spinal cord lesion. a Cartoon showing relevant transcriptional read-outs of
Wnt/β-catenin pathway activity, feedback regulatory mechanisms and strategies to interfere with signaling at different levels of the pathway. Abbreviation:
β-cat., β-catenin. b Detection of gfp mRNA in the 6xTCF:dGFP transgenic reporter line shows transient activity of the Wnt/β-catenin pathway in the lesion
site during regeneration. c gfp expression is largely confined to the lesion edge in 6xTCF:dGFP transgenic larvae (arrow). A few additional cells are labelled
within the presumptive spinal cord region (empty arrows). Abbreviations: nc, notochord; sc, spinal cord; fin, dorsal fin fold. d The 6xTCF:dGFP Wnt reporter
is mostly active in subepidermal p63− cells (arrows; ≥ 69% of all 6xTCF:dGFP+ cells at 1 dpl and 2 dpl), but also in p63+ basal keratinocytes (arrowheads) in
the lesion site. # indicates non-specific signal. e Consistent with a fibroblast identity, subepidermal cells (below dashed line) co-express col1a2 (red) and gfp
mRNA (green) in a lesioned 6xTCF:dGFP transgenic animal (arrow). Dashed line indicates junction between basal epithelium and adjacent connective tissue.
f Fibroblast-like (6xTCF:dGFP+/p63−) cells are found in close proximity to regenerating axons (anti-acetylated Tubulin+) in the spinal lesion site at 1 dpl
(arrows). A single optical section is shown. a–f Views are lateral (b,c,f; dorsal is up, rostral is left) or transversal (d,e; dorsal is up) as indicated.
BF: brightfield. Scale bars: whole mounts, 100 µm b,c and 25 µm f; sections: 100 µm. Error bars indicate s.e.m
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Fig. 3 Wnt/β-catenin signaling in non-neural cells is required for axon regeneration and functional recovery. a Schematic timeline of the experimental
design using the TetON system. b–d axin1 overexpression selectively in cells in the lesion site (b; lef1+) is sufficient to interfere with axon regeneration
(c; Fischer’s exact test: ***P< 0.001) and functional recovery (d; two-way ANOVA: F1,156= 14.82, P< 0.0005; t-test: ***P< 0.001). e–g axin1
overexpression throughout the fish e interferes with axon regeneration (f; Fischer’s exact test: *P< 0.05) and functional recovery (g; two-way ANOVA:
F1,129= 4.716, P< 0.05; t-test: ***P< 0.001). h–j Neuronal axin1 overexpression, indicated by YFP labelling of parenchymal cell bodies and neuropil in the
spinal cord h, does not interfere with axon regeneration i or functional recovery (j; two-way ANOVA shows no interaction between lesion and treatment).
k–m axin1 overexpression in ependymoradial glial cells, indicated by YFP labeling in cell bodies lining the central canal, their radial processes and pial
end feet k does not interfere with axon regeneration l or functional recovery (m; two-way ANOVA shows no interaction between lesion and treatment).
b–e Views are transversal (b,e,h,k; dorsal is up) or lateral (c,f,i,l; dorsal is up, rostral is left). BF: brightfield. n.s.: not significant. Scale bars: whole mounts,
200 and 100 µm; sections: 100 µm. Error bars indicate s.e.m
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col12a1b by 88% and 98% respectively (Fig. 4c). RT-PCR of lesion
site-enriched trunk tissue confirmed that IWR-1 treatment
interfered with lesion-induced col12a1a and col12a1b upregula-
tion at 1 dpl, while col1a1a expression levels remained unaffected
by Wnt/β-catenin pathway inhibition (Supplementary Fig. 8c).
Consistent with our finding that Wnt/β-catenin pathway activity
is mainly required within the first 24 h after a lesion for axonal
re-growth (Supplementary Fig. 5d), IWR-1 treatment for 24 h
between 1 dpl and 2 dpl had no effect on col12a1a/b expression.
(Supplementary Fig. 8d). This indicates that sustained Wnt/β-
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Activation of Wnt/β-catenin signaling through overexpression
of wnt8 for 24 h in hs:wnt8 transgenic fish47 enhanced expression
of both col12a1 genes at 1 dpl specifically in the lesion
site (Fig. 4d). Thus, gain- and loss-of-function experiments
for Wnt/β-catenin pathway activity support that zebrafish
orthologs of the col12a1 gene are transcriptionally controlled
by Wnt/β-catenin signaling in a spinal lesion site in zebrafish
larvae during the initial phase of axon regeneration.
To determine whether Wnt/β-catenin signaling regulates
col12a1a/b transcription in the lesion site likely directly or
indirectly, we compared the kinetics of down-regulation of
col12a1a/b expression after pathway inhibition with that of the
direct transcriptional target gene axin2 at 1 dpl. Short-term
inhibition of Wnt/β-catenin pathway activity through
axin1 overexpression in hs:Axin1 transgenic fish for 6 h was
sufficient to abolish expression of axin2 while col12a1a and
col12a1b expression was not affected at that early time point
(Supplementary Fig. 8e). This indicates delayed and thus indirect
control of col12a1a/b transcription by Wnt/β-catenin
signaling. Taken together, these data support a scenario in which
Wnt/β-catenin signaling promotes axonal regeneration by
initiating col12a1a and col12a1b expression after a lesion.
To characterize the col12a1a and col12a1b-expressing cells in
the lesion site, we used multicolour fluorescence in situ
hybridization. The majority of col12a1a and col12a1b-expressing
cells co-labeled with pdgfrb:GFP48 reporter transcripts, a marker
for pericytes and reactive fibroblasts, at 1 dpl (Supplementary
Fig. 8f,g)49. Inhibition of Wnt/β-catenin signaling (IWR-1
treatment) did not overtly inhibit appearance of pdgfrb:GFP+
cells, indicating that Wnt/β-catenin signaling does not act on
potential migration of col12a1a/b-expressing cells into the lesion
site (Supplementary Fig. 8h). Some of the col12a1a and col12a1b-
expressing cells were also positive for 6xTCF:dGFP reporter
transcripts at 1 dpl (arrows in Fig. 4e). However, a substantial
proportion of col12a1a/b-expressing cells were not co-labelled
with 6xTCF:dGFP reporter transcripts, indicating that
expression of col12a1a and col12a1b was not exclusive to acutely
Wnt-responding cells. Hence, Wnt/β-catenin pathway activity
could have already ceased in the majority of col12a1a
and col12a1b-expressing cells at the time point of analysis or
Wnt-responding cells could induce additional non-neural cells in
the lesion site to express these genes.
We next assessed whether Col XII protein deposition
was altered by inhibition of Wnt/β-catenin signaling. We found
increased immunoreactivity of Col XII in the lesion site at 1 dpl
and 2 dpl in control lesioned larvae compared to adjacent
unlesioned trunk tissue or unlesioned control animals (arrows in
Figs. 4f,g and Supplementary Fig. 9a). Inhibition of Wnt/β-
catenin signaling by IWR-1 treatment or after heat shock-induced
overexpression of dkk1 in hs:dkk1 transgenic fish, led to lower Col
XII immunoreactivity in lesioned larvae than in DMSO-treated
controls (Fig. 4h, Supplementary Fig. 9b). Hence, strongly
reduced levels of Col XII matrix are laid down in the lesion site
under conditions of Wnt/β-catenin pathway inhibition.
To analyse the relationship of regenerating axons and Col XII,
we used double-immunolabelling of axons (anti-acetylated
Tubulin+) and Col XII. This showed little to no Col XII
deposition in the lesion site at 0.5 dpl (12 hpl) and no axons that
had entered the lesion site at this time point (asterisk in
Supplementary Fig. 9c). In contrast, at 1 dpl we detected
prominent anti-Col XII immunoreactivity (Supplementary
Fig. 9c) and regenerating axons were present in the lesion site
in close proximity to Col XII immunoreactivity (arrowheads in
Fig. 4i, Supplementary Movie 5). The trajectory of axonal fascicles
frequently appeared to follow longitudinal fibres of Col XII
immunoreactive ECM material (arrowheads in Fig. 4j). We found
31 axonal fascicles of 45 in close apposition with Col XII positive
fibres at 1 dpl (n= 14 fish). Thus, Col XII deposition correlates
well with axonal re-growth in larvae.
In adult zebrafish, lesion site-specific expression of col12a1a as
well as Col XII deposition was also observed at 7 dpl and 14 dpl
(Supplementary Fig. 10a,b). At 14 dpl, anti-acetylated Tubulin+
spinal axons entered the lesion site in close contact with Col XII
immunoreactivity, resembling the larval pattern (Supplementary
Fig. 10b). Thus, after spinal cord injury, deposition of Col XII
matrix in the lesion site is conserved across developmental
stages in zebrafish. Taken together, this supports a scenario in
which Wnt/β-catenin signaling is necessary for the correct
expression and deposition of Col XII in the spinal lesion site,
which in turn promotes axon regeneration.
Col XII promotes functional spinal cord regeneration. To
determine whether Col XII deposition is required for functional
axonal regeneration, we co-injected Vivo-Morpholinos (MO),
which act as cell-permeable translation blocking anti-sense
molecules for col12a1a and col12a1b, into the circulation for
efficient distribution in 3 dpf larvae (Supplementary Fig. 11a50).
This approach effectively reduced Col XII immunoreactivity
in the lesion site compared to control MO-injected larvae
(Fig. 5a,b). In contrast, immunoreactivity for Fibronectin
and Collagen I was unaffected (Supplementary Fig. 11b),
indicating specificity of the manipulation for col12a1a/b
expression.
The proportion of larvae with an axonal bridge (determined in
Xla.Tubb:DsRED transgenic animals) was reduced by 43% in
col12a1a/b morphants compared to control MO-injected larvae
at 2 dpl (Fig. 5c). In lesioned col12a1a/b morphants swimming
Fig. 4 Wnt/β-catenin signaling controls col12a1a/b transcription and Col XII deposition in a spinal lesion site. a Wnt/β-catenin pathway inhibition (IWR-1)
results in lower expression of select collagen genes (red box) in the lesion site at 1 dpl, determined by in situ hybridization. b col12a1a and col12a1b
expression is transiently upregulated in the lesion site during regeneration. c Inhibition of Wnt/β-catenin signaling (IWR-1) interferes with col12a1a/b
expression in the lesion site (t-test: ***P< 0.001). d wnt8 overexpression upregulates col12a1a/b expression in the lesion site in hs:wnt8 transgenic fish
(t-test: *P< 0.05, **P< 0.01). Signal was underdeveloped to optimize detection of differences in signal strength. e A subpopulation of col12a1a or col12a1b-
expressing cells (red) in the lesion site co-labels with transcripts of the 6xTCF:dGFP Wnt reporter (green, arrows). f,g Anti-Col XII immunoreactivity is
increased in the lesion site (arrows) compared to adjacent unlesioned trunk tissue at 1 dpl. Shown is a confocal image of a whole mount (f, confocal depth
was limited to spinal cord) and a transversal section though the lesion site g,h Inhibition of Wnt/β-catenin signaling (IWR-1) interferes with Col XII
deposition in the lesion site (t-test: **P< 0.01). Note continuity of tissue in IWR-1-treated animals as shown by re-epithelialization of the lesion site by
basal keratinocytes in krtt1c19e:EGFP transgenic fish. i,j Double immunolabelling of axons (anti-acetylated Tubulin+) and Col XII shows Col XII matrix
deposition in the lesion site through which regenerating axons grow i. Shown is a maximum intensity projection in i with inset higher magnification;
the confocal depth was limited to spinal cord. Arrowheads point to regenerating axonal fascicle in close apposition to Col XII immunoreactivity (also
see Supplementary Movie 5). Note, that the trajectory of axonal fascicles appear to follow longitudinal fibres of Col XII immunoreactive ECM
material in the lesion site (j, arrowheads). a–j Views are lateral (a–d,f,h–j; dorsal is up, rostral is left) or transversal (e,g; dorsal is up). BF: brightfield.
Scale bars: 100 µm a–d,f,h, 50 µm e,g,i, 25 µm j. Error bars indicate s.e.m
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distance was reduced by 58% compared to unlesioned col12a1a/b
MO-injected larvae (Fig. 5d). Importantly, Vivo-Morpholino
treatment was not toxic, since lesioned control MO-injected
larvae recovered to the same swimming capacity as unlesioned
age-matched control MO-injected larvae at 2 dpl, and col12a1a/b
MO treatment did not impair swimming in unlesioned animals.
Impaired functional regeneration after MO knockdown
supports that Col XII is part of the axon-growth promoting
ECM in the lesion site.
To independently confirm the function of col12a1a/b, we
used transient CRISPR/Cas9-mediated gene editing. Injection
of small guide-RNA (gRNA) and cas9 mRNA into the
zygote efficiently generates biallelic mutations of targeted genes
in a very high proportion of cells, leading to loss-of-function
phenotypes51. Indeed, targeting of col12a1a and coll12a1b
efficiently disrupted both genes in CRISPR-injected embryos, as
shown by loss of targeted endonuclease restriction sites (Fig. 6a,
b). Quantitative RT-PCR indicated reduced abundance of
transcripts at 1 dpf, likely caused by non-sense mediated RNA
decay in CRISPR-manipulated larvae (hereafter referred to as
Crispants; Fig. 6c). Similarly, after a spinal lesion in Crispants the
abundance of both col12a1a and col12a1b mRNAs in the lesion
site was also reduced, as determined by quantification of
fluorescence in situ hybridisation signals (Fig. 6d). Targeting of
only col12a1a or col12a1b did not affect axonal regeneration,
possibly due to compensation of the non-targeted paralog
(Supplementary Fig. 12a). In contrast, in Crispants in which
both col12a1 genes were targeted, the proportion of larvae with
axonal continuity (anti-acetylated Tubulin+) between spinal cord
ends was reduced by 31% compared to controls (Fig. 6e). Single
larvae analysis showed that lack of axonal bridging in col12a1a
and col12a1b-targeted animals (analysed in Xla.Tubb:DsRED
transgenic fish) correlated with high gene editing efficiency of
both col12a1 paralogs, supporting specificity of the CRISPR/Cas9
manipulation (Supplementary Fig. 12b). Hence, both MO
knockdown and CRISPR manipulation indicate an important
contribution of Col XII to functional spinal cord regeneration in
zebrafish.
To determine the relevance of Col XII as a downstream effector
of Wnt/β-catenin signaling, we asked whether experimentally
increasing expression of col12a1a was sufficient to rescue the
regeneration phenotype induced by inhibition of the Wnt/β-
catenin pathway. To this end, we created zebrafish that are
transgenic for heat shock-inducible expression of full-length
col12a1a (hs:col12a1a-p2a-Cerulean, short hs:col12a1a; Supple-
mentary Fig. 13a). Activation of the transgene in unlesioned
animals increased anti-Col XII immunoreactivity in develop-
mental Col XII domains but also in ectopic sites, including the
spinal cord (arrow in Supplementary Fig. 13b). To increase Col
XII deposition in the lesion site, we applied repetitive heat shocks
to hs:col12a1a transgenic animals until immediately before the
lesion (3 dpf). This treatment increased detectability of transgene
mRNA for at least 24 h after the last heat shock (Fig. 7a) and was
sufficient to increase Col XII immunoreactivity in the lesion site
of larvae in which the Wnt/β-catenin pathway was inhibited
(IWR-1 treatment; analyzed at 2 dpl; arrow in Fig. 7b). We found
that under these experimental conditions, col12a1a overexpres-
sion more than doubled the proportion of IWR-1-treated larvae
with axonal bridge to 77% of all lesioned larvae, compared to 32%
in only IWR-1-treated lesioned larvae (determined in Xla.Tubb:
DsRED transgenic animals; Fig. 7c). This represents a rescue of
the axonal bridging phenotype to near wild type levels (compare
Supplementary Fig. 1b). col12a1a overexpression also improved
functional recovery in IWR-1-treated larvae (+ 55% of the swim
distance covered by Wnt/β-catenin pathway-inhibited lesioned
animals; Fig. 7d). This identifies Col XII as a major downstream
effector of Wnt/β-catenin signaling in the regenerating zebrafish
spinal cord.
We next asked whether col12a1a overexpression is sufficient
to augment axon regeneration. To this end, we assessed
Xla.Tubb:DsRED
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Fig. 5 Knockdown of col12a1a/b inhibits functional axon regeneration. a Cartoon showing strategy used for systemic delivery of Vivo-Morpholino (MO),
which acts as cell-permeable translation blocking anti-sense molecules. MOs against col12a1a and col12a1b were co-injected into the cardiac ventricle at
3 dpf, 4 h before lesion. b col12a1a/b MO injection strongly reduces Col XII immunoreactivity in the lesion site compared to control MO injected animals.
(t-test: ***P< 0.001). c col12a1a/b MO injection inhibits axon regeneration after lesion (Fischer’s exact test: ***P< 0.001). d col12a1a/b MO injection
interferes with functional recovery after lesion (two-way ANOVA: F1,116= 5.534, p< 0.05; t-test: ***P< 0.001). a–d Lateral views are shown (dorsal is up,
rostral is left). BF: brightfield. n.s.: not significant. Scale bars: 200 µm c and 100 µm (b,c). Error bars indicate s.e.m
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axonal bridging in hs:col12a1a transgenic animals and their
wild type control siblings at 18 hpl (Fig. 7e). At this early
time point, 41% of lesioned control larvae showed axonal
continuity (anti-acetylated Tubulin+) between spinal cord ends.
Remarkably, col12a1a overexpression increased the proportion of
larvae with axonal bridge to 63%. Thus, Col XII is sufficient
to enhance axon regeneration after a spinal lesion in
zebrafish. Taken together, these findings determine Col XII as
major pro-regenerative, Wnt/β-catenin-controlled ECM factor in
the spinal lesion site.
Discussion
Here, we demonstrate an important role for Wnt/β-catenin
signaling in controlling the composition of the spinal lesion ECM,
which is essential for functional axon regeneration in
zebrafish. Our data support a model (Fig. 8) in which spinal cord
transection triggers upregulation of Wnt/β-catenin signaling in
non-neural cells. The vast majority of these are fibroblast-like
cells accumulating in the lesion site. Wnt/β-catenin signaling
regulates col12a1 transcription and deposition of Col XII by
fibroblast-like cells in the spinal lesion ECM. The presence of Col
XII in the ECM promotes axon growth across the lesion site and
functional recovery.
How does Col XII support axonal regeneration? Col XII is
abundant in the spinal lesion site in species of high regenerative
capacity, such as in larval and adult zebrafish (this report) and
salamanders6. Col XII is a member of the FACITs family of
collagens, which do not form supramolecular aggregates but
are associated with Collagen fibrils46, 52. Previously, Col XII
was found to interact with Col I fibrils52. However, we find that
Col I immunoreactivity remained grossly unchanged after
interfering with col12a1a/b translation. Col XII also interacts
with Col VI in forming matrix bridges between developing
osteoblasts53. Interestingly, we find in our expression screen
that col6a2, coding for a Col VI α-chain, is co-regulated
with col12a1a/b by Wnt/β-catenin signaling, which may be
related to functional interactions of the proteins. In
addition, Col XII binds a variety of other matrix proteins, such as
Tenascin-X, Decorin, and Fibromodulin54, 55. Hence, Col XII
could promote growth of axons indirectly by organising the
lesion site ECM. Another possibility is that Col XII could
directly interact with axons via specific receptors. This is
supported by our observation that overexpression of col12a1a
alone is sufficient to enhance axonal regeneration.
While specific axonal receptors for Col XII have not been
identified, potential direct Col XII-axon interactions could
be mediated by its integrin-binding site, the NC1 domain,
as reported for Col IV46, 56, 57. Future studies will need to
clarify the precise mechanism by which Col XII promotes axonal
re-growth.
While our results identify Col XII as critical factor for axon
regeneration, several additional ECM molecules likely contribute
to establishing the growth promoting lesion site environment
found in zebrafish. For example, Tenascin-C has been shown
to be important for spinal cord regeneration in zebrafish, but
possible interactions with Col XII are not known5. Furthermore,
Col I and Fibronectin, which we find to be abundantly present in
the lesion site, are also known ECM components that promote
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Fig. 6 CRISPR/Cas9-mediated disruption of col12a1a/b leads to depletion of mRNA and impaired axonal regeneration. a Cartoon showing strategy used for
CRISPR/Cas9-mediated col12a1a/b gene disruption. cas9 mRNA and small guide-RNA (gRNA) targeting col12a1a and col12a1b were co-injected into the
zygote. Crispants were analysed for col12a1a/b mRNA levels and axonal regeneration as indicated in the timeline. b Restriction fragment length
polymorphisms (RFLP) analysis reveals efficient somatic mutation in the gRNA target site (indicated by resistance to restriction endonuclease digest;
arrowheads) in both col12a1 paralogs after microinjection. c col12a1a/b Crispants exhibit reduced developmental col12a1a and col12a1b mRNA
expression, determined by quantitative RT-PCR. Representative plot from three independent experiments for each mRNA are shown. mRNA levels in
gfp gRNA-injected control animals were set to 100%. d col12a1a/b Crispants exhibit reduced col12a1a and col12a1b mRNA levels after lesion, determined by
quantification of fluorescent in situ hybridization signal in the lesion site (t-test: **P< 0.01, *P< 0.05). e col12a1a/b Crispants show reduced axonal bridging
events after lesion (t-test: **P< 0.01). a–e Views are lateral (dorsal is up, rostral is left). BF: brightfield. Scale bars: 200 µm e and 100 µm d,e. Error bars
indicate s.e.m
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How does Wnt/β-catenin signaling act on col12a1a/b
expression? Wnt-responding cells co-express col12a1a/b. Hence,
Wnt/β-catenin pathway activity likely acts in the same cells to
increase expression of col12a1a/b after a lesion. Regulation of
Collagens in fibroblasts by Wnt/β-catenin signaling has also
been observed in dermal fibroblasts or myofibroblasts in the
context of fibrosis8–10, 60. However, a sizable population of
fibroblast-like cells showed Wnt-dependent col12a1a/b
upregulation without having detectable Wnt/β-catenin pathway
activity. Our results show that the effect of Wnt/β-catenin
pathway inhibition on col12a1a/b expression is delayed and
therefore likely indirect and that Wnt/β-catenin signaling does
not need to be sustained for col12a1a/b expression and successful
regeneration. These observations are consistent with the
possibility that Wnt/β-catenin signaling is only transiently active
in col12a1a/b-expressing cells. Alternatively, secondary signals
from Wnt-responding cells could instruct transcriptional
regulation of col12a1a/b in non-Wnt-responsive cells.
Are astroglia-like cell bridges a necessary substrate for axonal
regeneration across a spinal lesion site? Regenerating axons could
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Fig. 7 Overexpression of col12a1a promotes axon regeneration in Wnt/β-catenin pathway-inhibited and wild type zebrafish larvae. a cerulean mRNA is
robustly detectable 24 h after the last heat shock in hs:col12a1a-p2a-Cerulean transgenic larvae. b col12a1a overexpression increases anti-Col XII
immunoreactivity in the lesion site of Wnt/β-pathway-inhibited (IWR-1 treatment) hs:col12a1a transgenic larvae (arrow; t-test: ***P< 0.001). c col12a1a
overexpression rescues axon regeneration in Wnt/β-catenin pathway-inhibited (IWR-1 treatment) hs:col12a1a transgenic larvae (Fischer’s exact test:
***P< 0.001). d col12a1a overexpression improves functional recovery in Wnt/β-catenin pathway-inhibited (IWR-1 treatment) hs:col12a1a transgenic larvae
(t-test: ***P< 0.001). e col12a1a overexpression is sufficient to augment axon regeneration (Fischer’s exact test: *** P< 0.001). a–e Views are lateral (dorsal
is up, rostral is left). BF: brightfield. Scale bars: 200 µm c and 100 µm a–c, e. Error bars indicate s.e.m
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directly interact with the lesion site ECM or simply follow glial
processes that bridge the lesion site. In histological preparations
this is difficult to assess, as axons and glial processes tend to
fasciculate27. Indeed, at 2 dpl almost all tissue bridges
were composed of neuronal and glial processes. However,
simultaneous time-lapse video microscopy imaging of axonal
and glial processes indicated that the majority of axons highly
dynamically enter and cross the lesion site independently of glial
processes. Moreover, our data show that re-establishment of
axonal continuity of the transected spinal cord precedes that of
glial continuity, similar to observations in the lesioned spinal cord
of the adult eel61. Finally, in contrast to reducing the amount of
Col XII protein in the lesion site, massive depletion of glial
processes did not reduce the proportion of animals that showed
axonal continuity after regeneration. While these observations
support the relative importance of the ECM compared to that of
glial substrates for axonal regeneration, we cannot exclude that
fine glial processes that escaped detection and ablation still served
as a substrate for axon re-growth. Moreover, glial processes are
likely to support regeneration by physically aligning with regen-
erating fascicles27 and producing essential growth-factors28,
which may be more important in a larger lesion site of adult
zebrafish.
Is larval regeneration comparable to adult spinal cord
regeneration? In both larvae and adult zebrafish, functional
regeneration after complete spinal cord transection depends
on axons successfully crossing a non-neural lesion site (this report
and refs. 11, 13, 28) and forming connections11, 12. Both show
lesion-specific upregulation of col12a1a and axons regenerate in
close proximity to Col XII in larval and adult zebrafish (this
report). At least some axons grow independently of glia at both
developmental stages (this report and ref. 27) and, crucially both
larval and adult regeneration depend on Wnt/β-catenin signaling
(this report and refs. 14, 15). This suggests that key aspects of
regeneration are conserved across developmental stages. How-
ever, regeneration times in adults are much longer than in lar-
vae62, such that timing of signaling processes may differ in adults.
In conclusion, Col XII deposition, controlled by Wnt-
responsive fibroblasts, promotes spinal cord regeneration in
zebrafish. Interestingly, transplanting Wnt3a-secreting fibroblasts
into a spinal lesion site in rats enhances functional recovery63.
Thus, elucidating the molecular cues that promote axon
regeneration in zebrafish could provide strategies in mammals
to modulate the composition of the lesion site to tip the balance
towards a growth-conducive ECM environment.
Methods
Animals. All fish were kept and bred in our laboratory fish facility according to
standard procedures64, and all experiments have been approved by the British
Home Office (project license no.: 70/8805). Details of the transgenic zebrafish
lines used can be found in Supplementary Note 1. We used the WIK wild type
strain of zebrafish and the following transgenic zebrafish lines: 6xTCF/Lef-
miniP:2dGFP (6xTCF:dGFP24); 7xTCF-Xla.Siam:nlsmCherry1a5 (7xTCF:
mCherry23); gfap:Gal4ffs995;UAS-E1b:Eco.NfsB-mCherryc264 (gfap:Gal4ffs995;UAS:
NTR-mCherry31);gfap:GFPmi200129, her4.3:EGFPy83 (formerly known as her4.1:
EGFP30); her4.3:irtTAM2(3F)-p2a-AmCyanulm6 (her4.3:TetA AmCyan25); her4.1:
Tet-GBD-p2A-mCherrytud6 (her4.3:mCherry41); hsp70l:dkk1-GFPw32 (hs:dkk142);
hsp70l:Mmu.Axin1-YFPw35 (hs:Axin134); hspl70l:wnt8a-GFPw34(hs:wnt847);
krtt1c19e:EGFPsq1744, pdgfrb:Gal4ffncv24;UAS:GFP (pdgfrb:GFP48) TetRE:Mmu.
Axin1-YFPtud1 (TetRE:Axin1-YFP41); Top:dGFPw2522; ubiquitin:irtTAM2(3F)-p2a-
AmCyanulm2(ubi:TetA AmCyan25);Xla.Tubb:DsREDzf14826. The lef1:irtTAM2(3F)-
p2a-AmCyanulm11 (lef1:TetA AmCyan), Xla.Tubb:irtTAM2(3F)-p2a-AmCyanue103
(Xla.Tubb:TetA AmCyan) and hsp70l:col12a1a-p2a-Cerulenue104 (hsp70l:col12a1a)
transgenic zebrafish lines were established by Tol2-mediated transgenesis65 using
the DNA constructs described below.
DNA constructs. The lef1:irtTAM2(3F)-p2A-AmCyan construct was generated by
replacing the translation start codon of lef1 in the BAC clone CH73-164H6 with
the previously described irtTAM2(3F)-p2A-AmCyan TetActivator cassette41, 66
using standard BAC recombination techniques67. Additionally, Tol2 inverted
repeats were introduced into the BAC backbone. The final BAC was purified using
the HiPure Midiprep kit (Invitrogen). The Xla.Tubb:irTAM2(3F)-p2A-AmCyan
construct was generated by cloning the previously described sequence of the
Xenopus laevis neural-specific beta tubulin regulatory element (Xla.Tubb2b)
upstream of the published doxycycline (DOX)-inducible transcriptional
activator [irtTAM2(3F)] tagged with p2a and AmCyan26, 41, 66. For generation of
the hsp70l:col12a1a-p2a-Cerulean construct, 3 overlapping fragments spanning
the full-length col12a1a CDS were amplified from 1 dpl cDNA (primer
sequences are given in Supplementary Table 1) and fused via internal restric-
tion sites (BsiWI, BsrGI). The complete col12a1a CDS was then subcloned into the
hsp70l:irtTAM-p2a-Cerulean construct41 thereby replacing the irtTAM TetActi-
vator CDS.
Reverse transcriptase PCR and quantitative RT-PCR. To assess the effect
of IWR-1 treatment on lesion-induced gene expression total RNA from lesion site-
enriched trunk tissue was extracted using Trizol (Invitrogen). Twenty larvae
were pooled for each experimental condition. To assess the effect of col12a1a/b
gRNA/cas9 mRNA microinjection on developmental col12a1a/b mRNA levels
total RNA from ten 24 hpf embryos was extracted using Trizol. Reverse
transcription of 500 ng RNA was performed with the SuperScript III kit
(Invitrogen) using a combination of oligo(dT) and random hexamer primer.
Standard RT-PCR (58 °C, 30 cycles) was performed using 10 mM of each
dNTP and 10 μM of each primer. qRT-PCR was performed at 58 °C using
Roche Light Cycler 96 and relative mRNA levels determined using Roche Light
Cycler 96 SW1.1 software. Samples were run in triplicate and expression levels




















Fig. 8 Model for Wnt/β-catenin function during axonal regeneration in the
zebrafish spinal cord. Spinal cord (sc) lesion triggers Wnt/β-catenin
pathway activation in fibroblast-like cells. Wnt/β-catenin signaling controls
col12a1a/b transcription and deposition of Col XII in the lesion site ECM,
through which axons regenerate to facilitate functional recovery.
Interference with Wnt/β-catenin signaling in fibroblast-like cells or Col XII
deposition prevents axon regeneration and functional recovery
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junction using Primer-BLAST software. Primer sequences are given in
Supplementary Table 2.
Spinal cord lesions and behavioral recovery. Zebrafish larvae (3 dpf) were
anesthetized in PBS containing 0.02% aminobenzoic acid ethyl methyl ester
(MS222; Sigma-Aldrich). For dorsal incision lesions, larvae were transferred to a lid
of a plastic Petri dish. Following aspiration of excess water, which placed the larvae
in a lateral position, the tip of a sharp 30 G syringe needle was used to inflict a
lesion in the dorsal trunk at the level of the anal pore. Survival of larvae was
typically > 95%. Larvae that had undergone extensive damage to the notochord
showed the formation of a notochord-derived bulgy tissue structure (~ 10%). Those
larvae were excluded from further analysis. For less invasive stab lesions, larvae
were transferred to an agarose-coated Petri dish and larvae were placed in a lateral
position through removal of excess water. The tip of a sharp 30 G syringe needle
was pushed through the spinal cord at the level of the anal pore immediately dorsal
to the notochord. Kinetics of anatomical/functional spinal cord regeneration were
comparable in larvae that underwent dorsal incision lesion or stab lesion. After
surgery, larvae were returned to E3 medium for recovery and kept at 28.5 °C.
Wherever possible, Xla.Tubb:DsRED transgenic larvae were used for experiments
to visually verify completeness of spinal cord transection after lesion. Analysis of
behavioral recovery was performed as described previously13. Behavioral data are
shown as distance travelled within 15 s after touch, averaged for triplicate measures
per larvae. Adult spinal cord lesions have been described previously62. Briefly, fish
(≥ 3 month post-fertilization) were anesthetized by immersion in 0.02% MS222 in
PBS for 5 min. A longitudinal incision was made at the side of the fish to expose the
vertebral column. The spinal cord was completely transected under visual control,
3.5 mm caudal to the brainstem-spinal cord junction.
Drug treatments and heat-shock treatments. Heat shocks and drug treatments
were performed according to the schematic timelines shown with each experiment.
For heat shocks, larvae were kept in 50 ml conical centrifuge tubes filled with 40 ml
E3 embryo medium, which floated in a programmable thermostat-controlled water
bath (Lauda, Germany). Heat shocks of transgenic animals and non-transgenic
sibling controls were performed for 1 h at 38 °C after which larvae were returned to
28.5 °C. For drug treatments, up to 10 larvae were incubated in 7 ml of E3 embryo
medium, containing the drug. Larvae were kept in the dark at 28.5 °C and water
was exchanged daily. The Axin1 stabilizer IWR-1 (Sigma-Aldrich) was dissolved in
DMSO (6 mM stock) and used at a final concentration of 15 µM. Doxycycline
(DOX; Sigma-Aldrich) was dissolved in 50% EtOH (50 mg/ml stock) and used at
a final concentration of 40 µg/ml. For targeted cell ablation, the pro-drug
Metranidozole (MTZ; Sigma-Adrich) was dissolved in DMSO (200 mM) and used
at a final concentration of 2 mM.
Morpholino injection. Knockdown of col12a1a/b was performed by injecting
Vivo-Morpholinos (MO) to col12a1a/b, which act as cell-permeable
translation blocking anti-sense molecules, into the circulation for efficient
distribution in 3 dpf larvae (Supplementary Fig. 11a50). Two translation blocking
Vivo-Morpholinos, antisense to the transcriptional start site of col12a1a
(ENSDART00000154728) and col12a1b (ENSDART00000025926), were
designed (Gene Tools, Philomath, OR, USA): col12a1a MO 5′-CGGCCAAAGA-
CAACCTGATCTTCAT-3′; col12a1b MO 5′-TGCCAAATGCCTGACCGA-
CATCTTC-3′. 100% homology of MO sequences to target sites were confirmed
by sequencing. Approximately a total of 27 nl injection mix (9 repetitive injections
3 nl each), containing Cascade Blue Dextran (MW: 3000; Molecular Probes) and
0.25 mM of each Morpholino, was injected directly into the ventricle of 3 dpf larvae
as described previously50. Larvae that showed strong and ubiquitous
fluorescence at 2–3 h post-injection were subsequently lesioned. As control a
standard Vivo-Morpholino from Gene Tools was used.
CRISPR-mediated genome editing. CRISPR col12a1a and col12a1b gRNA were
designed using a combination of different webtools: ZiFit (http://zifit.partners.org/
ZiFiT), CRISPR Design (http://crispr.mit.edu), and Mojo Hand (http://talendesign.
org). gRNA expression vectors were built by ligation of annealed oligonucleotides
into pT7-gRNA expression vector (Addgene #46759) as described previously51.
Capped sense nls-zCas9-nls RNA was synthesized using mMESSAGE mMACHINE
T3 kit (Ambion) and pT3TS-nCas9n (Addgene # 46757) as template51. RNA was
purified using RNAeasy Mini Kit (Qiagen). gRNA was in vitro transcribed from
gRNA expression vectors using mMESSAGE mMACHINE T7 kit and purified
using mirVana miRNA isolation kit (Ambion). All synthesized RNAs were assessed
for size and quality by gel electrophoresis. A mix of 75 pg gRNA and 150 pg nls-
zCas9-nls RNA was microinjected into one-cell-stage embryos to determine effi-
ciency of individual gRNAs to introduce mutations in the target site in pools of 24
hpf embryos using restriction fragment length polymorphisms (RFLP) analysis. For
subsequent experiments we used a combination (75 pg each) of col12a1a gRNA#1
(target sequence 5′-GGCTGTGGTTCAGTACAGCT-3′; targeting exon 6) and
col12a1b gRNA#1 (target sequence 5′- GGTCAGGCATTTGGCAGCGG-3′;
targeting exon 2) and 150 pg nls-zCas9-nls RNA for microinjection. A previously
described gRNA targeting GFP (target sequence: 5′GGCGAGGGCGATGC-
CACCTA-3) served as control68. Efficient mutagenesis of target loci was confirmed
after each injection by RFLP analysis as follows. For col12a1a gRNA#1, a 308 bp
fragment was amplified using primers 5′- TGGAGTGTGGGAAGAGAAAACTT-
3′ and 5′- CTAATGAGAATTTGTCGGCAGCG-3′ and digested with AluI. For
col12a1b gRNA#1, a 400 bp fragment was amplified using primers 5′-TGGAG-
CATGTATTTTCCCCTTGA-3′ and 5′-GCTCCAGTCCTTTTGTTCATTCC-3′
and digested with AciI.
Live imaging of zebrafish larvae and time-lapse imaging. For live confocal
imaging, zebrafish larvae were anesthetized in PBS containing 0.02% MS222 and
mounted in the appropriate orientation in 1%low melting point agarose (Ultra-
PureTM, Invitrogen). During imaging the larvae were covered with 0.01% MS222-
containing fish water to keep preparations from drying out. For time-lapse ima-
ging, agarose covering the lesion site was gently removed after gelation. Time-lapse
imaging was performed for 19 h starting at 6 hpl. After initial visual inspection,
acquired time-lapse images were denoised to improve image quality (enhance
detail). Background noise, caused by the low signal to noise ratio, was removed
from acquired time-lapse images using the ImageJ plugin CANDLE-J algorithm,
which allows to remove the noise compartment while preserving the structural
information with high fidelity69. We verified that this procedure did not remove
signals from processes of low fluorescence intensity by comparing raw movies
with CANDLE-J-processed movies, which showed that that edges of features
remained conserved after denoising.
Quantifications and statistics. Re-established axonal or glial connections
(bridges) were scored in static preparations (fixed immunolabelled samples, live
transgenic animals) or in still images of time-lapse movies at time points of interest.
Larvae were directly visually evaluated using a compound fluorescence microscope
(Zeiss Imager.Z1), or after confocal imaging (Zeiss LSM 710, 880). A larva was
scored as having a bridged lesion site when continuity of the neuronal or glial
labeling between the rostral and caudal part of the spinal cord was observed.
Continuity of labeling was defined as at least one fascicle being continuous between
rostral and caudal spinal cord ends irrespective of the fascicle thickness. Larvae in
which the lesion site was obscured by melanocytes were excluded from analysis.
For all quantifications, the observer was blinded to the experimental treatments.
Scores of key experiments were validated by a second independent observer.
Quantification of axonal and glial fascicle composition in static preparations at
1 dpl was performed after confocal imaging (Zeiss LSM 880) of immunolabeled or
live animals. Fascicles were identified as fluorescent protrusions from the severed
spinal cord that projected into the injury site for at least 20 µm or had crossed it
completely. This was done by inspecting single optical sections and 3D renderings
of the lesion site. If more than half of the length of a fascicle contained fluorescence
for both glial and neuronal markers it was scored as “mixed”, otherwise it was
scored as purely “axonal” or “glial” depending on the markers used. The threshold
of half the length was used to exclude situations in which one type of process
followed the other long after that one was established.
For quantification of axonal and glial fascicle composition in time-lapse movies
we included only fascicles that grew during the observation period.
Fascicles were classified as purely “axonal” or “glial” when the distal part of a
given fascicle was labelled by the respective marker throughout the entire
observation period. In “mixed” fascicles, both markers were present in the distal
portion of the fascicle.
Fascicles were considered to be in close apposition with ECM in histological
preparations when > 50% of an axonal fascicle that had entered or crossed the
lesion site was aligned with ECM immunoreactivity. This was assessed in single
optical sections and 3D renderings.
Quantification of immunohistochemistry or fluorescent in situ hybridization
signal in the lesion site was performed on captured images of whole mount samples
using ImageJ software as described in subsection “Image analysis”. Samples were
imaged using a compound fluorescence microscope (Zeiss Imager.Z1) or confocal
microscope (Zeiss LSM 710, 880). Measurements were performed in a blinded
fashion.
Quantification of GFP+/p63+ and GFP+/p63− cells in 1 dpl and 2 dpl 6xTCF:
dGFP transgenic larvae was performed on immunolabeled sections of individual
animals (n= 10).
For non-quantitative data, the number of specimens that showed a given
phenotype and the total number of specimens analyzed is given as a ratio in each
figure. Phenotypes were scored in a blinded fashion.
All experiments were performed at least three times. Animals were randomly
assigned to different experimental groups but no formal method of randomisation
was used. Power analysis of pilot experiments informed minimum samples size.
All quantitative data were tested for normality and analyzed with parametric and
non-parametric tests as appropriate. An F-test was used to check for equal
variances. We used one-way ANOVA followed by Dunn’s multiple comparison
test, two-way ANOVA, followed by Student’s t-test, or Fischer’s exact test, as
indicated in the figure legends. *P< 0.05, **P< 0.01, ***P< 0.001, n.s. indicates not
significant. Error bars always indicate the standard error of the mean (SEM).
Image analysis. Quantitative analysis of immunohistochemistry or fluorescent
ISH signals in the lesion site was performed on captured images. Samples were
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imaged using a compound fluorescence microscope (Zeiss Imager.Z1) or confocal
microscope (Zeiss LSM 710, 880). Analysis of confocal images were performed on
maximum intensity projections that were generated from confocal stacks. Image
analysis was based on published protocols for fluorescent signal quantification70.
For all measurements except in Fig. 7b, ImageJ software was used to determine the
number of pixel above an intensity threshold (thresholded pixel area) in the region
of interest (ROI) (an example of such a measurement is shown in Supplementary
Fig. 14). In brief, a minimum intensity threshold was applied to all raw images
from the same dataset, limiting pixels to only those of equal or higher intensity.
The intensity threshold was determined for each experimental data set individually,
using untreated lesioned control samples as reference. The threshold was set such
that the thresholded pixel area included most pixels of the fluorescence signal
domain in the lesion site while low background signal in the vicinity of the lesion
site was largely excluded (efficient image segmentation). After thresholding, a ROI
was additionally defined manually to exclude pixels from analysis that fell within
the threshold intensity range but were located outside the lesion site. This was
necessary in some samples to exclude autofluorescence (e.g., from blood vessels)
or constitutively labelled domains (e.g., myosepta for Col XII). Measurements
of immunoreactivity in the lesion site, shown in Fig. 7b, was performed by
determining the pixel area in a pre-defined ROI of constant size without prior
thresholding. This was necessary due to low signal to noise ratio. In brief, the image
was converted to a binary image using the automated binary thresholding function
of ImageJ. The ROI was placed in the center of the lesion site. All measurements
were performed in a blinded fashion.
In situ hybridization. All incubations were performed at room temperature unless
stated otherwise.
For chromogenic and Fast Red fluorescence whole mount in situ hybridization
(ISH), larvae were fixed overnight at 4 °C in 4% PFA-PBS. On the following
day, larvae were washed twice in PBT (0.1% Tween-20 in PBS) and incubated for
30 min in PBT containing 40 μg/ml Proteinase K (Invitrogen). Thereafter, larvae
were washed briefly in PBT and were refixed for 20 min in 4% PFA-PBS followed
by five washes in PBT for 5 min each. Thereafter, larvae were incubated at 65 °C for
> 1 h in pre-warmed hybridization buffer (5x SSC, 500 μg/ml type VI Torula yeast
RNA, 50 μg/ml Heparin, 0.1% Tween 20, 9 mM citric acid [Monohydrate]), 50%
deionized formamide, pH 6.0). Hybridization buffer was replaced with digoxigenin
(DIG) and/or fluorescein-labelled ISH probes diluted in hybridization buffer and
incubated at 65 °C overnight. On the following day, larvae were washed at 65 °C
once in hybridization buffer, three times in 50% 2×SSCT/50% deionized
formamide, and twice in 2xSSCT for 20 min each, followed by four washes at 65 °C
in 0.2x SSCT (30x SSC: 300 mM NaCl, 200 mM Na-Citrate, pH 7; SSCT: 0.1 %
Tween 20 in 1xSSC) for 30 min each. Thereafter, larvae were washed twice in
PBT and incubated for > 1 h in blocking buffer (5% heat-inactivated sheep serum,
10 mg/ml BSA in PBT) for 5 min each under slow agitation. Subsequently, larvae
were incubated overnight at 4 °C in blocking buffer containing pre-absorbed anti-
DIG or anti-fluorescein antibody coupled to alkaline phosphatase (1:3000–4000).
On the following day, larvae were washed six times in PBT for 20 min each,
followed by three washes in staining buffer (50 mMMgCl2, 100 mM NaCl, 100 mM
Tris-HCl, 0.1% Tween 20, pH 9.5) for 5 min each. Color reaction was performed by
incubating larvae in staining buffer supplemented with NBT/BCIP (Sigma-Aldrich)
or SIGMAFAST Fast Red (Sigma-Aldrich) substrate. The staining reaction was
terminated by washing larvae in PBT. For chromogenic ISH, background staining
was cleared by incubating larvae two times in 100% EtOH for 15 min each and
once in 50% EtOH-PBT for 5 min, followed by five washes in PBT for 5 min each.
TSA fluorescence ISH was performed using the TSA Plus System Kit (Perkin
Elmer) as described for chromogenic ISH with some modifications. 1) Proteinase K
treatment was performed for 20 min (20 µg/ml Proteinase K). 2) Before pre-
hybridization, endogenous peroxidase activity was quenched by incubating larvae
in 1% H2O2 for 20 min. 3) Larvae were blocked in blocking reagent (1% in PBT)
provided with the kit. 4) Antibodies used to detect labelled RNA hybrids were anti-
digoxigenin or anti-fluorescein antibodies coupled to peroxidase (1:500). 5) Color
reaction was performed for 30 min in amplification buffer containing Tyramid
substrate (1:500) provided with the Kit, followed by washes in PBT for 20 min each.
Simultaneous detection of two different mRNAs by ISH was performed using
two-color TSA fluorescence or combinations of Fast Red and TSA fluorescence.
Stained samples (Fast Red and TSA fluorescence) were embedded in 4% Agarose-
PBS and sectioned at 50–100 µm using a vibratome. Sections were stained for DAPI
(Thermo Scientific) to visualize nuclei, followed by two washes in PBS and
mounted in 75% Glycerol-PBS. Larvae were incubated for 30 min in 2% H2O2 after
the first color reaction to deactivate antibody-conjugated peroxidase.
For Fast Red fluorescent ISH on floating agarose sections of larval zebrafish,
larvae were fixed in 4% PFA-PBS at 4 °C overnight. After two brief washes in PBT
(0.1% Tween-20 in PBS), larvae were embedded in 4% Agarose-PBS and sectioned
at 50–100 µm using a vibratome. Sections were incubated for 20 min in PBT
containing 10 μg/ml Proteinase K (Invitrogen) and further processed as described
for whole mount preparations.
For Fast Red fluorescent ISH on floating agarose sections of adult zebrafish
tissue, zebrafish were transcardially perfused with PBS followed by fixative
(4% PFA). The lesion site with surrounding non-neural tissue and spinal cord was
dissected in a semi-intact preparation and the tissue was post-fixed in 4% PFA
overnight. Tissue was embedded in 4% Agarose-PBS and sectioned at 100–200 µm
using a vibratome. Sections were briefly rinsed in PBS, incubated for 30 min in
PBT containing 40 μg/ml Proteinase K (Invitrogen) and further processed as
described for whole mount preparations.
To detect gfp transcripts in 6xTCF:dGFP;hs:Axin1-YFP double transgenic larvae
we used a probe against the destabilizing signal (sequence coding for residues
422–461 of mouse ornithine decarboxylase [MODC] as reported previously25.
To detect cerulean transcripts in hs:col12a1a-p2a-Cerulean transgenic fish we
used a probe against the closely sequence-related gfp as described previously25.
Information on ISH probes, including primer sequences used for molecular
cloning, is provided in the Supplementary Data 1. Where possible, probes to detect
collagen chains-coding transcripts were designed to include 3′UTR, which in most
cases contained sequences with the lowest possible similarity to other collagen
genes. During the ISH screen only genes were considered detectably expressed for
which probes showed a signal in the lesion site within 8 h after initiation of staining
reaction. Functionality of probes that showed no staining in the lesion site was
verified by the presence of specific staining domains in non-lesion site tissue, which
was true for all probes except col4a4, col8a1b, and col16a1, which did not show
constitutive expression domains in 4 dpf larvae. Lesion-induced upregulation of
genes in the lesion site was determined by comparing the signal intensity in the
lesion site to that in adjacent unlesioned trunk tissue.
Immunofluorescence. All incubations were performed at room temperature unless
stated otherwise.
For whole mount acetylated Tubulin/GFAP immunolabeling, larvae were fixed
in 2% TCA-PBTx (1% Triton X-100 in PBS) for 3 h, followed by brief washes in
PBTx and PBS. Thereafter, larvae were incubated for 30 min in 0.25% Trypsin
(Gibco) diluted in PBS, followed by five washes in PBTx for 5 min each. Larvae
were blocked in 4% BSA-PBTx for 1 h and incubated with primary antibody
(1:300) diluted in blocking buffer at 4 °C overnight. On the following day, larvae
were washed six times in PBTx for 20 min each, followed by incubation with
secondary antibody of interest diluted in blocking buffer (1:300) at 4 °C overnight.
On the following day, larvae were washed six times each in PBTx for 20 min each,
followed by mounting in PBS or 75% Glycerol-PBS.
For whole mount GFP/acetylated Tubulin/p63 immunolabelling in 6xTCF:
dGFP transgenic larvae, larvae were fixed in 4% PFA-PBS containing 1% DMSO at
4 °C overnight. On the following day, larvae were washed four times in PBS,
followed by two washes in PBTx (0.2% Triton X-100 in PBS) for 5 min each.
Thereafter, larvae were permeabilized by incubation in PBS containing 2 mg/ml
Collagenase (Sigma-Aldrich) for 25 min. To terminate Collagenase digest, larvae
were briefly rinsed in PBTx. Subsequently, larvae were incubated in 50 mM glycine
in PBTx for 10 min, followed by a brief rinse in PBTx. Larvae were blocked
in blocking buffer (0.7% PBTx, 1% DMSO, 1% normal donkey serum, 1% BSA)
for 2 h, and incubated with primary antibody (1:300–1:500) diluted in blocking
buffer at 4 °C overnight. On the following day, larvae were washed three times in
PBTx for 15 min each, followed by incubation with secondary antibody of interest
diluted in blocking buffer (1:300) at 4 °C overnight. On the following day, larvae
were washed three times in PBTx and once in PBS for 15 min each, before
mounting in 75% Glycerol-PBS.
For whole mount acetylated Tubulin/GFAP immunolabelling, as well as all
other combinations of immunolabelling on whole mounts (e.g., acetylated Tubulin/
Col XII), larvae were fixed in 4% PFA-PBS for 1 h, followed by brief washes in 0.1%
PBT (0.1% Tween-20 in PBS). Thereafter, larvae were stepwise dehydrated by
successive incubation in 25% MeOH-PBT, 50% MeOH-PBT, 75% MeOH-PBT,
100% MeOH for 5 min each, and stored at −20 °C until need. When required, head
and tail of larvae were removed and lesion site-enriched trunk tissue was incubated
in 100% MeOH at −20 °C overnight. On the following day, samples were
rehydrated by successive incubations in 75% MeOH-PBT, 50% MeOH-PBT and
25% MeOH-PBT for 5 min each, followed by four washes each in PBT for 5 min
each. Larvae were washed twice in distilled H2O for 5 min each, followed by
incubation in 100% Acetone (pre-chilled to −20 °C) at −20 °C for 10 min.
Thereafter, larvae were washed twice in distilled H2O for 5 min each, followed by
two 5min washes in PBT. Subsequently, larvae were incubated in PBT containing
10 µg/ml Proteinase K (Invitrogen) for 15 min, followed by two brief washes in
PBT and re-fixation in 4% PFA-PBS for 15 min. Thereafter, larvae were washed
tree times in PBTx (1% Triton X-100 in PBS) 10 min each and incubated in
blocking buffer (4% BSA in PBTx) for 1 h. Thereafter, larvae were incubated with
primary antibody (1:300) diluted in blocking buffer at 4 °C for 2–3 days. Thereafter,
larvae were washed eight times in PBTx for 20 min each, followed by incubation
with secondary antibody of interest diluted in blocking buffer (1:300) at 4 °C for
1–2 days. Thereafter, larvae were washed six times in PBTx for 20 min each and
once in PBS for 15 min before mounting in 75% Glycerol-PBS.
For immunohistochemistry on floating agarose sections of larval zebrafish,
larvae were fixed in 4% PFA-PBS containing 1% DMSO at 4 °C overnight.
After two brief washes in PBT (0.1% Tween-20 in PBS), larvae were embedded
in 4% Agarose-PBS and sectioned at 50–100 µm using a vibratome. Sections were
briefly rinsed in PBS and incubated in PBS containing 2 mg/ml Collagenase
(Sigma-Aldrich) for 20 min. Thereafter, sections were washed several times in
PBTx (0.5% Triton X-100 in PBS) followed by incubation in blocking buffer
(0.7% PBTx, 1% DMSO, 1% normal donkey serum, 1% BSA) for 1 h, and incubated
with primary antibody (1:50–1:200) diluted in blocking buffer at 4 °C for 2–3 days.
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Thereafter, sections were washed eight times in PBTx for 20 min each, followed
by incubation with secondary antibody of interest diluted in blocking buffer (1:300)
at 4 °C overnight. On the following day, larvae were washed six times in PBTx
and twice in PBS for 20 min each. Sections were stained for DAPI (Thermo
Scientific) to visualize nuclei, followed by two washes in PBS and mounted in
75% Glycerol-PBS.
For immunohistochemistry on floating agarose sections of adult zebrafish
tissue, zebrafish were transcardially perfused with PBS followed by fixative
(4% PFA-PBS). The lesion site with surrounding non-neural tissue and spinal cord
was dissected in a semi-intact preparation and the tissue was post-fixed in 4% PFA
for 1 h. Tissue was embedded in 4% Agarose-PBS and sectioned at 100–200 µm
using a vibratome. Sections were briefly rinsed in PBS and washed several times in
PBTx (1% Triton X-100 in PBS) for a total of 1 h followed by incubation in
blocking buffer (4% BSA in PBTx). Thereafter, sections were incubated with
primary antibody (1:250) diluted in blocking buffer at 4 °C for 3 days. Thereafter,
sections were washed eighteen times in PBTx for 10 min each, followed by
incubation with secondary antibody of interest diluted in blocking buffer (1:250)
at 4 °C for 2 days. On the following day, sections were washed twelve times in PBTx
and twice in PBS for 20 min each. Sections were mounted in 75% Glycerol-PBS.
All primary antibodies used are given in Supplementary Table 3. Primary
antibodies used are specific for zebrafish antigens as shown in the indicated
publications. To detect basal keratinocytes, we used anti-p63
immunohistochemistry, which is a commonly used marker for this cell lineage37.
The antibody used in this study, anti-tp63 antibody (Sigma-Aldrich), replicates
selective labelling of monolayered basal keratinocytes found in previous
publications with other antibodies to this antigen. Secondary fluorophore-
conjugated antibodies were from Jackson Immuno Research.
Data availability. The authors declare that all data supporting the findings of this
study are available within the article and its supplementary information files, or
from the corresponding authors on reasonable request.
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Dynamic control of proinflammatory cytokines Il-1β
and Tnf-α by macrophages in zebrafish spinal cord
regeneration
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Spinal cord injury leads to a massive response of innate immune cells in non-regenerating
mammals, but also in successfully regenerating zebrafish. However, the role of the immune
response in successful regeneration is poorly defined. Here we show that inhibiting inflam-
mation reduces and promoting it accelerates axonal regeneration in spinal-lesioned zebrafish
larvae. Mutant analyses show that peripheral macrophages, but not neutrophils or microglia,
are necessary for repair. Macrophage-less irf8 mutants show prolonged inflammation with
elevated levels of Tnf-α and Il-1β. Inhibiting Tnf-α does not rescue axonal growth in irf8
mutants, but impairs it in wildtype animals, indicating a pro-regenerative role of Tnf-α. In
contrast, decreasing Il-1β levels or number of Il-1β+ neutrophils rescue functional regenera-
tion in irf8 mutants. However, during early regeneration, interference with Il-1β function
impairs regeneration in irf8 and wildtype animals. Hence, inflammation is dynamically con-
trolled by macrophages to promote functional spinal cord regeneration in zebrafish.
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Zebrafish, in contrast to mammals, are capable of functionalspinal cord regeneration after injury. Recovery of swim-ming function critically depends on regeneration of axonal
connections across the complex non-neural injury site1,2. It is
therefore important to determine the factors that allow axons to
cross the lesion site in zebrafish.
In mammals, a prolonged immune response, consisting of pro-
inflammatory macrophages3, microglia cells4 and neutrophils5
together with cytokines released from other cell types, such as
endothelial cells, oligodendrocytes, or fibroblasts6 contribute to
an inhibitory environment for axonal regeneration. However,
activated macrophages can also promote axonal regeneration7–9,
suggesting complex roles of the immune response after spinal
injury.
In zebrafish, we can dissect the roles of these cell types in
successful functional spinal cord repair10. Zebrafish possess an
innate immune system from early larval stages and develop an
adaptive immune system at juvenile stages, similar to those in
mammals11. Indeed, microglia is activated after spinal cord injury
in adult12,13 and larval zebrafish14, suggesting functions of innate
immune cells in repair. Adaptive immunity is also important for
spinal cord regeneration15.
Larval zebrafish regenerate more rapidly than adults. Axonal
and functional regeneration is observed within 48 h after spinal
cord injury in 3 day-old larvae1,2. At the same time, the larval
system presents complex tissue interactions that allow us to
analyse how axons cross a non-neural lesion environment. For
example, axons encounter Pdgfrb+ fibroblast-like cells that
deposit regeneration-promoting Col XII in the lesion site in a
Wnt-signalling dependent manner1. These cells and molecules
are present also in the injury sites of adult zebrafish and
mammals1,6. How immune cells contribute to this growth-
conducive lesion site environment in zebrafish is unclear.
Here we show that peripheral macrophages control axonal
regeneration by producing pro-regenerative tumour necrosis
factor alpha (Tnf-α) and by reducing levels of interleukin-1 β (Il-
1β). While early expression of il-1β promotes axonal regenera-
tion, prolonged high levels of Il-1β in the macrophage-less irf8
mutant are detrimental. Preventing formation of Il-1β producing
neutrophils or inhibiting excess il-1β directly, largely restored
repair in irf8 mutants. This indicates that regulation of a single
immune system-derived factor, Il-1β, is a major determinant of
successful spinal cord regeneration.
Results
The immune response coincides with axonal regeneration. We
analysed axonal regrowth in larval zebrafish that underwent
complete spinal cord transection at 3 days post-fertilisation (dpf)
in relation to invasion of the injury site by different cell types.
Axons were present in the injury site by 1 day post-lesion (dpl).
The thickness of the axonal bundle that connects the injured
spinal cord increased up to 2 dpl and thereafter plateaued for up
to at least 4 dpl (Supplementary Fig. 1A). The thickness of the
connecting axon bundle positively correlated with the recovery of
touch-evoked swimming distance for individual animals at 2 dpl
(Supplementary Fig. 2A–C). This is consistent with previous
results showing continuous axon labelling over the lesion site
(axon bridging) in 80% of animals by 2 dpl, which then plateaued.
Presence of an axon bridge correlates with functional recovery, as
animals without axon bridge showed worse recovery of touch-
evoked swimming distance1 and re-lesioning abolished functional
recovery14. Hence, a percent score of larvae with bridged injury
sites is a quick and reliable measure for anatomical repair1,14.
After injury, we observed a rapid and massive influx of
immune cells, with neutrophils (Mpx+) peaking at 2 h post-lesion
(hpl) and macrophages (mpeg1:GFP+; 4C4-) and microglia
(mpeg1:GFP+; 4C4+) accumulating in the lesion site a few hours
later and peaking at 2 dpl (Fig. 1a, Supplementary Movie 1).
Myelinating cells (cldnK:GFP+) and endothelial cells (fli1:GFP+)
were not abundant in the lesion site during axonal regrowth
(Supplementary Fig. 1C, D), in contrast to functionally important
pdgfrb:GFP+ fibroblasts1 that were present in the lesion site at 1
dpl, peaking at 2 dpl (Supplementary Fig. 1B). This suggests that
myelinating cells and endothelial cells are not essential for axon
bridging. However, at later time points after injury, axons were
clearly associated with processes of myelinating cells (Supple-
mentary Fig. 1C), which may impact functional repair. In
contrast, the spatio-temporal pattern of immune cell invasion
of the injury site suggests an early role for the immune system in
orchestrating axon growth over the lesion site.
Immune system activation promotes axonal regeneration. To
determine the importance of the immune reaction, we inhibited it
using the anti-inflammatory synthetic corticosteroid dex-
amethasone14. This reduced the number of microglia14, macro-
phages and neutrophils in the injury site (Fig. 1b–d) and the
proportion of larvae exhibiting axon bridging (control: 78% of
examined animals, dexamethasone: 30%; Fig. 1e). The average
thickness of axon bridges was also reduced by dexamethasone
treatment and correlated with impaired recovery of touch-evoked
swimming distance. (Supplementary Fig. 2A–C). gfap:GFP+
astroglia-like processes that cross the injury site slightly later than
axons1 also showed reduced bridging, from 77.6% of examined
animals to 48.3% (Supplementary Fig. 2D) under dexamethasone
treatment. In addition, depleting the number of immune cells
with a well-established morpholino combination against pu.1 and
gcsfr16 reduced the proportion of larvae with axonal bridges from
81% of examined animals to 57% (Supplementary Fig. 3A, B).
For a gain-of-function approach, we used incubation with
bacterial lipopolysaccharides (LPS)17. This increased the number
of neutrophils and macrophages in the lesion site (Fig. 1f–h). To
detect a potential accelerating effect on axonal regrowth, we
analysed larvae at 18 hpl, when axonal regeneration was
incomplete in untreated animals. This showed an increase in
the proportion of larvae with axonal bridges from 41% of
examined animals in wildtype to 60% in LPS-treated animals
(Fig. 1i). Hence, immune system activity is necessary for and
promotes axonal regeneration across a spinal lesion site.
Macrophages determine regenerative success. To analyse the
role of different immune cell types in repair, we used mutants. In
mutants for the macrophage-lineage determining transcription
factor irf8, macrophages and microglial cells, but not neutrophils
are missing during early development18. Homozygous mutants
are adult viable and show no overt developmental aberrations,
except for an increased number of neutrophils18. In situ hybri-
disation for the macrophage and microglia marker mpeg1 con-
firmed expression in the ventral trunk of unlesioned larvae and in
a spinal lesion site at 2 dpl in wildtype larvae, but complete
absence of signal in unlesioned and lesioned irf8 larvae (Fig. 2a).
Next, we determined axonal regrowth and recovery of
parameters of swimming capacity in irf8 mutants compared to
wildtype animals. Wildtype and mutants showed comparable
proportions of animals with axon bridges at 1 dpl (wildtype: 44%
of examined animals; irf8 mutant: 43%). At 2 dpl, however,
axonal continuity was observed in 80% of wildtype animals but
only in 41% of irf8mutants (Fig. 2b). At 5 dpl–2.5 times as long as
wildtype animals need for maximal axon bridging—the propor-
tion of mutant larvae with bridged lesion sites was increased
compared to 2 dpl (55% of examined animals vs. 41%), but
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regenerative success was still strongly reduced compared to
wildtype controls (55% of examined animals vs. 87%; Fig. 2c).
Analysing touch-evoked swimming, we found that wildtype
animals swam comparable distances to unlesioned controls at 2
dpl, as previously described1. In contrast, recovery of touch-
evoked swimming distance in irf8 larvae plateaued at 2 dpl and
did not reach levels of unlesioned animals to at least 5 dpl
(Fig. 2c). This indicates that in the absence of macrophages and
microglia in irf8 mutants, initial axonal regeneration is unaf-
fected, but axonal regrowth and functional recovery after spinal
cord injury are impaired long-term.
To determine the importance of microglia for regeneration, we
analysed csf1ra/b double-mutants (see Methods) in which the


















































































































































































































































Fig. 1 Spinal injury leads to an inflammatory response that promotes axonal regeneration. a Neutrophils, macrophages, and microglial cells show different
dynamics after injury. Neutrophils (Mpx+) accumulate in the injury site very early, peaking at 2 hpl. Macrophages (mpeg1:GFP+/4C4−) and microglial cell
(mpeg1:GFP+/4C4+) numbers peak at 48 hpl. Fluorescence images were projected onto transmitted light images. b–e Incubation with dexamethasone
(timeline in b) reduces neutrophil and macrophage numbers (c, d; Mann–Whitney U-test: **P < 0.01, ***P < 0.001), as well as the proportion of animals
with axonal bridging (e; Fisher’s exact test: ***P < 0.001). f–i, Incubation of animals with LPS during early regeneration (timeline in f) increased numbers of
neutrophils and macrophages (g, h; t-test: **P < 0.01, ***P < 0.001), as well as the proportion of animals with axonal bridging at 24 hpl (i Fisher’s exact test:
*P < 0.05). Lateral views of the injury site are shown; rostral is left. Rectangles indicate region of quantification; arrows indicate axonal bridging. Scale bars:
50 μm; Error bars indicate SEM
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compromised. Csf1r is selectively needed for microglia differ-
entiation19. After injury in csf1ra/b mutants, we observed a strong
reduction in the number of microglial cells (to 17% of wildtype),
but an increase in macrophage numbers (by 55% compared to
wildtype) in the injury site (Fig. 3a, c). Interestingly, neutrophil
numbers were also strongly reduced (to 64.1% of wildtype at 2 hpl
and 16% at 1 dpl) (Fig. 3b), perhaps due to feedback regulation
from increased macrophage numbers. Whereas microglia cells
were reduced in number in the entire fish, neutrophils were
still present in the ventral trunk area. In these mutants, axon
bridging was unimpaired (Fig. 3d). Hence, microglia are not
necessary for axonal regeneration and reduced numbers of
neutrophils do not negatively affect axonal regrowth. Combined
with results from the irf8 mutant, this indicates that recruitment
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Macrophages are not necessary for Col XII deposition. Next, we
asked whether macrophages act via a previously reported
regeneration-promoting mechanism, comprising Wnt-dependent
deposition of Col XII in the lesion site by pdgfrb:GFP+ fibroblast-
like cells1. Inhibition of the immune response with dex-
amethasone did not inhibit appearance of pdgfrb:GFP+
fibroblast-like cells in the lesion site (Supplementary Fig. 4A). By
crossing a reporter line for Wnt pathway activity (6xTCF:dGFP)1
into the irf8 mutant, we found that activation of the pathway was
unaltered in the mutant (Supplementary Fig. 4E). Similarly,
expression of col12a1a and col12a1b mRNA in irf8 mutants was
indistinguishable from that in wildtype animals (Supplementary
Fig. 4B). Deposition of Col I protein and mRNA expression of 11
other ECM components were also not altered in the irf8 mutant
at 1 and 2 dpl (Supplementary Fig. 4B, C). Moreover, immuno-
labelling against Tp63 showed that by 2 dpl, the injury site in the
irf8 mutants was completely covered by basal keratinocytes, an
additional source of Col XII1, as in wildtype animals (Supple-
mentary Fig. 4D). In contrast, a PCR screen of 21 potentially
macrophage-derived ECM-modifying matrix metalloprotei-
nases20 (mmps) indicated lower mRNA levels for mmp11a,
mmp16a/b, mmp24, and mmp28 in the injury site of irf8 mutants
compared to wildtype animals (Supplementary Fig. 5A, B). This
suggests a potential for macrophages to alter the lesion site ECM
with Mmps. Overall, macrophages do not overtly regulate Wnt-
signalling, deposition of some crucial ECM components or basal
keratinocyte coverage of the injury site during regeneration.
Cellular debris is not a major impediment to regeneration.
Macrophages could serve as a substrate for axon growth or
promote regeneration by removing debris by phagocytosis—a
major function of macrophages in peripheral nerve regeneration
in zebrafish21,22. In time-lapse movies of double transgenic ani-
mals in which neurons (Xla.Tubb:DsRed) and macrophages
(mpeg1:GFP) were labelled (Supplementary Fig. 6B and Supple-
mentary Movie 2) we observed axons crossing the spinal lesion
site at the same time macrophages migrated in and out of the
injury site. However, no obvious physical interactions between
these cell types were observed, making it unlikely that macro-
phages acted as an axon growth substrate.
We frequently observed macrophages ingesting neuronal
material and transporting that away from the injury site in
time-lapse movies (Supplementary Fig. 6B and Supplementary
Movie 2). In agreement with this observation, TUNEL labelling
indicated strongly increased levels of dead or dying cells in the
late (48 hpl), but not the early (24 hpl) phase of axonal
regeneration in the injury site of irf8 mutants (Supplementary
Fig. 6A).
To determine the impact of debris on regeneration, we
prevented cell death and consequently debris accumulation in
irf8 larvae using the pan-caspase inhibitor QVD23, that is
functional in zebrafish24. This treatment led to lower debris
levels that were comparable to those seen in wildtype larvae at 2
dpl (Supplementary Fig. 6C), but failed to increase regenerative
success in irf8 mutants (control, 38% of examined larvae with
axon bridges; QVD, 40%. Thickness of axon bridge: control 19.03
+/−2.14 µm; QVD: 18.32+/−2.53 µm; t-test: P > 0.05. Supple-
mentary Fig. 6E). Conversely, inhibiting debris phagocytosis with
the pharmacological inhibitor O-phospho-L-serine (L-SOP)25 in
wildtype animals increased levels of debris in the injury site, but
did not impair axonal bridging (Supplementary Fig. 7A–C). This
suggests no obvious connection between debris levels and/or
phagocytosis and regenerative success.
Pro-and anti-inflammatory phases are altered in irf8 mutants.
To determine a possible role of cytokines in the regenerative
failure of irf8 mutants, we analysed relative levels of pro-and anti-
inflammatory cytokines in the lesion site during regeneration in
wildtype animals and irf8 mutants by qRT-PCR. In wildtype
animals, expression levels of pro-inflammatory cytokines il-1β
and tnf-α were high during initial regeneration (>25-fold for il-
1β; >12-fold for tnf-α for approximately to 12 hpl) and reduced
again during late regeneration (12–48 hpl), although still elevated
compared to unlesioned controls (Fig. 4a, b). Anti-inflammatory
cytokines, such as tgf-β1a and tgf-β3 were expressed at low levels
during initial regeneration, and upregulated during late regen-
eration (approximately 3-fold for tgf-β1a and 2-fold for tgf-β3),
indicating a bi-phasic immune response within the 48-h time
frame of analysis (Fig. 4c, d).
In irf8 mutants, levels of pro-inflammatory cytokines remained
high during the late phase of regeneration (Fig. 4a, b) and anti-
inflammatory cytokines were not upregulated (Fig. 4c, d),
resulting in a sustained pro-inflammatory environment in irf8
mutants.
The lack of anti-inflammatory cytokines correlated with the
lack of macrophages and microglia in irf8 mutants. We
performed qRT-PCR in fluorescence activated flow sorted
mpeg1:GFP cells in wildtype animals to determine whether
macrophages and microglial cells expressed tgf-β1a and tgf-β3.
mpeg1:GFP+ cells, but also mpeg1:GFP– cells expressed these
cytokines (Supplementary Fig. 8A). In situ hybridisation showed
wide-spread labelling with some more strongly labelled cells
around the injury site in wildtype, but not irf8 mutants
(Supplementary Fig. 8B). This is consistent with expression of
tgf-β1a and tgf-β3 in microglia/macrophages and other cell
types26. Hence, the immune response is bi-phasic with an initial
pro-inflammatory phase, followed by an anti-inflammatory phase
in wildtype animals. In the absence of macrophages in irf8
mutants, animals fail to switch to an anti-inflammatory state.
Tnf-α promotes axonal regeneration. To determine whether
increased levels of pro-inflammatory cytokines contributed to
impaired axon growth in irf8 mutants, we first inhibited Tnf-α
signalling. Pomalidomide, a pharmacological inhibitor of Tnf-α
release27, had no effect on axonal regrowth in irf8 mutants. In
Fig. 2 In the irf8 mutant, axonal regeneration and functional recovery after injury show long-term impairment. a In situ hybridisation for mpeg1 confirms the
absence of macrophages and microglial cells before and after injury in the irf8mutant compared to controls. Arrows indicate labelling around the injury site
and brackets indicate the ventral area of the larvae where the macrophages can be found in the circulation. Note that blackish colour is due to melanocytes.
b Quantification of the proportion of larvae with axonal bridging (anti-acetylated Tubulin) shows that at 1 dpl, axonal bridging is unimpaired in irf8 mutants,
whereas at 2 dpl, irf8 mutants fail to show full regrowth and even by 5 dpl, the proportion of irf8 larvae with a bridged lesion site is still lower than in
wildtype controls (Fisher’s exact test: ***P < 0.001, n.s. indicated no significance). c Irf8mutants never fully recover touch-evoked swimming distance in the
observation period, whereas wildtype control animals do. Representative swim tracks are displayed. Note that unlesioned irf8 larvae show swimming
distances that are comparable to those in wildtype controls (Two-way ANOVA: F15,1372= 11.42, P < 0.001; unles.= unlesioned, les.= lesioned). All lesions
are done at 3 dpf. Lateral views of the injury site are shown; rostral is left. Arrows indicate axonal bridging. Scale bars: 200 μm in a and 50 μm in c. Error
bars indicate SEM
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contrast, in wildtype animals Pomalidomide strongly inhibited
axon bridging at 1 dpl (control: 62% of examined animals showed
an axonal bridge; Pomalidomide: 36%) and 2 dpl (control: 75% of
examined animals; Pomalidomide: 45%) (Fig. 5a).
To confirm pharmacological results, we targeted tnf-α by using
CRISPR manipulation with a gene-specific guideRNA (gRNA).
Injection of the gRNA into the zygote efficiently mutated the gene
as shown by restriction fragment length polymorphism (RFLP)
analysis (Fig. 5b) and produced function-disrupting insertion-
deletion mutations in a highly conserved domain28 (Supplemen-
tary Table 1). Western blots of 4-day old larvae and immuno-
histochemistry in the injury site showed robustly reduced Tnf-α
protein levels (Supplementary Fig. 9A, B).
Axon bridging was inhibited in wildtype animals by tnf-α
gRNA injection in a way that was comparable to drug treatment
(1 dpl: control: 51% of examined animals showed bridging;
gRNA: 27%; 2 dpl: control: 88% of examined animals showed
bridging; gRNA: 40%). At 5 dpl, axon bridging was still strongly
impaired (control: 84.1% of examined animals showed bridging;
gRNA: 38.3%; Fig. 5c), indicating long-term impairment of
regeneration. Hence, tnf-α dysregulation is not a major cause of
regenerative failure in irf8 mutants, but tnf-α is necessary for
axonal regeneration in wildtype animals.
To determine which cells expressed tnf-α in wildtype animals,
we used immunohistochemistry for L-Plastin, labelling all
immune cells, in tnf-α:GFP transgenic fish (Fig. 6d). Nearly all
tnf-α:GFP+ cells co-labelled with L-Plastin (96%) at 12 hpl. Thus,
expression of tnf-α occurred mainly in immune cells (Fig. 6a).
Double-labelling tnf-α:GFP reporter fish with neutrophil (Mpx),
microglia (4C4) and macrophage (Mfap4) markers at 24 hpl,
when axons were actively growing, indicated that >95% of tnf-α:
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Fig. 3 Absence of microglial cells and reduced neutrophil numbers do not affect axon bridging. a Numbers of microglial cells (4C4+; arrows) in the injury
site of the csf1ra/bmutants are much lower than in wildtype animals (t-test: ***P < 0.001). b Fewer neutrophils (Mpx+) are found in the injury site (arrows)
of csf1ra/b mutants than in wildtype animals (t-test: *P < 0.05, ***P < 0.001). Note neutrophils ventral to the injury site (brackets). c The number of
macrophages (Mfap4+) is increased in the injury site in the mutants at 1 dpl, but not at 2 dpl (t-test: ***P < 0.001, ns indicates no significance). d
Immunostaining against acetylated tubulin shows that axon bridging (arrows) is not affected in the mutants compared to wildtype animals at 2 dpl (Fisher’s
exact test: ns indicates no significance). Lateral views of the injury site are shown; rostral is left. Wt=wildtype; Scale bars: 50 µm in a, b, d; 25 µm in b.
Error bars indicate SEM
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other cell types, such as neurons29, may also express tnf-α. More
than 72% of macrophages were tnf-α:GFP+, whereas for
microglia (<6.5%) and neutrophils (<0.7%) the proportion was
much smaller. Over time, the proportion of tnf-α:GFP+
macrophages was reduced (from 72.5% at 1 dpl to 59% at 2
dpl) (Fig. 6b). Our observations suggest that macrophages
promote regeneration by expressing tnf-α.
To elucidate effects of tnf-α inhibition, we determined numbers
of neutrophils and macrophages/microglia at 24 and 48 hpl in tnf-α
gRNA injected animals. This showed no changes in macrophages,
but a 49.7% increase in the number of neutrophils at 1 dpl (Fig. 6c).
qRT-PCR indicated that il-1β mRNA levels were increased by
108%, whereas tnf-α, tgf-β1a and tgf-β3 mRNA levels remained
unchanged at 2 dpl (Fig. 6d). This suggests a moderate enhance-
ment of the pro-inflammatory response when Tnf-α is inhibited.
Il-1β inhibits regeneration in irf8 mutants. To test whether
sustained high levels of Il-1β were responsible for regenerative
failure in irf8 mutants, we interfered with il-1β function in three
different ways. Firstly, we inhibited caspase-1, which is necessary
for activation of Il-1β, using the pharmacological inhibitor YVAD
that is functional in zebrafish30 (Fig.7a–e). Secondly, we disrupted
il-1β RNA splicing with an established morpholino (Supple-
mentary Fig. 10A–D)31. Finally, we targeted il-1β in a CRISPR




























































































































































































Fig. 4 Inflammation is bi-phasic and dysregulated in irf8 mutants. a, b Absence of macrophages in the irf8 mutant fish leads to increased il-1β and tnf-α mRNA
levels during the late stage of inflammation (>12 hpl). An early peak in tnf-α expression is missing in irf8mutants. c, d Expression of anti-inflammatory cytokines,
tgf-β1a and tgf-β3, which peak during late regenerative phases in wildtype animals, is strongly reduced in irf8mutants (t-tests: *P < 0.05, **P < 0.01, ***P < 0.001;
wt=wildtype animals). # indicates statistical significance when compared to unlesioned animals. Error bars indicate SEM
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To determine whether interfering with Il-1β function mitigated
inflammation in irf8 mutants, we quantified immune cells,
expression of il-1β, tnf-α, and dead cells. Indeed, after YVAD
treatment we observed a reduction of neutrophil peak numbers
(by 38% at 2 hpl; Fig. 7b), as well as strongly reduced levels of il-
1β and tnf-α mRNA expression (at 2 dpl; Fig. 7a) in irf8 mutants.
Moreover, the number of TUNEL+ cells was reduced at 2 dpl in
the irf8 mutant, but not to wildtype levels (Fig. 7c). In lesioned
wildtype animals, YVAD reduced peak numbers of neutrophils
(by 40% at 2 hpl) and macrophages (by 28% at 48 hpl), but no
influence on low numbers of TUNEL+ cells at 2 dpl was observed.
Hence, interfering with Il-1β function reduces inflammation in
irf8 mutants and wildtype animals.
Axon bridging in wildtype animals was not affected by YVAD
treatment at 2 dpl (control: 79% of examined animals showed
bridging; YVAD: 78%) (Fig. 7d), indicating that high levels of Il-
1β were not necessary for axonal regeneration. In contrast, in
YVAD-treated irf8 mutants, we observed a remarkable rescue of
axon bridging at 2 dpl (control: 38% of examined animals showed
bridging; YVAD: 69%) (Fig. 7d).
Injecting a well-established31 morpholino targeting il-1β into
irf8 mutants at the one-cell-stage inhibited il-1β splicing
(Supplementary Fig. 10A, D). Morpholino-injected animals
showed a rescue of axon bridging at 2 dpl (control: 40% of
examined animals showed bridging; YVAD: 60%) (Supplemen-
tary Fig. 10B, C).
Finally, injecting a gRNA targeting il-1β at the one-cell stage
led to somatic mutation in the target site of il-1β, indicated by
RFLP analysis (Supplementary Fig. 10E, H). This strongly rescued
axonal bridging in lesioned irf8 mutants (control: 40% of
examined animals showed bridging; acute il-1β gRNA: 70%)
(Supplementary Fig. 10F, G). Hence, three independent manip-
ulations show that excessive il-1β levels in irf8 mutants are a key
reason for impaired axonal regeneration.
Il-1β promotes axonal regeneration during the early regen-
eration. To determine whether roles of Il-1β and general inflam-
mation differed for different phases of the inflammation, we
separately analysed early (0–1 dpl; Supplementary Fig. 11A) and
late (1–2 dpl; Supplementary Fig. 11B) regeneration by drug incu-
bation. During the early phase, YVAD treatment led to a weak
inhibition of axonal regeneration in both wildtype (control: 58% of
examined animals showed bridging; YVAD: 41%) and irf8 mutants
(control: 41% of examined animals showed bridging; YVAD: 36%).
Similarly, dexamethasone treatment inhibited axonal regeneration
in both wildtype (control: 57.5% of examined animals showed
bridging; dexamethasone: 36.6%) and irf8 (control: 44.6% of
examined animals showed bridging; dexamethasone: 34%). Inter-
estingly, while LPS promoted regeneration in the early phase in
wildtype animals (control: 53.2% of examined animals showed
bridging; LPS: 68.7%), it was detrimental in irf8 mutants (control:
39% of examined animals showed bridging; LPS: 25.5%), perhaps
because baseline inflammation was already high in the mutant.
During late regeneration, only dexamethasone had an
inhibitory effect in wildtype animals (from 82.1% of examined
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Fig. 5 Tnf-α is essential for axonal regeneration. a Tnf-α inhibition by Pomalidomide reduces the proportion of wildtype animals with axon bridging at 1 and
2 dpl. No effect is observed in irf8 mutants (Two-way ANOVA followed by Bonferroni post-test: F3,16= 12.16, **P < 0.01, n.s indicates no significance). b
CRISPR/Cas9-mediated disruption of tnf-α is effective as shown by RFLP analysis. This reveals efficient somatic mutation in the gRNA target site, indicated
by resistance to restriction endonuclease digestion (arrow). c Axonal bridging (arrow; Xla.Tubb:DsRed+) is strongly impaired after disruption of the tnf-α
gene. (Fisher’s exact test: ***P < 0.001) and the impairment persists at 5 dpl. Lateral views of the injury site are shown; rostral is left. Scale bar: 50 μm. Error
bars indicate SEM
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wildtype animals during late regeneration, when il-1β was already
down-regulated (control: 81% crossing; YVAD: 78% crossing),
but a strong rescue effect of YVAD was observed in the irf8
mutant (control: 37% of examined animals showed bridging;
YVAD: 68%). This rescue effect was comparable to that observed
when Il-1β was suppressed for the entire 48 h (cf. Fig. 7d). LPS
had no effect in wildtype or mutants during late regeneration.
Hence, early inflammation and il-1β upregulation promote
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Fig. 7 Inhibition of Il-1β function rescues axonal regeneration in irf8 mutants. Lateral views of the injury site are shown; rostral is left. a YVAD reduces
expression levels of il-1β and tnf-α in irf8 mutants (two-sample t-test: *P < 0.05) at 2 dpl. b YVAD impairs migration of peripheral macrophages (Mfap4+)
and neutrophils (Mpx+) in wildtype animals and irf8 mutants (only neutrophils quantified, due to absence of macrophages) (t-tests: ***P < 0.001). c YVAD
moderately reduces the number of TUNEL+ cells in the irf8 mutants at 2 dpl. (Two-Way ANOVA followed by Bonferroni multiple comparisons: F3,121=
112.5, ***P < 0.001). d YVAD does not influence axonal regeneration in wildtype animals but rescues axonal bridging (arrows) in irf8 mutants (Fisher’s
exact test: **P < 0.01, ns indicates no significance) at 2 dpl. e Impaired touch-evoked swimming distance in irf8 mutants is rescued by YVAD treatment, to
levels that are no longer different from lesioned and unlesioned wildtype animals at 2 dpl. YVAD has no influence on swimming distance in lesioned or
unlesioned wildtype animals (Two-way ANOVA followed by Bonferroni multiple comparisons: F1,309= 35.229, ***P < 0.0001, ns indicates no significance).
Rectangle in b denotes quantification area. Scale bar: 50 μm for b, d. Error bars indicate SEM
Fig. 6 Tnf-α is expressed by macrophages and regulates the immune response. a Top row: tnf-α:GFP labelling occurs almost exclusively in L-plastin+
immune cells (L-plastin in green; tnf-α:GFP in magenta; yellow arrow indicates a rare tnf- α:GFP+ microglial cell; 12 hpl) b In the injury site, the number and
proportion of macrophages (Mfap4+) that are tnf-α:GFP+ are much higher than numbers and proportions of microglia (4C4+) and neutrophils (Mpx+),
indicating that the main source of Tnf-α is the macrophages. Arrows indicate double-labelled cells and arrowheads indicate immune cells that are tnf-α:
GFP-. Single optical sections are shown; the proportion of macrophages that are tnf-α:GFP+ decreases over time, whereas the proportion of tnf-α:GFP+
microglial cells slightly increases (One-way ANOVA followed by Bonferroni post-test: F4,195= 376.3, **P < 0.01, *P < 0.05). c Quantification of the immune
cells after tnf-α gRNA injection shows that Tnf-α disruption leads to increased numbers of neutrophils (Mpx+) at 1 dpl but not at 2 dpl, whereas the
numbers of macrophages/microglia (mpeg1:GFP+) remains unchanged (Mann–Whitney U-test: *P < 0.05, ns indicates no significance). d qRT-PCR
indicates that tnf-α disruption leads to increased levels of il-1β mRNA at 2 dpl (t-tests: *P < 0.05). Lateral views of the injury site are shown; rostral is left.
Scale bars: 50 μm. Error bars indicate SEM
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Reduction of Il-1β levels rescues swimming in irf8 mutants. To
determine whether ll-1β inhibition also rescued recovery of
swimming function in irf8 mutants, we analysed touch-evoked
swimming distances. YVAD had no effect in unlesioned mutant
or wildtype animals and did not affect recovery in lesioned
wildtype animals (Fig. 7e). In contrast, YVAD-treatment rescued
the touch-evoked swimming distance in irf8mutants to levels that
were indistinguishable from wildtype lesioned or unlesioned
animals (Fig. 7e). Mean velocity and path shape (meandering)
were also rescued (Supplementary Fig. 10I, J). These observations
indicate that inhibition of Il-1β alone restores most axonal
regeneration and recovery of touch-evoked swimming parameters
in the absence of macrophages.
Neutrophils are a major source of il-1β. To understand il-1β
regulation, we determined the source of Il-1β in wildtype and irf8
mutants. Using Il-1β immunohistochemistry and a transgenic
reporter line (il-1β:GFP), we found expression in microglia,
macrophages, neutrophils and basal keratinocytes in the injury
site (Fig. 8c, d; Supplementary 12A). Neuronal labelling
(HuC/D+) did not overlap with il-1β:GFP labelling (Supple-
mentary Fig. 12B). While numbers of il-1β:GFP+ immune cells
did not change significantly between 1 and 2 dpl, the percentage
of macrophages (from 50.6 to 34.3%) and neutrophils that were
labelled for the il-1β:GFP transgene were reduced (from 53.3 to
23.7%), likely reflecting resolution of inflammation (Supplemen-
tary Fig. 12A).
In irf8 mutants, detection of il-1β mRNA by qRT-PCR and
in situ hybridisation confirmed increased levels at 2 dpl, but not 1
dpl (Fig. 8a, b), despite lack of il-1β expressing microglia and
macrophages. Instead, we observed increased numbers of Il-1β+
neutrophils (by 97%) and basal keratinocytes (by 58%) compared
to wildtype animals at 1 dpl (Fig. 8c, d). Importantly, the
proportion of neutrophils that were Il-1β+ was also increased
from 33.6% in wildtype animals to 49% in the irf8 mutant at 1
dpl. This demonstrates that neutrophils are more likely to express
il-1β in the absence of macrophages.
Increased numbers of Il-1β+ neutrophils in irf8 mutants
could, at least in part, be due to higher overall numbers of
neutrophils in the injury site. We found a peak of neutrophil
numbers in the lesion site of irf8 mutants at 2 hpl, as in wildtype
animals (Fig. 9a). However, the number of neutrophils was 27%
higher than in wildtype, potentially due to the higher abundance
of this cell type in the irf8 mutant18. While neutrophil
numbers declined over time in wildtype and irf8 mutants, they
did so more slowly in irf8 mutants. At 24 hpl, twice, and at 48
hpl, three times the number of neutrophils as in wildtype
animals remained in the mutant. Hence, macrophages control
number of and cytokine expression by neutrophils32, leading to
prolonged presence of Il-1β+ neutrophils in the injury site of
irf8 mutants.
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Fig. 8 Levels of il-1β expression are increased in the injury site of irf8 mutants. a At 1 dpl, expression levels of il-1β are comparable between irf8 mutants and
wildtype (Wt) animals but are higher in the mutant at 2 dpl in qRT-PCR (t-test: **P < 0.01, ns indicates no significance). b In situ hybridisation confirms
increased expression of il-1β mRNA at 2 dpl. c In the injury site, the number and proportion of neutrophils (Mpx+) that are Il-1β immuno-positive (arrows)
are increased in irf8 mutants at 1 dpl compared to wildtype animals. d The number of basal keratinocytes (Tp63+) that are Il-1β immuno-positive is
increased in irf8 mutants. Single optical sections are shown; boxed areas are shown in higher magnifications (t-test: *P < 0.05, **P < 0.01). Lateral views of
the injury site are shown; rostral is left. Scale bars: 100 μm in b, c, d and 50 µm for higher magnification areas. Error bars indicate SEM
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Neutrophils inhibit regeneration in irf8 mutants. To determine
the relative importance of the neutrophils for regenerative failure
in irf8 mutants, we reduced their numbers using pu.1/gcsfr
morpholino treatment. This strongly reduced numbers of neu-
trophils by 84.6% in the injury site at 2 hpl, when the neutrophil
reaction peaked in untreated irf8 mutants (Fig. 9b). pu.1/gcsfr
morpholino treatment also reduced il-1β mRNA levels by 54%
and tnf-α mRNA levels by 70% at 2 dpl (Fig. 9c). Remarkably,
axon bridging (control: 43% of examined animals showed brid-
ging; pu.1/gcsfr morpholino: 60%; Fig. 9d) and recovery of touch-
evoked swimming distance were partially rescued in these
neutrophil-depleted mutants at 2 dpl (Fig. 9e). This shows that in
the absence of macrophages, the prolonged presence of Il-1β+
neutrophils is detrimental to regeneration.
Discussion
We identify a biphasic role of the innate immune response for
axonal bridging of the non-neural lesion site in larval zebrafish.
Initial inflammation and Il-1β presence promote axon bridging,
whereas later, Il-1β levels need to be tightly controlled by per-
ipheral macrophages. Inhibiting Il-1β largely compensated for the
absence of macrophages, underscoring the central role of this
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Fig. 9 Preventing neutrophil formation partially rescues functional spinal cord regeneration in the irf8 mutant. a In irf8 mutants, higher peak numbers of
neutrophils (Mpx+) at 2 hpl and slower clearance over the course of regeneration are observed (Two-Way ANOVA followed by Bonferroni multiple
comparisons: F8,427= 13.19 *P < 0.05, **P < 0.01, ***P < 0.001). Note that wildtype data are the same as shown in Fig. 1a, as counts in irf8 mutants and
wildtype animals were done in the same experiments. b Combination treatment with pu.1 and gcsfr morpholinos efficiently prevents neutrophil
accumulation in the lesion site (Mann–Whitney U-test: ***P < 0.001). c In pu.1/gcsfr morpholino injected irf8 mutant fish, levels of il-1β and tnf-α mRNA
expression are reduced at 2 dpl, as shown by qRT-PCR (t-test: ***P < 0.001). d, e In pu.1/gcsfr morpholino injected irf8 mutant fish, axonal bridging (arrows,
d Fisher’s exact test: **P < 0.01) and behavioural recovery (e One-Way ANOVA followed by Bonferroni multiple comparisons: F5,142= 23.21, **P < 0.01, ns
indicates no significance) are partially rescued. Lateral views of the injury site are shown; rostral is left. Scale bars: 100 μm. Error bars indicate SEM
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partially by reducing neutrophil number and il-1β levels (sum-
marised in Supplementary Fig. 13). This indicates important and
highly dynamic functions of the immune system for successful
spinal cord regeneration.
The function of the immune system changes dramatically over
time. Within the first hours after injury, neutrophils and the pro-
inflammatory cytokines il-1β and tnf-α dominate the injury site.
Initially, inflammation promotes axonal growth. This is indicated
by reducing effects on axon bridging of early Il-1β inhibition and
the promoting effect of LPS in wildtype animals. Indeed, it has
been reported that Il-1β can promote neurite growth33,34. How-
ever, from about 12 hpl, macrophages and anti-inflammatory
cytokines are in the lesion site and during this late phase of
regeneration, Il-1β mediated inflammation in macrophage-less
mutants strongly inhibits regeneration.
How does Il-1β inhibit spinal cord regeneration? High Il-1β
levels may condition the environment to be inhibitory to axonal
regrowth. Blocking excessive Il-1β signalling in irf8 mutants
revealed that Il-1β increases numbers of neutrophils, levels of il-
1β and tnf-α expression, as well as cell death in the lesion
environment. Morevover, reduced expression of some metallo-
proteinases in the irf8 mutant suggest that the lesion site ECM
may be altered. However, several ECM components, including
functionally important Col XII1, were unaltered in expression in
the irf8 mutant. Similar to our observations, an Il-1β deficient
mouse showed slightly increased axonal regrowth after spinal
injury35.
Axonal regeneration is promoted by Tnf-α. Even though il-1β
and tnf-α were similarly upregulated in the irf8 mutant, only
reducing Il-1β levels rescued the mutant. Conversely, in wildtype
animals, Il-1β had only a relatively small promoting effect on
early regeneration, whereas Tnf-α was indispensable for axonal
regrowth. Different functions for the two pro-inflammatory
cytokines have been reported36. They also differ in cell type of
origin. Whereas Il-1β is expressed by a substantial proportion of
neutrophils, microglia and macrophages, Tnf-α is mainly
expressed by macrophages in the injury site. This indicates a clear
difference between tissue-resident microglia and peripheral
macrophages. In mammals, tnf-α is produced by both microglia
and macrophages37.
Tnf-αmay exert its positive role for regeneration at least in part
by controlling neutrophil numbers and Il-1β levels. Both of these
parameters are increased when Tnf-α is inhibited and are inhi-
bitory to regeneration. Anti-inflammatory actions of Tnf-α have
been described in the context of auto-immunity38, but whether
this interaction between Tnf-α and Il-1β is direct or indirect,
needs to be elucidated. For example, Tnf-α can be neuroprotec-
tive after CNS injury36,39 and thus indirectly reduce inflamma-
tion. In the regenerating fin, Tnf-α has an important promoting
function for blastema formation40. This suggests that Tnf-α may
be involved in remodelling repair cells in the lesion site after
spinal injury, which then creates an axon growth-promoting
environment.
The role of Tnf-α for axonal regeneration in mammals is not
clear. Some reports indicate axon growth promoting properties of
Tnf-α41,42, whereas others show inhibition of axon growth43.
Negative effects of Tnf-α on lesion-induced cell death44 and
functional recovery37,45 have also been reported. However, knock
out of Tnf-α had no reported effect after spinal injury46.
Preventing neutrophil formation in irf8 mutants, indicates that
il-1β expressing neutrophils are major mediators of the inhibitory
immune response in the absence of microglia and macrophages.
However, the rescue of axon regrowth and swimming function
was only partial. This could be explained by the absence of the
early regeneration-promoting influence of the inflammation or
basal keratinocytes still expressing il-1β in neutrophil-depleted
irf8 mutants. In mammals, neutrophils cause secondary cell
death47,48 and depleting neutrophils leads to favourable injury
outcomes5, similar to our observations.
Macrophages control inflammation, as their absence in irf8
mutants leads to abnormally high expression levels of pro-
inflammatory cytokines il-1β and tnf-α. This is similar to obser-
vations in fin regeneration49. In the absence of macrophages,
positive feedback regulation of il-1β takes place, as indicated by
more il-1β positive neutrophils and basal keratinocytes in the irf8
mutants and reduced il-1β mRNA levels when Il-1β function was
inhibited. Moreover, a higher proportion of neutrophils were Il-
1β+ in irf8 mutants, showing that without macrophages, neu-
trophils have a more pro-inflammatory phenotype. We show that
macrophages/microglia, together with other tissues, express anti-
inflammatory cytokines tgf-β1a and tgf-β3 and could thus be
partly responsible for reducing pro-inflammatory phenotypes in
wildtype animals.
Macrophages do not promote regeneration primarily by pre-
venting cell death or removing debris. We observed phagocy-
tosing macrophages by time-lapse imaging and debris levels were
clearly increased it the absence of macrophages in irf8 mutants.
However, when axon regrowth was rescued in the mutant by Il-1β
inhibition, debris levels were still higher than in controls. Pre-
venting cell death did not rescue axon growth and inhibition
phagocytosis in wildtype animals did not impair regeneration.
Hence, regenerative success does not correlate with debris
abundance. Interestingly, in fin regeneration, lack of macrophages
also leads to increased cell death. As this leads to death of tissue
progenitor cells, fin regeneration is inhibited49. In mammalian
spinal injury, debris, especially myelin debris, is inhibitory to
regeneration50.
Are macrophages the most important immune cell type for
axonal regrowth? Unimpaired axonal regrowth in the csfr1a/b
mutant, in which microglial cells are absent and neutrophils are
strongly reduced in number, indicates that these cells may be
dispensable for regeneration. However, the increase in peripheral
macrophages in this mutant could have compensated for a pos-
sible regeneration-promoting role of microglia. Since some neu-
trophils are still present in the injury site in csfr1a/b mutants,
these might contribute to promoting axonal regrowth.
Endothelial cells and myelinating cells are unlikely to be major
mediators of early regeneration in larval spinal cord regeneration.
Endothelial cells from injured blood vessels were slow to reform
blood vessels and were rarely invading the lesion site. In contrast,
in mammals endothelial cells accumulate in the injury site, where
they may have anti-inflammatory functions51. Myelinating cells
bridged the lesion site, but were not abundant and only did so,
when axons had already crossed the lesion site. Although rela-
tively late, axons become remyelinated, which may contribute to
recovery of some swimming parameters after injury. In mammals,
transplanted myelinating cells, such as olfactory ensheathing cells
and Schwann cells have been shown to improve recovery after
spinal injury52,53.
Astroglia-like processes cross the injury site and this depends on
the immune response, as we show here. While these processes cross
the injury site independently of and slightly later than axons and
axons still cross when these cells are ablated1, astroglia-like pro-
cesses produce growth factors that support axonal regeneration54,55.
Timing of the immune response is crucial for regenerative
success after spinal lesion. Macrophages in mammals3,37 and
zebrafish56 display pro-inflammatory and anti-inflammatory
phenotypes and the anti-inflammatory phenotypes are seen as
beneficial for regeneration7–9. We show that inflammation is
rapidly downregulated in zebrafish concurrent with the upregu-
lation of anti-inflammatory cytokines, which does not readily
occur in mammals3.
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In summary, we have established an accessible in vivo system to
study complex interactions of immune cells and a spinal injury site
in successful regeneration. This allows fundamental insight into the
role of immune cells that may ultimately inform non-regenerating
systems. Here, we demonstrate a pivotal role of macrophages in
promoting functional spinal cord regeneration, by producing Tnf-α
and controlling Il-1β-mediated inflammation.
Methods
Animals. All zebrafish lines were kept and raised under standard conditions57 and
all experiments were approved by the British Home Office (project license no.: 70/
8805). Regeneration proceeds within 48 h of the lesion, therefore most analyses of
axonal regrowth, cellular repair, and behavioural recovery can be performed before
the fish are protected under the A(SP)A 1986, reducing the number of animals used
in regeneration studies following the principles of the 3 rs. Approximately 11,000
larvae of either sex were used for this study, of which 8% were over 5 dpf.
The following lines were used: WIK wild type zebrafish, Tg(Xla.Tubb:DsRed)
zf14826, abbreviated as Xla.Tubb:DsRed58; Tg(mpeg1:EGFP)gl22, abbreviated as
mpeg1:GFP59, and Tg(mpx:GFP)uwm1, abbreviated as mpx:GFP60, Tg(fli1:EGFP)y1,
abbreviated as fli1:GFP61; irf8st95/st95, abbreviated as irf8mutants18; csf1raj4e1/j4e1 ×
csf1rb+/re01 incrosses, phenotypically sorted for absence of 4C4+ cells in the head,
abbreviated as csfr1a/b mutants19; TgBAC(pdgfrb:Gal4FF)ncv24; Tg(UAS:GFP),
abbreviated as pdgfrb:GFP62,Tg(6xTCF/LefminiP:2dGFP), abbreviated as 6xTCF:
dGFP63, Tg(claudin k:Gal4)ue101; Tg(14xUAS:GFP) abbreviated as cldnK:GFP64, Tg
(tnfa:eGFP-F)sa43296, abbreviated as tnf-α:GFP56 and Tg(il-1β:eGFP)sh445,
abbreviated as il-1β:GFP65.
Drug treatment. Dexamethasone (Dex) (Sigma, Gillingham, UK) was dissolved in
DMSO to a stock concentration of 5 mM. The working concentration was 10 μM
prepared by dilution from stock solution in fish water. Ac-YVAD-cmk (YVAD)
(Sigma) was dissolved in DMSO to a stock concentration of 10 mM. The working
concentration was 50 μM prepared by dilution from the stock solution in fish
water. Q-VD-OPh (Sigma), abbreviated as QVD in the manuscript, was dissolved
in DMSO to a stock concentration of 10 mM. The working concentration was 50
μM. O-Phospho-L-serine (L-SOP) (Sigma) was dissolved in PBS to a stock con-
centration of 10 mM. The working concentration was 10 μM prepared by dilution
from stock solution. Lipopolysaccharides from Escherichia coli O55:B5 (LPS,
Sigma) were dissolved in PBS to a stock concentration of 1 mg/ml. The working
dilution was 50 μg/ml. Pomalidomide (Cayman Chemicals, Michigan, USA) was
diluted in DMSO at a stock concentration of 10 mg/ml. For the treatments, 6.9 μl of
the stock where diluted in 1.5 ml of fish water. Larvae were pre-treated for 2 h
before the injury and were incubated for 24 and 48 hpl. Larvae were collected from
the breeding tanks and were randomly divided into Petri dishes at a density of
maximally 30 larvae per dish, but no formal randomisation method was used. For
most drug treatments, larvae were incubated with the drug from 3 dpl until 5 dpl, if
not indicated differently.
Spinal cord lesions. Zebrafish larvae at 3 dpf were anaesthetised in PBS containing
0.02% aminobenzoic-acid-ethyl methyl-ester (MS222, Sigma), as described1. Larvae
were transferred to an agarose-coated petri dish. Following removal of excess water,
the larvae were placed in a lateral position, and the tip of a sharp 30 ½ G syringe
needle was used to inflict a stab injury or a dorsal incision on the dorsal part of the
trunk at the level of the 15th myotome.
Behavioural analysis. Behavioural analysis was performed as previously descri-
bed14. Briefly, lesioned and unlesioned larvae were touched caudal to the lesion site
using a glass capillary. The swim distance of their escape response, the mean
velocity and the meandering were recorded for 15 s after touch and analyzed using
a Noldus behaviour analysis setup (EthoVision version 7). Data given is averaged
from triplicate measures per fish. Between repeated measures, the larvae were left to
recover for 1 min. The observer was blinded to the treatment during the beha-
vioural assay. The assay was performed on five independent clutches in order to
assess the behavioural recovery in the irf8 mutants and three independent clutches
after the YVAD treatment.
Fluorescence-activated cell sorting. Macrophages and microglia were isolated
from 4 dpf transgenic mpeg1:eGFP embryos by FACS. For this purpose, about 500
fish were lesioned by transecting the spinal cord. Trunk-containing lesion site were
dissected and collected at 24 hpl and used for cell dissociation66. Cells purified after
FACS were used for qRT-PCR.
Quantitative RT-PCR. RNA was isolated from the injury sites of the larvae using
the RNeasy Mini Kit (Qiagen, Hilden, Germany). Forty larvae were used for each
condition. cDNA used as template was created using the iScript™ cDNA Synthesis
Kit (Bio-Rad, Munich, Germany). Standard RT-PCR was performed using SYBR
Green Master Mix (Bio-Rad). qRT-PCR was performed at 58 °C using Roche Light
Cycler 96 (Roche Diagnostics, West Sussex, UK) and relative mRNA levels
determined using the Roche Light Cycler 96 SW1 software. Samples were run in
duplicates and expression levels were normalised to β-actin control. Primers were
designed to span an exon-exon junction using Primer-BLAST. Sequences are given
in supplementary Table 2. All experiments were carried out at least as biological
triplicates.
In situ hybridisation. For whole mount in situ hybridisation1, after fixation in 4%
PFA, larvae were digested with 40 μg/ml Proteinase K (Invitrogen, Carlsbad, USA).
Thereafter, larvae were washed briefly in PBT and were re-fixed for 20 min in 4%
PFA followed by washes in PBT. After washes, larvae were incubated at 67 °C for 2
h in pre-warmed hybridisation buffer. Hybridisation buffer was replaced with
digoxigenin (DIG) labelled ISH probes diluted in hybridisation buffer and incu-
bated at 67 °C overnight. The next day, larvae were washed thoroughly at 67 °C
with hybridisation buffer, 50% 2× SSCT/50% deionized formamide, 2x SSCT and
0.2x SSCT. Larvae were then washed in PBT and incubated for 1 h in blocking
buffer under slow agitation. Thereafter, larvae were incubated overnight at 4 °C in
blocking buffer containing pre-absorbed anti-DIG antibody. The next day, larvae
were washed in PBT, followed by washes in staining buffer. Colour reaction was
performed by incubating larvae in staining buffer supplemented with NBT/BCIP
(Sigma-Aldrich) substrate. The staining reaction was terminated by washing larvae
in PBT.
Immunofluorescence. All incubations were performed at room temperature unless
stated otherwise. Antibodies used are listed in supplementary Table 3. For most
immunolabelling experiments, the larvae were fixed in 4% PFA-PBS containing 1%
DMSO at 4 °C overnight. After washes in PBS, larvae were washed in PBTx. After
permeabilization by incubation in PBS containing 2 mg/ml Collagenase (Sigma) for
25 min larvae were washed in PBTx. They were then incubated in blocking buffer
for 2 h and incubated with primary antibody (1:50–1:500) diluted in blocking
buffer at 4 °C overnight. On the following day, larvae were washed times in PBTx,
followed by incubation with secondary antibody diluted in blocking buffer (1:300)
at 4 °C overnight. The next day, larvae were washed three times in PBTx and once
in PBS for 15 min each, before mounting in glycerol.
For whole mount immunostaining using primary antibodies from the same host
species (rabbit anti-Il-1β, rabbit anti-Mpx, rabbit anti-Tp63) the samples were
initially incubated with the first primary antibody at 4 °C overnight. After washes
with PBTx the samples were incubated with the conjugated first secondary
antibody overnight at 4 °C. Subsequently, samples were incubated with blocking
buffer for 1 h at RT in order to saturate open binding sites of the first primary
antibody. Next, the samples were incubated with unconjugated Fab antibody
against the host species of the primary antibody in order to cover the IgG sites of
the first primary antibody, so that the second secondary antibody will not bind to
it. After this, samples were incubated with the second primary antibody overnight
at 4 °C and subsequently with the second conjugated secondary antibody overnight
at 4 °C before mounting in glycerol. No signal was detected when the second
primary antibody was omitted, indicating specificity of the consecutive
immunolabeling protocol.
For whole mount immunostaining of acetylated tubulin1, larvae were fixed in
4% PFA for 1 h and then were dehydrated and transferred to 100% MeOH and
then stored at −20 °C overnight. The next day, head and tail were removed, and the
samples were incubated in pre-chilled Acetone. Thereafter, larvae were washed and
digested with Proteinase K and re-fixed in 4% PFA. After washes the larvae were
incubated with BSA in PBTx for 1 h. Subsequently the larvae were incubated for 2
overnights with primary antibody (acetylated tubulin). After washes and
incubation with the secondary antibody the samples were washed in PBS for 15
min each, before mounting in glycerol.
Evaluation of cell death using acridine orange. In order to assess the levels of cell
death after injury we used the acridine orange live staining as described by others67.
Briefly, at 1 and 2 dpl the larvae were incubated in 2.5 μg/ml solution of dye diluted
into conditioned water for 20 min. After the staining, the larvae were washed by
changing the water and larvae were live-mounted for imaging.
Identification of dying cells after injury. In order to assess the levels of cell death
after injury cross sections of larvae were used. Larvae were fixed in 4% PFA
overnight at 4 °C. After washes with 0.5% PBSTx, the larvae were transferred to
100% methanol and incubated for 10 min at room temperature. After rehydration,
the larvae were washed with PBSTx 0.5%. Following this, larvae were mounted in
4% agarose and 50 μm sections were performed using a vibratome (MICROM HM
650 V, VWR, Leicestershire, UK). The sections were then permeabilized using 14
μg/ml diluted in 0.5% PBSTx. After brief wash with PBSTx the sections were
postfixed in 4% PFA for 20 min. Excess PFA was washed out and the samples were
incubated with the TUNEL reaction mix according to the In-situ Cell Death
Detection Kit TMR red protocol (Roche).
Western blotting. Zebrafish larvae were sacrificed by an overdose of MS-222 at 4
dpf and used for protein extraction. Around 60 fish per condition were homo-
genised in 250 µl of 1x PBS/1% Triton X-100 (containing protease inhibitor
cocktail complete, Roche Diagnostics), using a tissue grinder. After 1 h incubation
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at 4 degrees, lysates were centrifuged at 12,000 rpm for 20 mins to remove Triton-
X-100-insoluble debris. Protein concentrations were quantified using a BCA assay
following manufacturer’s instruction and the same amount of protein for each
sample was loaded on a denaturating 12% acrylamide gel. After the electrophoretic
run, the proteins were transferred on a nitrocellulose membrane (BioRad, Ger-
many) and, after 1 h blocking in PBS/5% non-fat dry milk/0.1% Tween-20, probed
with either rabbit anti-TNFα (1:2000, Anaspec; Fremont, CA), rabbit anti IL-1
(1:200, Proteintech, Manchester, UK) or mouse anti-α Tubulin (1:2000, DSHB) O/
N at 4 degrees. Goat anti-rabbit (IRdye680LT, LI-COR, Lincoln, Nebraska, USA)
and goat anti-mouse (IRdye800CW, LI-COR) secondary antibodies were used and
the signal was detected by an Odyssey (LI-COR) imaging system and analysed with
the Image Studio Lite software version 5.2.
Morpholino injection. All morpholinos were injected into single cell stage larvae in
total volume of 2 nl. Knockdown of il-1β was carried out using the antisense
morpholino against il-1β (5ʹ-CCCACAAACTGCAAAATATCAGCTT-3ʹ), target-
ing the splice site between intron 2 and exon 3 according to31. In order to block
neutrophil development, we used the previously described MO combination of pu.1
(5′-GATATACTGATACTCCATTGGTGGT-3′) which targets the translational
start (ATG) of the pu.1 and the splice blocking MO against gcsfr (5′-
TTTGTCTTTACAGATCCGCCAGTTC-3′)16. All morpholinos and standard
control (5′-CCTCTTACCTCAGTTACAATTTATA-3′) were obtained from Gene
Tools, LLC, Oregon, USA.
CRISPR-mediated genome editing. CRISPR gRNA for il-1β was designed using
CRISPR Design (http://crispr.mit.edu) and ZiFit (http://zifit.partners.org/ZiFiT)
webtools. Vectors were generated by ligating the annealed oligonucleotides into the
pT7-gRNA expression vector1. The gRNA was transcribed using the mMESSAGE
mMACHINE T7 kit (Ambion, ThermoFisher SCIENTIFIC, Loughborough, UK)
and assessed for size and quality on an electrophoresis gel. The injection mix
consisted of 75 pg il-1β gRNA (target sequence: 5′-TGTGGAGCGGAGCCT
TCGGCGGG-3′) and 150 pg Cas9 RNA and was injected into single cell stage
larvae. The CrRNA for tnf-α (target sequence: 5′-CCCGATGATGGCATTTA
TTTTGT-3′) and the tracrRNA were ordered from Merck KGaA (Germany,
Darmstadt). The injection mix included 1 μl Tracer 250 ng/μl, 1 μl gRNA, 1 μl Cas9
protein, 1 μl RNAse free H20, 1 μl fluorescent dextran. Larvae injected with GFP
gRNA (target sequence: 5′GGCGAGGGCGATGCCACCTA-3) and uninjected
larvae were used as controls. The efficiency of the mutagenesis was assessed by
RFLP analysis.
Live imaging of zebrafish larvae and time-lapse imaging. For the acquisition of
all fluorescent images, LSM 710 and LSM 880 confocal microscopes were used. For
live confocal imaging, zebrafish larvae were anesthetized in PBS containing 0.02%
MS222 and mounted in 1.5% low melting point agarose (Ultra-PureTM, Invitro-
gen). During imaging, the larvae were covered with 0.01% MS222-containing fish
water to keep preparations from drying out. For time-lapse imaging, agarose
covering the lesion site was gently removed after gelation. Time-lapse imaging was
performed for 19 h starting at 6 hpl. Acquired time-lapse images were denoised
using the ImageJ plugin CANDLE-J algorithm. Comparison of raw movies with
CANDLE-J-processed movies showed that edges of features remained conserved
after denoising.
Scoring and measurement of spinal cord bridging. Axonal and astroglial brid-
ging was scored in fixed and live mounted samples using fluorescence-equipped
stereomicroscope (Leica MDG41) and confocal microscopes (LSM 710, LSM 880)
at time points of interest as previously described1. Any continuity of labelling
between the two spinal cord stumps was scored as “bridged”. In some cases, the
thickness of the axonal bridge was measured in collapsed confocal image stacks, by
determining the length of (a) vertical line(s) that covers the width of crossing
fascicles at the centre of the injury site. The observer was blinded to the experi-
mental condition before scoring or measuring and experiments were performed
blinded to the experimental condition on at least three independent clutches of
larvae.
Cell counting in whole-mounted larvae. A volume of interest was defined centred
on the lesion site from confocal images. The dimensions were: width= 200 μm,
height= 75 μm (above the notochord), depth= 50 μm. Images were analysed using
the Imaris (Bitplane, Belfast, UK) or ImageJ software. The number of cells was
quantified manually in 3D view, blinded to the experimental condition on at least
three independent clutches of larvae.
Quantification of diffuse signals in whole-mount larvae. For most quantifica-
tions of diffuse signal, e.g., acridine orange, image stacks, centred in the lesion site
(height: 50 µm) were collapsed and an area of interest defined: width= 100 μm,
height= 50 μm (above the notochord). The image was thresholded and the
‘’Analyze Particles” tool in Fiji with default settings was used to calculate the
percentage of area taken up by signal.
To quantify Col I and Tnf-α in the injury site (Supplementary Figs 4C and 9A)
we used a previously published protocol1. Briefly, image stacks were collapsed,
thresholded and the area of the signal was measured.
All analyses were performed blinded to the experimental condition on at least
three independent clutches of larvae.
Statistical analysis. Power analysis using G*Power68, was used to calculate power
(aim > 0.8) for the experiments and determine the group sizes accordingly. Sta-
tistical power was >0.8 for all experiments. All quantitative data were tested for
normality and analyzed with parametric and non-parametric tests as appropriate.
The statistical analysis was performed using IBM SPSS Statistics 23.0. Shapiro-
Wilk’s W-test was used in order to assess the normality of the data. Quantitative
RT-PCR data were analyzed as previously described69,70. Kruskal–Wallis test fol-
lowed by Dunn’s multiple comparisons, One-way ANOVA followed by Bonferroni
multiple comparisons test, two-way ANOVA, followed by Bonferroni multiple
comparisons, t-test, Mann–Whitney U-test or Fischer’s exact test were used, as
indicated in the figure legends. *P < 0.05, **P < 0.01, ***P < 0.001, n.s. indicates no
significance. Error bars indicate the standard error of the mean (SEM). The Figures
were prepared with Adobe Photoshop CC and Adobe Illustrator CC. Graphs were
generated using GraphPad Prism 7.
Data availability
The authors declare that all data supporting the findings of this study are available
within the article and its supplementary information files, or from the corre-
sponding authors on reasonable request.
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